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ABSTRACT	
 
Synthesis of Functional 1,2,3-Triazoles and Its Applications in 
Transition Metal Catalysis 
Wuming Yan 
 
Several new methodologies for synthesizing functional 1,2,3-triazoles which include 
arylation, vinylation, propargylation and allenation, have been successfully developed. 
These resulting new methods are of great benefit to the organic chemists who are 
working on the research fields related to 1,2,3-triazoles. Particularly, the iron catalyzed 
propargylation and allenation have initiated the iron chemistry with 1,2,3-triazoles as the 
ligand. For example, our efforts led to the discovery of a practical approach for the 
synthesis of conjugated enynes that is challenging through conventional methods. In the 
synthesis of conjugated enyne, 1,2,3-triazoles were revealed as the only ligand effectively 
promoting this important and challenging transformation (gave up to 95% yields). Other 
tested N-heterocycles, including the 1,2,4-triazole, tetrazole, and pyridine, all gave poor 
results (< 10%) even with similar binding pattern, which demonstrating the unique role of 
1,2,3-triazole in iron catalysis. 
In addition, the complexes [Ir(L^X)(ArTriaz)2] and [Ir(bbpy)(ArTriaz)2]Cl have 
been successfully prepared through N-2-aryl-1,2,3-triazoles as the efficient binding 
ligands in coordination with iridium salt in excellent yields. These air and moisture stable 
Ir(III) complexes showed effective catalytic reactivity in photoredox catalysis. 
The N-2-aryl-1,2,3-triazole derivatives (NATs) were developed as a new class of 
UV/blue-light-emitting fluorophores. Though both N-1-aryl-1,2,3-triazoles and N-2-aryl-
1,2,3-triazoles gave strong photo absorption under excitation at 330 nm, only the N-2-
analogous showed strong fluorescence emission in the UV/blue range with high 
efficiency in various solvents. The computational studies along with X-ray crystal 
structures indicated the significance of the effective conjugation between triazole ring 
and aryl groups on the N-2 position. The planar intramolecular charge transfer (PICT) 
mechanism was proposed, which was supported by solvent effect studies. 
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1 
Chapter One: Synthesis of functional 1,2,3-triazoles 
1.1 Introduction 
1.1.1 Synthesis of precursor: NH-1,2,3-triazole 
The 1,3-dipolar cycloaddition reaction between two unsaturated reactants gave an access 
to various five-membered heterocycles, which was developed by Huisgen in the early 
1960’s.1 The cycloaddition of acetylenes and azides to synthesize 1,2,3-triazoles is by far 
the most useful member of this family. However, the 1,3-dipolar cycloaddition of 
terminal alkynes and organic azides afforded the 1,2,3-triazole as the mixture of 1,4-
adduct and 1,5-adduct under thermal conditions (Scheme 1), 2  since the activation 
energies for the formation of both adducts were very close in this concerted process based 
on the mechanism study. In addition, the 1,4-adduct can be obtained only if the acetylene 
component is attached to an electron-withdrawing group (EWG), such as a carbonyl or 
cyano group (CN).3 However, these reactions usually required long reaction time and 
high temperature as alkynes are poor 1,3-dipole receptors.4 
Scheme 1: Thermal 1,3-dipolar cycloaddition of acetylenes and azides. 
 
To avoid these disadvantages of Huisgen azide-alkyne cycloaddition, Sharpless and 
co-workers have successfully discovered that the cycloaddition reaction is dramatically 
accelerated in the presence of copper catalyst, to give the 1,4-disubstituted 1,2,3-triazoles 
with excellent regioselectivity and high efficiency (yields are > 95%).5 Furthermore, this 
2 
copper catalyzed azide-alkyne cycloaddition (CuAAC), which is referred to as “click 
chemistry”, was well tolerant to various other functional groups and can be performed in 
various organic solvents, and water with a variety of (partially) miscible organic solvents, 
including DMSO, DMF, tBuOH and acetone (Scheme 2).  
Scheme 2: The synthesis of 1,4-disubstituted 1,2,3-triaozles by Click chemistry. 
 
Although several Cu(I) sources can be used directly in this process, such as 
copper(I) bromide (CuBr) or copper(I) iodide (CuI), the catalyst was better prepared in 
situ by the reduction of Cu(II) salts (e.g. CuSO4) with reductants such as sodium 
ascorbate or ascorbic acid (Scheme 3). This transformation exhibited a broad substrate 
scope and produced the 1,4-disubstituted 1,2,3-triaozles in good to excellent yields with 
near perfect regioselectivity. 
Scheme 3: Example of CuAAC reported by Shapless. 
 
The reaction mechanism has been investigated using density functional theory 
calculations (DFT).6 The copper(I) species generated in situ formed a -complex with the 
triple bond of a terminal alkyne. In the presence of a base, the terminal hydrogen, being 
the most acidic was deprotonated first to give a Cu(I) acetylide intermediate (therefore 
3 
indicated why internal alkynes failed to react by this process). Studies have shown that 
the transition state involved two copper atoms. One copper atom was bonded to the 
acetylide while the other Cu atom served to activate the azide. The metal center 
coordinated with the electrons on the nitrogen atom. The azide and the acetylide were not 
coordinated to the same Cu atom in this case. The ligands employed were labile and 
weakly coordinating. The azide displaced one ligand to generate a copper-azide-acetylide 
complex (CuAAC). At this point cyclization took place and followed by protonation; the 
source of proton being the hydrogen which was pulled off from the terminal acetylene by 
the base. The product was formed by dissociation of copper-azide-acetylide complex and 
the catalyst ligand complex was regenerated for further reaction cycles (Figure 1). 
Figure 1: Proposed reaction mechanism of “Click chemistry” 
 
Since the discovery of the CuAAC reaction in 2001, the 1,2,3-triazoles have been 
the subject of considerable research mainly due to their usefulness as the valuable 
synthetic intermediates in organic chemistry7 and also because of the important biological 
properties, which have found broad use in biology8 and medicinal chemistry.9 However, 
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despite being a very efficient method for the synthesis of N-substituted triazoles, one 
major limitation of the CuAAC was the lack of reactivity toward unsubstituted azides, 
such as NaN3 and HN3. Therefore, to prepare NH-1,2,3-triazoles by CuAAC, the organic 
azides were usually applied with removable N-protecting groups followed by the 
deprotection (Scheme 4).10 
Scheme 4: Synthesis of NH-1,2,3-triazoles through CuAAC. 
 
Besides the CuAAC approach, the 1,3-dipolar cycloaddition between -nitroalkene 
and sodium azide was considering another popular methodology for the synthesis of NH-
1,2,3-triazoles and was first reported by Zefirov in 1971.11 With DMSO as the solvent, 
the authors reported the formation of corresponding triazole at room temperature in 
roughly 60% yield along with “considerable quantities” of the corresponding byproduct 
1,3,5-triarylbenzene (Scheme 5). 
Scheme 5: The synthesis of NH-1,2,3-triazoles by Zefirov’s method. 
 
However, Zard and co-worker re-examined this reaction in 2005 and discovered the 
above result was not reproducible. 12 As a result, they figured out the optimal condition 
5 
which involved a slow addition of -nitroalkene to a hot solution of the excess amount of 
sodium azide (2-4 equiv.) at 80-90 oC (Scheme 6).  
Scheme 6: Thermal condensation of -nitroalkene and sodium azide (Zard’s method). 
 
Under the optimized condition, the NH-1,2,3-triazoles could be obtained in good to 
excellent yields (96% in one single case) with a very small amount of the byproduct 
1,3,5-triarylbenzene. However, the challenging access of the olefin precursor -
nitroalkene significantly limited the application of this reaction. 
Our group reported a Lewis base-catalyzed cascade nitroalkene-aldehyde-azide 
condensation for the synthesis of 4,5-disubstituted NH-1,2,3-triazoles in 2008 (Scheme 
7).13 More than 25 new NH-1,2,3-triazoles were prepared in good to excellent yields 
under mild conditions. The C-5 vinyl group of triazole can be readily converted into other 
functional groups. 
Scheme 7: Shi’s Approach: Lewis base-catalyzed cascade nitroalkene-aldehyde-azide 
condensation. 
 
The reaction mechanism was also investigated (Figure 2). The 1-aryl diene 
intermediate was produced by the Herny reaction of nitroalkene and aldehyde, and then 
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quenched by azide anion (N3-) to give cycloaddition product triazole with elimination of 
the nitro group (NO2-). 
Figure 2: Mechanism for synthesis of 4,5-disubstituted NH-1,2,3-triazoles. 
 
1.1.2 Our strategy: How to reach the N-2 substitution of NH-1,2,3-triazoles? 
To the best of our knowledge, the copper catalyzed azide-alkyne cycloaddition (CuAAC) 
gave N-1 substituted triazoles only (see section 1.1.1), due to the nature of azides. 
Alternatively, N-2 substituted triazoles may be accessed by the conversion of non-
substituted NH-triazoles with appropriate electrophiles. However, as we know, before 
2008, no effective strategy for regioselective N-2 substituted of 1,2,3-triazoles had been 
reported in the literature. 
With a strong dipole moment and high electron density on the nitrogens, the NH-
1,2,3-triazole could be a good nucleophile, which will react with electrophiles under 
suitable conditions. However, among the reported examples, 14  the N-1 substituted 
triazoles were the dominant products. This was caused by the higher electron density 
associated with two terminal nitrogens (N-1 and N-3) than the internal nitrogen (N-2). 
Therefore, regioselective N-2 substitution was a big challenge in triazole derivatization. 
To develop an efficient synthesis of N-2 substituted triazoles, our group has put 
numerous efforts and concluded successfully a strategy which was that the C-4 and C-5 
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substituent groups could deliver the necessary steric hindrance to provide N-2 as the 
preferred nucleophilic site (Figure 3). 
Figure 3: Strategy for selective N-2 substitution (two bulky groups on C-4 and C-5). 
N
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To evaluate the effectiveness of this strategy, our group has developed successfully 
the N-2 alkylation of NH-1,2,3-triaozles (Scheme 8).15 
Scheme 8: Synthesis of N-2-alkyl-1,2,3-triazoles. 
N
N
NH
R
Ph
K2CO3, Acetone, rt N
N
N
R
Ph
R'
+ R'X
R' = alkyl
22 examples
65-98% yield of N-2  
As reported in the paper, the N-2 alkylation reactions usually gave very less amount 
of N-3 substituted triazoles. From the crystal structures,*  the aryl group on the C-4 
position was nearly coplanar with the triazole ring. The N-3 position was then blocked 
for electrophilic addition (Figure 4). Surprisingly, the benzyl ketone triazole gave 
excellent N-2 selectivity and even formed only the N-2 product in some cases (Scheme 
9). Based on the conformational control analysis, the benzoyl group on C-5 position 
would like to be coplanar with the triazole ring to minimize the electronic repulsion 
                                                 
* Check the compounds 2a, N-1-3a, N-1-5a and N-2-4a in the supporting information of N-2 alkylation 
published paper (see ref. 15). 
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between the keto oxygen and the N-1 nitrogen (Figure 5). Therefore, the phenyl group 
effectively blocked the N-1 position. 
Figure 4: The C-4 aryl group was nearly coplanar with the triazole ring. 
N
N
N
Ph O
Aryl group adopts co-planar
conformation to block the N-3 position
 
Scheme 9: The alkylation of benzyl ketone triazole. 
 
Figure 5: Conformational control for selective N-2 substitution. 
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1.2 Efficient synthesis of N-2-aryl-1,2,3-triazole fluorophores via post-
triazole arylation† 
1.2.1 Reported method for synthesizing N-2-aryl-1,2,3-triazole 
One important class of triazole derivatives is the N-2-aryl triazoles, where the two 
aromatic rings adopt a coplanar conformation. With the characteristic electron density 
distribution in the HOMO and LUMO, these bis-aromatic compounds give unique 
photonic properties. One example is the commercially available o-hydroxyphenyl 
benzotriazoles (such as Tinuvin P), which has been applied as an efficient light absorber 
to prevent polymer degradation from light radiation.16 
Currently, the general approach for N-2-aryl triazole involves the hydrazine/-
hydoxyketone condensation, 17  as shown in Scheme 10. The need of various aryl 
hydrazines and -hydoxyketones as starting materials significantly limited the 
application of this methods and only specific N-2 aryl triazole can be prepared with good 
yields. Therefore, an effective regioselective N-2 arylation approach will be of great 
importance for the triazole related research.18 
Scheme 10: The hydrazine/-hydoxyketone condensation. 
 
                                                 
† Reproduced in parts with permission from Org. Lett. 2008, 10, 5389-5392. Copyright 
2008, with permission from the American Chemical Society. 
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1.2.2 Research Objective and Results 
Our group has recently reported the synthesis of 4,5-disubstituted-NH-traizoles through 
Lewis base catalyzed process.13 With these compounds in hand, we recently reported a 
successful post-triazole N-2 alkylation through substrate conformation control.15 
Encouraged by these results, we wondered if this strategy could be further extended to 
the regioselective N-2-arylation. 
Table 1: Post-triazole arylation via SNAr reactionsa 
N
N
N
R2
R1
Ar
N
N
N
R2
R1
H + Ar X
DMSO, 2 equiv K2CO3
1.2.2 1.2.3
N
N
N
R2
R1
N-1-1.2.3
Ar
1.2.1
3
2
1
N
N
N H
1.2.1a
N
N
N
Ph
H
H N
N
N
Ph
H
Ph N
N
N
Ph
H
Ph
O
1.2.1b 1.2.1c 1.2.1d
+
 
Entry Triazole Ar-X 
Temp 
(oC) 
Time 
(h) 
Convn 
(%)b 
Yield N-2 
:N-1  (%)c 
1 1.2.1a 
 
1.2.2a 
rt 2 100 1.2.3a: 92 1:3 
2 1.2.1b rt 2 100 1.2.3b: 90 1.7:1d 
3 1.2.1c rt 2 100 1.2.3c: 95 6:1 
4 1.2.1d rt 2 100 1.2.3d: 95 1:0 
5 1.2.1c 
 
1.2.2b: X = F; R = NO2 80 1 100 1.2.3e: 92 10:1 
6 1.2.1c 1.2.2c: X = Cl; R = NO2 80 30 90 1.2.3e: 85 10:1 
7 1.2.1c 1.2.2d: X = F; R = CN 80 30 66 1.2.3f: 62 10:1 
8 1.2.1c 1.2.2b: X = Cl; R = CN 80 30 0 - - 
a 1.2.1:1.2.2 = 1:1.5, c = 0.2 M; b based on the consumption of 1.2.1 by NMR; c isolated yields of all 
isomers; d structure of N-1-1.2.3b was determined by X-ray crystallography. 
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To evaluate the regioselectivity, the SNAr substitution was first studied with a 
variety of 1,2,3-triazoles. The results are summarized in Table 1. Due to the absence of 
C-N bond exchange under the reaction condition in the arylation products 1.2.3, the SNAr 
reaction provided direct measurement of C-4 and C-5 groups influence on the 
regioselectivity. As indicated in Table 1, the benzotriazole 1.2.1a gave modest selectivity 
with N-1 substituted triazole as the major product. On the other hand, the 4-phenyl 
triazole 1.2.1b improved the N-2 selectivity, giving N-2 arylation as the major product, 
though with poor selectivity. To our pleasure, the application of 4,5-disubstituted triazole 
1.2.1c and 1.2.1d gave N-2 arylation as the dominant products with excellent 
regioselectivity. As mentioned previously, the selectivity was driven by the conformation 
control of the C-4 and C-5 substitute groups. However, at higher temperature, the 
selectivity should be only driven by the steric effect. To our pleasure, increasing the 
reaction temperature (80 oC) gave improved N-2 selectivity (entry 5, 6 and 7), which 
suggested that the regioselectivity of post-triazole arylation could be achieved at higher 
temperature. Moreover, the less electron-deficient substrates were also suitable for this 
SNAr transformation to form the corresponding N-2 arylation products as dominate 
products (entries 5-7). Although the SNAr reaction of triazoles gave excellent N-2 
regioselectivity, it only worked with electron-deficient aromatic halide substrates. 
To extend the generality of N-2 arylation of 1,2,3-triazoles, we then explored the 
possible coupling strategy for aromatic systems with higher electron density. Numerous 
copper catalyzed N-aryl halide reactions have been reported in the last several years, but 
the reaction mechanism was not clear.19 The most likely mechanism involves a Cu(I) 
oxidative addition to Cu(III) intermediate followed by reductive elimination, which was 
12 
proposed by Buchwald, Hartwig and Stahl. 20  Hartwig also suggested that oxidative 
addition of the carbon halogen bond likely occurs in the catalytic cycles with strong 
ligand effects.20b Based on these remarkable results, we rationalized that NH-1,2,3-
triazole might be another good nitrogen source for copper mediated aryl halide amidation. 
With the focus on the ligand effect for optimal performance, reactions between NH-
triazole 1.2.1c and phenyl iodide 1.2.5a were then carried out (Table 2). 
Table 2: Screening reaction conditions for coupling with PhIa 
 
Entry Cu cat Ligandc Solvent Temp (oC) Time (h) Convn (%)d Yield (%)d
1 CuI - DMSO 110 24 low 0 
2 CuI proline DMSO 110 24 100 71 
3 CuCl proline DMSO 110 24 100 88 
4 otherb Cu cat. proline DMSO 110 24 <92 <79 
5 CuCl proline other solventsb 110 24 <85 <74 
6 CuCl proline DMSO w 160　  0.5 98 92 
7 CuCl glycine DMSO w 160　  0.5 trace trace 
8 CuCl Me-Gly DMSO w 160　  0.5 60 30 
9 CuCl DMG DMSO w 160　  0.5 98 86 
10 CuCl EDA DMSO w 160　  0.5 53 29 
11 CuCl DMEDA DMSO w 160　  0.5 70 47 
12 CuCl TMEDA DMSO w 160　  0.5 trace trace 
13 CuCl DACH DMSO w 160　  0.5 53 44 
a 1.2.1c:1.2.4a = 1:1.5, c = 0.2 M; b see supporting information; c Me-Gly: N-methyl glycine; DMG: N,N-
dimethyl glycine; EDA: ethyleneediamine; DMEDA: N,N-dimethylethylenediamine; TMEDA: N,N,N,N-
tetramethylethylenediamine; DACH: trans-diaminohexane; d Based on the 1H NMR with 1,3,5-
trimethoxybenzene as internal standard. 
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Among all the tested reactions, the coupling product 1.2.5a was not formed, if no 
ligands were applied. Different nitrogen containing ligands have been investigated in this 
Cu mediated amidation of NH-triazole, and we found proline was the best ligand for this 
transformation. To our satisfaction, excellent regioselectivity was received with N-2 
arylation as the dominant product. Both Cu(I) and Cu(II) could effectively catalyze this 
reaction (entries 2-4). Screening of the solvents gave DMSO as the solvent choice. 
Considering of its low cost, good reaction performance and easy handling, CuCl was 
selected as the catalyst for this reaction. The optimal reaction condition is shown in entry 
3. The use of microwave irradiation significantly shortened the reaction time form 24 
hours to 30 minutes. 
With the optimal reaction conditions, different NH-triazoles and aryl iodides were 
applied to evaluate the reaction substrate scope (Table 3). As shown in Table 3, 
benzotriazole 1.2.1a gave the N-1 arylation as the dominant product with only 8% N-2 
product isolated. The N-2 selectivity was increased while 4-phenyl substituted 1.2.1b was 
applied, giving 60% N-2 isomer with another 15% N-1 isomer and only trace amount of 
N-3 isomer. Significant difference was observed when 4,5-disubstituted triazoles were 
used, where, as expected, in all cases only N-2 isomers were isolated with excellent 
yields. The substrate scope of this transformation covered different substituted groups on 
C-5 position of triazoles and various aryl iodides with EDG, EWG and pyridine. Due to 
the diminished reactivity of aryl bromides in the oxidative addition, application of aryl 
bromides resulted in significant decrease in the reaction conversion and yield. Moreover, 
this copper mediated aryl halide amidation of 1,2,3-NH-triazoles did not work well with a 
heterocyclic halide, because of the chelating interaction between heterocyclic structure 
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and copper catalyst. Notably, the substrate 1.2.1j gave 45% of desired N-2 arylation 
product 1.2.5j and 40% of N-3-arylation product N-3-1.2.5j (structures were determined 
by X-ray diffraction), which suggested the Cu-chelation between the phenol oxygen and 
triazole-N-3 position. The production of the steric disfavored N-3 arylation product 
strongly supports the Cu(III) reductive elimination mechanism. 
Table 3: Substrate scope for Cu catalyzed triazole amidationa 
+ Ar
R1
N
NH
N
R2
1.2.1 1.2.4
I
10% CuCl, 20% proline
2 equiv K2CO3, DMSO, w 160 oC
R1
N
N
N
R2
Ar
1.2.5
R1
N
NH
N
Ph
1.2.1b: R1= H
1.2.1c: R1=
1.2.1d: R1=
1.2.1e: R1=Bn
1.2.1f: R1=
1.2.1g: R1=
Ph
O
OH
5
O
Ph Ph
N
NH
N
Ph
N
NH
NPh
1.2.1h
1.2.1i
N
NH
N
OH
1.2.1j  
 ArI yield (%)b  ArI yield (%)b 
1.2.1a 1.2.4a 1.2.5b:  8c 1.2.1f 1.2.4a 1.2.5f: 60 
1.2.1b 1.2.4a 1.2.5c: 68d 1.2.1g 1.2.4a 1.2.5g: 85 
1.2.1c 1.2.4a 1.2.5a: 87 1.2.1h 1.2.4a 1.2.5h: 87 
1.2.1d 1.2.4a 1.2.5d: 85e 1.2.1i 1.2.4a 1.2.5i: 80 
1.2.1e 1.2.4a 1.2.5e: 85 1.2.1j 1.2.4a 1.2.5j: 45e, f 
1.2.1c 
 
1.2.4b: R =  p-Me 1.2.5k: 86 
1.2.1c  1.2.4h 1.2.5r: 70 1.2.1d 1.2.4c: R = p-NO2 1.2.5l: 88 
1.2.1c 1.2.4d: R = p-OMe 1.2.5m: 74
1.2.1c
1.2.1d  
1.2.4i 
1.2.5s:70 
1.2.5t:60 
1.2.1i 1.2.4e: R = o-Me 1.2.5n: 70 
1.2.1c 1.2.4f: R = p-I 1.2.5o: 67e,g
1.2.1c 
1.2.1d  
1.2.4g 
1.2.5p: 88 
1.2.5q: 83e
1.2.1c
 
1.2.4j 1.2.5u: 70e 
a 1.2.1:1.2.4 = 1:1.5, c = 0.2 M; b Isolated yield; c N-1-1.2.5b 60% yield; d N-1-1.2.5c 11% yield. e Structure 
determined by X-ray crystallography. f N-3-1.2.5j 40% yield; g di-amidation product 1.2.5v was formed in 
10%. 
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The strong dependence on ligands of this transformation initiated our interest in 
evaluating trans-metallation as an alternative pathway to further extend the substrate 
scope, especially for heterocyclic substrates. Therefore, the trans-metallation reactions 
between triazoles 1.2.1c and phenyl boronic acid 1.2.6a were investigated. Excitingly, 
transmetallation indeed produced the desired N-2 arylation product. Further screening of 
reaction conditions revealed THF as the best solvent (see other conditions in supporting 
information) (Scheme 11). To achieve the efficient turnover of the copper catalyst, 
oxygen gas was required. 
Scheme 11: Copper catalyzed transmetalation between triazoles and boronic acids. 
 
Figure 6: Products from trans-metallation coupling with arylboronic acids. 
 
Reaction conditions: 1.2.1c:1.2.6 = 1:1.5, c = 0.1 M, THF, 0.2 equiv. Cu(OAc)2, 2 
equiv, pyridine, O2 1 atm, 50 oC, 24 h. 
                                                 
 Check the detail in Table 2 (entry 6-13). 
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With triazole 1.2.1c, the N-2 isomer was the only product isolated, while 1.2.1a and 
1.2.1b gave less than 40% N-2 isomers. We then focused on applying this strategy for the 
synthesis of N-2 aryl substrates that were difficult to be prepared from aryliodide 
amidation. The results are summarized in Figure 6. 
Finally, with a series of new N-2-aryl-1,2,3-triazoles in hand, the photonic 
properties which included UV absorption and fluorescence emission have evaluated. 
Besides the strong UV absorptions, the new triazole derivatives N-2-aryl-1,2,3-triazoles 
produced strong photonic luminescence and their emission pattern really depended on the 
substituted groups. 
Figure 7: Comparison of photonic luminescence of selected N-1 and N-2-aryl triazoles 
(1.2.5b and 1.2.5c): the sample was measured in CH3OH, c = 10 M; ex = 254 nm. 
 
The importance of fluorescence active molecules has been well documented in 
various research fields.21 As shown in the Figure 7, both N-2 phenyl 1,2,3-triazoles 
(1.2.5b and 1.2.5c) gave strong fluorescence emissions, while N-1 aryl analogues gave 
17 
weak emissions. These results suggested the N-2-aryl group is crucial for photonic 
emission. More importantly, the 4,5-disubstituted triazoles showed much stronger 
emission comparing to benzyl triazole derivatives (Figure 8). The N-2-aryl-1,2,3-
triazoles as a new class of UV-Blue emitting fluorophores have been systematic 
investigated (see Chapter Three).22 
Figure 8: Photonic luminescence of N-2-aryl triazoles with different substituted groups 
on the C-5 position: the sample was measured in CH3OH, c = 10 M; ex = 254 nm. 
 
1.2.3 Conclusion 
In conclusion, the first regioselective post triazole-arylation of NH-1,2,3-triazoles was 
developed through substrate controlled N-arylation. The importance of ligand effect in 
the copper mediated coupling with aryl iodide was observed and optimal condition 
allowed the formation of N-2 aryl products in excellent yields. Alternative approaches, 
including SNAr and boronic acid transmetallations, have also been proved with excellent 
18 
regioselectivity. Moreover, the newly prepared N-2 aryl products gave interesting 
photonic luminescent emission, which re-emphasized the significance of the N-2-aryl-
triazoles and reported methodologies. 
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1.3 Highly efficient synthesis of vinyl substituted triazoles by Au(I) 
catalyzed alkyne activation† 
1.3.1 Reported methods for synthesis vinyl substituted triazoles 
N-vinyl 1,2,3-triazole is a member of vinyl monomer family (Figure 9),23 which provides 
the attractive features of thermal and chemical stability and functional handles from 
reactive groups in the synthesis of advanced materials. As we can see, in the N-vinyl 
triazole, it has a very unique structure, reminiscent of both styrene (aromaticity) and vinyl 
pyridine (lone pairs),24 which displays a range of novel properties in the polymerization 
profiles similar to styrenic/acrylate systems. 
Figure 9: Structures of N-vinyl 1,2,3-triazoles. 
 
From the retrosynthetic analysis, the N-vinyl 1,2,3-triazole could be synthesized by 
the cycloaddition of alkynes with vinyl-substituted azides through either thermo 
conditions25 or metal catalyzed 1,3-dipolar cycloadditions. However, specifically, the 
metal catalyzed cycloaddition between alkynes and vinyl-substituted azides has never 
been reported in literature, possibly due to the poor stability of vinyl-substituted azides 
(high-energy material) and existence of different resonance structures in vinyl-substituted 
azides (Scheme 12). As a result, the preparation of vinyl-triazole was very challenging. 
                                                 
† Reproduced in parts with permission from Bioorg. Med. Chem. Lett. 2009, 19, 3899-
3902. Copyright 2009, with permission from Elsevier Ltd. 
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Scheme 12: Vinyl azide: challenging substrate for dipolar cycloaddition due to the 
existence of equilibrium. 
 
Figure 10: Synthesis of N-vinyl 1,2,3-triazole via elimination of alkyl triazole. 
 
Besides the elimination of alkyl substituted triazole approach (Figure 10), most two 
general methods have been reported in literature in the preparation of N-vinyl 1,2,3-
triazoles. One was the elimination of alkyl halide (Scheme 13).26 In this elimination 
approach, significant amounts of bis-triazole byproducts were usually formed and the 
substrate scope was very limited. Another one was the cyclization of vinyl azides with a 
highly reactive benzyne intermediate (Scheme 14). 27  The benzyne click chemistry 
provided an alternative strategy in preparing triazoles, however, again, it suffered poor 
yields and limited substrate scope. 
Scheme 13: Elimination of alkyl halide. 
 
Scheme 14: Benzyne click chemistry. 
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Therefore, efficient synthetic routes to access vinyl-triazoles are highly desirable. 
Considering the strong nucleophilicity of NH-1,2,3-triazole, we wondered whether the 
NH-triazole alkyne addition could be achieved as a new strategy for the synthesis of vinyl 
triazoles with high efficiency and a broad substrate scope. 
1.3.2 Research Objective and Results 
To optimize the reaction condition, the reactions between benzotriazole 1.2.1a and 
phenylacetylene 1.3.2a were performed in the presence of various catalysts (Table 4). 
Reactions at room temperature gave either very low yields or no reaction at all for all 
catalysts tested (included In(OTf)3, AuCl, AuCl3 and PPh3AuCl). By increasing the 
reaction temperature, the Au(I) catalysts were identified as the best catalysts in activating 
the triple bond other than other metals catalysts as listed in the Table 4. With 5% loading 
of PPh3AuOTf at 80 oC, the desired vinyl triazole 1.3.3a was obtained in quantitative 
yield (entry 5). The reaction gave excellent regio-selectivity, where by only the N-1 
substituted Markovnikov’s product was observed. As indicated in entry 7, the product 
was obtained in excellent yield (92%) even with 0.2% loading of PPh3AuOTf catalyst, 
though a longer reaction time (12h) required. Some other catalysts, such as In(OTf)3, 
indicated modest reactivity (68% yield), but the superior efficiency of the PPh3AuOTf 
catalyst made itself an ideal catalyst for this transformation. Different alkynes were then 
applied to the reaction to investigate the substrate scope. The results are summarized in 
Table 5. 
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Table 4: Screening of catalyst for triazole-alkyne addition.a 
 
Entry Catalyst Loading (%) Temp (oC) Time (hour) Yieldsb (%) 
1 AuCl 5 80 6 82 
2 AuCl3 5 80 6 88 
3 PPh3AuOTf 5 rt 12 15 
4 PPh3AuOTf 5 50 20 60 
5 PPh3AuOTf 5 80 5 > 99% 
6 PPh3AuOTf 1 80 6 96 
7 PPh3AuOTf 0.2 80 12 92 
8 CuI 5 80 12 N.R. 
9 Cu(OAc)2 5 80 12 N.R. 
10 Sc(OTf)2 5 80 12 < 5% 
11 HOTf 5 80 12 10 
12 In(OTf)3 5 80 12 68% 
13 La(OTf)3 5 80 12 N.R. 
14 AgOTf 5 80 12 20 
16 Pd(OAc)2 5 80 12 N.R. 
a Reactions were carried out by dissolving 1.2.1a (1.0 equiv), 1.3.2a (1.5 equiv) and catalyst in toluene (0.2 
M); b Determined by crude NMR. 
From Table 5, the transformation was suitable for a variety of substituted alkynes. 
The terminal alkynes gave higher than 90% yields of only the Markovnikov’s products 
even with 0.2% catalyst loading (1.3.3a-d). Impressively, the reaction also worked very 
well with symmetric internal alkynes, which are usually challenging substrates to be 
activated by metal catalysts. With 1% catalyst loading, the desired addition products were 
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prepared in good yields (1.3.3e-g). Notably, the reaction reached excellent double-bond 
selectivity and only the trans-addition products were formed in all cases, though the 
regio-selectivity of the asymmetric alkynes was poor (1.3.3h, 1.3.3i). The double-bond 
stereochemistry was confirmed by NOE experiments. Meanwhile, both alkyl and aryl 
substituted alkynes were suitable for this reaction. 
Table 5: Substate scope of alkynes in the Au(I) catalyzed triazole addition.a 
  
Alkyne Product  Cat. (%) Time (h) Yieldb (%)
 
 
1.3.3b: R3=p-Me-Ph 0.2 12 94 
 1.3.3c: R
3=p-F-Ph 0.2 10 96 
 1.3.3d: R
3=n-Bu 0.2 12 90 
 
 
1.3.3e: R3=R4=Ph 1.0 30 70 
 1.3.3f: R
3=R4=n-Pr 1.0 20 83 
 1.3.3g: R
3=CH3, R4=H 1.0 12 82 
 1.0 20 84 
 1.0 20 81 
a Reactions were carried out by dissolving 1.2.1a (1.0 equiv), 1.3.2 (1.5 equiv) and PPh3AuOTf  in toluene 
(0.2 M) and heating at 80 oC. b Isolated yields. 
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Scheme 15: Substituted scope of different NH-1,2,3-triazoles. 
R2
R1
N
N
N
H
R1
N
N
N+ R4R3
0.2-1% PPh3AuOTf
Tol. 80 oC
1.2.1 1.3.2 1.3.4
R2
R3
R4
Ph
N
N
N
1.3.4a
0.2% cat., 91% yield
N1:N2:N3 = 22:78:0
Ph
N
N
N
1.3.4b
0.2% cat., 87% yield
N1:N2:N3 = 20:80:0
Ph
N
N
N
1.3.4c
1.0% cat., 81% yield
N1:N2:N3 = 18:82:0
Ph
N
N
N
1.3.4d
0.2% cat., 90% yield
N1:N2:N3 = 24:71:5
Ph
Ph
N
N
N
1.3.4e
1.0% cat., 85% yield
N1:N2:N3 = 22:78:0
Ph
Ph
N
N
N
1.3.4f
0.2% cat., 88% yield
N1:N2:N3 = 20:80:0
Ph
Ph
N
N
N
1.3.4g
0.2% cat., 87% yield
N1:N2:N3 = 29:71:0
1
2
3
Ph
N
N
N
1.3.4i
0.2% cat., 84% yield
N1:N2:N3 = 0:100:0
O
Ph
Ph
N
N
N
1.3.4h
0.2% cat., 93% yield
N1:N2:N3 = 18:82:0
Ph
Ph Cy Pr
H
Pr
Ph Pr
H
Pr
Ph
PhPh
Cy
 
a Reactions were carried out by dissolving 1.2.1 (1.0 equiv), 1.3.2 (1.5 
equiv) and PPh3AuOTf  in toluene (0.2 M) and heating at 80 oC. b Ratio of 
the two products were determined by NMR. 
With this highly efficient catalytic triazole addition strategy, we then investigated 
the N-selectivity with different NH-1,2,3-triazoles (Scheme 15). All NH-triazoles were 
suitable for this transformation, giving the alkyne addition products in excellent yields. 
Only trans additions were observed, giving exclusive single double-bond isomers. The 
substituents on the triazoles showed a strong influence on the N-regio-selectivity, where 
most C-4-phenyl substituted triazoles gave N-2 isomers as the major products. Increasing 
the steric hindrance on the C-4 and C-5 positions did not show a dramatic difference 
towards the regio-selectivity. However, application of carbonyl-substituted NH-triazole 
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led to the formation of a single N-2 isomer (1.3.4i), similar to the results from N-2 
alkylation15 and N-2 arylation (see Section 1.2) of NH-triazoles. 
1.3.3 Conclusion 
In conclusion, the first successful method in achieving vinyl substituted 1,2,3-triazoles 
through the Au(I) catalyzed alkyne additions was developed. Various vinyl-triazoles were 
prepared in good to excellent yields (up to 98%) with as low as 0.2% catalyst loading. 
Furthermore, excellent stereoselectivity of double bonds was achieved. Considering the 
great efficiency, excellent stereoselectivity of double bonds, broad substrate scope and 
controllable triazole nitrogen regioselectivity, it is our belief that the reported method 
provides a good strategy for the preparation of various vinyl-triazoles and thereby 
benefiting researches involving 1,2,3-triazoles as building blocks in material science and 
medicinal chemistry. 
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1.4 Iron catalyzed C-O bond activation for the synthesis of propargyl-
1,2,3-triazoles and 1,1-bis-triazoles† 
1.4.1 Examples of traditional propargylation 
The propargylic moiety is a widely distributed structure in medicinal and organic 
chemistry due to the high synthetic value of the alkyne functionality.28 The electron-rich 
triple bond, in combination with the fairly acidic character of the terminal acetylenic 
hydrogen atom, makes it a versatile entity for further chemical transformations.29 In 
addition, various natural products, fine chemicals and pharmaceuticals containing 
propargylic subunits as components of their structures have been reported.30 
In general, the propargylation could be challenging since the nucleophiles would 
potentially attack the triple bond other than propargyl position, to give corresponding 
allene intermediates that further convert into other products, such as Meyer-Schuster 
rearrangement (Scheme 16).31  
Scheme 16: Meyer-Schuster rearrangement and its mechanism. 
 
                                                 
† Reproduced in parts with permission from Org. Lett. 2010, 12, 3308-3311. Copyright 
2010, with permission from the American Chemical Society. 
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In last several years, many methods regarding propargylation have been reported. 
One attractive method was the Brønsted acid catalyzed propargylation.32 Among these 
reactions, two of most common nucleophiles were 1,3-diester33 and allylsilane.34 Another 
efficient way for making this propargylic moiety was the direct propargylation of arenes 
or heteroarenes with propargyl alcohols via transition metal catalyzed Friedel-Crafts35 
and ene-type36 alkylation reactions (Scheme 17).  
Scheme 17: Metal promoted propargylation of arenes. 
 
With the fast-growing research applications of 1,2,3-triazoles, the effective methods 
in  preparing diverse 1,2,3-triazole derivatives are strongly needed. Therefore, we are 
committed to the development of new strategies to introduce functional groups on the 
nitrogen of the triazole ring. At this time, we are focused on the propargylation of NH-
1,2,3-triazoles with propargyl alcohols to synthesize propargyl-1,2,3-triazoles. 
1.4.2 Research Objective and Results 
To investigate the propargylation of NH-1,2,3-triazole, we first studied the SN2 reaction 
between benzotriazole 1.2.1a and propargyl bromide 1.4.2a and obtained propargyl-
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1,2,3-triaozle 1.4.3a in excellent yield (98%) as shown in Scheme 18. We then wondered 
whether the propargyl triazoles could be produced via simple SN2 reactions of propargyl 
acetates. The propargyl acetate 1.4.2b was reacted with benzotriazole 1.2.1a to give no 
reaction at all with a base Cs2CO3 (Scheme 19). Treating the acetate under harsher 
conditions (DMSO and strong base) led to the formation of complex reaction mixtures 
with no desired propargyl triazole 1.4.3b observed. Moreover, attempts in converting 
propargyl alcohol 1.4.4a into propargyl tolsylate or halide failed, which was likely caused 
by the undesired side reactions (such as Nazarov cyclization37) associated with propargyl 
carbon cations (better leaving groups). We therefore deduced that one practical synthesis 
of propargyl triazoles could likely occur from the effective C-O bond activation of 
readily available propargyl alcohol. 
Scheme 18: Synthesis of propargyl triazole 1.4.3a. 
 
Scheme 19: Challenges in the triazole propargylation. 
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A series of different commonly used Lewis acid catalysts were investigated in 
promoting the propargylation of triazole 1.2.1a and propargyl alcohol 1.4.4a. The results 
are summarized in Table 6. 
Table 6: Catalyst screening.a 
 
 Catalyst Loading (%) Solv. Temp (oC) Time (h) Conv. (%)
b Yield 
(%)c N1:N2
c 
1 FeCl3 20 DCE 60 17 100 90 8:1 
2 Cu(OAc)2 20 DCE 60 17 57 <5  
3 CuI 20 DCE 60 17 22 <5  
4 PdCl2 20 DCE 60 17 13 <5  
5 RuCl3 20 DCE 60 17 69 49 1.1:1 
6 IrCl3 20 DCE 60 17 96 65 2:1 
7 Co(OAc)2 20 DCE 60 17 28 <5  
8 LaCl3 20 DCE 60 17 21 <5  
9 CeCl3 20 DCE 60 17 30 <5  
10 Ti(O-iPr)4 20 DCE 60 17 52 <5  
11 AlCl3 20 DCE 60 17 26 <5  
12 TfOH 20 DCE 60 17 100 35 1.5:1 
13 H3PO4 20 DCE 60 17 73 9 1:1 
14 FeCl3 20 THF 60 7 90 70 6:1 
15 FeCl3 20 Toluene 60 7 100 40 2:1 
16 FeCl3 20 MeOH 60 7 60 44 7:1 
17 FeCl3 20 MeNO2 60 7 90 <5  
18 FeCl3 20 DMF 60 7 <5 <5  
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19 FeCl3 20 DMSO 60 7 <5 <5  
20 FeCl3 20 MeCN 60 7 91 85 10:1 
21 FeCl3 20 MeCN rt 12 62 50 9:1 
22 FeCl3 20 MeCN 90 5 100 93 11:1 
23 FeCl3 10 MeCN 90 10 100 90 10:1 
24 FeCl3 5 MeCN 90 12 90 82 9:1 
a Standard reaction condition: 1 eqiuv propargyl alcohol 1.1.4a, 1.2 equiv triazole 1.2.1a, 0.2 equiv catalyst 
and solvent; b conversions were determined based on the consumption of 1.4.4a; c yields determined by 
NMR with 1,3,5-trimethoxybenzene as internal standard, and ratio determined by NMR of crude reaction 
mixtures. 
As shown in Table 6, the significant decomposition of 1.4.4a occurred with most of 
the Lewis acid catalysts. Some catalysts, such as RuCl3 and IrCl3, promoted this reaction 
in modest yields, but gave poor regioselectivities of 1:1 to 2:1 ratio of N1/N2 isomers 
(entry 5, 6, 12 and 13). Based on the observed performance of the various catalysts, FeCl3 
was revealed as the effective catalyst in promoting this transformation and gave the 
desired product 1.4.3b in good yield with high regioselectivity, with an 8:1 ratio of 
N1/N2 isomers (entry 1). Further solvent screening revealed that this reaction was totally 
shut down in polar solvents, like DMSO, DMF. Surprisingly, the reaction gave almost no 
product formation with the 90% conversion of propargyl alcohol when MeNO2 applied as 
the reaction solvent, because of the formation of -unsaturated ketone product from 
Meyer-Schuster rearrangement (entry 17). Finally, we found the MeCN as the optimal 
solvent (entries 15-20) to give effective conversion even with decreased catalyst loading 
(entries 23-24). With the optimal condition in hand, different triazoles and propargyl 
alcohols were applied to investigate the reaction substrate scope (Figure 11). 
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Figure 11: Substrate scope of triazole propargylation.a 
 
a Yields were determined by NMR with 1,3,5-trimethoxybenzene as internal standard, and ratios 
determined by NMR of crude reaction mixtures. The N-2 1.4.3f structure was confirmed by X-ray 
crystallography. 
As shown in Figure 11, this Fe(III)-catalyzed propargylation was suitable for 
various different propargyl alcohols, which further enriched the available methods for 
effective post-triazole functionalization. Similar to our previously reported strategy (see 
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Section 1.1.2), the regioselectivity of 1,2,3-triazole strongly depends on the nature of 
triazole substrates. For example, the benzotriazole gave primarily N-1 substituted 
products, while keto-modified 4,5-disubstituted triazoles produced the dominant N-2 
isomers (i.e., 1.4.3c, 1.4.3g). Meanwhile, the C-4 phenyl triazole gave a mixture of both 
N-1 and N-2 isomers with roughly 4:1 ratio, favoring the N-2 isomer. 
The substituted groups on the propargyl position were critical for this 
transformation. The reaction generally worked well with aromatic substituted propargyl 
alcohols, except substrates with strong electron withdrawing groups (the p-nitrobenzene 
gave no reaction). No reactions were observed with aliphatic substituted propargyl 
alcohols due to the insufficient reactivity of C-O bond. Impressively, the reaction 
proceeded smoothly with vinyl-substituted substrate (such as 1.4.3r), giving the 
corresponding triazole substituted enynes in excellent yields. Notably, Nazarov 
cyclization products were not observed in these reactions (Figure 12), which highlighted 
the rather mild conditions of the reported method. 
Figure 12: Potential formation of Nazarov cyclization product with vinyl-substituted 
propargyl alcohols. 
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Excellent yields were generally received for internal alkynes with different 
substituted groups, including alkyl, aryl, TMS, and cyclopropyl. The reaction was also 
suitable for terminal alkynes and gave the corresponding propargyl triazoles in good 
yields based on NMR. Surprisingly, these substrates were not stable upon condensation 
for further purification purpose and gave complex mixtures (Scheme 20). We then 
thought the terminal propargyl triazoles would undergo further transformations in the 
presence of FeCl3. To remove the FeCl3 factor, the deprotection of TMS protected 
propargyl triazole 1.4.3n was carried out. Unfortunately, we obtained exactly the same 
result, which was the decomposition of terminal propargyl triazole upon condensation. 
One potential pathway could be triazole-alkyne 5-endo-dig cyclization which has been 
reported by Chen in our group.38 
Scheme 20: Unexpected decomposition of terminal propargyl triazole. 
 
1.4.3 Application in synthesis of 1,1-bis-triazoles via ‘click’ chemistry 
During the last four years, our group has been working on the development of 1,2,3-
triazole derivatives as ligands in transition metal catalysis.39 These triazole complexes 
have shown significant influence on the metal catalyst reactivity by serving as effective 
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nitrogen -donor. Our further studies of triazole-metal coordination initiated our interest 
in the synthesis the bis-triazole compounds as potential interesting bidentate ligands to 
coordinate with transition metal cations.  
Scheme 21: Three Different Types of Bis-triazole Compounds. 
 
Considering the different kind of substitution pattern, the bis-triazole compounds 
could be summarized in three different classes: N-N type,40 C-C type,41 and N-C type 
(Scheme 21). While the N-N and C-C type bis-triazoles have been successfully 
synthesized from either post-triazole alkylation (Scheme 21a)15 or double click chemistry 
(Scheme 21b), the N-C type bis-triazoles have not been reported. These unsymmetrical 
N−C type bis-triazoles, especially the 1,1-bis-triazoles, are particularly interesting 
because of the presence of the stereocenter. A brief synthetic design of this type of 
compounds is shown in Scheme 21c, where the two triazole moieties are introduced by 
post-triazole propargylation and sequentially click chemistry. Although the retrosynthesis 
design looked straightforward, the actual preparation was much more challenging than 
we expected, especially the click chemistry of propargyl triazoles. 
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The click chemistry worked well with terminal alkynes rather than internal alkynes. 
However, the terminal propargyl triazoles undergo decomposition upon condensation, as 
we mentioned before. Therefore, we focused on searching a proper displacement of 
terminal propargyl triazole which can be applied in click chemistry, such as readily 
prepared TMS protected propargyl triazole. 
Scheme 22: Synthesis of unsymmetrical N-C type bis-triazoles.a 
 
a Isolated yields for all cases. 
With the click chemistry of TMS protected alkynes, the universal procedures were 
TMS deprotection under basic condition first and subsequently ‘click’ chemistry in two 
individual steps. However, we have combined the TMS deprotection and click chemistry 
in one single step. Fortunately, the reactions between TMS protected propargyl triazoles 
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and corresponding azides gave the desired bis-triazoles (1.4.5a-h) in excellent yields 
under standard “click chemistry” condition (Scheme 22). 
1.4.4 Conclusion 
In conclusion, a highly efficient FeCl3 catalyzed post-triazole propargylation method was 
developed, giving the desired propargyl triazole in excellent yields. Application of this 
strategy led to the synthesis of unsymmetrical 1,1-bis-triazoles. This study not only 
provided another efficient post-triazole functionalization strategy for the preparation of 
diverse triazole propargyl analogues, but provided entry to a new class of 1,1-bis-triazole 
compounds, which would likely be of interest for medicinal chemistry research, transition 
metal catalysis and material science. 
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1.5 Synthesis of allene triazole through iron catalyzed regioselective 
addition to propargyl alcohols† 
1.5.1 Previous approaches for synthesis allene compounds 
During last few decades, allene chemistry has received ample attention from organic and 
medicinal chemists, due to their synthetic potential in regio- and stereoselective C-C and 
C-X bond forming reactions42 and unique axis-to-center chirality transfer properties. 43 
Moreover, allene subunits have been widely found in many natural products and 
pharmacologically active compounds.44 Therefore, the allene chemistry has created the 
great demand of new methods for synthesis of any kind of allenes as precursors. 
All the classical reaction types (addition, 45  elimination, 46  substitution 47  and 
rearrangement48 ) have been applied to the synthesis of allenes and transition metal 
catalyzed allene synthesis have also been developed.49 Among these methods, one of 
most convenient and general strategy for the synthesis of allenes was the nucleophilic 
SN2′ substitution of propargylic compounds with a leaving group. A variety of labile 
groups, including propargylic acetates, mesylates, carbonates, and halides, etc. have been 
used as leaving groups (Figure 13). 
Figure 13: Most general method for synthesis allenes via nucleophilic SN2′ substitution. 
 
                                                 
† Reproduced in parts with permission from Chem. Commun. 2012, 48, 3521-3523. 
Copyright 2012, with permission from The Royal Society of Chemistry. 
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In the nucleophilic SN2′ substitutions, various types of nucleophiles, such as 
hydrides, halides, and organometallic reagents, have been employed. With hydride 
nucleophiles, most common hydride sources were aluminum hydride reagents, such as 
lithium aluminum hydride (LiAlH4), and diisobutylaluminum hydride (DIBAL-H). 50 
Recently, Cp2Zr(H)Cl has been applied to the anti-SN2′-type reductive substitution of the 
in situ generated zinc or magnesium alkoxides of propargylic alcohols furnishing allenes 
in good yields and high ee’s (Scheme 23).51 This approach provided stereospecific access 
to allenes directly from propargylic alcohols and then greatly improved the efficiency. 
Scheme 23: Cp2Zr(H)Cl catalyzed preparation of chiral allenes. 
 
Haloallenes were synthesized by the SN2′ substitutions of propargyl alcohols with 
halide nucleophiles which are useful substrates in substitution reactions52 and transition-
metal catalyzed cross-coupling reactions. 53  The typical reaction condition for the 
preparation of haloallenes from paropargyl alcohols was Appel-type reaction condition 
containing halide source (NXS or CBr4) and appropriate OH activating reagent, such as 
phosphane-like PPh3, (n-Bu)3P and trisubstituted amines (i-PrNEt) (Scheme 24).54 Other 
conditions also have been reported. For example, treatment of propargyl diethanolamine 
boronates with N-halosuccinimides gave the corresponding allenyl halides in high yields 
(Scheme 25).55 Moreover, the reaction of secondary or tertiary propargylic alcohols with 
NbBr5 afforded allenylic bromides in moderate to good yields (Scheme 26).56 
39 
Scheme 24: Appel-type reactions for synthesis haloellenes. 
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Scheme 25: Synthesis of haloellenes from propargyl diethanolamine boronates. 
 
Scheme 26: Formation of bromoallenes by using NbBr5 as the catalyst and bromide 
source. 
 
Allenes can be synthesized via the direct SN2′ addition of organometallic reagents, 
such as copper, indium,57 zinc58 etc. to propargylic alcohols. Especially, diorganocopper 
reagents (Gilman’s cuprates) have been widely used to prepare allenes from propargyl 
moieties with excellent chemoselectivity of SN2′ substitutions rather than direct SN2 
reactions.59 There are also many different organocopper catalysts involving a catalytic 
amount of a copper(I) salt (like CuBr) with an excess amount of organometallic reagents, 
which included organolithium,60 Grignard reagents,61 organozinc,62 and organozirconium, 
have been reported in the literature (Scheme 27).63 
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Scheme 27: Application of organometallic reagents in preparation of allenes. 
 
1.5.2 Examples for allene as either ligand or catalyst. 
It is well known that the allene compound has played an important role in the organic 
reactions as synthetic intermediate. However, there are only a few examples of allenes 
being used as catalysts or ligands have been reported in the literature. The first example 
was reported by Soai and co-workers in 2002. They have developed the asymmetric 
synthesis of pyrimidin-5-yl alkanol in the addition of (i-Pr)2Zn to pyrimidine-5-
carbaldehyde with excellent ee’s by using chiral 1,3-disubstituted hydrocarbon allenes as 
catalysts (Scheme 28).64 Later, they also pointed out the actual effectiveness of the allene 
as a chiral modulator was difficult to gauge because other experiments with the same 
system indicated that a strong nonlinear effect coupled with autocatalysis conspire to 
amplify even unmeasurable enantiomeric excesses.65 
Scheme 28: Enantioselective addition of (i-Pr)2Zn to 2-(alkynyl)peprinidine-5-
carbaldehyde in the presence of chiral allenes. 
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In 2009, Ready and co-workers demonstrated that chirality of chiral allenes can be 
transferred to products in asymmetric catalysis. In the paper, they prepared a series of 
allene-containing biphosphine oxide catalysts, which were utilized in the asymmetric ring 
opening of meso-epoxides reactions with good enantioslectivities (Scheme 29).66 The 
allene-containing biphosphine oxide catalysts revealed the very high efficiency in the 
reaction (0.1% loading only). Moreover, they successfully used chiral allene-containing 
biphosphine oxides as ligands in transition metal catalysis in 2011 (Scheme 30).67 
Scheme 29: Asymmetric ring opening of meso-epoxides with SiCl4. 
 
Scheme 30: Enantioselective addition of boronic acids to -keto esters catalyzed by 
RhI(AllenePhos) complexes. 
 
These studies opened the potential door of allenes compounds in the asymmetric 
catalysis. Considering the triazole binding pattern, we wondered whether the allenyl 
triazoles have the unique catalytic properties in transition metal catalysis. However, more 
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importantly, there is no effective method for synthesis of allenyl triazoles. We 
subsequently reported for the first time, the successful synthesis of allene triazoles 
through iron catalyzed regioselective triazole addition to the propargyl alcohol.  
1.5.3 Research Objective and Results 
Based on the literature reported strategies, two common approaches were proposed for 
the allene-triazole synthesis. One proposed pathway for synthesis of allene-triazole 
invovles the deprotonation of propargyl triazoles at the propargyl position, followed by 
the treatment with H+ or other electrophiles (Scheme 31). 
Scheme 31: Proposed approaches from deprotonation of propargyl triazoles. 
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Unfortunately, the treatment of propargyl triazole 1.4.3a with different base like 
nBuLi or KOtBu followed by the quenching with either water or NBS gave a complex 
reaction mixture with no allene product formation. We then focused on alternative 
plausible SN2′ strategy, the triazole addition to propargyl alcohol derivatives. However, 
the reaction between propargyl acetate 1.5.2a and benzotriazole 1.2.1a gave no allene 
product even after the reaction mixture was refluxed for 10 hours with triazole anion 
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(Scheme 32). These results suggested that the synthesis of an allene-triazole was indeed a 
great challenge using conventional methods. 
Scheme 32: Proposed SN2′ strategy of propargyl acetate with triazole anion. 
 
Considering our previous success in the synthesis of propargyl triazoles through 
iron-catalyzed C-O bond activation, we decided to apply this process for the preparation 
of allene triazoles. According to literature, few examples have been reported for synthesis 
of allenes from propargyl alcohols by directly using Lewis acids as the catalysts (Scheme 
33).68 
Scheme 33: Lewis acids activation strategy for synthesizing allenes. 
 
As shown in Figure 14, the propargylation product can be formed if triazole 
substituted on the propargylic position (SN2), while the allenation product will be 
produced if the triazole attacked the triple bond (SN2′). Therefore, the di-substituted 
propargyl alcohols will be used with the hope to increase the steric hindrance at the 
propargyl position to direct the triazole to the alkyne based on our understanding of C-O 
bond activation. Although the di-substitution limited the reaction substrate scope, the 
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success of this strategy led to the first synthesis of the allene triazole and open the door 
for further development. 
Figure 14: Iron-catalyzed C-O bond activation. 
 
To test our hypothesis, diphenyl substituted propargyl alcohol 1.5.3a was reacted 
with benzotriazole 1.2.1a in the presence of FeCl3 and MeCN as reaction solvent, both 
products from propargylation (1.5.5a) and allenation (1.5.4a) in a 1:3 ratio were obtained 
with 57% NMR yield (Scheme 34). The allene product 1.5.4a has been characterized by 
X-ray crystallography. 
Scheme 34: First reaction for investigation triazole allene product formation. 
  
Encouraged by this result, the reactions between propargyl alcohol 1.5.3a and 
benzotriazole 1.2.1a have been investigated under various catalysts (Table 7). As shown 
in Table 7, the decomposition of propargyl alcohol 1.5.3a occurred with most Lewis 
acids catalysts. However, we found FeCl3 was the best choice of catalyst to give modest 
yield 57% and fair regioselectivity (3:1 ratio) for this transformation. Compared to other 
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transition metals, iron catalysts had many advantages, such as inexpensive, nontoxic and 
easy to handle. 
Table 7: Catalyst screeninga 
 
 Catalyst Loading (%) Sol.
b Temp (oC) 
Time 
(h) 
Tonv. 
(%)c 
Yield 
(%)d 1.5.4a:1.5.5a
d 
1 FeCl3 10 MeCN 60 5 86 57 3:1 
2 Cu(OAc)2 10 MeCN 60 5 <5 <5 - 
3 CuI 10 MeCN 60 5 <5 <5 - 
4 PdCl2 10 MeCN 60 5 30 <5 - 
5 RuCl3 10 MeCN 60 5 82 36 1:1 
6 IrCl3 10 MeCN 60 5 85 25 1:2 
7 Fe(acac)3 10 MeCN 60 5 <5 <5 - 
8 LaCl3 10 MeCN 60 5 19 <5 - 
9 CeCl3 10 MeCN 60 5 25 <5 - 
10 Bi(OTf)3 10 MeCN 60 5 71 42 2:1 
11 AlCl3 10 MeCN 60 5 63 7 1:5 
12 TfOH 10 MeCN 60 5 75 10 2:1 
13 SnCl2 10 MeCN 60 5 69 29 1:1 
14 FeCl2 10 MeCN 60 5 50 20 1:1 
15 LiCl 10 MeCN 60 5 <5 <5 - 
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a Standard reaction condition: 1 eqiuv propargyl alcohol (0.25 mmol), 1.3 equiv triazole (0.325 mmol), 0.1 
equiv catalyst (0.025 mmol) and 2 mL solvent; b DCE: 1,2-dichlorethane, EtOAc: ethyl acetate; c 
conversions were determined based on the consumption of propargyl alcohol; d NMR yields of 4a with 
1,3,5-trimethoxybenzene as internal standard. 
 
Table 8: Solvent screeninga 
 
 Catalyst Loading (%) Sol.
b Temp (oC) 
Time 
(h) 
Conv. 
(%)c 
Yield 
(%)d 1.5.4a:1.5.5a
d 
16 FeCl3 10 Acetone 60 5 83 32 2:1 
17 FeCl3 10 THF 60 5 73 42 2:1 
18 FeCl3 10 Toluene 60 5 30 <5 - 
19 FeCl3 10 MeOH 60 5 71 <5 - 
20 FeCl3 10 MeNO2 60 5 78 60 4:1 
21 FeCl3 10 DMSO 60 5 <5 <5 - 
22 FeCl3 10 DMF 60 5 <5 <5 - 
23 FeCl3 10 CHCl3 60 5 80 40 3:1 
24 FeCl3 10 EtOAc 60 5 78 56 4:1 
25 FeCl3 10 DCE 60 5 100 90
e >20:1 
26 FeCl3 10 DCE rt 5 50 40 8:1 
a Standard reaction condition: 1 eqiuv propargyl alcohol (0.25 mmol), 1.3 equiv triazole (0.325 mmol), 0.1 
equiv catalyst (0.025 mmol) and 2 mL solvent; b DCE: 1,2-dichlorethane, EtOAc: ethyl acetate; c 
conversions were determined based on the consumption of propargyl alcohol; d NMR yields of 4a with 
1,3,5-trimethoxybenzene as internal standard; e Isolated yield. 
To further improve the regioselectivity of this reaction, different solvents was 
screened (Table 8). A polar solvent, such as DMSO, DMF, totally quenched the reaction. 
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To our surprise, the regioselectivity of the reaction, as indicatd by the ratio of 1.5.4a and 
1.5.5a increased dramatically (> 20:1 ratio) when 1,2-dichloroethane (DCE) was used as 
the reaction solvent. Interestingly, the ratio between 1.5.4a and 1.5.5a was dependent on 
the reaction temperature, where regioselectivity was dropped to 8:1 ratio at room 
temperature (entry 26). 
With the optimal condition in hand, a series of different propargyl alcohols were 
investigated to explore the reaction substrate scope (Figure 15). As shown in Figure 15, 
the alkyne terminal R3 position could be tolerated TMS, n-Bu, t-Bu, vinyl and 
cyclopropanyl groups. Although a longer reaction time (12 h) was required, the bulky t-
Bu group gave 1.5.4e in 91% yield. No enyne decomposition (1.5.4f, 1.5.4r) or 
cyclopropane ring opening (1.5.4d, 1.5.4s) products were observed. The phenyl 
substituted alkyne gave the corresponding hydration product instead of the formation of 
desired triazole allene. The terminal alkynes (R3 = H) gave a complex reaction mixture 
under the optimal conditions. This limitation could be easily overcome by TMS 
deprotection. 
Various substitutions on the propargyl position have also been investigated. The di-
alkyl substituted propargyl alcohols were unreactive enough even at higher temperature for 
longer time (60 oC, 24 h). The fact that aryl-alkyl substituted groups gave no allene triazole 
product was likely caused by the elimination of propargyl alcohols. For the electron-rich 
aryl substitution, higher yields were observed at room temperature (1.5.4g-1.5.4k).  
Heterocycles, such as thiophene (1.5.4l), were suitable for this reaction. Surprisingly, this 
transformation can tolerate a variety of functional group, such as the phenol substituted 
propargyl alcohols afforded the corresponding products (1.5.4j, 1.5.4k) in good yields. 
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Figure 15: Reaction substrate scopea 
 
a Isolated yield; b Room temperature; c Ratio(N2:N1) was determined by crude NMR of reaction 
mixture. 
Substituents on the triazole indicated little influence on the reaction (1.5.4m-1.5.4s), 
likely due to the excellent overall nucleophilicity of the NH-triazole. Impressively, the 
alkyne-substituted propargyl alcohol was also suitable for this reaction, giving the 
conjugated alkyne-allene triazole in good yield. The sturcture of 1.5.4t was confirmed by 
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X-ray crystallography. The electron-deficient aryl substituted propargyl alcohols did not 
work because the strong electron-withdrawing group on the benzene ring decreases the 
reactivity of C-O bond. Interestingly, although the triazole ring is a highly electron-
deficient aromatic ring, the allene bis-triazole 1.5.4u was obtained in modest yield under 
standard conditions, suggesting the potential triazole-Fe coordination in the activation of 
propargyl C-O bond.  
Figure 16: Extending the substrate scope with propargyl acetate.a,b 
 
a Reaction condition: 1 eqiuv propargyl acetate (0.25 mmol), 1.3 equiv 
triazole (0.325 mmol), 0.1 equiv catalyst (0.025 mmol) and 2 mL solvent; 
b Isolated yield; c Ratio(N2:N1) was determined by crude NMR of 
reaction mixture. 
 
As we metioned before, the electron-deficient aryl substituted propargyl alcohols 
were not suitable for this transformation, due to the lower reactivity of the C-O bond. To 
further extend the substrate group of electron-deficient ring, we have tuned the reactivity of 
propargyl alcohol derivatives. Therefore propargyl acetates 1.5.6 were prepared to react 
with triazoles. Excitingly, the desired allene triazoles (1.5.4v-1.5.4z) with electron-
withdrawing group substituents were obtained in good to excellent yields, as shown in 
Figure 16. 
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Scheme 35: TMS-deprotection and X-ray crystal structures 
 
Surprisingly, the allene-triazole shows significantly higher stability than the regular 
allene. For example, when the allene 1.5.4h was treated with 2 equivalents of TfOH in wet 
DCM at room temperature, no allene decomposition (even the TMS deprotection) was 
observed after 12 hours based on the recovered yield of 1.5.4h (97%). The TMS group 
could be readily removed by treatment with base as shown in Scheme 35. 
The X-ray crystal structures not only confirmed the formation of the allene-triazoles, 
but also revealed the detailed configuration. Among all five allene-triazole crystal 
structures (1.5.4a, 1.5.4g, 1.5.4u, 1.5.4y and 1.5.7a), excellent conjugations between 
triazole ring and the allene -bond were observed, even with bulky TMS group on the 
same carbon center. This extended conjugation likely accounted for the improved allene 
stability. 
1.5.4 Conclusion 
Herein, we reported the first synthesis of allene-substituted 1,2,3-triazole derivatives to 
fill the “missing piece” of triazole functionalizations. With the improved allene stability, 
the allene-triazoles are expected to exhibit potential new reactivity that may lead to 
51 
interesting chemical and physical properties, such as ligand development and material 
construction. 
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1.6 Mitsunobu reaction of 1,2,3-NH-triazoles: regio- and stereo-
selective synthesis of triazole derivatives† 
1.6.1 Two practical problems from previous 1,2,3-triazole functionalizations 
Since 2008, our group have successfully reported five different functionalizations of 
1,2,3-triaozles which included alkylation, arylation, vinylation, propargylation and 
allenation (Figure 17). 
Figure 17: Five different functionalizations of 1,2,3-triaozles. 
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From these studies, we learned that the N-1 and N-2 selectivities of 1,2,3-triazoles 
heavily depended on the placement of substituents on the 1,2,3-triaozles, such as 4,5-
disubstituted 1,2,3-NH-triazoles gave absolutely dominant N-2 substituted products and 
4-substituted 1,2,3-NH-triazoles produced slightly dominant N-2 regioisomers, while 
                                                 
† Reproduced in parts with permission from Chem. Asian. J. 2011, 6, 2720-2724. 
Copyright 2011, with permission from Willey-VCH Verlag GmbH & Co. KGaA, 
Weinheim. 
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benzotriazole gave N-1 substituted products as significantly major products in all 
functionalizations (Figure 18). Therefore, the first practical problem was carried out 
regarding the regioselective synthesis of N-2 triazoles. How can we improve the N-2 
regioselectivity of 1,2,3-triazoles, especially for N-1 preferred triazoles, such as 1H-
1,2,3-triazole and benzotriazole. Although some strategies which was focused on the 
development of the appropriate substituents on the C-4 and C-5 positions to reach good 
N-2 selectivity have been reported in literature,69 new strategies that can encourage N-2 
selectivity from “N-1-substitution favored” 1,2.3-NH-triazole were highly desired. 
Figure 18: N-1 & N-2 selectivities of 1,2,3-NH-triazoles. 
 
Scheme 36: The propargylation of benzotriazole with enantioenriched propargyl alcohol. 
 
Due to the presence of a stereogenic center, the propargylation of triazoles gave the 
potential opportunity to synthesize chiral propargyl triazole derivatives. We then 
investigated the reaction between benzotriazole and an enantioenriched propargyl alcohol 
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(92% ee) (Scheme 36). Unfortunately, we obtained a racemic propargyl triazole product. 
This result suggested the chiral propargyl triazoles could not be synthesized via 
propargylation. Then the second practical challenge was the selective synthesis of 
enantioenriched triazole derivatives.  
The N-1 nitrogen of 1,2,3-triazole is usually more basic (higher electron density) 
than the N-2 nitrogen, however, because the center N-2 nitrogen is much less steric 
hindered, N-2 substitution is kinetically favored. As a result, the highly stereochemistry 
sensitive Mitsunobu reactions could potentially favorer the kinetic product and increase 
the N-2 selectivity. Meanwhile, the rather high acidicity (pKa around 8-10) and the 
excellent nucleophilicity of NH-1,2,3-triazoles make them suitable coupling partners with 
alcohols under Mitsunobu conditions. Moreover, the excellent stereoselectivity associated 
with the Mitsunobu reaction could be achieved, where complete inversion of alcohol 
stereogenic center occurred through SN2 addition. Combining these two ideas, we 
postulated that the Mitsunobu reaction could be used to install chirality on the triazoles 
compounds. 
1.6.2 Introduction of Mitsunobu reaction 
The Mitsunobu reaction is an organic reaction which provides the substitution of primary 
or secondary alcohols with nucleophiles mediated by the combination of a trialkyl or 
triarylphosphine and a dialkyl azodicarboxylate (DEAD or DIAD). 70  Because of its 
scope, stereospecificity, and mild reaction conditions, the Mitsunobu reaction has played 
a critical role in organic synthesis and medicinal chemistry. 71  A wide range of 
compounds can be synthesized using a Mitsunobu protocol, such as esters,72 amines,73 
azides,74 ethers,75 cyanides,76 thiocyanides,77 thioesters,78 and thioethers79. (Scheme 37). 
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Scheme 37: Mitsunobu reaction. 
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Although the Mitsunobu reaction is widely used in synthetic organic chemistry, the 
reaction mechanism of Mitsunobu reaction was fairly complex. The reaction 
intermediates have been the subject of debate.80 A possible mechanism was shown in 
Scheme 38.  
Scheme 38: Postulated mechanism for the Mitsunobu reaction. 
 
The first step is the irreversible formation of the intermediate betaine I from the 
nucleophilic attack of phosphine (PR3) upon dialkyl azodicarboxylate, which has been 
confirmed by NMR81 and ESI-MS.82 In the second step, the betaine I deprotonates the 
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hydrogen of the nucleophile to give the species II. The intermediate II then reacts with 
the alcohol to form the alkoxyphosphonium III. Finally, the desired product is produced 
by the attack of nucleophilic anion upon intermediate III. The byproducts of Mitsunobu 
reaction are phosphine oxide and dialkyl hydrazine-1,2-dicarboxylate. 
1.6.3 An example: Improvement of regioselective N-2 isomers from ligand control. 
Despite our successes on the application of conformational control strategy for the 
synthesis of regioselective N-2 substituted 1,2,3-triazoles (see Section 1.1.2), we realized 
this strategy is not effective for specific substrates, which were discussed in Section 
1.6.1.  
Scheme 39: N-2 arylation was reported by Shi and Buchwald. 
 
In 2008, we reported the copper(I) mediated N-2 arylation of 1,2,3-NH-triazoles 
(Section 1.2). We obtained poor to moderate N-2 regioselectivity for both benzotriazole 
and 4-substituted 1,2,3-NH-triazoles. Recently, Buchwald83 and coworkers described a 
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palladium-catalyzed N-arylation of 1,2,3-triazoles with exceptional levels of N-2 
regioselectivity by using the very bulky biaryl phosphine ligand (Scheme 39). The ratios 
of N-2 and N-1 triazole regio-isomers were 1:7.5 and 6:1 for benzotriazole and 4-
phenyltriazole individually by utilization of our approach, while they were 1:1 and 32:1 
roughly from Buchwald’s method. We therefore have known the N-2 selectivity of 1,2,3-
triazoles could be improved significantly by using a bulky ligand. 
1.6.4 Research Objective and Results 
To verify our hypothesis as mentioned in the section 1.6.1, the reactions between benzyl 
alcohol 1.6.2a and benzotriazole 1.2.1a were performed under standard Mitsunobu 
reaction and alkylation conditions separately (Scheme 40).  
Scheme 40: Mitsunobu reaction and alkylation of benzotriazole. 
  
As shown in Scheme 40A, the dehydration product 1.6.3a was obtained in excellent 
isolated yields (97%, combined N-1 and N-2 isomers) under Mitsunobu conditions. 
Compared to the alkylation reaction of benzotriazole, where only trace amount (< 5%) of 
N-2-1.6.3a was isolated (Scheme 40B), the Mitsunobu reaction provided significantly 
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better overall yields of the N-2 isomer. To verify how different alcohols influenced the 
reactivity and regioselectivity, alcohols 1.6.2 reacted with 1.2.1a. The results were 
summarized in Table 9. 
Table 9: Reaction substrate scope with benzotriazole (BTA)a 
BTA
Ph
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a Standard reaction condition: 1 equiv of alcohols 1.6.2, 1.2 equiv of 
triazoles 1.2.1a, 1.2 equiv of triphenylphosphine (PPh3) and 1.2 equiv of 
diisopropyl azodicarboxylate (DIAD) were mixed in the distilled 
tetrahydrofuran (THF). b Isolated yields. c Ratios determined by NMR of 
crude reaction mixtures. 
As shown in Table 9, the Mitsunobu reaction was suitable for a number of different 
alcohols 1.6.2, giving the coupling products in excellent yields (> 85%). Significantly 
improved N-2 products (compared with the alkylation of 1,2,3-triazoles) were obtained in 
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all cases. The Mitsunobu reactions produced N-1 isomers as the dominant products in 
primary alcohols. However, compared to alkylation, they improved the regioselectivities 
significantly. Although secondary alcohols required longer reaction times (8 to 12 h), 
they gave the N-2 isomers as the major products, which supported our hypothesis that 
stereochemistry sensitive Mitsunobu reaction help the formation of kinetic N-2 addition 
even with highly N-1 preferred benzotriazole.  
Table 10: Reaction substrate scope with various triazoles.a,b 
 
a Standard reaction conditions: 1 equiv of alcohols, 1.2 equiv of triazoles, 
1.2 equiv of triphenylphosphine (PPh3) and 1.2 equiv of diisopropyl 
azodicarboxylate (DIAD) were mixed in the distilled tetrahydrofuran 
(THF). b Yields determined by NMR with 1,3,5-trimethoxybenzene as 
internal standard, and ratios determined by NMR of crude reaction 
mixtures. 
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Different NH-1,2,3-triazoles were subsequently used to investigate their influence 
on regioselectivity and also further extend the reaction substrate scope (Table 10). 
Among all the tested NH-1,2,3-triazoles, significantly improved N-2 selectivity was 
observed.  For example, as we have reported in previous alkylation of triazoles, the 
reaction between the 4-phenyl-NH-1,2,3-triazole (1.2.1b) with benzyl bromide (PhCH2Br) 
gave N-1 substituted benzyl 1.6.4a as the major product (N-2:N-1 = 1:5 roughly). 
Under the Mitsunobu conditions, the desired N-2 isomer became the major product 
(N-2:N-1 = 1.7:1). Good to excellent isolated yields of the N-2 isomers were obtained. 
The Mitsunobu reactions of NH-1,2,3-triazoles not only provided an alternative approach 
for NH-1,2,3-triazole functionalization, but also, more importantly allowed the N-2 
functionalization through altering different alcohols instead of adjusting the substitution 
groups on 1,2,3-triazoles. 
The significance of Mitsunobu reaction in altering the N-1/N-2 selectivity was 
further highlighted in the synthesis of bis-N-2-triazole derivatives as shown in Scheme 
41. Generally speaking, the N-1/N-1-bis-triazoles could be readily prepared through the 
double click chemistry from di-alkynes. On the other hand, the N-2/N-2-bistriazoles, 
were extremely challenging to prepare due to the unfavored statistic from mathematics 
calculation. For example, assuming the mono substitution gave N-1:N-2 = 5:1, the ratio 
of the double substitution of the same reaction would be N-1/N-1:N-1/N-2:N-2/N-2 = 
25:10:1 ((N-1:N-2)  (N-1:N-2) = N-1/N-1:N-1/N-2:N-2/N-1:N-2/N-2 = 25:5:5:1, where 
N-1/N-2 = N-2/N-1 ). The theoretical yields for N-2/N-2 product would be only 2.7%.  
The Mitsunobu conditions, by altering the N-1 and N-2 selectivity, gave the great 
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opportunity to synthesize the N-2/N-2 isomer for the first time through the simple post 
triazole derivatization.  
Scheme 41: Synthesis of challenging N-2-bis-triazoles. 
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As indicated in Scheme 41, bis-triazole 1.6.5a which has been confirmed by X-ray 
crystallography was successfully prepared even with benzotriazole, which gives 
predominantly N-1 products (Figure 19). The yields of the N-2/N-2 isomers were 
significantly improved with the 4-phenyl-triazole (1.6.5b) and derivatives (1.6.5d and 
1.6.5f). Notably, only trace amount of the N-2/N-2 bis-triazoles were observed while 
treating the 4-phenyl-triazole with the di-chloro/bromo alkanes due to the unfavored 
statistic discussed above. 
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Figure 19: Crystal structure of 1.6.5a 
 
From above studies, the NH-1,2,3-triazoles have been confirmed as the good 
coupling partner of Mitsunobu reaction with good reactivities. We then investigated the 
stereoselectivity of this transformation. The Mitsunobu reaction can be transfer the 
complete inversion of alcohol stereogenic center to product via SN2 addition. The trans-
2-methylcyclohexanol 1.6.2b and trans-2-methylcyclopentanol 1.6.2c were reacted with 
benzotriazole (BTA) 1.2.1a and phenyl-triazole (PTA) 1.2.1b. As expected, excellent 
stereoselectivity were achieved with only the corresponding cis-products (1.6.6a - 1.6.6d) 
observed via complete stereochemistry inversion (Scheme 42). 
Scheme 42: Complete stereochemistry inversion. 
 
                                                 
 The relative stereochemistries of 1.6.6a - 1.6.6d were determined by the NMR. 
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Encouraged by these exciting results, we synthesized enantiomeric pure 1,2,3-
triazole derivatives through the coupling of triazoles and chiral alcohols under Mitsunobu 
conditions. As shown in Scheme 43, the chiral triazoles 1.6.7a and 1.6.7b were prepared 
from enantiomeric pure alcohol 1.6.2d and quinine 1.6.2e with excellent stereochemistry 
control. Under the Mitsunobu conditions, the enantiomeric pure alcohol 1.6.2d gave near 
complete chirality transfer, forming the chiral triazole 1.6.7a in 96% ee (determine by 
HPLC). 
Scheme 43: Asymmetric synthesis of chiral triazole derivatives. 
 
Due to the large difference of polarity between N-1 and N-2 isomers, they were 
easily separated by column chromatography, which made this method very attractive 
strategy for the preparation of the enantiomeric pure triazoles. Similar to previous cases, 
the secondary alcohols improved the yields of the N-2 isomers even with benzotriazole. 
                                                 
 The ee of N-2-1.6.7a was not determined due to the difficulty in separation of the two 
enantiomers in HPLC. However, large optical rotation of N-2-1.6.7a was observed with 
[]25D = -55.40 (CH2Cl2, c 1.0), which confirmed the likely similar excellent 
stereochemistry inversion was associated with the product. 
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The synthesis of 1.6.7b (structure confirmed by X-ray crystallography) highlighted the 
strength of Mitsunobu reaction of NH-1,2,3-traizoles in the preparation of highly 
functional triazole analogous (Figure 20). To the best of our knowledge, these are the 
first examples of the synthesis of enantiomeric pure triazoles. We are expected that these 
compounds can certainly be applied as potential novel ligand and catalysis in asymmetric 
catalysis. 
Figure 20: Crystal structure of N-2-1.6.7b. 
 
1.6.5 Conclusion 
In conclusion, the Mitsunobu reactions between NH-triazoles and alcohols is a practical 
strategy for 1,2,3-triazole functionalization with excellent yields under mild conditions. 
Unlike previous strategies reported in literature, where different substituents of triazoles 
were required to achieve good yields of N-2 isomers, the Mitsunobu conditions favored 
the formation of the kinetic product N-2 isomers, even with highly N-1 preferred 1,2,3-
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triazoles (such as benzotriazole). Therefore, this method provided an alternative approach 
to achieve triazole N-2 substitution without changing the substituents on the triazoles. 
Moreover, with the excellent stereochemistry control, the reported method allowed 
asymmetric synthesis of enantiomeric pure triazole derivatives, which could certainly 
help the further development of 1,2,3-triazole as potential new ligands in transition metal 
catalysis. 
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Chapter Two: 1,2,3-trizazoles applied as ligands in transition 
metal catalysis 
2.1 Introduction 
2.1.1 Substituted 1,2,3-triazoles as neutral ligands 
The transition metal catalysis has revolutionized the traditional way synthetic chemists 
construct organic molecules in last several decades.84 Compared to classical syntheses, 
transition metal catalysis provided new efficient and sustainable routes for organic 
synthesis and the production of fine chemicals. One key correlation of successful 
transition metal mediated catalysis was the fundamental understanding of ligand-metal 
coordination (referred as “ligand field theory”), which represented an application of 
molecular orbital theory to transition metal complexes. 85  In addition to the unique 
chemical properties of the individual metal elements, the binding ligand plays a crucial 
role in transition metal catalysis. 86  Besides providing the spatial arrangement 
(asymmetric synthesis) at the metal center, ligand influences the electronic environment, 
thus adjusting metal reactivity.87 Ligand variation provide a powerful tool in transition 
metal catalysis, because key features of transition metal catalysts such as reactivity, 
selectivity, and stability may be tuned by the steric and electronic properties of the 
coordinated ligands.88 Considerable effort has focused on the development of new novel 
metal binding ligands,89 such as BINAP,90 BOX,91 DuPhos,92 TADDOL93 and salen.94 All 
of these ligands which have been extensively and successful applied in organic synthetic 
chemistry (Figure 21). 
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Figure 21: Famous ligands in transition metal catalysis. 
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With the strong -donor and weak -acceptor properties of the triazole ring, 1,2,3-
triazoles offer attractive ligands for coordination with transition metals.95 However, due 
to the limited access of functional triazole derivatives, only a few studies that utilize 
triazoles as ligands were reported in the literature before 2001.96 Since the discovery of 
“click chemistry”, the application of 1,2,3-triazoles in several fields have been widely 
studied. However, these studies regarding the application of 1,2,3-triazoles as ligand in 
transition metal catalysis still remain undeveloped. 
One of the earliest studies which revealed the excellent metal binding ability of 
1,2,3-traizoles was reported by Sharpless in 2004. They synthesized the C3-synmmetric 
polytriazolylamines as ligands for copper(I) catalyst. As they claimed, the loading of 
copper(I) catalyst can be decreased as low as 0.25-1 mol% (normally 5 mol% in standard 
condition of “click chemistry”), because these powerful ligands stabilize the copper(I) 
catalyst, by protecting it from oxidation and disproportionation, while enhancing its 
catalytic activity in the click chemistry (Scheme 44).97 This new class of ligands is 
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capable of binding to the copper(I) species by forming a five member chelate between the 
N-3 nitrogen of triazole ring and the amine. 
 Scheme 44: Application of C3-symmetric polytriazoles as the replacement of sodium 
ascorbate salt in click chemistry. 
 
Table 11: Screening of various triazoles as stabilizing ligands for copper(I) catalyst. 
 
Based on the screening of various ligands (Table 11), the best ligand was tris-
(benzyltriazolylmethyl)amine (TBTA). Its tetradentate binding ability is believed to 
completely envelope the copper(I) center, leaving no free binding sites available for 
potential destabilizing interactions (Figure 22). 98  The tertiary amine and the 1,2,3-
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triazole functionalities likely work in concert to make TBTA so efficient:  the more basic 
and sterically encumbered nitrogen, accelerates the catalysis by providing additional 
electron density on the metal center, while the latter, being more labile, comes off the 
copper center only temporarily to allow the formation of the copper(I)-acetylide/ligand 
complex, which is then carried through the catalytic cycle. 
Figure 22: Proposed structure of CuI(TBTA) complex. 
 
In 2005, Zhang reported a new type of monophosphine ligand (ClickPhos) bearing a 
triazole heterocycle in the backbone, which was showing high reactivity in the Pd-
catalyzed Suzuki-Miyaura coupling and amination reactions of aryl chlorides.99 Later, 
van Marseveen and co-workers introduced a 1,2,3-triazoles as part of bidentate P,N-type 
ligand (ClickPhine), 100 which is an important class of ligands that have been applied in 
various catalytic transformations.101 In the ClickPhine ligand, the 1,2,3-triazole played 
the role of nitrogen donor. A series of ligands were synthesized from readily available 
starting materials to give several homogenous and heterogeneous dendritic and polymeric 
catalysts (Scheme 45). 
According to the NMR studies of the precursor palladium chloride IV (when R = 
Ph), the 1H NMR spectra gave broad signals for the allylic protons (except for the central 
proton) indicated isomerization via  rotation or -rearrangement. The 31P NMR 
spectrum showed a broad signal at 20.6 ppm and revealed a monodentate binding of the 
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ClickPhine ligand with the chloride still coordinated to the palladium. After mixing 
compound IV with AgBF4, the formation of cationic palladium-allyl triazole complex in 
which the ligand shows bidentate P,N coordination, as confirmed by NMR data. The 1H 
NMR signal of the triazole proton shifted 0.71 ppm to lower field (from 8.15 to 8.86 ppm) 
after ion exchange, and the CH2 group gave rise to an AB pattern showing that these 
protons became inequivalent. In addition, the signal in the 31P NMR spectrum shifted 
from 20.6 to 40.5 ppm and became sharper. This was the first example that provided 
direct evidence of triazole binding to a transition metal. Furthermore, preliminary 
experiments found the efficiency of these ClickPhine ligands in the Pd-catalyzed allylic 
alkylation reaction. 
Scheme 45: Synthesis route of “ClickPhine” P,N-ligand and their Pd-complexes. 
 
Additional examples of N-coordination of a 1,2,3-triazole to a metal was reported in 
2007. Koten, Gebbink and co-workers reported the first examples of 1,4-disubstituted 
1,2,3-triazoles as monodentate Lewis-basic ligands for cationic Pd- and Pt- pincer 
complexes with reported crystal structure (Scheme 46). 102 The 1,2,3-triazole coordinated 
metal complexes were accessed by the addition of the triazole to the pincer Pd and Pt 
cations, which is generated in situ upon reaction with AgBF4. The single X-ray 
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crystallographic structure of the complex revealed an M(II) ion which is four coordinate 
with a distorted square-planar ligand environment by virtue of the donor atoms of the 
tridentate pincer ligand and the N-3 nitrogen of the triazole.  
Scheme 46: 1,2,3-triazoles as monodentate Lewis-basic ligands for cationic Pd- and Pt- 
pincer complexes 
 
A comparison study of relative coordination strength of 1,2,3-trizaoles with respect 
to more traditional Lewis bases PPh3, 1-methyl-imidazole, Et2S, DMSO, anline, MeCN 
and pyridine was performed by means of 1H NMR spectroscopy which represented as the 
relative association constant, Kass (Scheme 47). 
Scheme 47: The definition of Kass. 
 
The experiments showed that 1,2,3-triazole L1 is a stronger ligand than Et2S, 
DMSO, H2O and MeCN (Table 12), but is weaker than PPh3, pyridine and N-methyl 
imidazole in strength. Entries 9-11 indicated that the coordination strengths of triazoles 
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ligands toward the pincer Pt cation can be tuned by the appropriate functionalization of 
1,4-disubstituted triazoles.  
Table 12: Kass values for Lewis base coordination to Pt-pincer complex compared to L1 
for several competing ligands Lx. 
Entry Lx Kass Entry Lx Kass 
1 H2O - 6 Pyridine 19.5 
2 DMSO 0.002 7 PPh3 >>a 
3 MeCN 0.02 8 N-methyl imidazole >>a 
4 Et2S 0.03 9 1H-1,2,3-triazole 4.16 
5 Anline 0.3 10 L2 6.47 
 11 L3 18.5 
a Full conversion to 2Lx occurred 
Recently, 1,2,3-triazol-5-ylidenes were found to be the good alternative NHC 
ligands for forming complexes with transition metals, 103  such as gold, 104  silver, 105 
rhodium,106 ruthenium,107  palladium108 and copper109  which have been applied in the 
some classical organic synthesis. For example, Fukuzawa and co-workers demonstrated 
the utility of their new PdCl2(TMes)2 complex in Suzuki reactions (Scheme 48), where 
the TMes (triazole-based NHC bearing mesityl groups).108b Indeed, complex 
PdCl2(TMes)2 was successful in catalyzing the Suzuki reaction between aryl chlorides 
and various aryl boronic acids in good to excellent yields. Following their previous 
results with PdCl2(TMes)2 complex, they extended the chemistry of 1,2,3-triazolylidene 
ligands by synthesizing new copper complexes, such as CuCl(aNHC) and CuCl(TPh).109 
These complexes were evaluated as catalysts for the CuAAC azide-alkyne cycloaddition 
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reaction to give 1,4-substituted 1,2,3-triazoles in excellent yields at room temperature 
with short reaction times (Scheme 49). They also claimed complex CuCl(TPh) was 
particularly effective for the reaction between sterically hindered azides and alkynes. 
Moreover, Crowley104 and co-workers disclosed the first gold ‘click’ 1,2,3-triazolylidene 
complex and its utility in gold(I)-catalysis (Scheme 50). The air and moisture stable 
gold(I) complex proved to be a good catalyst for carbene transfer reactions from diazo 
compounds into O–H, N–H and C–H bonds, hydroalkoxylation of allenes and enyne 
cyclizations. In 2011, Grubbs107b applied the stabilized 1,3,4-triaryl-1,2,3-triazol-5-
ylidene carbenes to displace the phosphine ligand of Hoveyda-Grubbs catalyst, 
generating a family of 1,3,4-triaryl-1,2,3-triazol-5-ylidene containing ruthenium 
metathesis catalysts (Scheme 51). These complexes were found to be active room-
temperature catalysts for the ring-opening metathesis polymerization of cyclic olefins and 
for ring-closing olefin metathesis reactions. The catalytic properties of the Ru-1,2,3-
triazolylidene complexes are strongly influenced by the nature of the MICs’ substituents. 
Scheme 48: Suzuki couplings with aryl chlorides catalyzed by the Pd-1,2,3-triazolylidene 
complex PdCl2(TMes)2. 
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Scheme 49: CuAAC reactions catalyzed by copper(I)-1,2,3-triazolylidene complexes 
 
Scheme 50: Carbene transfer reactions from diazo compounds catalyzed by the gold(I)-
1,2,3-triazolylidene complex. 
 
Scheme 51: Ring opening and ring closing metathesis using Grubbs’ 1,3,4-triaryl-1,2,3-
triazol-5-ylidene containing ruthenium catalysts. 
 
75 
2.1.2 1,2,3-NH-triazoles as anionic ligands 
Compared to N-substituted triazoles, the NH-triazoles provide acidic N-H protons (pKa < 
10),110 therefore, they can be applied as anionic ligands with multiple binding sites. On 
the basis of reported literatures so far, all efforts regarding triazole as anionic binding 
ligand have focused on benzotriazoles,111 which decreased the overall interests in this 
class of complexes, due to limited functionality availability. In one of the earliest 
example of benzotriazole as a ligand, Oro and co-workers discovered the application of 
benzotriazole and benzotriazolate anion in Rh(I) complexes. 112  To investigate the 
structure and binding patterns of Rh(I)-triazole complexes, they successfully synthesized 
mono- and di nuclear rhodium complexes of the general formula RhClL2(btzH), [Rh(-
btz)L2]2, Rh2(-btz)(-N3)(L2)2 and Rh2(-btz)(-SCN)(COD)2 [L2 = diolefin, (CO)2 or 
(CO)(PPh3)] (Scheme 52). For example, the addition of benzotriazole to [Rh(-
Cl)(COD)]2 suspended in acetone resulted in the formation of [RhCl(COD)(btzH)] 
complex as stable yellow solid in excellent yield (88%). 
Scheme 52: Synthesis of [Rh(btz)(COD)]2 complexes reported by Oro. 
[Rh( -Cl)(COD)]2 + btzH
acetone [RhCl(COD)(btzH)]
Et3N
88% yield
[Rh( btz)(COD)]2
yellow solid
[Rh( -Cl)(COD)]2 + btzH
KOH
[Rh( btz)(COD)]2
94% yield  
Although the molecular structure of Rh(I)-triazole complex remains to be 
determined, a square planar arrangement was proposed with the benzotriazole 
coordinated through a pyridyl nitrogen atom. Moreover, the addition of triethylamine to a 
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solution of [RhCl(COD)(btzH)] in methanol, led to elimination of the acidic proton of the 
benzotriazole ligand with the formation of [Rh(-btz)(COD)]2. A direct route to prepare 
[Rh(-btz)(COD)]2, complex, in high yield involved the reaction of [Rh(-Cl)(COD)]2 
with benzotriazole and KOH. The molecular weight measurements on [Rh(-
btz)(COD)]2 complex indicated a dinuclear complex (Rh-Rh 3.27Ǻ), therefore suggesting 
that the nitrogen atoms of the benzotriazolate ligand involved in coordination are adjacent 
to each other (Figure 23). This proposed dinuclear structure for these complexes was 
confirmed by the X-ray study of [Rh(-btz)(COD)]2. 
Figure 23: Proposed dinuclear structure of Rh(I)-triazole complexes. 
 
In addition, Oro and co-workers studied the only known example of a 4,5-
disubstituted-(NH)-1,2,3-triazole coordination with Rh(I). 113  Neutral bi- and mono-
nuclear dicyanotriazolate (DcTz) complexes of formula [Rh2(-DcTz)2L2L′2] (L2 = L′2 = 
diolefin; L = CO, L′ = PPh3 or P(OPh)3; L = L′ = P(OPh)3; L2 = COD, L′ = P(OPh)3) and 
[Rh(DcTz)L2L′] (L2 = diolefin, L′ = PPh3; L = PPh3, L′ = CO) and the ionic derivative 
[Rh(dppe)2][DcTz] have been synthesized. Based on the study by Rasmussen114 showing 
that the coordinating ability of the ligands can be influenced by the presence of cyan 
substituents on the heterocyclic ring, the authors investigated the coordinating ability of 
4,5-dicyano-1,2,3-triazole (HDcTz). Treatment of [Rh(acac)(COD)] with 4,5-dicyano-
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1,2,3triazolate led to the formation of the Rh(I) dicyanotriazole complex in high yields 
(Scheme 53). 
Scheme 53: Synthesis of [Rh(-DcTz)(COD)]2 complex. 
 
2.1.3 Achievements of our group by using 1,2,3-triazoles as the ligands 
During the past several years, our group has been working on the development of new 
catalysts with 1,2,3-triazoles as ligands in transition metal catalysis. These efforts led to 
the discoveries of triazole-Rh and triazole-Au catalysts with interesting new reactivities. 
On the basis of our success in the synthesis of 4,5-disubstituted-(NH)-1,2,3-triazoles 
through Lewis base-catalyzed cascade nitroalkene-aldehyde-azide condensation.13 Duan 
in our group examined the binding ability of a triazole anion with Rh(I) by treating the 
4,5-disubstituted-(NH)-1,2,3-triazoles with [Rh(COD)Cl]2 under basic conditions 
(Scheme 54). 115 As expected, the triazole anion effectively substituted the chloride (Cl-) 
and triazole-Rh(I) complexes ([Rh(COD)(Triaz]2) were obtained in near quantitative 
yields. These complexes showed excellent stability towards both air and moisture, and 
can be purified by column chromatography. As a new class of transition metal 
complexes, these compounds display effective catalytic reactivity in the Pauson-Khand 
reaction.  
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Encouraged by the successful synthesis of triazole-Rh(I) complexes, we 
investigated triazoles as ligands for the synthesis of Au(I) complexes. In comparison with 
the more expensive NHC ligands,116 the simple triazoles are also known to possess a 
nitrogen -donor and a lower LUMO aromatic antibonding orbital for metal back-
bonding. The triazole-Au(I) complexes were prepared successfully in quantitative yields 
using a preparation procedure similar to triazole-Rh(I) complexes (Scheme 55). 117 
Further studies revealed that the triazole-Au(I) catalyst gave excellent reactivity, 
selectivity and improved thermal stabilities in several organic transformations which 
included hydroamination and synthesis of Hashmi phenol, 118  E--haloenones, 119 
enones 120  and allenes. 121  Based on the synthesis of allenes form rearrangement of 
propargyl alcohols, we deducted one of unique properties of triazole-Au complexes was 
no further activation of allene intermediates with activation of triple bond only, while 
other regular gold catalysts can activate both (Scheme 56).121a 
Scheme 54: Synthesis of triazole-Rh(I) complexes and its application in Pauson-Khand 
reactions. 
 
 
79 
Scheme 55: Synthesis of triazole-Au(I) complexes. 
 
Scheme 56: Asymmetric synthesis of substituted allenes. 
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2.2 Synthesis of [Ir(L^X)(ArTriaz)2] and [Ir(bbpy)(ArTriaz)2]Cl 
complexes and their application in photoredox catalysis 
2.2.1 Reported examples of triazole-Ir(III) complexes 
1,2,3-triazoles have been extensively studied in the past decade due to the discovery of 
“click chemistry”. The synthesis of 1,2,3-triazole related chelate ligands was first 
described using the “click chemistry” of amino acid derived alkynes or azides in 2006.122 
The resultant chelate ligands are bound through a primary amine and either the N-3 
nitrogen or, in some cases, the N-2 nitrogen of the triazoles (Figure 24). Since then, 
several additional examples of this “click-to-chelate” approach have been reported, and 
this field has been reviewed.123 The majority of examples use either 2-ethynyl pyridine,124 
which tends to give five-membered chelation (Figure 24A), or 2-picolylethyne,125 which 
gives six-membered chelation (Figure 24B). Both of these ligands coordinate through N-
3 nitrogen as expected, since DFT calculations have shown that N-3 nitrogen is a better 
donor than N-2 nitrogen.126 However, coordination through N-2 nitrogen is also possible 
using ligands of type C,127 but the complexes are less stable than those of type A, as has 
been confirmed experimentally and computationally for a series of palladium 
complexes.127c  
Figure 24: Chelating triazoles derived from 2-ethynyl pyridine (A), 2-picolylethyne (B), 
and 2-azidomethylpyridine (C). 
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The luminescence of pyridine triazoles is sensitive to the presence of metal ions,128 
and the ease of tuning the electronic properties of these ligands has been used to control 
the luminescence of biscyclometalated iridium(III) complexes (Figure 25). 129 
Luminescent Ir(III) complexes have been used in various applications such as biological 
labeling reagents,130 photosensitizers for light-driven catalytic water reduction,131 single 
oxygen sensitizers,132 and sensors.133 Moreover, the most important application of the 
Ir(III) complexes is as emitters in electroluminescent devices including organic light-
emitting devices (OLEDs)134 and light-emitting electrochemical cells (LEECs).135  
Figure 25: Different kind of biscyclometalated iridium complexes. 
 
The luminescent properties of biscyclometalated iridium(III) complexes 
significantly changed when 1,2,3-triazoles was the subunits of iridium(III) complexes 
structures. For example, Zysman-Colman reported the incorporation of 4-aryl-1-benzyl-
1H-1,2,3-triazoles (atl) as cyclometallating ligands into new heteroleptic iridium(III) 
complexes containing diimine (N^N) ancillary ligands 2,2-bipyridine (bpy) and 4,4-
ditert-butyl-2,20-bipyridine (dtBubpy) in 2011.136 These complexes emit from the yellow 
to sky blue in acetonitrile (MeCN) solution at room temperature. Their photoluminescent 
quantum efficiencies are markedly higher (between 25 and 80%) than analogous 
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(C^N)2Ir(N^N)+ type complexes, where C^N is a 2-phenylpyridine ligand (Figure 26). 
The results of a computational investigation suggested that for these complexes, the 
highest occupied molecular orbital (HOMO) is located on both the aryl fragment of the 
atl ligands and the iridium metal while the lowest unoccupied molecular orbital (LUMO) 
is located essentially exclusively on the ancillary ligand. 
Figure 26: Enhanced luminescent Ir(III) complexes bearing aryltriazole cyclometallated 
ligands reported by Zysman-Colman. 
 
Furthermore, De Cola and Fernández-Hernández synthesized and characterized two 
biscyclometalated Ir(III) complexes isomers depending on the reaction temperatures 
which are N,N-trans-[Ir-(dfptrBz)2(dmbpy)]+PF6-, with cis-C,C and trans-N,N 
arrangement of the C^N ligands at 140 oC, and N,N-cis-[Ir-(dfptrBz)2(dmbpy)]+PF6-, cis-
C,C and cis-N,N C^N ligand orientation at 80 oC (dmbpy = 4,4-dimethyl-2,2-bipyridine 
and dfptrBz = 1-benzyl-4-(2,4-difluorophenyl)-1H-1,2,3-triazole). 137 More interestingly, 
both isomers showed significantly different photophysical and electroluminescent 
properties, depending on the mutual arrangement of the C^N ligands (Figure 27). 
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Figure 27: Control of the Mutual Arrangement of Cyclometalated Ligands in Cationic 
Ir(III) Complexes. 
 
Although these triazole-Ir(III) complexes revealed the unique and important 
luminescent properties, the triazole-Ir(III) complexes have not yet been explored for use 
in homogeneous transition metal catalysis. Therefore, we develop new transformations 
using triazole-Ir(III) complexes as the catalysts to take advantage of their unique 
luminescent properties to develop systems that are capable of photoredox catalysis. 
2.2.2 Synthesis of [Ir(L^X)(ArTriaz)2] and [Ir(bbpy)(ArTriaz)2]Cl complexes 
These biscyclometalated iridium(III) complexes are generally synthesized through a two-
step process, the first step being a reaction between the HC^N ligand and IrCl3·nH2O to 
form a dichloro-bridged dinuclear Ir(III) dimer, [Ir(C^N)2(-Cl)]2.138 Further reaction of 
the dichloro-bridged dimer with a third cyclometalating ligand yields triscyclometalated 
complexes that can be homoleptic, [Ir(C^N)3], 139 if the C^N are identical or heteroleptic, 
[Ir(C^N)2(C^N′)], if a different C′^N′ is used.140 The chloride dimer can also react with 
chelating ligands, leading to a wide range of neutral bis-cyclometalated complexes 
[Ir(C^N)2(L^X)] (L^X = anionic ligands as β-diketonates, picolinates, pyridineazolates, 
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etc.) or cationic complexes [Ir(C^N)2(L^L′)]+ (e.g. L^L′ = neutral ligands such as 
diimines, phosphines, etc.) (Figure 28).141  
Figure 28: Four different kinds of biscyclometalated Ir(III) complexes. 
 
With 4-aryl-1-alkyl-1H-1,2,3-triazoles as cyclometallating ligands (HC^N) into 
Ir(III) complexes, the triazoles can act as the directing group to facilitate C-H activation 
on the phenyl ring to form cyclometalated N,C chelates.142 Based on our previous study 
for the efficient synthesis of N-2-aryl-1,2,3-triazoles as mentioned in Section 1.2, our 
efforts turned to the application of these N-2-aryl-1,2,3-triazoles as new cyclometallating 
ligands in the preparation of iridium(III) complexes. As shown in Figure 29, these are 
three different potential binding sites N(1)^C(6′′), N(3)^C(2′′) and N(3)^C(2′) for the 
formation of iridium(III) complexes. Considering steric effects, the binding site 
N(1)^C(6′′) is less steric hindered than the other two sites N(3)^C(2′′) and N(3)^C(2′), we 
then expect the binding site N(1)^C(6′′) is more favored to bind with iridium(III) ion. To 
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evaluate this hypothesis, the reactions between IrCl3 and 2,4-diphenyl-2H-1,2,3-triazole 
are carried out (Scheme 57). As we expected, each reaction gave only one single product 
which was the desired triazole-Ir(III) complexes binding with N(1)^C(6′′) site in the 
triazole ligand in excellent yield. These new Ir(III) complexes showed excellent stability 
towards both air and moisture and could be easily purified by column chromatography. 
Figure 29: Three different potential binding sites for forming Ir(III) complexes in the 
1,2,3-triazole ligands. 
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Scheme 57: General method of synthesis for triazole-Ir(III) complexes. 
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On the basis of this developed procedure for the synthesis triazole-Ir(III) complexes, 
we have isolated four different [Ir(L^X)(ArTriaz)2] complexes in excellent yields (Figure 
30). Single crystals of complexes 2.2.3b, 2.2.3c and 2.2.3d, suitable for X-ray 
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crystallographic analysis, were successfully grown from dichloromethane (DCM) and are 
shown in Figure 31, Figure 32 and Figure 33 respectively. 
Figure 30: Six different [Ir(L^X)(ArTriaz)2] complexes. 
 
Figure 31: X-ray crystal structure for triazole bound Ir(III) complex 2.2.3b. 
 
Figure 32: X-ray crystal structure for triazole bound Ir(III) complex 2.2.3c. 
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Figure 33: X-ray crystal structure for triazole bound Ir(III) complex 2.2.3d. 
 
As revealed by the crystal structures, in all three complexes, the phenyl substituent 
on the C-4 position of the triazole ring are direct away from each other, therefore 
avoiding the possibility of a - stacking interaction between them (Figure 34). 
Figure 34: Conformational stability analysis of triazole-Ir(III) complexes. 
 
With these triazole-Ir(III) complexes in hand, the UV absorption (Figure 35) and 
photoluminescence (Figure 36 and Figure 37)  have been investigated. From Figure 37, 
it is clearly noted that the emission wavelength varies from 415 nm to 527 nm at 
excitation  = 369 nm, depending on the ancillary ligand structure, even although their 
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UV absorption spectra were almost the same. This phenomenon is consistent to the 
reported literatures.141c 
 
Figure 35: UV absorption spectra of triazole-Ir(III) complexes. Sample preparation: 1.0 x 
10-5 mol/L in MeOH and measured in 1 cm-length quartz cell). 
 
 
Figure 36: Fluorescence spectra of triazole-Ir(III) complexes. Sample preparation: 1.0 x 
10-5 mol/L in MeOH, excitation at  = 286 nm with 2.5 nm slit. 
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Figure 37: Fluorescence spectra of triazole-Ir(III) complexes. Sample preparation: 1.0 x 
10-5 mol/L in MeOH, excitation at  = 369 nm with 2.5 nm slit. 
2.2.3 Evaluation of catalytic reactivity 
During the last decade, visible-light photoredox catalysis has shown great promise as a 
green and sustainable method. As a result of its high natural abundance, benign 
environmental impact, cleanliness, and sustainability,143 photocatalysis using visible light 
is a reliable and powerful energy source.144 In this context, there are several examples of 
its usefulness, including asymmetric alkylation of aldehydes,145 [3+2] cycloaddition of 
aryl cyclopropyl ketones, 146  [2+2] cycloaddition of enones, 147  reductive 
dehalogenation,148 Oxidation,149 radical addition to unsaturated bonds,150 and coupling 
reactions.151 Since 2010, Stephenson and co-workers reported the application of visible-
light photoredox catalysis for the formation of C-C bonds between tertiary N-arylamines 
and nitroalkanes via an oxidative aza-Henry reaction. In the presence of 1 mol % 
Ir(ppy)2(dtbbpy)PF6, efficient coupling of nitroalkanes with in situ-generated iminium 
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ions provides the desired products in up to 96% yield (Scheme 58).152  Mechanistic 
studies suggest that reductive quenching of the Ir3+ excited state by the tertiary amine 
leads to the ammonium radical cation, with subsequent catalyst turnover (Ir2+ → Ir3+) 
likely affected by atmospheric oxygen (Figure 38). 
Scheme 58: An oxidative aza-Henry reaction between tertiary N-arylamines and 
nitroalkanes. 
 
Figure 38: Proposed mechanism for oxidative aza-Henry reaction by Stephenson. 
 
To evaluate the catalytic reactivity of this new class of Ir(III) complexes, we have 
synthesized the iridium complex [Ir(bbpy)(ArTriaz)2]Cl (Scheme 59). We then tested its 
reactivity in aza-Henry reaction of 2-phenyl-1,2,3,4-tetrahydroisoquinoline. 
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Scheme 59: Synthesis of complex [Ir(bbpy)(ArTriaz)2]Cl. 
 
Scheme 60: Aza-Henry reaction of 1,2,3,4-tetrahydroisoquinoline catalyzed by 
[Ir(bbpy)(ArTriaz)2]Cl complex. 
 
Surprisingly, we found this reaction was wavelength sensitive. As shown in 
Scheme 60, different light sources gave different efficiency of this transformation. At the 
same time, we have known [Ir(bbpy)(ArTriaz)2]Cl complexes were the effective catalysts 
for photoredox catalysis. We then wondered whether the new methodology which 
combined crossed-conjugate addition and photoredox catalysis could be achieved for the 
synthesis of new novel nitroalkene derivative. The Lewis base activated crossed-
conjugate addition of nitroalkene chemistry is well-known in our group.153 
Our initial attempts were to treat 2-phenyl-1,2,3,4-tetrahydroisoquinoline 2.2.5 and 
nitroalkenes 2.2.7 in the presence of the Lewis base L-proline. Unfortunately, no products 
were obtained (Scheme 61). Based on a proposed mechanism as shown in Figure 38, O2 
could be the oxidant to turn over the catalytic cycle of Ir catalyst. In our reaction system, 
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it failed to generate the iminium ion intermediate which suggests the nitromethane is very 
critical for the turnover catalytic cycle of iridium catalyst (Figure 39). We then tested the 
parallel reactions with different reaction solvents (Scheme 62). 
Scheme 61: Aza-Henry reaction with nitroalkene activated by Lewis base. 
 
Figure 39: Mechanistic insight of Aza-Henry reaction with nitroalkene. 
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Scheme 62: Solvent factor for reaction system. 
 
As shown in Scheme 62, the product formed only from nitromethane as the reactant, 
while the activated nitroalkene was not involved in the reaction. These above results 
indicated the proper oxidant to make the effective turnover of iridium catalyst is vital for 
the Aza-Henry reaction with activated nitroalkene. Therefore, we need to put further 
efforts to investigate the optimal conditions for this new transformation. 
2.2.4 Conclusion 
In conclusion, we have successfully developed the synthesis and structural 
characterization of N-2-aryl-1,2,3-triazoles as cyclometallating ligands in coordination 
with Ir(III) salt to give [Ir(L^X)(ArTriaz)2] and [Ir(bbpy)(Triaz)2]Cl complexes in 
excellent yields. One of the first examples of X-ray structure of N-2-aryl-1,2,3-triazole as 
the ligands bound with iridium salt is presented. Although the new methodology for aza-
Henry reaction with activated nitroalkene has yet to be demonstrated, these complexes 
showed effective catalytic activity in the aza-Henry reaction, indicating the potential of 
this Ir(III) triazole complexes as a new class of photoredox catalysts. 
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2.3 1,2,3-Triazole as Unique Ligand in Promoting Iron Catalyzed 
Propargyl Alcohol Dehydration for the Synthesis of Conjugated 
Enynes 
2.3.1 General introduction of Iron chemistry 
The development of efficient, fast, selective, and clean synthetic methods is highly 
desirable in organic chemistry. With this point, numerous metal-mediated catalysts have 
been developed and played vital roles in the organic syntheses. Many of them are derived 
from heavy or rare metals and their toxicity and prohibitive prices constitute severe 
drawbacks for large-scale applications. As we know, iron is one of the most abundant 
metals on earth which is closely related to the life of the human being, and consequently 
one of the most inexpensive and environmentally friendly ones. 154 Most impotantly, 
many iron salts and complexes are commercially available,155 or are reported in the 
literature. 156  Due to its advantages and significance, the development of iron-based 
chemistry in organic synthesis has led to various iron-catalyzed organic transformations, 
including nucleophilic additions, 157  substitutions, 158  reductions, 159  oxidations, 160 
hydrogenations, 161  cycloadditions, 162  isomerizations, 163  rearrangements, 164  and 
polymerizations.165 
In the last decade, Fürstner’s group explored several organoiron catalyzed cross 
coupling reactions with Grignard reagents (Scheme 63).166 They showed that iron salts 
allow various types of electrophiles, such as aryl chlorides, aryl tosylates, alkyl halides, 
alkynyl epoxides, enol triflates and phosphates, acid chlorides and thiolesters, to be 
activated under mild conditions. Such iron-catalyzed processes occur very rapidly even at 
low temperature and therefore are distinguished by broad functional group compatibility. 
Furthermore, recent advances in carbon-heteroatom bond formation and studies relevant 
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to the general reactivity of in situ generated and structurally defined “low-valent” iron 
complexes which have been confirmed by X-ray crystallography are presented (Scheme 
64).167 These complexes revealed the excellent catalytic reactivity for a variety of Alder-
ene, [4+2], [5+2], and [2+2+2] cycloadditon and cycloisomerization reactions of 
polyunsaturated substrates which tolerate esters, ketones, sulfonamides, acetals, ethers, 
cyclopropanes, remote alkenes, amines and aryl halides (Scheme 65). 
Scheme 63: Iron-catalyzed cross coupling reaction between organic halide/pseudohalide 
and Grignard reagents. 
 
Scheme 64: Different “low-valent” iron complexes. 
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Scheme 65: One “low-valent” iron complex as the catalyst in a variety of transformations. 
 
The C-H activation has gained many attentions from organic chemists, because it 
meets not only the efficient and sustainable requirement of organic transformations but 
also the understanding of the intrinsic features of the broadly existing C-H bonds in 
organic molecules.168 Iron-containing enzyme-catalyzed C-H activation has been reported 
and suggested a potential application of iron catalysis in C-H activation.169 Combining 
the advantages of both iron chemistry and C-H activation, the significance of iron-
catalyzed C-H activation has stimulated rapid development in the past several years.170 
The C-H bond oxidation is one of the most common processes in C-H activation. In 
the synthetic field, iron-catalyzed systems for C-H oxidation can be traced back to one 
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century ago, and this was summarized as Gif chemistry171 and Fenton chemistry,172 as 
well as other non-heme mimic systems.173 Recently, iron-catalyzed oxidation was mostly 
focused on sulfide oxidations,174 epoxidation,175 and olefin dihydroxylation.176 In contrast, 
iron catalyzed C-H bond oxidation has had few significant breakthroughs for a rather 
long time, until recent years. 
In 2007, White and co-worker made a significant improvement in the oxidation of 
general sp3 C-H bonds.177 They reported the iron catalyzed aliphatic C-H oxidation by 
using [Fe(PDP)(SbF6)2] complex. In this report, a highly selective oxidation of 
nonactivated sp3 C-H bonds via iron catalysis was well investigated (Scheme 66). Iron 
(PDP) complex [PDP = 2-({(S)-2-[(S)-1-(pyridin-2-ylmethyl)pyrrolidin-2-yl]pyrrolidin-
1-yl}methyl)pyridine] was essential for this transformation and the higher rigid PDP 
ligand led to the increase of selectivity. This process was rather clean, since the oxidant 
was hydrogen peroxide, which was cheap, easily available, and frequently used in 
traditional iron-catalyzed Gif171 and Fenton172 chemistry. In this transformation, the 
electronic feature rather than the steric effect of C-H bonds plays an important role, since 
electron rich tertiary C-H bonds showed a higher reactivity than either secondary or 
primary C-H bonds. An electron-withdrawing group (EWG) on the  or  carbon of the 
C-H bond quenched the reactivity (Figure 40). 
Scheme 66: Iron-catalyzed oxidation of unactivated sp3 C-H Bonds. 
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Figure 40: Reactivity of different C-H bonds. 
 
Considering the mechanistic insight among iron catalyzed transformations, the iron 
species generally could either serve as Lewis acid or as redox center through single 
electron transfer (SET) process. For example, various iron-containing domains of the 
enzymes showed their high catalytic abilities in C-H oxidations, in which the SET 
process was considered as a possible pathway to facilitate the C-H oxidation.178 
2.3.2 Research Objective and Results 
Conjugated enynes are fundamental building blocks in biology, 179 material science180 and 
fine chemical synthesis.181 As a result, the synthesis of enynes has received considerable 
attention during recent decades, and new methods for their preparation have been 
developed. Among these various methods, the metal-catalyzed dimerization of terminal 
alkynes was a straightforward approach (Scheme 67A, R=R′, R′=H).182 Unfortunately, 
the complicated regio- and stereoselectivity of the dimerization process significantly 
limited the wide application of this method. To minimize this drawback, the solution was 
the coupling of alkynes with structurally defined organometallic alkenes (Scheme 
67B).183 However, organometallic alkenes are usually difficult to handle and are very 
toxic in general, especially those that are volatile. 
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Scheme 67: Classical approaches for synthesizing conjugated enynes. 
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The most employed protocol for the synthesis of conjugated enynes has been the 
cross-coupling reactions between vinyl halides and terminal acetylenes catalyzed by 
palladium complexes and copper(I) iodide, namely, the Sonogashira reaction (Scheme 
67C). 184  This elegant process does not require the stoichiometric amount of an 
organometallic reagent. However, the major limitation of this method was the preparation 
of the vinyl halide. In view of the limitations and shortcomings of these established 
methods, we believed that the simple and efficient methods that can install this 
unsaturated hydrocarbon moiety are highly desirable.185 
The catalytic propargyl alcohol dehydration, without any doubt, is one of most 
atom-economic and practical approaches for conjugated enyne synthesis. Although some 
methods related to propargyl alcohol dehydration strategy have been reported (Scheme 
68), such as the phosphoric esters syn-elimination186 and cyclopropane ring opening,187 
these methods only work for limited specific substrates. Therefore, this simple 
transformation is challenging and problematic. 
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Scheme 68: The dehydration propargyl alcohol for specific substrates in synthesis of 
conjugated enynes. 
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To achieve alcohol elimination, a Lewis acid was generally required (for OH 
activation). However, the carbocation intermediate and conjugated enynes products are 
highly reactive under these conditions. This often leads to undesired decomposition and 
polymerization. As illustrated in Table 13, the commonly used Lewis acids all gave poor 
yields of enyne 2.3.2a, even though most of the propargyl alcohol 2.3.1a was consumed.  
Therefore, to fill this “missing methodology”, new catalysts need to be developed either 
by providing proper acidicity (only activating the C-O bond without formation of “pure” 
carbocation) or by going through alternative reaction path (such as radical) to avoid the 
undesired decomposition. The recent studies on triazole-Au complex revealed excellent 
chemoselectivity of this triazole catalyst and the triazole-borane complexes suggested the 
ability of triazole to stabilize a single electron reaction center.188 Additionally, in the 
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synthesis of triazole-allenes (Section 1.5), the higher yield and improved regioselectivity 
was obtained when we pre-mixed the FeCl3 and triazole before the addition of propargyl 
alcohol (Table 14). On the basis of these results, we postulated that triazole ligands might 
provide the needed reactivity for this simple but important transformation. 
Table 13: Direct propargyl alcohol dehydration: a challenging transformation.a 
 
Entry Catalyst Temp (oC) Convn (%)b Yield (%)c 
1 TfOH 60 90 30 
2 AlCl3 60 10 <5 
3 Bi(OTf)3 60 90 21 
4 NiCl3 60 22 <5 
5 In(OTf)3 60 80 15 
6 CeCl3 60 23 <5 
7 LaCl3 60 26 <5 
8 RuCl3 60 78 22 
9 IrCl3 60 75 20 
10 PdCl2 60 30 <5 
11 Cu(OAc)2 60 52 <5 
12 Co(OAc)3 60 26 <5 
13 Ti(Oi-Pr)4 60 71 9 
14 FeCl2 60 30 <5 
15 FeCl3 60 95 29 
16 Fe(acac)3 60 59 12 
17 FeCl3 rt 32 11 
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a General reaction conditions: 2.3.1a (0.25 mmol, 1.0 equiv.) and Lewis acid catalyst (10 mol%) in MeCN 
(5 mL); b Conversions were determined based on the consumption of propargyl alcohol; c NMR yields of 
2.3.2a with 1,3,5-trimethoxybenzene as internal standard. 
Table 14: A small detail from allenation of triazole. 
 
Catalyst Loading (%) Sol.
b Temp (oC) 
Time 
(h) 
Conv. 
(%)c 
Yield 
(%)d 1.5.4a:1.5.5a
d 
FeCl3 
(w/o pre-coord.) 10 MeCN 60 5 86 57 3:1 
LiCl 10 MeCN 60 5 90 70 6:1 
Table 15: Screening of ligandsa,b,c 
N
N
N
L:
CH3
conv. 63%
yield 43%
L1
N
N
N
NPh
conv. 49%
yield 10%
L2
N N
N
Ph
conv. 78%
yield 33%
L3
N N N
conv. 31%
yield <5%
L4
conv. 80%
yield 61%
L5
N
N
N
Ph N
N
N
OPiv
N N
N
NN
N
PhPh
conv. 79%
yield 29%
L6
conv. 67%
yield 48%
L7
N
N
N
Ph
NHTs
N
NNOH
OPiv
conv. 73%
yield 41%
L8
N
NN
OPiv
conv. 75%
yield 31%
L9
HO
conv. 83%
yield 70%
L10
N
N
N
OH
conv. 71%
yield 50%
L11
N
N
N
OH
O
Bu
Ph
HO
Bu
Ph
10 mol% FeCl3, MeCN
20 mol% L, 60 oC, 7 h
2.3.1a 2.3.2a
 
a General reaction conditions: 2.3.1a (0.25 mmol, 1.0 equiv.), ligands (10 mol%) and 
Lewis acid catalyst (10 mol%) in MeCN (5 mL); b Conversions were determined 
103 
based on the consumption of propargyl alcohol; c NMR yields of 2.3.2a with 1,3,5-
trimethoxybenzene as internal standard. 
To test our hypothesis, various triazole-FeCl3 mixtures were employed as the 
catalysts to react with 2.3.1a. To ensure the consistency, all reactions were conducted 
under identical conditions and the reaction mixtures were measured after 7 hours (Table 
15). To our surprise, the simple addition of N-methyl benzotriazole L1 to FeCl3 
significantly decreased undesired decomposition of 2.3.1a, giving the desired enyne 
2.3.2a in good yields. Screening the triazole ligands revealed even better reactivity of 
chelating ligands, giving enyne in excellent yields. On the basis of synthetic simplicity of 
triazole ligands, we have selected 2-(1H-benzo[d][1,2,3]triazol-1-yl)ethanol L10 as the 
optimal ligand for this transformation. 
Table 16: Screening of different heteroaromatic ligandsa,b,c 
 
a General reaction conditions: 2.3.1a (0.25 mmol, 1.0 equiv.), ligands (10 mol%) and 
Lewis acid catalyst (10 mol%) in MeCN (5 mL); b Conversions were determined 
based on the consumption of propargyl alcohol; c NMR yields of 2.3.2a with 1,3,5-
trimethoxybenzene as internal standard. 
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Furthermore, we have investigated other heteroaromatic ligands, including pyridine, 
imidazole, tetrazole and 1,2,4-triazoles. Interestingly, they did not catalyze this 
transformation at all, even with very similar binding patterns, which demonstrated the 
unique properties of 1,2,3-triazoles as ligands in adjusting iron cation reactivity (Table 
16). 
Table 17: Reaction substrate scope.a,b 
R3
R2
HO 10 mol% FeCl3, 20 mol% L10 R3
R2
2.3.1 2.3.2
MeCN, 60 oC, 0.5-10 hR1
R = H, 2.3.2a: 91%
n-Bu
Ph
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Ph
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90%
Ph
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Ph
Ph
2.3.2f
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Ph
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85%
Ph
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70%
TMS
Ph
2.3.2i
conv.: 50%; yield: 46%
TMS
2.3.2j
81%
Cy
Ph 2.3.2k
75%
TMS
p-MeO-
Ph
Php-MeO- 2.3.2l
80%
2.3.2m
85%
TMS
Pho-MeO-
n-Pr
R = Ph, 2.3.2n: 91%
R = n-Bu, 2.3.2o: 89%
R
Ph
2.3.2r
85%
H
Ph
COOHCOOH
R = Ph, 2.3.2p: 92%
R = n-Bu, 2.3.2q: 88%
R
Ph
R = Ph, 2.3.2s: 92%
R
Ph
COOH
p-F-
R = TMS, 2.3.2t: 88%
R = n-Bu, 2.3.2u: 83%
OH
R
Ph
2.3.1
R = Ph, TMS or n-Bu,
24 h, no rxn;
R1
R
R = Et, 2.3.2b: 95%
COOH
 
a General reaction conditions: 2.3.1a (0.25 mmol, 1.0 equiv.), ligands L10 
(20 mol%) and Lewis acid catalyst (10 mol%) in MeCN (5 mL); b isolated 
yields. 
The bi-dentate triazole-based ligands displayed better reactivity. Increasing the 
ligand loading revealed 2:1 (ligand/Fe) ratio as the optimal conditions, which was 
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consistent with the Fe3+ octahedral coordination (six coordination sites, requiring open 
coordination sites for OH binding in the transition state). Solvent screening revealed 
acetonitrile as the optimal solvent. Attempts in obtaining the iron-triazole complex crystal 
structure have been unsuccessful at this moment. Nevertheless, addition of readily 
available 1,2,3-triazole to FeCl3 provided a practical and highly efficient catalyst system, 
which gave the critical chemoselectivity for the C-O bond activation. To the best of our 
knowledge, this is the first catalytic system reported that can effectively promote this 
important transformation. 189  Various functional propargyl alcohols were prepared to 
investigate the reaction substrate scope. The results are summarized in Table 17. 
As indicated in Table 17, both terminal alkyne (2.3.2r) and internal alkyne were 
suitable for this reaction, giving the desired enynes in excellent isolated yields. The 
alkyne terminal can tolerate various substituted groups, including alkyl (2.3.2a, 2.3.2b), 
aryl (2.3.2e), TMS (2.3.2c), cyclopropanyl (2.3.2g) and even vinyl groups (2.3.2d). The 
propargyl position tolerates an aromatic ring with either electron donating (2.3.2j, 2.3.2k) 
or electron withdrawing (2.3.2s to 2.3.2u) groups. Elimination to the alkenes showed 
excellent stereoselectivity, with only one double bond isomer observed, which were 
unambiguously characterized by X-ray crystal structure (2.3.2n). Substrates 2.3.2n-
2.3.2u illustrated the good functional group tolerability of this method. The formation 
cyclohexenyl enyne 2.3.2i indicated slower reaction rate caused by the lower reactivity of 
the C-O bond. However, the starting material propargyl alcohol could be fully recovered, 
indicating the excellent chemoselectivity of the 1,2,3-triazole/Fe catalysts. Enynes with 
1,2-disubsitututed alkenes could not be formed because of the low reactivity of C-O bond 
under the reaction conditions. Raising the reaction temperature caused decomposition of 
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the propargyl alcohols. However, the highly reactive 1,4-enediynes could be easily 
synthesized with this method (Table 18), which highlighted the benefits of the milder 
reaction condition and improved chemoselectivity of this catalyst.  
Table 18: Synthesis of 1,4-endiynesa,b 
 
a General reaction conditions: identical as above; b Isolated yields. 
 
2.3.3 Tuning the reactivity of conjugated enynes in 1,4-bromolactonization. 
Halogen-promoted addition of nucleophiles to alkenes and alkynes is one of the most 
fundamental reactions in organic synthesis.190 Arguably, the halolactonization is very 
useful since the resulting lactone can easily be elaborated. 191  To date, several 1,4-
bromolactonizations of conjugated enynes to give the products synthetically valuable 
bromoallenes have been reported in natural product synthesis.192 Moreover, bromoallenes 
could be the important intermediates in organic transformations.193 In 2009, Tang and co-
workers reported a DABCO-catalyzed, highly regio- and diastereoselective 1,4-
bromolactonization of conjugated enynes (Scheme 69).194 In contrast to 1,2-addition to 
double bond in the conjugated enynes, where two adjacent stereogenic centers are created, 
107 
1,4-addition across conjugated enynes can produce a stereogenic center and an axially 
chiral allene simultaneously. However, in Tang’s paper, the substrates were relatively 
limited. As shown in Figure 41, the substituted group on R2 position was methyl or 
hydrogen only and also no substrate with an aromatic substituent on the R3 position has 
been reported, likely caused by the difficult enyne synthesis. 
Scheme 69: DABCO-catalyzed 1,4-Bromolactonization of conjugated enynes reported 
by Tang 
 
Figure 41: Limited substrates form Tang’s approach. 
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With our reported method here, these CO2H or ester (CO2Me) substrates could be 
readily prepared, we then tried to extend the substrate scope of Tang’s approach which is 
108 
DABCO-catalyzed 1,4-Bromolactonization of conjugated enynes. Treating 2.3.2n, 2.3.2o 
with NBS in the presence of 2 mol% DABCO resulted in 6-endo-trig cyclization products, 
giving the lactones 2.3.3a and 2.3.3b in good yields (Scheme 70). With the terminal 
alkyne substrate (2.3.2r), it gave complex reaction mixture. 
Scheme 70: The 6-endo-trig cyclization of conjugated enynyl acids. 
 
Based on above results, we thought two factors, which are the energetic favorite of 
cyclization (based on ring strain, six-membered ring is most stable) and relative 
reactivities of double bond and triple bond in the enynes, may be affected the success of 
1,4-bromolatctonization of conjugated enynes. Both extended carbon chain substrates 
2.3.2p and 2.3.2q have been subjected to the standard condition of 1,4-
bromolactonization, unfortunately, no six-membered ring containing bromoallenes were 
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formed (Scheme 71). We then focused on tuning the reactivities of double bond and 
triple bond in conjugated enynes. 
Scheme 71: The 7-endo-trig cyclization of conjugated enynyl acids. 
 
The enediynyl acids 2.3.2y' and 2.3.2z', which can be prepared in 3 steps, was 
reacted with NBS and gave no desired products. We thought that the formation of tertiary 
bromide generated the carbocation intermediate in situ, and then decomposed (Scheme 
72). Despite these negative results, we learned that the reactivities of double bond and 
triple bond were very critical for this transformation at least. Finally, to tune the 
electronic effect of substituted pattern on the both double bond and triple bond, these 
enynes 2.3.2s, 2.3.2t and 2.3.2u have been prepared successfully (Scheme 73). With our 
delight, the treatment 2.3.2s, 2.3.2t, 2.3.2u with NBS resulted in either 6-endo-trig or 5-
exo-trig cyclization, giving the lactone 2.3.3e or bromoallenes (2.3.3f, 2.3.3g) in 
excellent yields and diastereoselectivity (>20:1) (Scheme 74). Surprisingly, simply 
changing the substituted groups at the alkyne terminal, the 6-6-endo-trig or 5-exo-trig 
could be controlled with excellent stereoselectivity. 
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Scheme 72: The reactions with enediynyl acids as the reactants. 
 
 
Scheme 73: Synthesis of enynes 2.3.2s, 2.3.2t and 2.3.2u. 
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Scheme 74: Substituted group dependent enyne activation. 
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2.3.4 Mechanistic study. 
According to the literature, iron cation catalyzed reactions should undergo either Lewis 
acid electrophilic activation or single electron redox process. 195  To investigate the 
reaction mechanism of this triazole-ligand coordinated Fe3+ cation catalyst, the 
cyclopropane substituted propargyl alcohols (2.3.4a, 2.3.4b) were prepared and treated 
with FeCl3 under various conditions. As indicated in Figure 42, both Lewis acid 
catalyzed cyclopropane opening 196  and radical initiated ring opening 197  have been 
reported in literature. The NH-triazole nucleophile and radical trapper 1,4-
cyclohexyldiene (CHD) were then used to investigate the mechanism of the triazole-Fe 
catalysts. 
 
 
                                                 
 Relative stereochemistry of compounds 2.3.3e, 2.3.3f and 2.3.3g have been fully 
characterized through comprehensive 1D and 2D NMR analysis. Detailed spectra are 
provided in supporting information. 
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Figure 42: Mechanistic investigations. 
 
The reaction of 2.3.4a under the optimal conditions gave the chloro-enyne 2.3.5a as 
the only enyne product isolated (82% yield, Figure 42A). With the addition of NH-
triazole nucleophile (Figure 42B), triazole enynes 2.3.5b and 2.3.5c were isolated in 61% 
and 75% yield individually as the only double bond isomers (2.3.5c was confirmed by X-
ray). Addition of the radical trapper CHD did not lead to the formation of H-quenched 
enyne 2.3.2b (Figure 42C). Instead, the chloro-enyne 2.3.5a was the only enyne product 
isolated. These results suggested the reaction proceeds via carbocation ring opening 
instead of radical mechanism, which is consistent with our hypothesis that 1,2,3-triazole 
ligands provided the required electronic effect in adjusting Lewis acidity of Fe3+ to 
achieve the required chemoselectivity for this transformation. 
2.3.5 Conclusion 
In conclusion, 1,2,3-triazoles were identified as unique ligands for iron mediated catalysis. 
The challenging catalytic dehydration of propargyl alcohols to conjugated enynes was 
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successfully achieved with this new iron-based catalytic system. The fact that 1,2,3-
triazoles were the only heterocycles “working” among the tested ligands illustrate their 
ability in adjusting iron cation reactivity, thereby providing the foundation for further 
development of other important iron catalyzed transformations. Moreover, we have tuned 
the reactivity of conjugated enyne in the 1,4-bromolactonization reaction. 
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Chapter Three: N-2-aryl-1,2,3-triazoles: a new class of UV-
Blue emitting fluorophores through Planar-
Intramolecular-Charge-Transfer (PICT)† 
3.1 Introduction 
Photoactive molecules are important in chemistry, biology and material research.198 The 
last two decades evidenced the great advance in this research area, where fluorescent 
active dyes have been applied to many different research fields, such as biological target 
imaging,199 effective photosensors200 and novel photoactive materials. 201 
Two key features of fluorescence emitting molecules are quantum efficiency and 
the wavelengths of excitation and emission. Although several fluorophores have been 
developed over the years, effective UV/blue light emitting small molecules are still 
rare202  due to the relative high-energy gap required between the interactive orbitals, 
which may cause either poor photostability or low quantum efficiency.203 However, the 
fast growing research, such as OLED display204 and Förster resonance energy transfer 
(FRET) 205 studies, in photoactive compounds generated increasing needs for effective 
UV/blue emitting molecules. 
Two of main challenges in developing UV/blue emitting small molecules are the 
optical activity and photostability dilemma. As shown in Scheme 75A, although 
condensed polyaromatic structures have an effective aromatic conjugation, usually these 
compounds possess low energy gap between excited and ground states, thus giving 
emissions at a longer wavelength. Alternatively, bis-aromatic structures (Scheme 75B) 
                                                 
† Reproduced in parts with permission from Chem. Eur. J. 2011, 17, 5011-5018. 
Copyright 2011, with permission from Willey-VCH Verlag GmbH & Co. KGaA, 
Weinheim. 
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could provide the needed larger energy gap for potential UV/blue emitting.206 However, 
the steric repulsions between the ortho-substituted groups cause poor conjugations 
between the two aromatic rings and therefore significantly decrease the photoactivity. To 
overcome this problem, extended aromatic systems have been developed to enhance the 
conjugations (Scheme 75C).207 Blue light emission has been observed with this type of 
molecules, such as the commercial available blue dye disodium 4,4'-bis(2-
sulfostyryl)biphenyl (DSBP, STD-1).208  However, the photolabile C=C double bonds 
considerably limit the potential applications of these compounds.209 
Scheme 75: Different types of UV/blue emitting small molecules. 
 
3.2 Research Objective and Results 
3.2.1 Initiation 
Our interest in developing novel blue-emitting small molecules was initiated by our 
recent discovery (Figure 43). As shown in Figure 43, the N-2-phenyl triazole 3.1a 
showed good emission at 362 nm when it was excited at 254 nm, while the N-1-aryl 
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isomer 3.1a gave almost no emission. This interesting finding suggested suggested that 
the N-2-aryl-triazoles (NATs) might be applied as new building blocks to reach effective 
UV/blue emission by overcoming the challenges associated with other small molecule 
systems. Therefore, a series of NATs were prepared by using the method which has been 
described in Section 1.2 and the optical properties of these NATs were investigated as 
the new UV/blue dyes. 
Figure 43: Photoluminescent spectra of N-2-aryl-1,2,3-triazole: sample preparation: 1.0 x 
10-5 mol/L in MeOH, excitation at 254 nm with 5 nm slit, quantum yield of 3.1a 
quantum yield of 3.1a  
 
3.2.2 Influence of substituted groups on the C-4 and C-5 positions 
To evaluate these new fluorophores, one key concern is whether the optical properties 
(efficiency, excitation and emission wavelengths) of the NATs could be adjusted while 
maintaining effective emission in the UV/blue range. The structures of NATs allowed 
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substitutions on three different positions: C-4, C-5 and N-2.  Although the C-4 and C-5 
substitutions are away from the N-2 aryl groups, they may strongly influence conjugation 
at the N-2 position through electronic effect. This concern was confirmed by the X-ray 
crystal structures of compounds 3.1b and 3.1c shown in Figure 44. 
Figure 44: X-tray crystal structures of 3.1b and 3.1c. 
 
As shown in Figure 44, the N-2-phenyl group in compound 3.1b formed good 
conjugation with triazole ring with a dihedral angle 5.5o, which supported our proposed 
strategy that the N-2 aryl triazoles could provide much improved conjugations by 
avoiding the ortho-steric repulsion associated with typical bis-aromatic systems. The C-
4-phenyl, on the other hand, showed poorer conjugation (dihedral angle 21.8o) in the 
solid state. This steric influence was further emphasized by the structure of compound 
3.1c, where a nearly perpendicular conformation was observed (dihedral angle 81.1o) at 
the C-4 position when the bulky cyclohexenyl group was placed at the C-5 position, even 
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with the possible formation of intramolecular hydrogen bonds (between phenol hydroxy 
and triazole N-2 nitrogen). Moreover, the conformation of the C-4-aryl group also 
showed the influence on the conjugation at the N-2 position, at least in the solid state: a 
much bigger dihedral angle was observed for compound 3.1c (19.7o) than 3.1b (5.5o). 
These crystal structures provided a strong foundation in rationalizing the photoactivity of 
the NATs. However, it was expected that free -bond rotations at N-2 and C-4 positions 
could occur while the compounds were dissolved in solution.  
Table 19: Fluorescence emission of compounds with different C-5 substitutions.a 
 
 Absorption (nm) Emission (max) b Fluorescence Intensity (x 103)c 
3.1a 222 (0.127), 305 (0.222) 362 0.15 19.6 
3.1b 206 (0.128), 263 (0.250) 316 0.02 4.7 
3.1c 227 (0.257), 292 (0.268) 380, 400 0.06 10.8 
3.1d 220 (0.146), 296 (0.276) 348 0.09 23.0 
3.1e 220 (0.118), 294 (0.263) 347 0.35 46.3 
3.1f 220 (0.111), 290 (0.253) 342 0.45 56.6 
3.1g 221 (0.128), 285 (0.265) 342 0.30 52.4 
STD-1 207 (0.452), 234 (0.228), 349 (0.710) 402, 422 0.23 63.1 
STD-2 234 (0.423), 334 (0.068) 365 0.56 13.9 
a Sample information: 1.0 x 10-5 mol/L in MeOH, excitation at 254 nm with 5.0 nm slit; b Quantum yields 
() were determined based on 1.0 x 10-5 mol/L Quinine sulfate dihydrate (STD-2) in H2O ( = 0.56); c 
calculated photo emission integration from the original spectra. All fluorescence measured under identical 
conditions (see supporting information). STD-1 = disodium 4,4'-bis(2-sulfostyryl)biphenyl (DSBP). 
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To evaluate how the various substituted groups on the C-4 and C-5 positions 
influenced the overall excitation and emission, compounds 3.1d to 3.1g were designed 
and prepared with different substituted groups on the C-5 positions. The absorptions and 
emissions of these compounds are summarized in Table 19. 
Compared with N-2-phenyl benzotriazole 3.1a, the C-4-N-2-diphenyl triazoles 
generally gave stronger emissions (3.1e-3.1g). All of these substrates emitted in the UV-
blue range with max around 350 nm. The photoquenching by strong electron withdrawing 
carbonyl group were observed (3.1b). Notably, the highly steric hindered compound 3.1g 
gave similar strong emission for the much less hindered compound 3.1f, which suggested 
the little influence of the bulkiness on the C-5 position for the light emission. 
3.2.3 Variation on N-2-position 
With the N-2-aryl moiety as the fluorophore core, it is expected that the N-2 substituted 
groups will surely influence the overall optical performance. We wondered if this could 
be used to adjust the fluorescence emissions and make NAT tunable dyes.  Compounds 
with different substituted groups on the N-2-phenyl ring were prepared to investigate the 
substituent group effect on their optical properties. 
As shown in Table 20, most of the N-2-substituted aromatic compounds 3.2 gave 
good UV/blue light emissions. The overall quantum efficiency of NATs is around 30%, 
which are comparable with commercial blue dyes (for example, DSBP  = 0.23, 
measured under the identical conditions). These results suggested the promising future of 
these compounds as new UV/blue emitting fluorophores. Similar to other literature 
reports,210 photoquenching by NO2 (3.2e) and by a carbonyl group (3.2f) were observed. 
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Interestingly, a significant decrease of emission intensity was obtained with ortho-
pyridine compound 3.2h. Considering the similar electronic effect of para-pyridine 3.2g, 
this result was rather surprising.  The success in obtaining the X-ray crystal structures for 
both 3.2g and 3.2h helped to reveal the mechanistic reason behind this result (Figure 44). 
Table 20: Substituted group effect on the N-2 position.a 
N
N
N
Ph
R 3.2a: R=CN; 3.2b: R=F; 3.2c: R=Cl;3.2d: R=OMe; 3.2e: R=NO2; 3.2f: R=COPh
N
N
N
PhN
N
N
Ph
3.2g
N
N
N
N
Ph
3.2h
N
3.2i  
 Absorption (nm) Emission (max) 
b Fluorescence Intensity (x 103)c 
1e 220(0.118), 294(0.263) 347 0.35 46.3 
2a 224 (0.154), 309 (0.397) 350 0.31 138 
2b 240 (0.056), 294 (0.212) 343 0.34 35.0 
2c 298 (0.274) 344 0.35 72.1 
2d 245 (0.041), 298 (0.226) 374 0.31 61.6 
2e 225 (0.181), 336 (0.205) 342 <0.005 < 0.5 
2f 228 (0.135), 250 (0.14), 317 (0.365) 343 <0.005 < 0.5 
2g 220.5 (0.133), 300 (0.242) 341 0.28 52.2 
2h 238 (0.156), 276 (0.093) 341 0.15 1.7 
2i 222 (0.482), 260 (0.115), 296 (0.127) 375 0.27 29.6 
a Sample information: 1.0 x 10-5 mol/L in MeOH, excitation at 310 nm with 2.5 nm slit; b Quantum yields 
() were determined based on 1.0 x 10-5 mol/L Quinine sulfate dihydrate in H2O ( = 0.564); c calculated 
photo emission integration from the original spectra. All fluorescence measured under identical conditions 
(see supporting information). 
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Figure 45: X-tray crystal structures of 3.2g and 3.2h. 
 
As shown in Figure 45, the crystal structure of 3.2h exhibited a larger dihedral 
angle between the pyridine ring and triazole ring, due the electron repulsion between the 
long pair electrons of the nitrogen atoms on triazole and pyridine rings. This result 
supports our hypothesis that effective conjugation between triazole ring and N-2 aryl 
groups is crucial for good fluorescence emission. 
The quantum yield (), which indicates the percentage photon emission, is based 
on the photons absorbed. Therefore, although quantum yield is a very important 
parameter used to evaluate fluorescent active molecules, it may not completely represent 
the performance of the fluorophores since molecules may absorb photons with different 
efficiency (different absorption ). The fluorescence intensities of NATs were calculated 
(under the identical conditions) and shown in Table 20. 
The emission intensities of NATs are compatible or higher than both commercial 
the blue dyes quinine sulfate dihydrate and DSBP. Impressively, compounds 3.2a gave 
very intense emission, which was more than two times stronger than quinine sulfate 
dihydrate dye; extending conjugation in known to enhance photoabsorption. However, 
this strategy usually does not work well for blue emitting dyes because conjugation gives 
a red shift, resulting in the emission at a longer wavelength. To our surprise, this 
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undesired red shift did not occur in the NAT system. For compound 3.2i, only slight red 
shift (13 nm) was observed compared with compound 3.1e. The compound 3.2a, on the 
other hand, gave almost no red shift even with largely increased emission intensity. These 
unusual photoactivities highlighted the unique properties of these novel NAT dyes (also 
see computational studies in later section for the HOMO-LUMO distributions). 
3.2.4 Substituent group electronic effect 
To investigate substituent electronic effects, two series of compounds were compared 
with substituted groups either on the para-position of the N-2 phenyl or on the para-
position of the C-4 phenyl. The photoluminance spectra are depicted in Figure 46. 
Figure 46: Photoluminescent spectra of N-2-aryl-1,2,3-triazole. Sample information: 1.0 
x 10-5 mol/L in MeOH, excitation at 310 nm with 2.5 nm slit. 
(A) 
 
 
 
                                                 
 See the detailed excitation/emission data in supporting information. 
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(B) 
 
The F-, Cl-, CN- and OMe-substituted NATs all gave strong emission. Interestingly, 
a very similar trend was observed with substituted groups on either the N-2 phenyl ring 
(Figure 46A) or on the C-4 phenyl ring (Figure 46B). The NATs with electron deficient 
substituted groups (F, Cl, CN) showed very little wavelength shifts. In contrast, the 
strong electron donating methoxy group, gave noticeable red shifts when placed on either 
N-2 (3.2d) or C-4 (3.3f) positions. The CN-substituted compound 3.2a gave the highest 
emission intensity due to the more efficient light absorption through conjugation. Similar 
trends were also observed between F- and Cl-substituted NATs. Whereas similar 
quantum yields were observed, the Cl-substituted NATs gave higher fluorescence 
emission than F substituted NATs, which was due to the better resonance conjugation 
between lone pair electrons of Cl and the phenyl ring. The summarized absorption and 
emission data are shown in Table 21. 
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Table 21: Excitation and emission behavior of substituted NATs.a 
N
N
N
R2
R1
3.3k: R1 = Cl, R2 = H
3.3l: R1 = Cl, R2 = CN
3.3m: R1 = Cl, R2 = F
3.3n: R1 = Cl, R2 = Cl
3.3o: R1 = Cl, R2 = OMe
3.3a: R1 = F, R2 = H
3.3b: R1 = F, R2 = CN
3.3c: R1 = F, R2 = F
3.3d: R1 = F, R2 = Cl
3.3e: R1 = F, R2 = OMe
3.3f: R1 = OMe, R2 = H
3.3g: R1 = OMe, R2 = CN
3.3h: R1 = OMe, R2 = F
3.3i: R1 = OMe, R2 = Cl
3.3j: R1 = OMe, R2 = OMe
3.1e: R1 = H, R2 = H
3.2a: R1 = H, R2 = CN
3.2b: R1 = H, R2 = F
3.2c: R1 = H, R2 = Cl
3.2d: R1 = H, R2 = OMe  
 Excitation (max) Emission (max) b Fluorescence Intensity (x 103)c 
Stoke shift 
(nm) 
3.1e 298 347 0.34 46.3 49 
3.2a 312 350 0.31 138 38 
3.2b 298 343 0.34 35.0 45 
3.2c 292 344 0.35 72.1 52 
3.2d 304 374 0.31 61.6 70 
3.3a 278 343 0.39 35.2 65 
3.3b 305 351 0.51 99.1 46 
3.3c 277 343 0.40 45.5 66 
3.3d 279 343 0.25 79.6 64 
3.3e 280 373 0.33 96.3 93 
3.3f 284 360 0.39 82.2 76 
3.3g 318 401 0.32 111 83 
3.3h 283 360 0.34 78.6 77 
3.3i 287 364 0.34 89.8 77 
3.3j 284 369 0.34 114 85 
3.3k 280 341 0.35 134 61 
3.3l 306 352 0.45 174 46 
3.3m 281 343 0.41 77.3 62 
3.3n 283 345 0.36 99.0 62 
3o 285 376 0.35 101 91 
125 
a Sample information: 1.0 x 10-5 mol/L in MeOH, excitation at 310 nm with 2.5 nm slit; b Quantum yields 
() were determined based on 1.0 x 10-5 mol/L Quinine sulfate dihydrate (STD-2) in H2O ( = 0.56); c 
calculated photo emission integration from the original spectra. All fluorescence measured under identical 
conditions (see supporting information). 
3.2.5 NATs: Tunable UV/blue emitting small molecule dyes 
The large number of NATs spectra allowed us to explore the key factors that control the 
optical properties of novel tunable NATs UV/blue dyes. First, the emission enhancement 
by CN and Cl groups were confirmed, where strong emissions were observed in all cases 
with these two groups. When both CN and Cl are present (triazole 3.3l), the highest 
emitting intensity was achieved with max at 352 nm. Notably, though the fluorescence 
enhancement was believed to be a consequence of the extended conjugation, no 
significant red shift was observed. This UV emission was more than three times stronger 
than the commercial standard blue dye DSBP, which highlighted the superior 
photoactivity of these novel UV fluorophores. 
 Figure 47: Photoluminescent spectra of N-2-aryl-1,2,3-triazole. Sample information: 1.0 
x 10-5 mol/L in MeOH, excitation at 310 nm with 2.5 nm slit. 
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The electron donating OMe is an as the effective shift-tuning group for the NAT 
dyes. The red shifts were observed with OMe on either N-2 (3.2d) or C-4 (3.3f) positions. 
No further red shift occurred with OMe on both positions (3.3j), suggesting that 
cancellation of the inductive effects in 3.3j resulted in no further red shift. This 
hypothesis was further supported by the emission of compound 3.3g, where a red shift 
was achieved (emission max at 401 nm) when combination of OMe and electron 
withdrawing CN were applied on the opposite sites of NATs (Figure 47). 
Figure 48: Range of Stock shifts for N-2-aryl-1,2,3-triazole. Sample information: 1.0 x 
10-5 mol/L in MeOH, excitation at 310 nm with 2.5 nm slit. 
 
Besides the significant influence on the fluorescence intensity and emission 
wavelength, the various substituents could also affect the Stock shift. As shown in Table 
21, the Stock shifts for these tested compounds ranges from 38 nm to 93 nm (Figure 48).  
The CN modified NATs gave narrow emission band with smaller Stock shifts.  Whereas 
the OMe substituted NATs gave broader emission bands with larger Stock shifts.  The 
ability to modify the Stock shifts is consistent with good photoactivity of the NATs, 
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which allowed easy adjustment for the emission wavelength and the gap between 
excitation and emission. 
3.2.6 Computational investigations 
Time-dependent density function theory (TD-DFT) theoretical calculations were also 
carried out with the Gaussian 03211 packages by using the B3LYP/6-31G(d) model.212 
Unlike the orbitals in other simple bis-aromatic compounds, the HOMOs and LUMOs of 
the NATs were very similar for all N-2 substituted triazoles with LUMO locate between 
triazole and N-2 aryl rings. Examples of compounds 3.2d and 3.3g are given in Figure 49. 
The N-2-substituted NATs are much less polar compared with the N-1 analogous 
due to the homogenization of electron density through extended π-conjugation. The 
photoexcitation introduces a high extension of planarity to induce the homogeneous 
distribution of electron density throughout the triazole and N-2 aryl rings. This 
phenomenon, which has been well documented in the literature, is referred to as planar 
intramolecular charge transfer (PICT).213  
Figure 49: HOMO and LUMO orbitals of compounds 3.2d and 3.3g. 
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What makes the 1,2,3-triazole special comparing to other aromatic structures is the 
highly effective conjugation between triazole and N-2 aryl rings, even with the presence 
of theoretically free-rotatable N-C  bonds. These co-planar structures were confirmed 
not only by the X-ray crystal structures, as shown in earlier discussions, but also 
indicated by the computational studies as the most stable conformations for these 
molecules.  Solvent screenings of these dyes has been performed and indicated little 
change of the optical properties of these dyes in EtOAc, MeOH, CH2Cl2, THF or 
CH3CN,214  which supported the proposed intramolecular charge transfer mechanism. 
Moreover, the computational studies also indicated that the twisted non-planar 
conformation was the most energetic favored structures for N-1 isomers (Figure 50), 
which is consistent with the experimental observation that poor fluorescence emission 
was observed with all N-1 isomers. 
Figure 50: The most stable conformation of N-1-1e' from computational studies: twisted 
N-1-aryl ring. 
 
These computational studies revealed the unique features of the NATs (N-2 
isomers), which allow them to be effective fluorophores for UV/blue light emitting.  The 
calculated HOMO–LUMO gaps for 3.1e-3.3o (Table 22) are around 3.60-4.78 eV, which 
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are in good agreement with the experimental values of 3.90-4.48 eV from optical 
absorption spectra. 
Table 22: Calculated HUMO-LUMO energy gaps.a 
 Eg (eV) LUMO-HOMO (eV)  Eg(eV) LUMO-HOMO (eV) 
3.1e 4.16 3.95 3.3f 4.37 4.34 
3.2a 3.97 3.60 3.3g 3.90 3.73 
3.2b 4.16 4.06 3.3h 4.38 4.51 
3.2c 4.25 4.06 3.3i 4.32 4.51 
3.2d 4.08 3.94 3.3j 4.37 3.72 
3.3a 4.46 4.29 3.3k 4.43 4.27 
3.3b 4.07 3.94 3.3l 4.05 3.90 
3.3c 4.48 4.78 3.3m 4.41 4.04 
3.3d 4.44 4.77 3.3n 4.38 4.03 
3.3e 4.43 4.21 3.3o 4.35 4.16 
a Optical HOMO–LUMO gaps (Eg) were derived from the onset absorption wavelength: Eg (eV) ≈ 
1240/max 
 
3.2.7 Extended NAT fluorescence probes 
Encouraged by the good optical activity of these NATs and the mechanistic insight for 
tuning optical emission, we prepared compounds 3.4a and 3.4b as two new molecular 
probes (Scheme 76). Considering the UV/blue emission was achieved through the 
extended conjugations between triazole and N-2 aryl groups, we postulated that the bis- 
triazoles should behave as good fluorophores with even stronger emission efficiency. 
                                                 
 See detailed computational results of all compounds 3.1e to 3.3o in the supporting 
information 
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Compound 3.4a was prepared and tested. As expected, the two triazole rings provide 
good conjugation with the central phenyl groups (dihedral angle measured from X-ray 
crystal structure), giving significantly improved UV emission with quantum yield at 0.76. 
Notably, the emission max is 390 nm, still in the UV/blue range even with the further 
extended conjugation. The fluorescence intensity of 3.4a was more than 3 times stronger 
that the commercial blue dye DSBP, while measured at identical condition (excitations at 
both 254 nm and 310 nm).  The styrene groups in 3.4a gave the extra synthetic handle for 
any further modification, such as polymerization and metathesis coupling, making 3.4a a 
promising UV probe for further investigation. 
Scheme 76: Extended NAT probes. 
N
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N
N
Ph
Ph
Ph
dihedral angle 11.3o
3.4a
N
N
N
Ph
3.4b
NH
O
COOMe
NHBoc
emission max = 390 nm, = 0.76;
3.5 times stronger emissition than DSBP;
dihedral angle determined by X-ray
emission max = 370 nm, = 0.35;
no peptide fluorescence quenching
 
Effective UV/blue dye for biological systems is rare since the protein substrates 
may quench the emission.  To verify the biocompatibility of the NAT fluorophore, 
compound 3.4b was synthesized through coupling NAT with protected lysine.  The 
optical properties of this amino acid modified NAT were tested.  We were pleased to find 
that no photoquenching was observed.  Notably, compound 3.4b possessed selected 
protected acid and amine groups, which made it easier to be coupled with biological 
targets through either the C-terminal or the N-terminal.  Considering the unique UV/blue 
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emission of this NAT, It is expected that the amino acid modified NAT could be good 
new UV fluorescence probe for various chemical and biological studies. 
3.3 Conclusion 
We herein report the N-2-aryl-triazole (NAT) as a novel class of effective UV/blue 
emitting dyes. Through a comprehensive comparison of the substituted groups on C-4, C-
5 and N-2 positions, a general trend was revealed regarding how to effectively adjust the 
photoactivity of these compounds. Both emission wavelengths (from 350 nm to 400 nm) 
and Stocks shift (from 38 nm to 98 nm) could be adjusted with various substituted 
functional groups. The computational studies and X-ray crystal structures confirmed the 
effective co-planar structures as the most stable conformation, which was unique to the 
N-2 isomers. This information could initiate the new strategies for future dye designs.  
Finally, further derivatizations gave highly efficient UV-emitting bis-triazoles and 
biocompatible amino acid NAT probes, thus supporting the potential use of these novel 
dyes in related chemical, material and biological applications. 
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0.37; in THF Φ = 0.34. 
175 
 
Supporting information 
Chapter One: Synthesis of functional 1,2,3-triazoles 
1.2 Efficient synthesis of N-2-aryl-1,2,3-triazole fluorophores via post-triazole arylation 
General Information 
Unless otherwise noted all commercial materials and solvents were obtained from commercial 
provider and used without further purification. Air and/or moisture-sensitive reactions were 
carried out under an atmosphere of nitrogen using oven/flamed-dried glassware and standard 
syringe/septa techniques. 1H and 13C NMR spectra were recorded with 600 MHz NMR 
spectrometer. The Chemical shifts were reported relative to internal tetramethylsilane (δ 0.00 
ppm) or CDCl3 (δ 7.26 ppm) or DMSO (δ 2.49 ppm) for 1H and CDCl3 (δ 77.0 ppm) or DMSO 
(δ 39.5 ppm) for 13C. Melting points were measured on a Mel-Temp 1001D apparatus and 
uncorrected. HRMS were recorded on LTQ-FTUHRA spectrometer. UV-visible spectra were 
obtained on a Shimadzu UV-2500. Fluorescence spectra for emission and excitation were 
obtained on a Hitachi 7000. 
 
 
1H-benzo[d][1,2,3]triazole (1.2.1a) is commercial available. 4-Phenyl-2H-1,2,3-triazole (1.2.1b) 
was prepared according to Zard’s procedure.1 Other N-H triazoles (1.2.1c, 1.2.1d, 1.2.1f-1.2.1j) 
were prepared according to our procedures.2,3 
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Procedure for synthesis of 4-benzyl-5-phenyl-2H-1,2,3-triazole (1.2.1e) 
 
N
NH
N
Ph
Ph
OH
Pd/C, H2, MeOH
N
NH
N
Ph
Ph
1.2.1e  
 
To a 100 mL round-bottom bottle was added phenyl(5-phenyl-2H-1,2,3-triazol-4-yl)methanol2 
(1.0 g),  10% Pd/C (0.4 g) and methanol (20 mL). The bottle was capped and filled with 
hydrogen and the reaction mixture was stirred at room temperature for 2d. After Pd/C was 
filtrated, the filtrate was concentrated. The residue was added water (15 mL) then extracted with 
ethyl acetate (3 x 15 mL). The combined organic phases were washed with brine and dried over 
anhydrous Na2SO4. The solvent was removed under reduced pressure and flash silica gel 
chromatography (hexane-EtOAc, v/v = 4/1) gave the product. Yield 70%, 1H NMR (600 MHz, 
CDCl3): δ 7.62-7.59 (m, 2H), 7.41-7.33 (m, 3H), 7.27 (t, J = 7.8 Hz, 2H), 7.22-7.17 (m, 3H), 
4.24 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 144.0, 141.3, 138.1, 130.2, 128.7, 128.7, 128.5, 
128.3, 127.6, 126.6, 31.1. 
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General procedure for SNAr reaction of triazole with halobenzene 
 
N
N
N
R2
R1
Ar
N
N
N
R2
R1
H + Ar X
DMSO, 2eq. K2CO3 N
N
N
R2
R1
Ar
3
2
1
+
1.2.1 1.2.2 1.2.3 N-1-1.2.3  
 
To a 50 mL round-bottom bottle was added triazole (1 mmol), fluoro or chloro-substituted 
benzene (1.5 mmol), potassium carbonate (2 mmol) and DMSO (2 mL). The reaction mixture 
was stirred at room temperature (or heated up to 80 oC) and monitored by TLC. After the 
reaction was completed, water (20 mL) was added. The mixture was extracted with ethyl acetate 
(3 x 30 mL). The combined organic phases were washed with brine and dried with anhydrous 
Na2SO4. The solvent was removed under reduced pressure to get a residue, the residue was 
purified by recrystallization or flash silica gel chromatography gave the product.  
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General procedure for microwave assisted Cu-catalyzed coupling of triazoles with 
aryliodide 
  
+ PhPh
N
NH
N
Ph
1.2.1c 1.2.4a
I
Cu cat., co-cat.
base, solv.
Ph
N
N
N
Ph
Ph
1.2.5a  
 
To 10 mL microwave tube was successively added 4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 
(1a) (98.8 mg, 0.4 mmol), base (0.8 mmol), copper catalyst (0.04 mmol), ligand (0.08 mmol), 
and iodobenzene  (125 mg, 0.6 mmol) under N2, and then anhydrous solvent (2 mL) was added 
by syringes. The tube was put into microwave reactor and heated to certain temperature for 30 
min. After cool, to the reaction mixture was added 1,3,5-trimethoxybenzene (15-20 mg, accurate 
to 0.1 mg), water (15 mL), 10% HCl solution (1 mL) and extracted with ethyl acetate (2 x 15 
mL). The combined organic phases were washed with brine (10 mL), dried over anhydrous 
Na2SO4 and concentrated in vacuo. The residue was used to NMR analysis directly. The data 
were listed in Table S1 and Table S2. 
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Screening reaction conditions 
Table S1.2-1: Screening of the reaction conditiona 
a 1.2.1c:1.2.4a = 1:1.5, C=0.2 M; b Based on the consumption of 1.2.1c and formation of 1.2.5a 
using 1,3,5-trimethoxybenzene as internal standard; c  use PhBr instead of PhI; d loading was 
decreased to 5%; e loading was decreased to 10%. 
Ent Cat(10%) 
Co-cat 
(20%) 
Base 
(2.5eq) 
Sol T(oC) t(h) Conv.b Yieldb 
1 CuI - K2CO3 DMSO 110 24 0 0 
2 CuI L-proline K2CO3 DMSO 110 24 100 71 
3 CuCl L-proline K2CO3 DMSO 110 24 100 88 
4 CuCl2 L-proline K2CO3 DMSO 110 24 64 42 
5 CuSO4 L-proline K2CO3 DMSO 110 24 37 11 
6 Cu(OAc)2 L-proline K2CO3 DMSO 110 24 92 79 
7 CuCl L-proline K2CO3 DMF 110 24 85 74 
8 CuCl L-proline K2CO3 CH3CN 110 24 73 60 
9 CuI L-proline K2CO3 DMSO mw110 0.5 62 32 
10 CuCl L-proline K2CO3 DMSO mw110 0.5 82 68 
11 CuCl2 L-proline K2CO3 DMSO mw110 0.5 80 49 
12 CuSO4 L-proline K2CO3 DMSO mw110 0.5 low trace 
13 Cu(OAc)2 L-proline K2CO3 DMSO mw110 0.5 81 51 
14 CuCl L-proline K2CO3 DMSO mw140 0.5 96 87 
15 CuCl L-proline K2CO3 DMSO mw160 0.5 98 92 
16 CuCl L-proline Cs2CO3 DMSO mw160 0.5 84 55 
17 CuCl L-proline KOH DMSO mw160 0.5 75 45 
18 CuCl L-proline K2CO3 DMF mw160 0.5 87 64 
19 CuCl L-proline Cs2CO3 DMF mw160 0.5 90 71 
20 CuCld L-prolinee K2CO3 DMSO mw160 0.5 82 73 
21c CuCl L-proline K2CO3 DMSO mw160 0.5 40 10 
22c CuCl L-proline Cs2CO3 DMSO mw160 0.5 68 36 
23c CuI L-proline Cs2CO3 DMSO mw160 0.5 85 53 
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Table S1.2-2: Ligand Screeninga 
 
a 1.2.1c:1.2.4a = 1:1.5, C=0.2 M; b Me-Gly: N-methyl glycine; DMG: N,N-dimethyl glycine; 
EDA: ethylenediamine; DMEDA: N,N’-dimethylethylenediamine; TMEDA: N,N,N’,N’-
tetramethylethylenediamine; DACH: 1,2-trans-diaminocyclohexane; bipy: 2,2’-bipyiridine; ABC:  
2-aminobenzoic acid; DMABC: 2-(dimethylamino)benzoic acid; DBC: 1,2-benzenedicarboxic 
acid; PDC: pyridine-2,6-dicarboxylic acid. 
Ent Cat(10%) Co-cat (20%) 
Base 
(2.5eq) Sol T(
oC) t(h) Conv.b Yieldb 
12 CuCl L-proline K2CO3 DMSO mw160 0.5 98 92 
24 CuCl pyrrolidine K2CO3 DMSO mw160 0.5 low trace 
25 CuCl glycine K2CO3 DMSO mw160 0.5 low trace 
26 CuCl Me-GLY K2CO3 DMSO mw160 0.5 60 30 
27 CuCl DMG K2CO3 DMSO mw160 0.5 98 86 
28 CuCl EDA K2CO3 DMSO mw160 0.5 53 29 
29 CuCl DMEDA K2CO3 DMSO mw160 0.5 70 47 
30 CuCl TMEDA K2CO3 DMSO mw160 0.5 low trace 
31 CuCl DACH K2CO3 DMSO mw160 0.5 53 44 
32 CuCl bipy K2CO3 DMSO mw160 0.5 47 trace 
33 CuCl ABC K2CO3 DMSO mw160 0.5 40 trace 
34 CuCl DMABC K2CO3 DMSO mw160 0.5 48 7 
35 CuCl BDC K2CO3 DMSO mw160 0.5 50 trace 
36 CuCl PDC K2CO3 DMSO mw160 0.5 32 trace 
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General procedure for microwave assisted Cu-catalyzed coupling of triazoles with 
aryliodide 
 
+ Ar
R1
N
NH
N
R2
I
10% CuCl, 20%pro. cat.
2 eq. K2CO3, DMSO, µw 160 oC
R1
N
N
N
R2
Ar
1.2.1 1.2.4 1.2.5  
 
To 10 mL microwave tube was successively added N-H triazole (0.8 mmol), potassium 
carbonate (220 mg, 1.6 mmol), L-proline (18 mg, 0.16 mmol), copper (I) chloride (8 mg, 0.08 
mmol) and iodobenzene (250 mg, 1.2 mmol) under N2, and then anhydrous solvent (2 mL) was 
added by syringes. The tube was put into microwave reactor and heated to certain temperature 
for 30 min. After cool, to the reaction mixture was added water (15 mL) and extracted with ethyl 
acetate (3 x 20 mL). The combined organic phases were washed with brine and dried over 
anhydrous Na2SO4. The solvent was removed under reduced pressure and flash silica gel 
chromatography gave the product. 
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General procedure for Cu-catalyzed coupling of triazoles with arylboronic acid 
 
+ 2 eq pyridineArPh
N
NH
N
Ph
1.2.1c
B(OH)2 Ph
N
N
N
Ph
Ar
1.2.71.2.6  
 
To 25 mL round-bottom bottle was successively added N-H triazole (1c) (0.4 mmol), arylboronic 
acid (0.8 mmol), THF 10 mL, pyridine (125 mg, 0.8 mmol) and copper (II) acetate (14 mg, 0.08 
mmol). The bottle was equipped with a condenser with an oxygen balloon on top of it. The 
reaction mixture was refluxed and monitored by TLC. After cool, the reaction mixture was 
concentrated and added water (15 mL) then extracted with ethyl acetate (3 x 20 mL). The 
combined organic phases were washed with brine and dried over anhydrous Na2SO4. The solvent 
was removed under reduced pressure and flash silica gel chromatography gave the product. 
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General procedure for UV/VIS and Fluorescence measurements 
UV/VIS absorption, fluorescence emission and excitation spectra were recorded in methanol 
solvents in 1 cm-length quartz cell. The solution concentrations were 3 x 10-6 M for absorption 
spectroscopy and fluorescence spectroscopy. Emission spectra were recorded with an excitation 
wavelength at 254 nm. 
 
 
 
 
 
 
 
 
Reference 
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Compounds Characterization 
 
N
N
N
NO2
NO2
1.2.3a  
2-(2,4-dinitrophenyl)-2H-benzo[d][1,2,3]triazole 1.2.3a: yield 24%; m.p. 166-167 oC; 1H NMR 
(600 MHz, CDCl3): δ 8.70 (d, J = 2.4 Hz, 1H), 8.60 ( dd, J = 9.0 Hz, 2.4 Hz, 1H), 8.47 (d, J = 
9.0 Hz, 1H), 7.87-7.85 (m, 2H), 7.46-7.44 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 146.8, 146.1, 
143.4, 136.3, 129.0, 127.1, 126.7, 120.7, 118.7; UV (MeOH) λmax 221 (ε = 36000), 321 (ε = 
20000); HRMS Calculated for [C12H7N5O4+H]+: 286.05708, Found: 286.05725. 
 
N
N
N NO2
NO2
N-1-1.2.3a  
1-(2,4-dinitrophenyl)-1H-benzo[d][1,2,3]triazole N-1-1.2.3a: yield 74%; m.p. 185-187 oC; 1H 
NMR (600 MHz, CDCl3): δ 9.00 (d, J = 2.4 Hz, 1H), 8.70 (dd, J = 9.0 Hz, 2.4 Hz, 1H), 8.21 (d, J 
= 8.4 Hz, 1H), 8.02 (d, J = 9.0 Hz, 1H), 7.63 (t, J = 8.4 Hz, 1H), 7.52 (t, J = 8.4 Hz, 1H), 7.45 (d, 
J = 8.4 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 147.4, 146.3, 144.2, 134.3, 132.5, 129.8, 128.5, 
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128.4, 125.4, 121.8, 121.2, 108.8; UV (MeOH) λmax 221 (ε = 48000); HRMS Calculated for 
[C12H7N5O4+H]+: 286.05708, Found: 286.05709. 
 
N
N
N
Ph
O2N
NO2
1.2.3b  
2-(2,4-dinitrophenyl)-4-phenyl-2H-1,2,3-triazole 1.2.3b: yield 60%; m.p. 187-189 oC; 1H 
NMR (600 MHz, d6-DMSO): δ 8.99 (d, J = 2.4 Hz, 1H), 8.86 (s, 1H), 8.68 (dd, J = 9.0 Hz, 2.4 
Hz, 1H), 8.41 (d, J = 9.0 Hz, 1H), 7.96-7.94 (m, 2H), 7.78-7.77 (m, 2H), 7.76-7.74 (m, 1H); 13C 
NMR (125 MHz, d6-DMSO):  δ 151.4, 146.7, 142.2, 137.2, 134.7, 130.7, 130.0, 128.83, 128.81, 
127.0, 125.5, 121.8; HRMS Calculated for [C14H9N5O4+H]+: 312.07273, Found: 312.07280. 
 
N
N
N
Ph O2N
NO2
N-1-1.2.3b  
1-(2,4-dinitrophenyl)-4-phenyl-1H-1,2,3-triazole N-1-1.2.3b: yield 38%; m.p. 202-204 oC; 1H 
NMR (600 MHz, d6-DMSO): δ 9.30 (s, 1H), 8.98 (d, J = 2.4 Hz, 1H), 8.76 (dd, J = 9.0 Hz, 2.4 
Hz, 1H), 8.25 (d, J = 9.0 Hz, 1H), 7.91 (dd, J = 8.4 Hz, 1.2 Hz, 2H), 7.54-7.46 (m, 2H), 7.40 (t, J 
= 8.4 Hz, 1H); 13C NMR (125 MHz, d6-DMSO): δ 148.2, 148.1, 144.1, 133.5, 130.1, 129.8, 
129.5, 129.4, 128.6, 126.2, 123.2, 122.1; HRMS Calculated for [C14H9N5O4+H]+: 312.07273, 
Found: 312.07277. 
186 
 
 
N
N
NPh
Ph
O2N
NO2
1.2.3c  
2-(2,4-dinitrophenyl)-4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.2.3c: yield 84%; m.p. 
156-158 oC; 1H NMR (600 MHz, CDCl3): δ 8.62 (d, J = 2.4 Hz, 1H), 8.52 (dd, J = 9.0 Hz, 2.4 
Hz, 1H), 8.37 (d, J = 9.0 Hz, 1H), 7.64-7.61 (m, 2H), 7.37-7.34 (m, 2H), 7.32-7.25 (m, 6H), 5.98 
(s, 1H), 5.66 (s, 1H); 13C NMR (125 MHz, CDCl3):  δ 149.6, 149.0, 145.6, 141.9, 138.1, 137.6, 
135.2, 129.4, 128.55, 128.52, 128.51, 127.9, 126.9, 126.7, 124.3, 120.8, 120.2; UV (MeOH) λmax 
221 (ε = 116000), 266 (ε = 83600), 336 (ε = 33600); HRMS Calculated for [C22H15N5O4+H]+: 
414.11968, Found: 414.11997.  
 
N
N
NPh
Ph
O O2N
NO2
1.2.3d  
(2-(2,4-dinitrophenyl)-5-phenyl-2H-1,2,3-triazol-4-yl)(phenyl)methanone 1.2.3d: yield 92%; 
m.p. 164-166 oC; 1H NMR (600 MHz, d6-DMSO): δ 9.03 (d, J = 2.4 Hz, 1H), 8.73 (dd, J = 9.0 
Hz, 2.4 Hz, 1H), 8.49 (d, J = 9.0 Hz, 1H), 8.06 (d, J = 7.3 Hz, 2H), 7.81-7.67 (m, 3H), 7.60 (t, J 
= 7.8 Hz, 2H), 7.47-7.45 (m, 3H); 13C NMR (125 MHz, d6-DMSO): δ 186.7, 151.0, 146.9, 144.4, 
142.1, 135.9, 134.4, 133.7, 130.2, 130.1, 128.71, 128.69, 128.5, 128.3, 127.8, 126.2, 121.2; UV 
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(MeOH) λmax 221 (ε = 97600), 266 (ε = 76900); HRMS Calculated for [C21H13N5O5+H]+: 
416.09916, Found: 416.09895.  
 
N
N
NPh
Ph
NO2
1.2.3e  
2-(4-nitrophenyl)-4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.2.3e: yield 98%; m.p. 147-
149 oC; 1H NMR (600 MHz, CDCl3): δ 8.35 (d, J = 9.6 Hz, 2H), 8.32 (d, J = 9.6 Hz, 2H), 7.65-
7.63 (m, 2H), 7.40-7.38 (m, 2H), 7.26-7.24 (m, 6H), 5.97 (s, 1H), 5.67 (s, 1H); 13C NMR (125 
MHz, CDCl3): δ 148.4, 147.7, 146.2, 143.5, 138.7, 128.0, 129.3, 128.9, 128.47, 128.42, 128.37, 
127.8, 126.8, 125.1, 119.6, 118.8; UV (MeOH) λmax 336 (ε = 28600); HRMS Calculated for 
[C22H16N4O2+H]+: 369.13460, Found: 369.13481. 
 
N
N
NPh
Ph
CN
1.2.3f  
4-(4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazol-2-yl)benzonitrile 1.2.3f: yield 62%; m.p. 134-
135oC; 1H NMR (600 MHz, d6-DMSO): δ 8.26 (d, J = 8.4 Hz, 2H), 8.06 (d, J = 8.4 Hz, 2H), 
7.65-7.62 (m, 2H), 7.42-7.26 (m, 8H), 6.12 (s, 1H), 5.66 (s, 1H); 13C NMR (125 MHz, d6-
DMSO): δ 147.1, 146.9, 141.5, 137.9, 137.5, 134.1, 129.0, 128.9, 128.6, 128.4, 127.3, 126.4, 
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120.0, 118.8, 118.2, 109.9; UV (MeOH) λmax 210 (ε = 39100), 314 (ε = 28600); HRMS 
Calculated for [C23H16N4+H]+: 349.14477, Found: 349.14486. 
 
N
N
NPh
Ph
Ph
1.2.5a  
2,4-diphenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.2.5a: yield 87%; oil; 1H NMR (600 MHz, 
CDCl3): δ 8.17 (d, J = 8.4 Hz, 2H), 7.69 (d, J = 8.4 Hz, 2H), 7.47 ( t, J = 7.8 Hz, 2H), 7.40 (d, J 
= 8.4 Hz, 2H), 7.33 (t, J = 7.2 Hz, 1H), 7.30-7.20 (m, 6H), 5.93 (s, 1H), 5.64 (s, 1H); 13C NMR 
(125 MHz, CDCl3): δ 146.6, 145.9, 139.7, 139.2, 138.5, 130.2, 129.2, 128.35, 128.28, 128.13, 
127.7, 127.4, 126.8, 118.9, 118.8; UV (MeOH) λmax 297 (ε = 36300), 266 (ε = 76900); HRMS 
Calculated for [C22H17N3+H]+: 324.14952, Found: 324.14964. 
 
N
N
N
Ph
1.2.5b  
2-phenyl-2H-benzo[d][1,2,3]triazole 1.2.5b: yield 8%; m.p. 109-110 oC; 1H NMR (600 MHz, 
CDCl3): δ 8.36 (d, J = 7.2 Hz, 2H), 7.95-7.92 (m, 2H), 7.55 (t, J = 7.2 Hz, 2H), 7.45 (t, J = 7.2 
Hz, 1H), 7.44-7.40 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 145.0, 140.4, 129.4, 128.9, 127.2, 
120.6, 118.4; UV (MeOH) λmax 222 (ε = 48800), 310 (ε = 29600); HRMS Calculated for 
[C12H9N3+H]+: 196.08692, Found: 196.08691. 
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N
N
N
Ph
N-1-1.2.5b  
1-phenyl-1H-benzo[d][1,2,3]triazole N-1-1.2.5b: yield 60%; m.p. 85-87 oC; 1H NMR (600 
MHz, CDCl3): δ 8.14 (d, J = 8.4 Hz, 1H), 7.78 (d, J = 7.8 Hz, 2H), 7.74 (d, J = 8.4 Hz, 1H), 7.60 
(d, J = 7.8 Hz, 2H), 7.53 (t, J = 7.2 Hz, 1H), 7.49 (t, J = 7.8 Hz, 1H); 7.42 (t, J = 7.8 Hz, 1H); 13C 
NMR (125 MHz, CDCl3): δ 146.4, 136.9, 132.2, 129.8, 128.6, 128.2, 124.3, 122.8, 120.2, 110.3; 
UV (MeOH) λmax 222 (ε = 41400); HRMS Calculated for [C12H9N3+H]+: 196.08692, Found: 
196.08688. 
 
N
N
N
Ph
Ph
1.2.5c  
2,4-diphenyl-2H-1,2,3-triazole 1.2.5c: yield 68%; m.p. 43-45oC; 1H NMR (600 MHz, CDCl3): δ 
8.13 (d, J = 8.4 Hz, 2H), 8.04 (s, 1H), 7.89 (d, J = 7.2 Hz, 2H), 7.50-7.43 (m, 4H), 7.37 (t, J = 
7.2 Hz, 1H), 7.33 (t, J = 7.2 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 148.8, 139.9, 130.5, 130.0, 
129.2, 128.9, 128.8, 127.4, 126.1, 118.8; UV (MeOH) λmax 221 (ε = 44700), 294 (ε = 34700); 
HRMS Calculated for [C14H11N3+H]+: 222.10257, Found: 222.10262. 
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N
N
N
Ph
Ph
N-1-1.2.5c  
1,4-diphenyl-1H-1,2,3-triazole N-1-1.2.5c: yield 11%; m.p. 186-187oC; 1H NMR (600 MHz, 
CDCl3): δ 8.19 (s, 1H), 7.93-7.90 (m, 2H), 7.82-7.78 (m, 2H), 7.50-7.43 (m, 2H), 7.48-7.44 (m, 
3H), 7.37 (t, J = 7.2 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 148.4, 137.1, 130.3, 129.8, 128.9, 
128.8, 128.4, 125.8, 120.5, 117.6; UV (MeOH) λmax 222 (ε = 5100); HRMS Calculated for 
[C14H11N3+H]+: 222.10257, Found: 222.10269. 
 
N
N
NPh
Ph
O
Ph
1.2.5d  
Phenyl(2,5-diphenyl-2H-1,2,3-triazol-4-yl)methanone 1.2.5d: yield 85%; m.p. 115-117 oC; 1H 
NMR (600 MHz, d6-DMSO): δ 8.14-8.10 (m, 4H), 7.87-7.83 (m, 2H), 7.74 (t, J = 7.8 Hz, 1H), 
7.63 (t, J = 7.8 Hz, 2H), 7.60 (t, J = 7.8 Hz, 2H), 7.55-7.48 (m, 4H); 13C NMR (125 MHz, d6-
DMSO): δ 188.1, 150.3, 143.4, 139.3, 137.3, 134.6, 130.9, 130.5, 130.1, 129.6, 129.5, 129.3, 
129.19, 129.18, 119.9; UV (MeOH) λmax 210 (ε = 45200), 263 (ε = 30600); HRMS Calculated 
for [C21H15N3O+H]+: 326.12879, Found: 326.12876. 
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N
N
NPh
Ph
Ph
1.2.5e  
4-benzyl-2,5-diphenyl-2H-1,2,3-triazole 1.2.5e: yield 85%; m.p. 93-95 oC; 1H NMR (600 MHz, 
CDCl3): δ 8.14-8.11 (m, 2H), 7.69-7.65 (m, 2H), 7.50-7.45 (m, 2H), 7.42-7.24 (m, 8H), 7.23-
7.18 (m, 1H), 4.31 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 146.9, 145.0, 139.8, 138.4, 130.6, 
129.2, 128.7, 128.6, 128.5, 128.4, 127.7, 127.1, 126.5, 118.6, 31.7; UV (MeOH) λmax 221 (ε = 
37700), 290 (ε = 29900); HRMS Calculated for [C21H17N3+H]+: 312.14952, Found: 312.14965. 
 
N
N
N
Ph
Ph
O
HO
1.2.5f  
6-hydroxy-1-(2,5-diphenyl-2H-1,2,3-triazol-4-yl)hexan-1-one 1.2.5f: yield 60%; m.p. 73-75 oC; 
1H NMR (600 MHz, CDCl3): δ 8.18 (d, J = 8.4 Hz, 2H), 8.01 (d, J = 7.2 Hz, 2H), 7.53 (t, J = 7.2 
Hz, 2H), 7.50-7.40 (m, 4H), 3.67 (t, J = 6.6 Hz, 2H), 3.21 (t, J = 7.2 Hz, 2H), 1.84-1.77 (m, 2H), 
1.66-1.61 (m, 2H), 1.61-1.52 (br, 1H), 1.52-1.45 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 195.3, 
149.5, 143.2, 139.2, 129.5, 129.43, 129.40, 129.3, 128.5, 128.2, 119.3, 62.7, 40.6, 32.5, 25.4, 
23.6; UV (MeOH) λmax 221 (ε = 40200); HRMS Calculated for [C20H21N3O2+H]+: 336.17065, 
Found: 336.17086. 
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N
N
NPh
Ph
Ph
1.2.5g  
2,4-diphenyl-5-(1-phenylethyl)-2H-1,2,3-triazole 1.2.5g: yield 85%; oil; 1H NMR (600 MHz, 
CDCl3): δ 8.17 (d,  J = 8.4 Hz, 2H), 7.56 (d,  J = 7.2 Hz, 2H), 7.49 (t,  J = 8.4 Hz, 2H), 7.41-7.27 
(m, 8H), 7.20 (t, J = 7.2 Hz, 1H), 4.43 (q, J = 7.2 Hz, 1H), 1.76  (d, J = 7.2 Hz, 3H); 13C NMR 
(125 MHz, CDCl3): δ 149.9, 146.7, 145.0, 140.2, 131.0, 129.4, 128.8, 128.75, 128.5, 128.4, 
127.8, 127.2, 126.6, 118.9, 37.2, 23.3; UV (MeOH) λmax 221 (ε = 48400), 285 (ε = 34800); 
HRMS Calculated for [C22H19N3+H]+: 326.16517, Found: 326.16535. 
 
N
N
NPh
Ph
1.2.5h  
4-(naphthalen-1-yl)-2-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.2.5h: yield 87%; oil; 1H 
NMR (600 MHz, CDCl3): δ 8.19 (d, J = 7.2 Hz, 2H), 7.96 (d, J = 7.8 Hz, 1H), 7.82-7.76 (m, 2H), 
7.51-7.40 (m, 5H), 7.40-7.32 (m, 2H); 7.32-7.27 (m, 2H), 7.12-7.08 (m, 3H), 5.53 (s, 1H), 5.48 (s, 
1H); 13C NMR (125 MHz, CDCl3): δ 147.6, 146.3, 139.8, 139.0, 138.9, 133.6, 131.6, 129.2, 
129.1, 128.3, 128.2, 128.1, 127.8, 127.7, 127.4, 127.3, 126.4, 125.9, 125.7, 125.0, 118.8, 118.7; 
UV (MeOH) λmax 221 (ε = 96900), 295 (ε = 34600); HRMS Calculated for [C26H19N3+H]+: 
374.16517, Found: 374.16535. 
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N
N
N
Ph
Ph
1.2.5i  
4-cyclohexenyl-2,5-diphenyl-2H-1,2,3-triazole 1.2.5i: yield 80%; oil; 1H NMR (600 MHz, 
CDCl3): δ 8.11 (d, J = 7.8 Hz, 2H), 7.74 (d, J = 6.6 Hz, 2H), 7.48-7.41 (m, 4H), 7.40-7.35 (m, 
1H), 7.31 (t, J = 7.2 Hz, 1H), 6.12-6.11 (m, 1H), 2.43-2.39 (m, 2H), 2.19-2.14 (m, 2H), 1.80-1.74 
(m, 2H), 1.73-1.65 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 147.9, 145.4, 139.8, 131.5, 130.1, 
129.1, 128.6, 128.5, 128.3, 128.2, 127.0, 118.6, 27.6,  25.5,  22.7,  21.9; UV (MeOH) λmax 221 (ε 
= 70800), 290 (ε = 47300); HRMS Calculated for [C20H19N3-Ph+2H]+: 226.13387, Found: 
226.13388. 
 
N
N
N
Ph
OH
1.2.5j  
1-(5-cyclohexenyl-2-phenyl-2H-1,2,3-triazol-4-yl)naphthalen-2-ol 1.2.5j: yield 45%; m.p. 
124-126 oC; 1H NMR (600 MHz, CDCl3): δ 8.13 (d, J = 7.8 Hz, 2H), 7.84 (d, J = 9.0 Hz, 1H), 
7.79 (d, J = 7.8 Hz, 1H), 7.51-7.46 (m, 3H), 7.40-7.30 (m, 3H), 7.28 (d, J = 9.0 Hz, 1H); 6.55 (s, 
1H), 5.83 (s, 1H), 2.40-2.36 (m, 2H), 1.88-1.84 (m, 2H), 1.64-1.58 (m, 2H), 1.53-1.48 (m, 2H); 
13C NMR (125 MHz, CDCl3): δ 152.4, 149.7, 139.5, 139.4, 132.3, 131.1, 130.1, 129.3, 128.9, 
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128.2, 127.7, 127.5, 126.7, 124.7, 123.6, 118.6, 117.9, 110.2, 26.5, 25.5, 22.4, 21.7; UV (MeOH) 
λmax 227 (ε = 103000), 292 (ε = 37400); HRMS Calculated for [C24H21N3O+H]+: 368.17574, 
Found: 368.17578. 
 
N
N
N
OH
N-3-1.2.5j
Ph
 
4-cyclohexenyl-5-(2-phenoxynaphthalen-1-yl)-2H-1,2,3-triazole N-3-1.2.5j: yield 40%; m.p. 
313-315 oC; 1H NMR (600 MHz, d6-DMSO): δ 10.23 (s, 1H), 7.82 (d, J = 9.0 Hz, 1H), 7.74 (d, J 
= 7.8 Hz, 1H), 7.32-7.17 (m, 8H), 7.00 (d, J = 8.4 Hz, 1H), 5.91 (s, 1H), 2.24-2.11 (m, 2H), 1.88-
1.70 (m, 2H), 1.45-1.34 (m, 4H); 13C NMR (125 MHz, d6- DMSO): δ 155.2, 147.2, 137.2, 133.9, 
132.3, 129.6, 129.5, 129.0, 128.8, 128.4, 128.2, 128.1, 125.4, 124.6, 123.8, 123.3, 118.7, 107.6, 
26.3, 25.4, 22.7, 22.2; HRMS Calculated for [C24H21N3O+H]+: 368.17574, Found: 368.17588. 
 
N
N
NPh
Ph
1.2.5k  
4-phenyl-5-(1-phenylvinyl)-2-p-tolyl-2H-1,2,3-triazole 1.2.5k: yield 86%; 70-72 oC; 1H NMR 
(600 MHz, CDCl3): δ 8.04 (d, J = 7.8 Hz, 2H), 7.69-7.67 (m, 2H), 7.41-7.38 (m, 2H), 7.28-7.20 
(m, 8H), 5.92 (s, 1H), 5.63 (s, 1H), 2.38 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 146.3, 145.6, 
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139.3, 138.6, 137.6, 137.3, 130.3, 129.7, 128.3, 128.26, 128.2, 128.1, 127.7, 126.8, 118.8, 118.7, 
21.0; UV (MeOH) λmax 296 (ε = 21700); HRMS Calculated for [C23H19N3O+H]+: 338.14517, 
Found: 338.16510. 
 
N
N
NPh
Ph
O
NO2
1.2.5l  
(2-(4-nitrophenyl)-5-phenyl-2H-1,2,3-triazol-4-yl)(phenyl)methanone 1.2.5l: yield 88%; m.p. 
151-153 oC; 1H NMR (600 MHz, d6-DMSO): δ 8.46 (d, J = 9.0 Hz, 2H), 8.34 (d, J = 9.0 Hz, 2H), 
8.11 (d, J = 8.4 Hz, 2H), 7.86-7.81 (m, 2H), 7.75 (t, J = 7.2 Hz, 1H), 7.61 (t, J = 7.8 Hz, 2H), 
7.52-7.48 (m, 3H); 13C NMR (125 MHz, d6-DMSO): δ 187.2, 150.4, 146.6, 143.9, 142.5, 136.3, 
134.2, 130.3, 129.8, 128.7, 128.6, 128.5, 128.4, 125.6, 119.9; UV (MeOH) λmax 222 (ε = 48300), 
322 (ε = 31300); HRMS Calculated for [C21H14N4O3+H]+: 371.11387, Found: 371.11409. 
 
N
N
NPh
Ph
O
1.2.5m  
2-(4-methoxyphenyl)-4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.2.5m: yield 74%; oil; 1H 
NMR (600 MHz, CDCl3): δ 8.07 (d, J = 9.0 Hz, 2H), 7.69-7.66 (m, 2H), 7.41-7.39 (m, 2H), 
7.28-7.20 (m, 6H), 7.98 (d, J = 9.0 Hz, 2H), 5.92 (s, 1H), 5.63 (s, 1H), 3.84 (s, 3H); 13C NMR 
(125 MHz, CDCl3): δ 158.9, 146.1, 145.4, 139.2, 138.6, 133.5, 130.3, 128.32, 128.25, 128.13, 
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128.08, 127.6, 126.8, 120.2, 118.8, 114.3, 55.5; HRMS Calculated for [C23H19N3O+H]+: 
354.16009, Found: 354.16012. 
 
N
N
N
Ph
1.2.5n  
4-cyclohexenyl-5-phenyl-2-o-tolyl-2H-1,2,3-triazole 1.2.5n: yield 70%; oil; 1H NMR (600 
MHz, CDCl3): δ 7.78-7.72 (m, 2H), 7.66-7.64 (m, 1H), 7.45-7.40 (m, 2H), 7.40-7.35 (m, 1H), 
7.34-7.27 (m, 3H), 6.13-6.10 (m, 1H), 2.47 (s, 3H), 2.45-2.39 (m, 2H), 2.18-2.13 (m, 2H), 1.79-
1.74 (m, 2H), 1.71-1.66 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 147.2, 144.7, 139.5, 132.5, 
131.61, 131.59, 129.7, 128.5, 128.4, 128.3, 128.1(may 2), 126.5, 125.0, 27.6, 25.5, 22.7, 21.9, 
19.2; UV (MeOH) λmax 221 (ε = 51700); HRMS Calculated for [C21H21N3+H]+: 316.18082, 
Found: 316.18098. 
 
N
N
NPh
Ph
I
1.2.5o  
2-(4-iodophenyl)-4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.2.5o: yield 67%; oil; 1H 
NMR (600 MHz, CDCl3): δ 7.91 (d, J = 9.0 Hz, 2H), 7.78 (d, J = 9.0 Hz, 2H), 7.69 (dd, J = 7.8 
Hz, 1.8 Hz, 2H), 7.38 (dd, J = 7.8 Hz, 1.8 Hz, 2H), 7.29-7.10 (m, 6H), 5.93 (s, 1H), 5.63 (s, 1H); 
13C NMR (125 MHz, CDCl3): δ 147.0, 146.3, 139.4, 139.1, 138.4, 138.3, 129.9, 128.5, 128.4, 
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128.3, 128.2, 127.7, 126.8, 120.5, 119.1, 91.9; UV (MeOH) λmax 220 (ε = 66200), 304 (ε = 
49900); HRMS Calculated for [C22H16IN3+H]+: 450.04617, Found: 450.04614. 
 
N
N
NPh
Ph N
1.2.5p  
2-(4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazol-2-yl)pyridine 1.2.5p: yield 88%; m.p. 103-105 
oC; 1H NMR (600 MHz, CDCl3): δ 8.64 (s, 1H), 8.16 (d, J = 7.2 Hz, 1H), 7.88 (t, J = 7.8 Hz, 1H), 
7.76-7.70 (m, 2H), 7.40-7.36 (m, 2H), 7.32 (br, 1H), 7.28-7.20 (m, 6H), 5.96 (s, 1H), 5.70 (s, 
1H); 13C NMR (125 MHz, CDCl3): δ 150.7, 148.9, 147.8, 147.2, 138.9, 138.8, 128.3, 129.6, 
128.5, 128.3, 128.2, 128.1, 127.9, 126.8, 122.8, 119.4, 113.8;  HRMS Calculated for 
[C21H16N4+H]+: 325.14477, Found: 325.14470. 
 
N
N
NPh
Ph
O
N
1.2.5q  
Phenyl(5-phenyl-2-(pyridin-2-yl)-2H-1,2,3-triazol-4-yl)methanone 1.2.5q: yield 83%; m.p. 
133-135 oC; 1H NMR (600 MHz, CDCl3): δ 8.64 (dd, J = 4.8 Hz, 1.2 Hz, 1H), 8.17 (d, J = 8.4 Hz, 
1H), 8.12 (d, J = 8.4 Hz, 2H), 7.94-7.89 (m, 3H), 7.62 (t, J = 7.8 Hz, 1H), 7.48 (t, J = 7.8 Hz, 
2H), 7.42-7.40 (m, 3H), 7.39 (dd, J = 7.2 Hz, 4.8 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 188.0, 
150.8, 150.6, 149.1, 144.0, 139.0, 136.9, 133.7, 130.5, 129.5, 128.9, 128.8, 128.5, 128.4, 123.7, 
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114.4; UV (MeOH) λmax 221 (ε = 39200), 289 (ε = 29900); HRMS Calculated for 
[C20H14N4O+H]+: 327.12404, Found: 327.12404. 
 
N
N
NPh
Ph N
1.2.5r  
3-(4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazol-2-yl)pyridine 1.2.5r: yield 70%; 99-101 oC; 1H 
NMR (600 MHz, CDCl3): δ 9.47 (s, 1H), 8.61 (s, 1H), 8.45-8.42 (m, 1H), 7.71-7.67 (m, 2H), 
7.43 (dd, J = 7.8 Hz, 4.8 Hz, 1H), 7.41-7.37 (m, 2H), 7.31-7.23 (m, 6H), 5.96 (s, 1H), 5.66 (s, 
1H); 13C NMR (125 MHz, CDCl3): δ 148.2, 147.5, 146.8, 140.4, 138.9, 138.2, 136.1, 129.7, 
128.5, 128.4, 128.35, 128.25, 127.7, 126.8, 125.8, 123.7, 119.3,; UV (MeOH) λmax 221 (ε = 
68500), 301 (ε = 28400); HRMS Calculated for [C21H16N4+H]+: 325.14477, Found: 325.14474. 
 
N
N
NPh
Ph
N
1.2.5s  
4-(4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazol-2-yl)pyridine 1.2.5s: yield 70%; m.p. 107-
108oC; 1H NMR (600 MHz, d6-DMSO): δ 8.80 (bs, 2H), 8.06 (br, 2H), 7.70-7.66 (m, 2H), 7.43-
7.27 (m, 8H), 6.14 (s, 1H), 5.67 (s, 1H); 13C NMR (125 MHz, d6-DMSO): δ 151.4, 147.3, 147.1, 
144.5, 137.8, 137.5, 129.0, 128.9, 128.6, 128.5, 128.4, 127.3, 126.4, 120.0, 112.3; HRMS 
Calculated for [C21H16N4+H]+: 325.14477, Found: 325.14495. 
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N
N
NPh
Ph
O
N
1.2.5t  
Phenyl(5-phenyl-2-(pyridin-4-yl)-2H-1,2,3-triazol-4-yl)methanone 1.2.5t: yield 60%; m.p. 
119-121 oC; 1H NMR (600 MHz, CDCl3): δ 8.83 (br, 2H), 8.10 (d, J = 8.4 Hz, 4H), 7.90-7.84 (m, 
2H), 7.63 (t, J = 7.8 Hz, 1H), 7.50 (t, J = 7.8 Hz, 2H), 7.46-7.41 (m, 3H); 13C NMR (125 MHz, 
CDCl3): δ 187.5, 151.3, 151.1, 145.2, 144.3, 136.7, 133.9, 130.5, 129.8, 128.7, 128.67, 128.57, 
128.52, 113.3; UV (MeOH) λmax 221 (ε = 64300); HRMS Calculated for [C20H14N4O+H]+: 
327.12404, Found: 327.12402. 
 
N
N
NPh
Ph
1.2.5u  
2-(naphthalen-1-yl)-4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.2.5u: yield 70%; m.p. 96-
98 oC; 1H NMR (600 MHz, CDCl3): δ 8.44 (d, J = 8.4 Hz, 1H), 7.98-7.90 (m, 3H), 7.74 (dt, J = 
6.6 Hz, 1.8 Hz, 2H), 7.60-7.52 (m, 3H), 7.46 (dt, J = 6.6 Hz, 1.8 Hz, 2H), 7.30-7.22 (m, 6H), 
5.96 (s, 1H), 5.72 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 146.6, 145.9, 139.2, 138.7, 136.6, 
134.5, 130.2, 129.5, 128.4, 128.33, 128.31, 128.2, 128.16, 127.8, 127.43, 127.38, 126.9, 126.6, 
125.0, 123.7, 122.7, 119.1; UV (MeOH) λmax 222 (ε = 75300); HRMS Calculated for 
[C26H19N3+H]+: 374.16517, Found: 374.16534. 
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N
N
NPh
Ph Ph
PhN
N
N
1.2.5v  
4-phenyl-2-(4-(4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazol-2-yl)phenyl)-5-(1-phenylvinyl)-
2H-1,2,3-triazole 1.2.5v: yield 10%; m.p. 177-179oC; 1H NMR (600 MHz, CDCl3): δ 8.31 (s, 
4H), 7.70 (dd, J = 7.8 Hz, 1.8 Hz, 4H), 7.42 (dd, J = 7.8 Hz, 1.8 Hz, 4H), 7.31-7.24 (m, 12H), 
5.97 (s, 2H), 5.68 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 147.0, 146.3, 139.1, 138.5, 138.4, 
130.0, 128.5, 128.42, 128.36, 128.2, 127.7, 126.9, 119.5, 119.2; UV (MeOH) λmax 332 (ε = 
63800); HRMS Calculated for [C38H28N6+H]+: 569.24482, Found: 569.24498. 
 
N
N
NPh
Ph
S
1.2.7a  
4-phenyl-5-(1-phenylvinyl)-2-(thiophen-2-yl)-2H-1,2,3-triazole 1.2.7a: yield 40%; m.p. 83-
85oC; 1H NMR (600 MHz, CDCl3): δ 7.67-7.65 (m, 2H), 7.51 (dd, J = 3.6 Hz, 1.8 Hz, 1H), 7.40-
7.38 (m, 2H), 7.28-7.22 (m, 6H), 7.09 (dd, J = 5.4 Hz, 1.8 Hz, 1H), 7.00 (dd, J = 5.4 Hz, 3.6 Hz, 
1H), 5.94 (s, 1H), 5.65 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 146.7, 146.0, 142.6, 138.8, 138.3, 
129.7, 128.4, 128.36, 128.3, 128.2, 127.7, 126.8, 126.4, 121.0, 119.2, 115.9; HRMS Calculated 
for [C20H15N3S+H]+: 330.10594, Found: 330.10602. 
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1.2.7b  
4-phenyl-5-(1-phenylvinyl)-2-(thiophen-3-yl)-2H-1,2,3-triazole 1.2.7b: yield 60%; oil; 1H 
NMR (600 MHz, CDCl3): δ 7.73 (dd, J = 3.0 Hz, 1.2 Hz, 1H), 7.71 (dd, J = 4.8 Hz, 1.2 Hz, 1H), 
7.67-7.64 (m, 2H), 7.40-7.37 (m, 2H), 7.34 (dd, J = 5.4 Hz, 3.6 Hz, 1H), 7.27-7.19 (m, 6H), 5.92 
(s, 1H), 5.62 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 146.1, 145.4, 139.3, 139.1, 138.4, 130.0, 
128.33, 128.27, 128.1, 127.6, 126.8, 126.3, 120.5, 119.0, 112.2; HRMS Calculated for 
[C20H15N3S+H]+: 330.10594, Found: 330.10600. 
 
N
N
NPh
Ph S
1.2.7c  
2-(benzo[b]thiophen-2-yl)-4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.2.7c: yield 50%; 
259-261oC; 1H NMR (600 MHz, CDCl3): δ 7.80 (d, J = 8.4 Hz, 1H), 7.77 (d, J = 7.2 Hz, 1H), 7. 
74 (s, 1H), 7.68-7.66 (m, 2H), 7.41-7.32 (m, 4H), 7.29-7.22 (m, 6H), 5.96 (s, 1H), 5.68 (s, 1H); 
13C NMR (125 MHz, CDCl3): δ 147.3, 146.7, 141.6, 138.7, 138.5, 138.2, 136.2, 129.5, 128.6, 
128.4, 128.35, 128.26, 127.8, 126.8, 125.1, 124.8, 124.0, 122.3, 119.5, 111.4; HRMS Calculated 
for [C24H17N3S+H]+: 380.12159, Found: 380.12166. 
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1.2.7d  
2-(furan-2-yl)-4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.2.7d: yield 30%; oil; 1H NMR 
(600 MHz, CDCl3): δ 7.59-7.57 (m, 2H), 7.32-7.28 (m, 3H), 7.20-7.15 (m, 6H), 6.56 (dd, J = 3.6 
Hz, 1.2 Hz, 1H), 6.48 (dd, J = 3.0 Hz, 1.8 Hz, 1H), 5.87 (s, 1H), 5.58 (s, 1H); 13C NMR (125 
MHz, CDCl3): δ 147.1, 146.4, 139.6, 138.7, 138.3, 132.2, 129.5, 128.6, 128.4, 128.3, 128.2, 
127.8, 126.8, 119.4, 111.9, 97.7; HRMS Calculated for [C20H15N3O+H]+: 314.12879, Found: 
314.12884. 
 
N
N
NPh
Ph
O
1.2.7e  
2-(furan-3-yl)-4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.2.7e: yield 50%; oil; 1H NMR 
(600 MHz, CDCl3): δ 8.06 (s, 1H), 7.64 (dd, J = 7.8 Hz, 1.8 Hz, 2H), 7.45 (t, J = 1.2 Hz, 1H), 
7.40-7.36 (m, 2H), 7.28-7.21 (m, 6H), 7.04 (d, J = 1.2 Hz, 1H), 5.92 (s, 1H), 5.62 (s, 1H); 13C 
NMR (125 MHz, CDCl3): δ 146.3, 145.5, 143.4, 139.0, 138.4, 132.8, 130.1, 129.9, 128.4, 128.3, 
128.2, 127.7, 126.8, 119.0, 104.8; HRMS Calculated for [C20H15N3O+H]+: 314.12879, Found: 
314.12882. 
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N
N
NPh
Ph
1.2.7f
HO
 
2-(4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazol-2-yl)phenol 1.2.7f: yield 82%; oil; 1H NMR 
(270 MHz, CDCl3): δ 10.70 (s, 1H), 8.21 (d, J = 7.6 Hz, 1H), 7.72-7.65 (m, 2H), 7.44-7.37 (m, 
2H), 7.35-7.23 (m, 7H), 7.17 (d, J = 7.6 Hz, 1H), 7.02 (t, J = 7.6 Hz, 1H), 5.94 (s, 1H), 5.65 (s, 
1H); 13C NMR (67.5 MHz, CDCl3): δ 148.1, 144.8, 143.9, 138.3, 138.0, 129.1, 128.8, 128.7, 
128.4, 128.3, 127.7, 126.7, 124.9, 119.9, 119.4, 118.6; HRMS Calculated for [C22H17N3O+H]+: 
340.14444, Found: 340.14452. 
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ORTEP Drawing of the Crystal Structures 
 
	  
	  
Figure S1.2-1. Perspective view of the molecular structures of the two independent molecules of 
N-1-1.2.3b (C14H9N5O4) with the atom-labeling scheme. The thermal ellipsoids 
are scaled to enclose 30% probability. CCDC number: 702805 
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Figure S1.2-2. Perspective view of the molecular structures of the two independent molecules of 
1.2.5d (C21H15N3) with the atom-labeling scheme. The thermal ellipsoids are 
scaled to enclose 30% probability. CCDC number: 702800 
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Figure S1.2-3. Perspective view of the molecular structure of 1.2.5j (C24H21N3O) with the atom-
labeling scheme.  The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 702801 
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Figure S1.2-4:Perspective view of the molecular structure of N-3-1.2.5j (C24H21N3O) with the 
atom-labeling scheme. The thermal ellipsoids are scaled to enclose 30% 
probability. CCDC number: 702806. 
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Figure S1.2-5: Perspective view of the molecular structure of 1.2.5q (C20H14N4O) with the atom- 
labeling scheme. The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 702802 
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Figure S1.2-6. Perspective view of the molecular structure of 1.2.5u (C26H19N3) with the atom-
labeling scheme. The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 702804 
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Figure S1.2-7. Perspective view of the molecular structure of 1.2.5v (C38H28N6) with the atom-
labeling scheme. The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 702803 
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1.3 Highly efficient synthesis of vinyl substituted triazoles by Au(I) catalyzed alkyne 
activation 
General Methods and materials 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 
commercial provider and used without further purification. Air and/or moisture-sensitive 
reactions were carried out under an atmosphere of nitrogen using oven/flame-dried glassware 
and standard syringe/septa techniques.   1H-NMR and 13C-NMR spectra were recorded on Joel 
270 and Varian 600 MHz spectrometers. Chemical shifts were reported relative to internal 
tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) or DMSO (δ 2.49 ppm) for 1H and CDCl3 
(δ 77.0 ppm) or DMSO (δ 39.5 ppm) for 13C. Infrared (IR) spectra were obtained on a Prospect 
MIDAC FT-IR spectrometer. Flash column chromatography was performed on 230-430 mesh 
silica gel. Analytical thin layer chromatography was performed with precoated glass baked plates 
(250µ) and visualized by fluorescence and by charring after treatment with potassium 
permanganate stain. Rf  values were obtained by elution in the stated solvent ratios. 
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General Procedure for Au(I) catalyzed addition of triazoles to alkynes 
 
R2
R1
N
N
N
H
R1
N
N
N+ R4R3
0.2-1% PPh3AuOTf
Tol. 80 oC
1.2.1 1.3.2 1.3.4
R2
R3
R4
 
To a solution of benzotriazole 1.2.1 (59.5mg, 0.5mmol) in 2.5ml of freshly distilled toluene, was 
added PP3AuCl (12.5mg, 0.025mmol), AgOTf (6.5mg, 0.025mmol) and phenylacetylene 1.3.2 
(76.5mg, 0.75mmol). The reaction mixture was then heated at 80 oC for 12 hours. After heating, 
the reaction mixture was cooled, passed through a short silica plug and concentrated to remove 
toluene. The crude mixture was then purified by flash silica gel chromatography to give the vinyl 
triazole 1.3.4 as clear oil in quantitative yield. 
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Compound Characterization 
 
N
NN
1.3.3a  
1-(1-phenylvinyl)-1H-benzo[d][1,2,3]triazole 1.3.3a: purified by flash chromatography 
(Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 92%. 1H-NMR (600 MHz, 
CDCl3) δ 8.05-8.09 (m, 1H), 7.30-7.39 (m, 5H), 7.25 (d, J= 7.8Hz, 2H), 7.00-7.05 (m, 1H), 5.76 
(s, 1H), 5.73 (s, 1H);13C-NMR (67.5 MHz, CDCl3) δ 146.1, 142.6, 134.6, 132.9, 129.72, 128.8, 
127.7, 126.8, 124.1, 120.0, 111.1, 111.0; HRMS Calculated for [C14H11N3]+: 221.2572, Found: 
221.0953. 
 
N
NN
1.3.3b  
1-(1-p-tolylvinyl)-1H-benzo[d][1,2,3]triazole 1.3.3b: purified by flash chromatography 
(Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 94%. 1H-NMR (600 MHz, 
CDCl3) δ 8.08-8.10 (m, 1H), 7.33-7.36 (m, 2H), 7.16 (s, 4H), 7.05-7.08 (m, 1H), 5.73 (s, 1H), 
5.70 (s, 1H), 2.37 (s, 3H);13C-NMR (67.5 MHz, CDCl3) δ 146.4, 142.9, 140.2, 133.2, 132.0, 
129.7, 127.9, 127.0, 124.3, 120.3, 111.5, 110.4, 21.5; HRMS Calculated for [C15H13N3]+: 
235.2838, Found: 235.1109. 
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N
NN
F
1.3.3c  
1-(1-(4-fluorophenyl)vinyl)-1H-benzo[d][1,2,3]triazole 1.3.3c: purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 96%. 1H-
NMR (600 MHz, CDCl3) δ 8.08 (d, J= 6.6Hz, 1H), 7.34-7.39 (m, 2H), 7.24-7.24 (m, 2H), 7.08 
(d, J= 7.2Hz, 1H), 7.04 (t, J= 8.4Hz, 2H), 5.72 (d, J= 4.2Hz, 2H); 13C-NMR (67.5 MHz, CDCl3) 
δ 164.6, 163.0, 146.3, 141.9, 133.1, 131.1, 129.1, 128.2, 124.5, 120.4, 116.2, 111.3; HRMS 
Calculated for [C14H10FN3]+: 239.2477, Found: 239.0859. 
 
N
NN
1.3.3d  
1-(hex-1-en-2-yl)-1H-benzo[d][1,2,3]triazole 1.3.3d: purified by flash chromatography 
(Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 90%. 1H-NMR (600 MHz, 
CDCl3) δ 8.05 (d, J= 7.8Hz, 1H), 7.64 (d, J= 8.4Hz, 1H), 7.48 (t, J= 7.2Hz, 1H), 7.36 (t, J= 
7.8Hz, 1H), 5.38 (s, 1H), 5.24 (s, 1H), 2.89 (t, J= 7.2Hz, 2H), 1.43-1.48 (m, 2H), 1.32-14.38 (m, 
2H), 0.86 (t, J= 7.2Hz, 3H);13C-NMR (67.5 MHz, CDCl3) δ 146.4, 144.6, 132.5, 128.1, 124.4, 
120.3, 111.3, 106.3, 34.31, 29.3, 22.2, 13.9; HRMS Calculated for [C12H15N3]+: 201.2676, 
Found: 201.1266. 
215 
 
 
N
N
N
1.3.3e  
(Z)-1-(1,2-diphenylvinyl)-1H-benzo[d][1,2,3]triazole 1.3.3e: purified by flash chromatography 
(Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 70%. 1H-NMR (600 MHz, 
CDCl3) δ 8.14 (d, J= 8.4Hz, 1H), 7.34-7.41 (m, 6H), 7.22 (d, J= 9.0Hz, 2H), 7.06-7.13 (m, 4H), 
6.75 (d, J= 7.8Hz, 2H); 13C-NMR (67.5 MHz, CDCl3) δ 145.8, 136.6, 133.6, 133.5, 133.1, 129.3, 
128.9, 128.6, 128.5, 128.2, 128.0, 127.6, 125.9, 124.2, 120.0, 110.5; HRMS Calculated 
for[C20H15N3]+: 297.3532, Found: 297.1266. 
 
N
N
N
1.3.3f  
(Z)-1-(oct-4-en-4-yl)-1H-benzo[d][1,2,3]triazole 1.3.3f: purified by flash chromatography 
(Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 83%. 1H-NMR (600 MHz, 
CDCl3) δ 8.04 (d, J= 8.4Hz, 1H), 7.44 (t, J= 7.8Hz, 1H), 7.33 (q, J= 8.4Hz, 16.2Hz, 2H), 5.79 
(t, J= 7.2Hz, 1H), 2.55 (t, J= 7.8Hz, 2H), 1.68 (q, J= 7.2Hz, 14.4Hz, 2H), 1.26-1.34 (m, 4H), 
0.86(t, J= 7.2Hz, 3H), 0.74 (t, J= 7.8Hz, 3H);13C-NMR (67.5 MHz, CDCl3) δ 145.5, 135.2, 
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133.5, 129.7, 127.7, 124.0, 120.1, 110.3, 38.4, 29.6, 22.5, 20.5, 13.8, 13.5; HRMS Calculated for 
[C14H19N3]+: 229.3208, Found: 229.1579. 
 
1.3.3g
N
NN
 
1-(prop-1-en-2-yl)-1H-benzo[d][1,2,3]triazole 1.3.3g: purified by flash chromatography 
(Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 82%. 1H-NMR (600 MHz, 
CDCl3) δ 8.08 (d, J= 8.4Hz, 1H), 7.72 (d, J= 8.4Hz, 1H), 7.51 (t, J= 7.2Hz, 1H), 7.39 (t, J= 
7.8Hz, 1H), 5.44 (s, 1H), 5.21 (s, 1H), 2.55 (s, 3H);13C-NMR (67.5 MHz, CDCl3) δ 146.6, 140.6, 
132.0, 128.2, 124.5, 120.5, 111.6, 105.5, 21.3; HRMS Calculated for [C9H9N3]+: 159.1879, 
Found: 159.0796. 
 
N
N N
N
N
N
+
1.3.3h  
1-((Z)-1-phenylprop-1-enyl)-1H-benzo[d][1,2,3]triazole vs 1-((Z)-1-phenylprop-1-en-2-yl)-
1H-benzo[d][1,2,3]triazole 1.3.3h: purified by flash chromatography (Hexane-EtOAc, v/v 5/1) 
as yellow oil with overall isolated yield: 84%. 1H-NMR (600 MHz, CDCl3) δ 8.12 (d, J= 7.8Hz, 
1H), 8.02 (d, J= 8.4Hz, 1H), 7.36-7.41 (m, 2H), 7.16-7.28 (m, 6H), 7.06-7.08 (m, 2H), 6.97-7.02 
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(m, 3H), 6.73 (s, 1H), 6.68 (d, J= 7.2Hz, 2H), 6.59 (q, J= 7.2Hz, 13.8Hz, 1H), 2.48 (s, 2H), 
1.67(d, J= 7.2Hz, 3H);13C-NMR (67.5 MHz, CDCl3) δ 145.9, 145.8, 136.2, 135.9, 134.0, 133.8, 
131.8, 131.5, 129.0, 129.0, 128.9, 128.6, 128.2, 128.1, 128.0, 127.7, 127.1, 126.1, 126.0, 125.6, 
124.3, 124.1, 120.3, 120.0, 110.9, 110.6, 23.8, 14.1; HRMS Calculated for [C15H13N3]+: 
235.2838, Found: 235.1109. 
 
1.3.3i
+N
N
N
N
NN
 
1-((Z)-hex-2-en-2-yl)-1H-benzo[d][1,2,3]Triazole vs 1-((Z)-hex-2-en-3-yl)-1H-
benzo[d][1,2,3]triazole 1.3.3i: purified by flash chromatography (Hexane-EtOAc, v/v 5/1) as 
yellow oil with overall isolated yield: 81%. 1H-NMR (600 MHz, CDCl3) δ 8.05 (d, J= 9.0Hz, 
2H), 7.45 (t, J= 7.8Hz, 2H), 7.32-7.37 (m, 4H), 5.86 (q, J= 7.2Hz, 13.8Hz, 1H), 5.80 (t, J= 
7.8Hz, 1H), 2.57 (t, J= 7.2Hz, 2H), 2.23 (s, 3H), 1.71 (q, J= 7.2Hz, 14.4Hz, 2H), 1.40 (d, J= 
7.2Hz, 3H), 1.23-1.35 (m, 4H), 0.84 (t, J= 7.2Hz, 3H), 0.74 (t, J= 7.2Hz, 3H);13C-NMR (67.5 
MHz, CDCl3) δ 145.6, 145.5, 136.3, 133.4, 133.0, 131.1, 130.0, 127.8, 127.8, 124.1, 124.0, 
123.7, 120.2, 120.1, 110.4, 110.3; HRMS Calculated for [C12H15N3]+: 201.2676, Found: 
201.1266. 
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N
N
N
1.3.4a(N2)  
4-phenyl-2-(1-phenylvinyl)-2H-1,2,3-triazole 1.3.4a(N2): purified by flash chromatography 
(Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 91%. 1H-NMR (600 MHz, 
CDCl3) δ 8.02 (s, 1H), 7.85-7.86 (m, 2H), 7.36-7.48 (m, 8H), 5.97 (s, 1H), 5.41 (s, 1H);13C-
NMR (67.5 MHz, CDCl3) δ 148.9, 146.4, 135.0, 132.7, 130.1, 129.5, 129.2, 129.1, 128.6, 128.5, 
126.4, 107.6; HRMS Calculated for [C16H13N3]+: 247.2954, Found: 247.1109. 
 
N
N N
1.3.4a(N1)  
4-phenyl-1-(1-phenylvinyl)-1H-1,2,3-triazole 1.3.4a(N1): purified by flash chromatography 
(Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 91%. 1H-NMR (600 MHz, 
CDCl3) δ 7.83-7.85 (m, 2H), 7.79 (s, 1H), 7.32-7.46 (m, 8H), 5.85 (s, 1H), 5.54 (s, 1H);13C-
NMR (67.5 MHz, CDCl3) δ 147.6, 142.9, 134.6, 129.9, 128.9, 128.8, 128.7, 128.3, 127.3, 125.8, 
119.8, 109.4; HRMS Calculated for [C16H13N3]+: 247.2954, Found: 247.1109. 
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N
N
N
1.3.4b(N2)  
2-(1-cyclohexylvinyl)-4-phenyl-2H-1,2,3-triazole 1.3.4b(N2): purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 87%. 1H-
NMR (600 MHz, CDCl3) δ 7.93 (s, 1H), 7.82-7.84 (m, 2H), 7.42-7.44 (m, 2H), 7.34-7.37(m, 
1H), 5.83 (s, 1H), 4.90 (s, 1H), 3.07-3.12 (m, 1H), 2.01 (d, J =12.0 Hz, 2H) 1.74-1.84 (m, 3H), 
1.40-1.47 (m, 2H), 1.22-1.34 (m, 3H), ;13C-NMR (67.5 MHz, CDCl3) δ 151.6, 148.2, 131.8, 
130.5, 129.0, 128.8, 126.3, 101.1, 39.6, 32.2, 26.7, 26.6; HRMS Calculated for [C16H19N3]+: 
253.3422, Found: 253.1579. 
 
N
N N
1.3.4b(N1)  
1-(1-cyclohexylvinyl)-4-phenyl-1H-1,2,3-triazole 1.3.4b(N1): purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 87%. 1H-
NMR (600 MHz, CDCl3) δ 7.90 (s, 1H), 7.85 (d, J = 7.2 Hz, 2H), 7.39-7.43 (m, 2H), 7.31-
7.34(m, 1H), 5.36 (s, 1H), 5.00 (s, 1H), 2.90 (t, J= 9.0, 1H), 1.91 (d, J = 12.6 Hz, 2H), 1.80 (d, J 
= 14.4 Hz, 2H), 1.74 (d, J = 13.8 Hz, 2H), 1.19-1.41 (m, 4H);13C-NMR (67.5 MHz, CDCl3) δ 
149.7, 131.8, 130.6, 129.0, 128.7, 126.3, 118.4, 104.2, 40.9, 31.6, 26.4, 26.3; HRMS Calculated 
for [C16H19N3]+: 253.3422, Found: 253.1579. 
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N
N
N
1.3.4c(N2)  
2-((Z)-oct-4-en-4-yl)-4-phenyl-2H-1,2,3-triazole 1.3.4c(N2): purified by flash chromatography 
(Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 81%. 1H-NMR (600 MHz, 
CDCl3) δ 7.93 (s, 1H), 7.82 (d, J= 7.2Hz, 2H), 7.43 (t, J= 7.2Hz, 2H), 7.35 (t, J= 7.2Hz, 1H), 
5.49 (t, J= 7.2Hz, 1H), 2.62 (t, J= 7.2Hz, 2H), 2.21 (q, J= 7.2Hz, 9.0Hz, 2H), 1.41-1.47 (m, 4H), 
0.89-0.93 (m, 6H),;13C-NMR (67.5 MHz, CDCl3) δ 147.5, 138.8, 131.1, 130.7, 129.1, 128.6, 
126.2, 125.2, 37.51, 29.7, 22.9, 20.7, 14.0, 13.6; HRMS Calculated for [C16H21N3]+: 255.3580, 
Found: 255.1735. 
 
N
NN
1.3.4c(N1)  
1-((Z)-oct-4-en-4-yl)-4-phenyl-1H-1,2,3-triazole 1.3.4c(N1): purified by flash chromatography 
(Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 81%. 1H-NMR (600 MHz, 
CDCl3) δ 7.87 (d, J= 7.2Hz, 2H), 7.73 (s, 1H), 7.42 (t, J= 7.2Hz, 2H), 7.33 (t, J= 7.8Hz, 1H), 
5.60 (t, J= 7.2Hz, 1H), 2.52 (t, J= 7.8Hz, 2H), 1.95(q, J= 7.2Hz, 14.4Hz, 2H), 1.37-1.43 (m, 
4H), 0.90-0.93 (m, 3H), 0.85-0.88 (m, 3H); 13C-NMR (67.5 MHz, CDCl3) δ 147.1, 136.3, 130.8, 
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129.1, 128.4, 127.6, 125.9, 120.5, 38.4, 29.4, 22.7, 20.4, 13.9, 13.5; HRMS Calculated for 
[C16H21N3]+: 255.3580, Found: 255.1735. 
 
N
N
N
1.3.4d(N2)  
4-phenyl-2,5-bis(1-phenylvinyl)-2H-1,2,3-triazole 1.3.4d(N2): purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 81%. 1H-
NMR (600 MHz, CDCl3) δ 7.67-7.69 (m, 2H), 7.56-7.58 (m, 2H),  7.42-7.45 (m, 5H), 7.25-7.30 
(m, 6H), 6.04 (s, 1H), 5.95 (s, 1H), 5.66 (s, 1H), 5.46 (s, 1H);13C-NMR (67.5 MHz, CDCl3) δ 
146.7, 146.3, 146.0, 139.4, 138.8, 135.0, 130.3, 129.5, 128.62, 128.61, 128.58, 128.56, 128.52, 
128.4, 128.0, 127.1, 119.4, 107.8; HRMS Calculated for [C24H19N3]+: 349.4728, Found: 
349.1579. 
 
N
N
N
1.3.4d(N1)  
222 
 
4-phenyl-1,5-bis(1-phenylvinyl)-1H-1,2,3-triazole 1.3.4d(N1): purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 90%. 1H-
NMR (600 MHz, CDCl3) δ 7.86-7.88 (m, 2H), 7.30-7.33 (m, 2H), 7.24-7.28 (m, 2H), 7.16-7.22 
(m, 5H), 7.05-7.09 (m, 4H), 5.82 (s, 1H), 5.64 (s, 1H), 5.41 (s, 1H), 5.29 (s, 1H);13C-NMR (67.5 
MHz, CDCl3) δ 145.3, 143.0, 137.4, 136.4, 135.3, 133.9, 130.9, 129.5, 128.8, 128.7, 128.6, 
128.5, 128.2, 127.1, 126.5, 126.4, 121.4, 114.5; HRMS Calculated for [C24H19N3]+: 349.4728, 
Found: 349.1579. 
 
N N
N
1.3.4d(N3)  
5-phenyl-1,4-bis(1-phenylvinyl)-1H-1,2,3-triazole 1.3.4d(N3): purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 90%. 1H-
NMR (600 MHz, CDCl3) δ 7.29-7.31 (m, 2H), 7.21-7.25 (m, 3H), 7.14-7.18 (m, 3H), 7.07-7.12 
(m, 3H), 7.00-7.05 (m, 4H), 5.82 (s, 1H), 5.64 (s, 1H), 5.63 (s, 1H), 5.55 (s, 1H);13C-NMR (67.5 
MHz, CDCl3) δ 145.0, 143.0, 139.4, 139.3, 135.9, 135.3, 129.5, 129.4, 129.0, 128.8, 128.7, 
128.2, 127.9, 127.6, 127.1, 126.1, 118.5, 115.0; HRMS Calculated for [C24H19N3]+: 349.4728, 
Found: 349.1579. 
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N
N
N
1.3.4e(N2)  
2-((Z)-oct-4-en-4-yl)-4-phenyl-5-(1-phenylvinyl)-2H-1,2,3-triazole 1.3.4e(N2): purified by 
flash chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 85%. 
1H-NMR (600 MHz, CDCl3) δ 7.63 (d, J= 8.4Hz, 2H), 7.36 (d, J= 8.4Hz, 2H), 7.22-7.25 (m, 
6H), 5.88 (s, 1H), 5.57 (s, 1H),  5.50 (t, J= 7.2Hz, 1H), 2.65 (t, J= 7.2Hz, 2H), 2.27 (q, J= 
7.2Hz, 14.4Hz, 2H), 1.45-1.51 (m, 4H), 0.90-0.96 (m, 6H); 13C-NMR (67.5 MHz, CDCl3) δ 
145.1, 144.3, 139.6, 139.1, 138.7, 130.8, 128.6, 128.4, 128.2, 128.1, 127.8, 127.0, 125.0, 118.8, 
37.4, 29.9, 22.9, 20.8, 14.1, 13.6; HRMS Calculated for [C24H27N3]+: 357.4913, Found: 
357.2205. 
 
N
N
N
1.3.4e(N1)  
1-((Z)-oct-4-en-4-yl)-4-phenyl-5-(1-phenylvinyl)-1H-1,2,3-triazole 1.3.4e(N1): purified by 
flash chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 85%. 
1H-NMR (600 MHz, CDCl3) δ 7.85 (d, J= 7.2Hz, 2H), 7.24-7.31 (m, 8H), 6.01 (s, 1H), 5.51 (t, 
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J= 7.2Hz, 1H), 5.44 (s, 1H), 2.06 (t, J= 7.2Hz, 2H), 1.69 (q, J= 7.2Hz, 15.0Hz, 2H), 1.23-1.32 
(m, 4H), 0.77-0.82 (m, 6H);13C-NMR (67.5 MHz, CDCl3) δ 144.3, 137.5, 136.7, 135.2, 132.8, 
130.8, 130.5, 128.7, 128.6, 128.4, 127.7, 126.6, 126.2, 120.5, 37.5, 29.7, 22.1, 19.8, 13.7, 13.2; 
HRMS Calculated for [C24H27N3]+: 357.4913, Found: 357.2205. 
 
N
N
N
1.3.4f(N2)  
4-phenyl-5-(1-phenylethyl)-2-(1-phenylvinyl)-2H-1,2,3-triazole 1.3.4f(N2): purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 88%. 1H-
NMR (600 MHz, CDCl3) δ 7.48-7.52 (m, 4H), 7.39-7.42 (m, 3H), 7.27-7.36 (m, 8H), 5.95 (s, 
1H), 5.40 (s, 1H), 4.39 (q, J= 7.2Hz, 14.4Hz, 1H), 1.68 (d, J= 7.2Hz, 3H), ; 13C-NMR (67.5 
MHz, CDCl3) δ 149.4, 146.3, 146.2, 144.7, 135.0, 130.6, 129.1, 128.6, 128.5, 128.4, 128.3, 
128.2, 128.1, 127.6, 126.4, 106.9, 37.0, 23.1; HRMS Calculated for [C24H21N3]+: 351.4436, 
Found: 351.1735. 
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N
N
N
1.3.4f(N1)  
4-phenyl-5-(1-phenylethyl)-1-(1-phenylvinyl)-1H-1,2,3-triazole 1.3.4f(N1): purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 88%. 1H-
NMR (600 MHz, CDCl3) δ 7.34 (d, J= 7.8Hz, 4H), 7.25-7.29 (m, 2H), 7.16-7.24 (m, 7H), 7.04 
(d, J= 7.8Hz, 2H), 6.98 (d, J= 7.2Hz, 2H), 5.74 (s, 1H), 5.48 (s, 1H), 4.14 (q, J= 7.2Hz, 14.4Hz, 
1H), 1.76 (d, J= 7.2Hz, 3H); 13C-NMR (67.5 MHz, CDCl3) δ 148.5, 145.7, 143.1, 135.4, 134.6, 
129.6, 129.4, 129.0, 128.7, 128.6, 128.5, 127.7, 127.5, 126.47, 126.2, 114.5, 36.7, 22.7; HRMS 
Calculated for  [C24H21N3]+: 351.4436, Found: 351.1735. 
 
N
N
N
1.3.4g(N2)  
4-cyclohexenyl-5-phenyl-2-(1-phenylvinyl)-2H-1,2,3-triazole 1.3.4g(N2): was purified by 
flash chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 87%. 
1H-NMR (600 MHz, CDCl3) δ 7.67-7.69 (m, 2H), 7.48-7.50 (m, 2H), 7.38-7.41 (m, 5H), 7.34-
7.36 (m, 1H), 6.06-6.09 (m, 1H), 5.90 (s, 1H), 5.36 (s, 1H), 2.32-2.36 (m, 2H), 2.11-2.16 (m, 
2H), 1.70-1.76 (m, 2H), 1.63-1.69 (m, 2H); 13C-NMR (67.5 MHz, CDCl3) δ 147.9, 146.2, 145.4, 
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135.1, 131.6, 130.4, 129.3, 128.7, 128.6, 128.53, 128.50, 128.42, 128.37, 107.1, 27.8, 25.7, 22.8, 
22.1; HRMS Calculated for [C22H21N3]+: 327.4222, Found: 327.1735. 
 
N
N
N
1.3.4g(N1)  
5-cyclohexenyl-4-phenyl-1-(1-phenylvinyl)-1H-1,2,3-triazole 1.3.4g(N1): purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 87%. 1H-
NMR (600 MHz, CDCl3) δ 7.18-7.27 (m, 6H), 7.13 (d, J= 7.2Hz, 2H), 7.04 (d, J= 7.8Hz, 2H), 
6.05-6.16 (m, 1H), 5.75 (s, 1H), 5.46 (s, 1H), 2.29-2.36 (m, 2H), 2.03-2.10 (m, 2H), 1.65-1.71 
(m, 2H), 1.52-1.63 (m, 2H); 13C-NMR (67.5 MHz, CDCl3) δ 147.7, 146.4, 143.0, 135.7, 133.5, 
130.0, 129.4, 129.0, 128.6, 128.4, 128.3, 127.9, 126.1, 114.7, 27.3, 25.7, 22.9, 22.2; HRMS 
Calculated for [C22H21N3]+: 327.4222, Found: 327.1735. 
 
N
N
N
1.3.4h(N2)  
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4-benzyl-2-(1-cyclohexylvinyl)-5-phenyl-2H-1,2,3-triazole 1.3.4h(N2): purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 93%. 1H-
NMR (600 MHz, CDCl3) δ 7.54 (d, J= 7.2Hz, 2H), 7.26-7.32 (m, 3H), 7.21 (t, J= 7.8Hz, 2H), 
7.14 (t, J= 7.8Hz, 3H), 5.72 (s, 1H), 4.79 (s, 1H), 4.18 (s, 2H), 3.03(t, J= 11.4Hz, 1H), 1.95 (d, 
J= 12.6Hz, 2H), 1.75 (d, J= 13.8Hz, 2H), 1.34 (d, J= 13.2Hz, 2H), 1.17-1.27 (m, 4H); 13C-NMR 
(67.5 MHz, CDCl3) δ 151.5, 144.2, 138.8, 131.0, 128.9, 128.8, 128.7, 128.6, 128.4, 127.9, 126.6, 
100.6, 39.5, 32.2, 31.8, 26.7, 26.6; HRMS Calculated for [C23H25N3]+: 343.4647, Found: 
343.2048. 
 
N
N
N
1.3.4h(N1)  
5-benzyl-1-(1-cyclohexylvinyl)-4-phenyl-1H-1,2,3-triazole 1.3.4h(N1): purified by flash 
chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 93%. 1H-
NMR (600 MHz, CDCl3) δ 7.73 (d, J= 7.8Hz, 2H), 7.37 (t, J= 7.2Hz  2H), 7.25-7.32 (m, 3H), 
7.21 (t, J= 7.2Hz  1H), 7.03 (d, J= 7.8Hz, 2H), 5.15(s, 1H), 4.96(s, 1H), 4.24(s, 2H), 2.47 (t, J= 
10.8Hz  1H), 1.63-1.71 (m, 5H), 1.03-1.17 (m, 5H); 13C-NMR (67.5 MHz, CDCl3) δ 148.7, 
145.1, 137.1, 131.2, 131.1, 128.9, 128.7, 127.9, 127.8, 127.0, 126.9, 111.0, 42.7, 30.8, 29.3, 26.0, 
25.9; HRMS Calculated for [C23H25N3]+: 343.4647, Found: 343.2048. 
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ON
N N
1.3.4i(N2)  
Phenyl(5-phenyl-2-(1-phenylvinyl)-2H-1,2,3-triazol-4-yl)methanone 1.3.4i(N2): purified by 
flash chromatography (Hexane-EtOAc, v/v 5/1) as yellow oil with overall isolated yield: 84%. 
1H-NMR (600 MHz, CDCl3) δ 8.09(d, J= 7.2Hz, 2H), 7.84-7.85 (m, 2H), 7.57 (t, J= 7.2Hz, 1H), 
7.49-7.51(m, 2H), 7.38-7.46 (m, 8H), 6.06 (s, 1H), 5.54 (s, 1H); 13C-NMR (67.5 MHz, CDCl3) δ 
188.0, 150.3, 146.2, 143.1, 137.2, 134.3, 133.7, 130.8, 129.7, 129.5, 129.1, 128.9, 128.8, 128.6, 
128.5, 128.4, 109.5; HRMS Calculated for [C23H17N3O]+: 351.4006, Found: 351.1372. 
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1.4 Iron catalyzed C-O bond activation for the synthesis of propargyl-1,2,3-triazoles and 
1,1-bis-triazoles 
General Methods and materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware and standard syringe/septa techniques. 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 
commercial provider and used without further purification. 1H NMR and 13C NMR spectra were 
recorded on Varian 600 MHz spectrometers. Chemical shifts were reported relative to internal 
tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1H and CDCl3 (δ 77.0 ppm) for 13C. 
Flash column chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250µ) and visualized by 
fluorescence and by charring after treatment with potassium permanganate stain. Melting points 
were measured on a Mel-Temp 1001D apparatus and uncorrected. HRMS were recorded on 
LTQ-FTUHRA spectrometer. 
 
 
 
 
Substrates 1.4.2b, 1.4.4 were synthesized according to the literatures as below: 
1. Yu, M.; Zhang, G.; Zhang, L. Org. Lett. 2007, 9, 2147-2150. 
2. Marion, N.; Carlqvist, P.; Gealageas, R.; Fremont, P.; Maseras, F.; Nolan, S. P. Chem. Eur. J. 
2007, 13, 6437-6451. 
3. Wang, D.; Ye, X.; Shi, X. Org. Lett. 2010, 12, 2088-2091. 
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Representative procedure for the preparation of propargylic acetate 1.4.2a 
n-Bu H
1) n-BuLi, THF, -78 oC
2) PhCHO
3) Ac2O, 0 oC-RT
Ph
OAc
n-Bu  
To a solution of hex-1-yne (39 mmol) in anhydrous THF (50 mL) at -78 oC under N2 atmosphere 
was added n-BuLi (1.6 M solution in hexanes, 20.6 mL, 33 mmol). The reaction was stirred at 
this temperature for 20 min then at room temperature for one hour. After cooling to at -78 oC, 
benzaldehyde (30 mmol) was added to the mixture and was allowed to warm to room 
temperature gradually and stirred for an additional hour. After addition of acetate anhydrous (60 
mmol) at 0 oC, the reaction mixture was warmed to room temperature and stirred for 2h before 
quenched with aqueous NH4Cl. The mixture was extracted with EtOAc (3 x 20 mL), and the 
combined organic phases were washed with water and brine, dried with anhydrous MgSO4, and 
filtered. The filtrate was concentrated under reduced pressure and the residue was purified by 
flash chromatography on silica gel (hexanes/ethyl acetate, V/V, 20:1) to produce the desired 
acetate as yellow oil in quantitative yield. 
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Representative procedure for the preparation of propargylic alcohol 1.4.4 
R1 H
1) n-BuLi, THF, -78 oC
2) R2CHO
R2
OH
R1  
To a solution of alkyne (39 mmol) in anhydrous THF (50 mL) at -78 oC under N2 atmosphere 
was added n-BuLi (1.6 M solution in hexanes, 20.6 mL, 33 mmol). The reaction was stirred at 
this temperature for 20 min then at room temperature for 1h. After cooling to at -78 oC, aldehyde 
(30 mmol) was added to the mixture and was allowed to warm to room temperature gradually 
and stirred for an additional hour before quenched with aqueous NH4Cl. The mixture was 
extracted with EtOAc (3 x 20 mL), and the combined organic phases were washed with water 
and brine, dried with anhydrous MgSO4, and filtered. The filtrate was concentrated under 
reduced pressure and the residue was purified by flash chromatography on silica gel 
(hexanes/ethyl acetate, V/V, 15:1) to produce the desired alcohol as yellow oil in quantitative 
yield. 
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Representative procedure for propargylation of 1.4.4 with triazoles 
10% FeCl3, MeCN, 90oC
R2
OH
R1
N
H
N
NR
3
R4
+ N
N
NR
3
R4
R2 R1  
A solution of propargylic alcohol 1.4.4 (1 mmol) and triazole (1.2 mmol) with catalyst iron(III) 
chloride (0.1 mmol) in  acetonitrile (10 ml) was stirred at 90 degree in the presence of water 
condensor for 5h. The reaction mixture was quenched with 10 ml distilled water and then 
extracted with EtOAc (3 x 10 mL). The combined organic phases were washed with water and 
brine, dried with anhydrous MgSO4, and filtered. The filtrate was concentrated under reduced 
pressure and the residue was purified by flash chromatography on silica gel (hexanes/ethyl 
acetate, V/V, 15:1) to produce the desired product as yellow oil except for 1.4.3f. 
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Compounds Characterization 
 
N
N
N
Ph Bu
1.4.3a (N-1)  
1-(1-phenylhept-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.4.3a (N-1)): 1H-NMR (600 MHz, 
CDCl3) δ 8.04 (d, J = 8.4 Hz, 1H), 7.54-7.51 (m, 3H), 7.37-7.29 (m, 5H), 7.14 (s, 1H), 2.34 (dt, J 
= 7.2 Hz, 2.4 Hz, 2H), 1.56 (quintet, J = 7.2 Hz, 2H), 1.42 (hextet, J = 7.2 Hz, 2H), 0.90 (t, J = 
7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 146.7, 135.9, 131.3, 128.7, 128.6, 127.1, 123.9, 
120.0, 111.1, 90.3, 73.6, 55.5, 30.4, 21.9, 18.4, 13.4; HRMS Calculated for C19H20N3 [M+H]+: 
290.16572, Found: 290.16517. 
 
N
N
N
Ph Bu
1.4.3b (N-1)
Ph
  
4-phenyl-1-(1-phenylhept-2-ynyl)-1H-1,2,3-triazole (1.4.3b (N-1)): 1H-NMR (600 MHz, 
CDCl3) δ 7.89 (s, 1H), 7.82 (d, J = 7.8 Hz, 2H), 7.52 (d, J = 7.2 Hz, 2H), 7.41-7.30 (m, 6H), 6.73 
(s, 1H), 2.37 (dt, J = 7.2 Hz, 1.8 Hz. 2H), 1.60 (quintet, J = 7.2 Hz, 2H), 1.47 (hextet, J = 7.2 Hz, 
2H), 0.95 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 148.0, 136.7, 130.5, 129.0, 128.8, 
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128.7, 128.1, 127.1, 125.7, 118.0, 90.1, 74.4, 56.3, 30.4, 22.0, 18.5, 13.5; HRMS Calculated for 
C21H22N3 [M+H]+: 316.18137, Found: 316.18082. 
 
N N
N
Ph Bu
1.4.3b (N-2)
Ph
 
4-phenyl-2-(1-phenylhept-2-ynyl)-2H-1,2,3-triazole (1.4.3b (N-2)): 1H-NMR (600 MHz, 
CDCl3) δ 7.89 (s, 1H), 7.81 (d, J = 7.2 Hz, 2H), 7.59 (d, J = 7.2 Hz, 2H), 7.42 (t, J = 7.2 Hz, 2H), 
7.39-7.32 (m, 5H), 2.37 (dt, J = 7.2 Hz, 1.8 Hz, 2H), 1.59 (quintet, J = 7.2 Hz, 2H), 1.47 (hextet, 
J = 7.2 Hz, 2H), 0.94 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 147.9, 137.0, 131.7, 
130.3, 128.7, 128.6, 128.5, 128.4, 127.4, 126.0, 89.3, 74.7, 60.8, 30.4, 21.9, 18.6, 13.5; HRMS 
Calculated for C21H22N3 [M+H]+: 316.18137, Found: 316.18082. 
 
N
N
N
Ph Bu
1.4.3c (N-1)
Ph
Ph
O
 
phenyl(5-phenyl-1-(1-phenylhept-2-ynyl)-1H-1,2,3-triazol-4-yl)methanone (1.4.3c (N-1)): 
1H-NMR (600 MHz, CDCl3) δ 8.26 (d, J = 7.2 Hz, 2H), 7.56 (d, J = 7.2 Hz, 1H), 7.47 (t, J = 7.2 
Hz, 2H), 7.38-7.29 (m, 4H), 7.25-7.23 (m, 4H), 7.05 (dd, J = 7.2 Hz, 2.4 Hz, 2H), 6.27 (t, J = 3.6 
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Hz, 1H),  2.71 (dt, J = 7.2 Hz, 1.8 Hz, 2H), 1.54 (quintet, J = 7.2 Hz, 2H), 1.28 (hextet, J = 7.2 
Hz, 2H), 0.89 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 186.4, 141.9, 141.5,137.1, 
133.0, 131.9, 130.7, 129.8, 129.6, 128.7, 128.5, 128.4, 128.2, 127.8, 127.4, 126.8, 111.8, 103.4, 
32.3, 28.7, 22.0, 13.7; HRMS Calculated for C28H26N3O [M+H]+: 420.20759, Found: 420.20704. 
 
N N
N
Ph Bu
1.4.3c (N-2)
Ph
O Ph
 
phenyl(5-phenyl-2-(1-phenylhept-2-ynyl)-2H-1,2,3-triazol-4-yl)methanone (1.4.3c (N-2)): 
1H-NMR (600 MHz, CDCl3) δ 8.08 (d, J = 8.4 Hz, 2H), 7.83 (dd, J = 7.2 Hz, 2.4 Hz, 2H), 7.63 
(d, J = 7.2 Hz, 2H), 7.59 (t, J = 7.8 Hz, 1H), 7.46 (t, J = 7.8 Hz, 2H), 7.41-7.37 (m, 6H), 6.69 (t, 
J = 2.4 Hz, 1H), 2.37 (dt, J = 7.2 Hz, 2.4 Hz, 2H), 1.60 (quintet, J = 7.2 Hz, 2H), 1.48 (hextet, J 
= 7.8 Hz, 2H), 0.94 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 187.7, 149.9, 142.1, 
137.2, 136.4, 133.2, 130.6, 129.7, 129.0, 128.9, 128.8, 128.7, 128.2, 128.1, 127.6, 90.0, 74.3, 
61.5, 30.4, 21.9, 18.6, 13.5; HRMS Calculated for C28H26N3O [M+H]+: 420.20759, Found: 
420.20704. 
 
N
N
N
Ph
1.4.3d (N-1)  
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1-(3-cyclopropyl-1-phenylprop-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.4.3d (N-1)): 1H-NMR 
(600 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 1H), 7.52 (d, J = 7.8 Hz, 1H), 7.49 (d J = 7.2 Hz, 2H), 
7.38-7.29 (m, 5H), 7.10 (s, 1H), 1.40-1.37 (m, 1H), 0.86-0.83 (m, 2H), 0.78-0.75 (m, 2H); 13C-
NMR (150 MHz, CDCl3) δ 143.4, 136.0, 134.6, 131.8, 128.8, 128.7, 127.2, 127.0, 123.9, 120.0, 
111.1, 93.2, 68.7, 55.5, 8.4; HRMS Calculated for C18H16N3 [M+H]+: 274.13442, Found: 
274.13423. 
 
N
N
N
Ph Ph
1.4.3e (N-1)  
1-(1,3-diphenylprop-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.4.3e (N-1)): 1H-NMR (600 MHz, 
CDCl3) δ 8.08 (d, J = 7.2 Hz, 1H), 7.60-7.64 (m, 3H), 7.52 (d, J = 7.8 Hz, 2H), 7.40-7.33 (m, 
9H); 13C-NMR (150 MHz, CDCl3) δ 146.8, 135.4, 131.8, 131.4, 129.2, 128.9, 128.8, 128.4, 
127.4, 127.0, 124.0, 121.5, 120.1, 111.0, 89.1, 82.4, 55.7; HRMS Calculated for C21H16N3 
[M+H]+: 310.13442, Found: 310.13387. 
 
N
N
N
Ph Ph
1.4.3f (N-1)
Ph
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1-(1,3-diphenylprop-2-ynyl)-4-phenyl-1H-1,2,3-triazole (1.4.3f (N-1)): 1H-NMR (600 MHz, 
CDCl3) δ 7.96 (s, 1H), 7.83 (d, J = 8.4 Hz, 2H), 7.61 (d, J = 7.2 Hz, 2H), 7.55 (d, J = 7.2 Hz, 
2H), 7.44-7.37 (m, 8H), 7.33-7.31 (m, 1H), 6.99 (s, 1H); 13C-NMR (150 MHz, CDCl3) δ 148.3, 
136.2, 131.9, 130.5, 129.3, 129.2, 129.1, 128.8, 128.5, 128.2, 127.2, 125.8, 121.4, 118.1, 88.8, 
83.1, 56.7; HRMS Calculated for C23H18N3 [M+H]+: 336.15007, Found: 336.14992. 
 
N N
N
Ph Ph
1.4.3f (N-2)
Ph
 
2-(1,3-diphenylprop-2-ynyl)-4-phenyl-2H-1,2,3-triazole (1.4.3f (N-2)): 1H-NMR (600 MHz, 
CDCl3) δ 7.95 (s, 1H), 7.86 (d, J = 7.2 Hz, 2H), 7.72 (d, J = 7.2 Hz, 2H), 7.59 (dd, J = 7.2 Hz, 
2.4 Hz, 2H), 7.45 (q, J = 7.8 Hz, 4H), 7.40-7.35 (m, 5H), 6.94 (s, 1H); 13C-NMR (150 MHz, 
CDCl3) δ 148.2, 136.4, 131.9, 131.8, 130.2, 128.9, 128.8, 128.7, 128.5, 128.2, 127.5, 126.0, 
122.0, 88.0, 83.7, 61.0; HRMS Calculated for C23H18N3 [M+H]+: 336.15007, Found: 336.14992. 
 
N N
N
Ph Ph
1.4.3g (N-2)
Ph
Ph
O
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(2-(1,3-diphenylprop-2-ynyl)-5-phenyl-2H-1,2,3-triazol-4-yl)(phenyl)methanone (1.4.3g (N-
2)): 1H-NMR (600 MHz, CDCl3) δ 8.10 (d, J = 8.4 Hz, 2H), 7.86 (d, J = 7.8 Hz, 2H), 7.72 (d, J 
= 7.2 Hz, 2H), 7.60 (t, J = 7.8 Hz, 1H), 7.56 (d, J = 7.8 Hz, 2H), 7.47-7.34 (m, 11H), 6.94 (s, 
1H); 13C-NMR (150 MHz, CDCl3) δ 187.6, 150.1, 142.3, 137.2, 135.8, 133.3, 131.9, 130.6, 
129.6, 129.2, 129.1, 129.0, 128.9, 128.8, 128.4, 128.3, 128.2, 127.8, 121.8, 88.7, 83.1, 61.8; 
HRMS Calculated for C30H22N3O [M+H]+: 440.17629, Found: 440.17679. 
 
N
N
N
Bu
1.4.3h (N-1)  
1-(1-(naphthalen-1-yl)hept-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.4.3h (N-1)): 1H-NMR (600 
MHz, CDCl3) δ 8.25 (d, J = 9.0 Hz, 1H), 8.19 (d, J = 7.2 Hz, 1H), 7.99 (d, J = 8.4 Hz, 1H), 7.87 
(d, J = 8.4 Hz, 1H), 7.82 (d, J = 9.0 Hz, 2H), 7.55 (t, J = 7.2 Hz, 1H), 7.48-7.41 (m, 3H), 7.30-
7.23 (m, 2H), 2.32 (dt, J = 7.2 Hz, 2.4 Hz, 2H), 1.54 (quintet, J = 7.2 Hz, 2H), 1.39 (hextet, J = 
7.2 Hz, 2H), 0.88 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 146.6, 134.0, 131.7, 130.6, 
130.5, 130.3, 128.8, 127.1, 127.0, 126.5, 126.1, 124.8, 123.7, 122.9, 120.0, 111.1, 90.5, 74.3, 
53.7, 30.4, 21.9, 18.5, 13.5; HRMS Calculated for C23H22N3 [M+H]+: 340.18137, Found: 
340.18082. 
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N
N
N
Bu
1.4.3i (N-1)
F
 
1-(1-(4-fluorophenyl)hept-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.4.3i (N-1)): 1H-NMR (600 
MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 1H), 7.53-7.49 (m, 3H), 7.37 (t, J = 7.2 Hz, 1H), 7.33 (t, J = 
7.2 Hz, 1H), 7.11 (s, 1H), 7.02 (t, J = 8.4 Hz, 2H), 2.34 (dt, J = 7.2 Hz, 2.4 Hz, 2H), 1.56 
(quintet, J = 7.2 Hz, 2H), 1.41 (hextet, J = 7.2 Hz, 2H), 0.90 (t, J = 7.2 Hz, 3H); 13C-NMR (150 
MHz, CDCl3) δ 163.6, 162.0, 146.8, 131.9, 131.8, 131.2, 129.0, 128.9, 127.2, 124.0, 120.1, 
115.8, 115.6, 110.9, 90.6, 73.5, 54.8, 30.3, 21.9, 18.4, 13.4; HRMS Calculated for C19H19FN3 
[M+H]+: 308.15630, Found: 308.15588. 
 
N
N
N
Bu
1.4.3j (N-1)
Ph
F
 
1-(1-(4-fluorophenyl)hept-2-ynyl)-4-phenyl-1H-1,2,3-triazole (1.4.3j (N-1)): 1H-NMR (600 
MHz, CDCl3) δ 7.89 (s, 1H), 7.82 (d, J = 7.2 Hz, 2H), 7.51-7.49 (m, 2H), 7.38 (t, J = 7.8 Hz, 
2H), 7.30 (t, J = 7.2 Hz, 1H), 7.04 (t, J = 7.8 Hz, 2H), 6.68 (s, 1H), 2.35 (dt, J = 7.2 Hz, 2.4 Hz, 
2H), 1.58 (quintet, J = 7.2 Hz, 2H), 1.45 (hextet, J = 7.2 Hz, 2H), 0.93 (t, J = 7.2 Hz, 3H); 13C-
NMR (150 MHz, CDCl3) δ 163.7, 162.1, 148.0, 132.6, 132.5, 130.3, 129.0, 128.9, 128.7, 128.2, 
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125.7, 117.9, 115.9, 115.7, 90.4, 74.2, 55.7, 30.3, 22.0, 18.4, 13.5; HRMS Calculated for 
C21H21FN3 [M+H]+: 334.17195, Found: 334.17140. 
 
N N
N
Bu
1.4.3j (N-2)
Ph
F
 
2-(1-(4-fluorophenyl)hept-2-ynyl)-4-phenyl-2H-1,2,3-triazole (1.4.3j (N-2)): 1H-NMR (600 
MHz, CDCl3) δ 7.88 (s, 1H), 7.79 (d, J = 7.2 Hz, 2H), 7.57 (q, J = 4.8 Hz, 2H), 7.42 (t, J = 7.8 
Hz, 2H), 7.36-7.33 (m, 1H), 7.05 (t, J = 7.8 Hz, 2H), 6.64 (s, 1H), 2.36 (dt, J = 7.2 Hz, 2.4 Hz, 
2H), 1.58 (quintet, J = 7.2 Hz, 2H), 1.47 (hextet, J = 7.2 Hz, 2H), 0.93 (t, J = 7.2 Hz, 3H); 13C-
NMR (150 MHz, CDCl3) δ 163.9, 162.3, 148.3, 133.1, 133.0, 132.0, 130.5, 129.7, 129.6, 129.0, 
128.7, 126.3, 115.9, 115.7, 89.9, 74.9, 60.3, 30.7, 22.2, 18.8, 13.8; HRMS Calculated for 
C21H21FN3 [M+H]+: 334.17195, Found: 334.17140. 
 
N
N
N
Ph
1.4.3k (N-1)
Ph
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4-phenyl-1-(3-phenyl-1-p-tolylprop-2-ynyl)-1H-1,2,3-triazole (1.4.3k (N-1)): 1H-NMR (600 
MHz, CDCl3) δ 7.94 (s, 1H), 7.82 (d, J = 7.2 Hz, 2H), 7.54 (d, J = 7.2 Hz, 2H), 7.50 (d, J = 8.4 
Hz, 2H), 7.41-7.36 (m, 5H), 7.31 (t, J = 7.2 Hz, 1H), 7.23 (d, J = 8.4 Hz, 2H), 6.94 (s, 1H), 2.37 
(s, 3H); 13C-NMR (150 MHz, CDCl3) δ 148.2, 139.3, 133.2, 131.9, 130.5, 129.7, 129.3, 128.7, 
128.5, 128.2, 127.2, 125.7, 121.5, 118.1, 88.6, 83.3, 56.5, 21.1; HRMS Calculated for C24H20N3 
[M+H]+: 350.16572, Found: 350.16517. 
 
N N
N
Ph
1.4.3k (N-2)
Ph
 
4-phenyl-2-(3-phenyl-1-p-tolylprop-2-ynyl)-2H-1,2,3-triazole (1.4.3k (N-2)): 1H-NMR (600 
MHz, CDCl3) δ 7.92 (s, 1H), 7.83 (d, J = 7.2 Hz, 2H), 7.59-7.55 (m, 4H), 7.44 (t, J = 7.2 Hz, 
2H), 7.37-7.33 (m, 4H), 7.23 (d, J = 7.8 Hz, 2H), 6.89 (s, 1H), 2.37 (s, 3H); 13C-NMR (150 
MHz, CDCl3) δ 148.1, 138.8, 133.5, 132.0, 131.8, 130.3, 129.4, 128.8, 128.7, 128.4, 128.2, 
127.5, 126.0, 122.1, 87.8, 83.9, 60.8, 21.1; HRMS Calculated for C24H20N3 [M+H]+: 350.16572, 
Found: 350.16517. 
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N
N
N
Ph
1.4.3l (N-1)  
1-(3-phenyl-1-p-tolylprop-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.4.3l (N-1)): 1H-NMR (600 
MHz, CDCl3) δ 8.07 (d, J = 8.4 Hz, 1H), 7.62 (d, J = 8.4 Hz, 1H), 7.51-7.48 (m, 4H), 7.40-7.32 
(m, 6H), 7.18 (d, J = 7.8 Hz, 2H), 2.33 (s, 3H); 13C-NMR (150 MHz, CDCl3) δ 146.8, 138.9, 
132.5, 131.9, 131.4, 129.6, 129.1, 128.4, 127.3, 127.0, 124.0, 121.7, 120.1, 111.1, 88.9, 82.7, 
55.6, 21.1; HRMS Calculated for C22H18N3 [M+H]+: 324.15007, Found: 324.14952. 
 
N
N
N
Ph TMS
1.4.3m (N-1)
Ph
 
4-phenyl-1-(1-phenyl-3-(trimethylsilyl)prop-2-ynyl)-1H-1,2,3-triazole (1.4.3m (N-1)): 1H-
NMR (600 MHz, CDCl3) δ 7.87 (s, 1H), 7.81 (d, J = 8.4 Hz, 2H), 7.52 (d, J = 8.4 Hz, 2H), 7.42-
7.37 (m, 5H), 7.32(t, J = 8.4 Hz, 1H), 6.75 (s, 1H), 0.26 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 
148.2, 135.9, 130.5, 129.2, 129.0, 128.8, 128.2, 127.2, 125.7, 118.0, 98.8, 94.8, 56.6, -0.3; 
HRMS Calculated for C20H22N3Si [M+H]+: 332.15830, Found: 332.15790. 
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N N
N
Ph TMS
1.4.3m (N-2)
Ph
 
4-phenyl-2-(1-phenyl-3-(trimethylsilyl)prop-2-ynyl)-2H-1,2,3-triazole (1.4.3m (N-2)): 1H-
NMR (600 MHz, CDCl3) δ 7.88 (s, 1H), 7.81 (d, J = 7.2 Hz, 2H), 7.58 (d, J = 7.8 Hz, 2H), 7.43-
7.33 (m, 6H), 6.69 (s, 1H), 0.25 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 148.1, 136.1, 131.9, 
130.2, 128.8, 128.7, 128.6, 128.5, 127.5, 126.0, 99.1, 93.6, 61.0, -0.3; HRMS Calculated for 
C20H22N3Si [M+H]+: 332.15830, Found: 332.15790. 
 
N
N
N
Ph TMS
1.4.3n (N-1)  
1-(1-phenyl-3-(trimethylsilyl)prop-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.4.3n (N-1)): 1H-
NMR (600 MHz, CDCl3) δ 8.04 (d, J = 8.4 Hz, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.51 (d, J = 7.2 
Hz, 2H), 7.38-7.28 (m, 5H), 7.17 (s, 1H), 0.23 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 146.7, 
135.1, 131.3, 128.8, 128.7, 127.1, 126.9, 123.9, 120.0, 111.1, 98.0, 95.0, 55.7, -0.4; HRMS 
Calculated for C18H20N3Si [M+H]+: 306.14265, Found: 306.14210. 
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N N
N
Bu
1.4.3o (N-2)
Ph
 
2-(1-(hex-1-ynyl)cyclohex-2-enyl)-4-phenyl-2H-1,2,3-triazole (1.4.3o (N-2)): 1H-NMR (600 
MHz, CDCl3) δ 7.83 (s, 1H), 7.79 (d, J = 7.2 Hz, 2H), 7.42 (t, J = 7.8 Hz, 2H), 7.33 (t, J = 7.8 
Hz, 1H), 6.14 (s, 1H), 5.31-5.27 (m, 1H), 2.35-2.30 (m, 3H), 2.23-2.14 (m, 3H), 1.99-1.95 (m, 
1H), 1.77-1.72 (m, 1H), 1.51 (quintet, J = 7.2 Hz, 2H), 1.42 (sextet, J = 7.2 Hz, 2H), 0.92 (t, J = 
7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 147.7, 131.0, 130.8, 129.3, 129.0, 128.5, 126.2, 
126.1, 90.8, 81.1, 61.0, 31.0, 29.7, 29.0, 22.2, 20.1, 19.2, 13.8; HRMS Calculated for C20H24N3 
[M+H]+: 306.19702, Found: 306.19678. 
 
N
N
N
Bu
1.4.3p (N-1)  
1-(1-(hex-1-ynyl)cyclohex-2-enyl)-1H-benzo[d][1,2,3]triazole (1.4.3p (N-1)): 1H-NMR (600 
MHz, CDCl3) δ 8.06 (d, J = 7.8 Hz, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.45 (t, J = 7.2 Hz, 1H), 7.35 
(t, 7.2 Hz, 1H), 6.10 (s, 1H), 5.65-5.68 (m, 1H),  2.43-2.37 (m, 1H), 2.32 (t, J = 7.2 Hz, 3H), 
2.29-2.22 (m, 1H), 2.16-2.08 (m, 1H), 2.00-1.96 (m, 1H), 1.86-1.81 (m, 1H), 1.52 (quintet, J = 
7.2 Hz, 2H), 1.42 (sextet, J = 7.2 Hz, 2H), 0.92 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) 
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δ 146.5, 132.1, 128.8, 127.0, 126.9, 123.7, 120.1, 110.4, 91.3, 80.5, 56.4, 30.7, 29.5, 28.9, 21.9, 
20.6, 19.0, 13.6; HRMS Calculated for C18H22N3 [M+H]+: 280.18137, Found: 280.18082. 
 
N N
N
Bu
1.4.3p (N-2)  
2-(1-(hex-1-ynyl)cyclohex-2-enyl)-2H-benzo[d][1,2,3]triazole (1.4.3p (N-2)): 1H-NMR (600 
MHz, CDCl3) δ 7.87 (dd, J = 6.6 Hz, 3.0 Hz, 2H), 7.36 (dd, J = 6.6 Hz, 3.0 Hz, 2H), ), 6.19 (s, 
1H), 5.55-5.58 (m, 1H),  2.39-2.21 (m, 6H), 2.02-1.97 (m, 1H), 1.80-1.76 (m, 1H), 1.50 (quintet, 
J = 7.2 Hz, 2H), 1.41 (sextet, J = 7.2 Hz, 2H), 0.90 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, 
CDCl3) δ 144.4, 128.8, 126.7, 126.4, 118.3, 91.3, 81.0, 62.7, 30.9, 29.7, 29.6, 22.1, 20.1, 19.2, 
13.8; HRMS Calculated for C18H22N3 [M+H]+: 280.18137, Found: 280.18082. 
 
N
N
N
TMS
1.4.3q (N-1)  
1-(1-((trimethylsilyl)ethynyl)cyclohex-2-enyl)-1H-benzo[d][1,2,3]triazole (1.4.3q (N-1)): 1H-
NMR (600 MHz, CDCl3) δ 8.05 (d, J = 7.2 Hz, 1H), 7.54 (d, J = 8.4 Hz, 1H), 7.44 (t, J = 7.2 
Hz, 1H), 7.34 (t, J = 7.2 Hz, 1H), 6.23 (s, 1H), 5.65-5.61 (m, 1H), 2.44-2.37 (m, 1H), 2.33-2.30 
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(m, 1H), 2.25-2.20 (m, 1H), 2.14-2.08 (m, 1H), 2.01-1.95 (m, 1H), 1.85-1.78 (m, 1H), 0.17 (s, 
9H); 13C-NMR (150 MHz, CDCl3) δ 146.4, 132.1, 131.4, 127.1, 126.3, 123.8, 120.1, 110.2, 
104.7, 95.0, 56.1, 29.0, 28.7, 20.5, -0.2; HRMS Calculated for C17H22N3Si [M+H]+: 290.15830, 
Found: 290.15786. 
 
N
N
N
TMS
1.4.3r (N-1)
Ph
 
(E)-1-(1-phenyl-5-(trimethylsilyl)pent-1-en-4-yn-3-yl)-1H-benzo[d][1,2,3]triazole (1.4.3r (N-
1)): 1H-NMR (600 MHz, CDCl3) δ 8.07 (d, J = 7.8 Hz, 1H), 7.36-7.32 (m, 5H), 7.27-7.24 (m, 
3H), 6.92 (dd, J = 16.2 Hz, 6.6 Hz, 1H), 6.63 (d, J = 7.2 Hz, 1H), 5.65 (dd, J = 16.2 Hz, 1.8 Hz, 
1H), 0.18 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 146.4, 139.0, 136.6, 132.2, 129.0, 128.8, 
127.4, 127.3, 124.0, 120.2, 114.8, 110.2, 101.7, 97.8, 64.8, -0.3; HRMS Calculated for 
C20H22N3Si [M+H]+: 332.15830, Found: 332.15883. 
 
N
N
N
TMS
1.4.3s (N-1)
O
 
247 
 
1-(1-(2-methoxyphenyl)-3-(trimethylsilyl)prop-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.4.3s 
(N-1)): 1H-NMR (600 MHz, CDCl3) δ 8.02 (d, J = 8.4 Hz, 1H), 7.97 (dd, J = 7.8 Hz,1.8 Hz, 1H), 
7.60 (d, J = 8.4 Hz, 1H), 7.39 (t, J = 7.2 Hz, 1H), 7.34-7.28 (m, 3H), 7.05 (t, J = 7.8 Hz, 1H), 
6.80 (d, J = 8.4 Hz, 1H), 3.66 (s, 3H), 0.19 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 156.8, 146.0, 
131.9, 130.6, 129.2, 126.8, 123.5, 123.4, 120.5, 119.8, 110.9, 110.7, 99.1, 93.3, 55.4, 50.3, -0.4; 
HRMS Calculated for C19H22N3OSi [M+H]+: 336.15321, Found: 336.15266. 
 
N
N
N
1.4.5a
Ph N
N
N
Ph
 
1-((1-benzyl-1H-1,2,3-triazol-4-yl)(phenyl)methyl)-1H-benzo[d][1,2,3]triazole (1.4.5a): 1H-
NMR (600 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 1H), 7.65 (s, 1H), 7.49 (d, J = 8.4 Hz, 1H), 7.45 
(s, 1H), 7.41 (t, J = 7.2 Hz, 1H), 7.38-7.33 (m, 4H), 7.31-7.28 (m, 3H), 7.25-7.24 (m, 4H), 5.52 
(s, 2H); 13C-NMR (150 MHz, CDCl3) δ 146.1, 145.8, 137.3, 134.2, 132.7, 129.2, 128.9, 128.8, 
128.6, 128.0, 127.6, 127.2, 124.1, 123.8, 120.0, 110.3, 59.5, 54.4; HRMS Calculated for 
C22H19N6 [M+H]+: 367.16712, Found: 367.16789. 
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N
N
N
1.4.5b
Ph
Ph N
N
N
Ph
 
1-benzyl-4-(phenyl(4-phenyl-1H-1,2,3-triazol-1-yl)methyl)-1H-1,2,3-triazole (1.4.5b): 1H-
NMR (600 MHz, CDCl3) δ 7.87 (s, 1H), 7.74 (d, J = 7.2 Hz, 2H), 7.57 (s, 1H), 7.40 (t, J = 7.8 
Hz, 2H), 7.37-7.24 (m, 12H), 5.53 (s, 2H); 13C-NMR (150 MHz, CDCl3) δ 138.1, 134.5, 131.6, 
130.2, 129.1, 128.8, 128.7, 128.6, 128.5, 128.4, 128.0, 127.2, 126.0, 123.6, 65.5, 54.3; HRMS 
Calculated for C24H21N6 [M+H]+: 393.18277, Found: 393.18342. 
 
N N
N
1.4.5c
Ph
Ph N
N
N
Ph
 
1-benzyl-4-(phenyl(4-phenyl-2H-1,2,3-triazol-2-yl)methyl)-1H-1,2,3-triazole (1.4.5c): 1H-
NMR (600 MHz, CDCl3) δ 8.02 (s, 1H), 7.81 (d, J = 7.8 Hz, 2H), 7.56 (s, 1H), 7.41-7.27 (m, 
13H), 7.17 (s, 1H), 5.53 (s, 2H); 13C-NMR (150 MHz, CDCl3) δ 137.3, 134.0, 130.5, 129.3, 
129.1, 129.0, 128.8, 128.7, 128.4, 128.2, 127.5, 125.7, 123.4, 119.9, 60.7, 54.5; HRMS 
Calculated for C24H21N6 [M+H]+: 393.18277, Found: 393.18342. 
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N N
N
1.4.5d
Ph
N
N
N
Ph
Ph
 
(E)-1-benzyl-4-(3-phenyl-1-(4-phenyl-2H-1,2,3-triazol-2-yl)allyl)-1H-1,2,3-triazole (1.4.5d): 
1H-NMR (600 MHz, CDCl3) δ 7.87 (s, 1H), 7.78 (d, J = 7.2 Hz, 2H), 7.50 (d, J = 9.0 Hz, 1H), 
7.45 (s, 1H), 7.43-7.39 (m, 4H), 7.37-7.26 (m, 9H), 6.67-6.60 (m, 2H), 5.51 (s, 2H); 13C-NMR 
(150 MHz, CDCl3) δ 147.6, 139.3, 134.4, 131.1, 130.5, 129.1, 129.0, 128.8, 128.7, 128.6, 128.3, 
128.1, 128.0, 127.0, 126.0, 122.8, 119.9, 66.2, 54.1; HRMS Calculated for C26H23N6 [M+H]+: 
419.19842, Found: 419.19793. 
 
N
N
N
1.4.5e
N
N
N
Ph
 
1-(1-(1-benzyl-1H-1,2,3-triazol-4-yl)cyclohex-2-enyl)-1H-benzo[d][1,2,3]triazole (1.4.5e): 
1H-NMR (600 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 1H), 7.55 (d, J = 8.4 Hz, 1H), 7.45 (s, 1H), 
7.41-7.32 (m, 5H), 7.28-7.27 (m, 2H), 6.55 (s, 1H), 5.77-5.74 (m, 1H), 5.52 (s, 2H), 2.68-2.66 
(m, 2H), 2.34-2.30 (m, 1H), 2.25-2.19 (m, 1H), 2.14-2.08 (m, 1H), 1.97-1.90 (m, 1H); 13C-NMR 
(150 MHz, CDCl3) δ 148.1, 146.4, 134.5, 132.9, 132.2, 129.1, 128.8, 128.1, 127.0, 123.7, 121.4, 
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120.1, 119.5, 110.3, 56.3, 54.2, 29.4, 25.9, 20.4; HRMS Calculated for C21H21N6 [M+H]+: 
357.18277, Found: 357.18226. 
 
N
N
N
1.4.5f
N
N
N
PhO
 
1-((1-benzyl-1H-1,2,3-triazol-4-yl)(2-methoxyphenyl)methyl)-1H-benzo[d][1,2,3]triazole 
(1.4.5f): 1H-NMR (600 MHz, CDCl3) δ 8.02 (d, J = 8.4 Hz, 1H), 7.84 (s, 1H), 7.59 (s, 1H), 7.53 
(d, J = 8.4 Hz, 1H), 7.40 (t, J = 7.8 Hz, 1H), 7.36-7.30 (m, 4H), 7.28-7.23 (m, 4H), 6.89-6.85 (m, 
2H), 5.50 (s, 2H), 3.74 (s, 3H); 13C-NMR (150 MHz, CDCl3) δ 156.5, 145.9, 145.6, 134.4, 132.9, 
133.0, 129.1, 128.8, 128.7, 127.9, 127.2, 125.5, 123.8, 123.7, 120.8, 119.7, 110.8, 110.3, 55.5, 
54.2, 53.2; HRMS Calculated for C23H21N6O [M+H]+: 397.17768, Found: 397.17698. 
 
N
N
N
1.4.5g
N
N
N
OO
O
 
(4-((1H-benzo[d][1,2,3]triazol-1-yl)(2-methoxyphenyl)methyl)-1H-1,2,3-triazol-1-yl)methyl 
pivalate (1.4.5g): 1H-NMR (600 MHz, CDCl3) δ 8.04 (d, J = 8.4 Hz, 1H), 7.84 (s, 2H), 7.49 (d, 
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J = 8.4 Hz, 1H), 7.40 (t, J = 7.2 Hz, 1H), 7.31 (quintet, J = 7.2 Hz, 2H), 7.22 (d, J = 7.8 Hz, 1H), 
6.92-6.89 (m, 2H), 6.22 (s, 2H), 3.78 (s, 3H), 1.17 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 177.5, 
156.5, 146.1, 145.8, 133.0, 130.2, 128.6, 127.3, 125.2, 125.1, 123.9, 120.9, 119.9, 110.9, 110.2, 
69.8, 55.6, 53.2, 38.8, 26.7; HRMS Calculated for C22H25N6O3 [M+H]+: 421.19881, Found: 
421.19816. 
 
N
N
N
1.4.5h
Ph
N
N
N
Ph
Ph
 
(E)-1-benzyl-4-(3-phenyl-1-(4-phenyl-1H-1,2,3-triazol-1-yl)allyl)-1H-1,2,3-triazole (1.4.5h): 
1H-NMR (600 MHz, CDCl3) δ 7.89 (s, 1H), 7.79 (d, J = 7.2 Hz, 2H), 7.44 (s, 1H), 7.79 (t, J = 
7.8 Hz, 3H),  7.39-7.30 (m, 9H), 7.25 (d, J = 5.4 Hz, 1H), 7.04 (dd, J = 15.6 Hz, 5.4 Hz, 1H), 
6.54 (d, J = 15.6 Hz, 1H), 6.47 (d, J = 7.2 Hz, 1H), 5.50 (s, 2H); 13C-NMR (150 MHz, CDCl3) δ 
147.9, 138.1, 134.4, 131.3, 130.3, 129.1, 129.0, 128.9, 128.8, 128.7, 128.6, 128.4, 128.3, 128.1, 
127.4, 126.0, 122.4, 120.7, 70.5, 54.2; HRMS Calculated for C26H23N6 [M+H]+: 419.19842, 
Found: 419.19793 
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ORTEP Drawing of the Crystal Structures∗ 
 
Figure S1.4-1. Perspective view of the molecular structure of C22H24N6O3 (1.4.3f (N-2)) with the 
atom labeling scheme. The thermal ellipsoids are scaled to enclose 30% 
probability. CCDC number: 775267 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
∗ For details regarding the crystal structure, refer to supporting information for paper: Yan, W.; 
Wang, Q.; Chen, Y.; Petersen, J. L.; Shi, X. Org. Lett. 2010, 12, 3308-3311. 
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Figure S1.4-2. Perspective view of the molecular structure of C22H24N6O3 (1.4.5g) with the atom 
labeling scheme. The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 775268 
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1.5 Synthesis of allene triazole through iron catalyzed regioselective addition to propargyl 
alcohols 
General Methods and Materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware and standard syringe/septa techniques. 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 
commercial provider and used without further purification. 1H NMR and 13C NMR spectra were 
recorded on Varian 600 MHz spectrometers. Chemical shifts were reported relative to internal 
tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1H and CDCl3 (δ 77.0 ppm) for 13C. 
Melting points were measured on a Mel-Temp 1001D apparatus and uncorrected. Infrared (IR) 
spectra were obtained on a FT-IR spectrometer.Flash column chromatography was performed on 
230-430 mesh silica gel. Analytical thin layer chromatography was performed with precoated 
glass baked plates (250µ) and visualized by fluorescence and by charring after treatment with p-
anisaldehyde or potassium permanganate stain. HRMS were recorded on LTQ-FTUHRA 
spectrometer. UV-visible spectra were obtained on a Shimadzu UV-2550. 
 
 
 
Propargylic alcohols 1.5.3 were synthesized according to the literatures as below: 
Yan, W.; Wang, Q.; Chen, Y.; Petersen, J.; Shi, X. Org. Lett. 2010, 12, 3308-3311. 
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Representative procedure for propargylation of 1.5.4 with triazoles 
R1
OH
R2
R3
+
N
H
N
N
R3
•
R2
R1
N
N
N
R
R
10% FeCl3
1.5.3 1.5.4
DCE, 60 oC, 5h
R
R
 
A solution of triazole (1.3 mmol) with catalyst iron(III) chloride (0.1 mmol) in  1,2-
dichlorethane(DCE) (5 ml) was stirred at 60 oC for one hour, then propargyl alcohol 1.5.3 (1.0 
mmol) was added.  The reaction mixture was quenched with 10 ml distilled water and then 
extracted with EtOAc (3 x 10 mL) after 5 hours. The combined organic phases were washed with 
water and brine, dried with anhydrous MgSO4, and filtered. The filtrate was concentrated under 
reduced pressure and the residue was purified by flash chromatography on silica gel 
(hexanes/ethyl acetate, V/V, 20/1) to produce the desired product. 
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Compounds Characterization 
 
1.5.4a
Ph
•
N
TMSPh
N
N
 
1-(1-(trimethylsilyl)-3,3-diphenylpropa-1,2-dienyl)-1H-benzo[d][1,2,3]triazole (1.5.4a) was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as white solid. Isolated yield 84%; 
m. p. 127-129 oC; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.49; UV absorption: 232(0.182), 
263(0.134), 295(0.126); IR (neat), 2957, 1598, 1489, 1447, 1285, 1245, 1062, 936, 833, 767, 
694; 1H-NMR (600 MHz, CDCl3) δ 8.09 (d, J = 7.8 Hz, 1H), 7.82 (d, J = 7.8 Hz, 1H), 7.50-7.47 
(m, 4H), 7.43-7.38 (m, 5H), 7.37-7.32 (m, 3H), 0.50 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 
200.4 (C), 146.2 (C), 135.8 (C), 132.5 (C), 128.7 (CH), 128.4 (CH), 128.1 (CH), 127.9 (CH), 
124.3 (CH), 118.0 (CH), 115.3 (C), 111.9 (CH), 108.8 (C), -0.5 (CH3); HRMS Calculated for 
C24H24N3Si [M+H]+: 382.1734, Found: 382.1735. 
 
1.5.4b
Ph
•
N
n-BuPh
N
N
 
1-(1,1-diphenylhepta-1,2-dien-3-yl)-1H-benzo[d][1,2,3]triazole (1.5.4b) was purified by flash 
chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 74%; Rf 
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(hexanes/ethyl acetate, V/V, 10/1) = 0.45; UV absorption: 233(0.160), 259(0.129), 295(0.100); 
IR (neat), 2935, 1603, 1485, 1447, 1281, 1244, 1056, 957, 785, 744, 691; 1H-NMR (600 MHz, 
CDCl3) δ 8.08 (d, J = 7.8 Hz, 1H), 7.54 (d, J = 7.8 Hz, 1H), 7.46-7.43 (m, 4H), 7.42-7.30 (m, 
8H), 3.22 (t, J = 7.8 Hz, 2H), 1.75 (quin, J = 7.8 Hz, 2H), 1.47 (sex, J = 7.8 Hz, 2H), 0.93 (t, J = 
7.8 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 197.0 (C), 146.3 (C), 135.9 (C), 132.1 (C), 128.7 
(CH), 128.6 (CH), 128.4 (CH), 127.9 (CH), 124.3 (CH), 120.0 (CH), 119.8 (C), 113.5 (C), 111.6 
(CH), 31.2 (CH2), 29.2 (CH2), 22.3 (CH2), 13.8 (CH3); HRMS Calculated for C25H24N3 [M+H]+: 
366.1965, Found: 366.1964. 
 
1.5.4c
•
N
TMSPh
N
N
 
1-(1-(trimethylsilyl)-3-phenyl-3-p-tolylpropa-1,2-dienyl)-1H-benzo[d][1,2,3]triazole (1.5.4c) 
was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
80%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.51; UV absorption: 234(0.301), 263(0.209), 
299(0.195); IR (neat), 2930, 1600, 1485, 1449, 1281, 1246, 1068, 935, 838, 764, 693; 1H-NMR 
(600 MHz, CDCl3) δ 8.07 (d, J = 7.8 Hz, 1H), 7.79 (d, J = 7.8 Hz, 1H), 7.44 (d, J = 7.8 Hz, 2H), 
7.40-7.36 (m, 4H), 7.35-7.32 (m, 3H), 7.20 (d, J = 7.8 Hz, 2H), 2.38 (s, 3H), 0.46 (s, 9H); 13C-
NMR (150 MHz, CDCl3) δ 200.4 (C), 146.2 (C), 138.0 (C), 136.0 (C), 132.8 (C), 132.5 (C), 
129.5 (CH), 128.7 (CH), 128.5 (CH), 128.4 (CH), 128.0 (CH), 127.8 (CH), 124.3 (CH), 120.0 
(CH), 115.2 (C), 112.0 (CH), 108.7 (C), 21.2 (CH3), -0.5 (CH3); HRMS Calculated for 
C25H26N3Si [M+H]+: 396.1887, Found: 396.1883. 
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1.5.4d
•
N
Ph
N
N
 
1-(1-cyclopropyl-3,3-diphenylpropa-1,2-dienyl)-1H-benzo[d][1,2,3]triazole (1.5.4d) was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as white solid. Isolated yield 82%; 
m. p. 107-109 oC; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.48; UV absorption: 229(0.205), 
260(0.146), 295(0.102); IR (neat), 3008, 1598, 1490, 1449, 1278, 1161, 1078, 977, 853, 747, 
692; 1H-NMR (600 MHz, CDCl3) δ 8.09-8.07 (m, 1H), 7.54-7.51 (m, 1H), 7.41-7.32 (m, 12H), 
2.51-2.45 (m, 1H), 1.13-1.09 (m, 2H), 0.85-0.81 (m, 2H); 13C-NMR (150 MHz, CDCl3) δ 196.4 
(C), 146.4 (C), 135.7 (C), 132.0 (C), 128.7 (CH), 128.6 (CH), 128.5 (CH), 127.9 (CH), 124.3 
(CH), 120.9 (C), 120.0 (CH), 116.6 (C), 111.4 (CH), 11.8 (CH), 7.7 (CH2); HRMS Calculated 
for C24H20N3 [M+H]+: 350.1652, Found: 350.1653. 
 
1.5.4e
•
N
t-BuPh
N
N
 
1-(4,4-dimethyl-1,1-diphenylpenta-1,2-dien-3-yl)-1H-benzo[d][1,2,3]triazole (1.5.4e) was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
91%; m. p. 81-83 oC; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.47; UV absorption: 236(0.193), 
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265(0.215); IR (neat), 2972, 1589, 1490, 1451, 1274, 1231, 1062, 947, 810, 766, 694; 1H-NMR 
(600 MHz, CDCl3) δ 8.06-8.02 (m, 1H), 7.39-7.33 (m, 10H), 7.31-7.28 (m, 2H), 7.18-7.16 (m, 
1H), 1.38 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 200.6 (C), 145.0 (C), 135.2 (C), 134.3 (C), 
128.6 (CH), 128.5 (CH), 128.3 (CH), 127.5 (CH), 123.8 (CH), 119.7 (CH), 119.1 (C), 117.2 (C), 
110.6 (CH), 37.2 (C), 29.1 (CH3); HRMS Calculated for C25H24N3 [M+H]+: 366.1965, Found: 
366.1966. 
 
1.5.4f
•
N
Ph
N
N
 
1-(4-methyl-1,1-diphenylpenta-1,2,4-trien-3-yl)-1H-benzo[d][1,2,3]triazole (1.5.4f) was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
86%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.52; UV absorption: 235(0.165), 265(0.096), 
297(0.062); IR (neat), 3057, 1597, 1490, 1448, 1278, 1160, 1065, 1002, 908, 743, 695; 1H-NMR 
(600 MHz, CDCl3) δ 8.08 (d, J = 7.8 Hz, 1H), 7.45-7.34 (m, 12H), 7.29 (d, J = 7.8 Hz, 1H), 5.17 
(s, 1H), 4.66 (s, 1H), 2.15 (s, 3H); 13C-NMR (150 MHz, CDCl3) δ 204.6 (C), 145.4 (C), 136.0 
(C), 134.6 (C), 133.7 (C), 128.9 (CH), 128.8 (CH), 128.7 (CH), 127.7 (CH), 124.0 (CH), 120.0 
(CH), 118.7 (C), 115.4 (CH), 113.4 (C), 110.4 (CH2), 20.5 (CH3); HRMS Calculated for 
C24H20N3 [M+H]+: 350.1651, Found: 350.1650. 
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1.5.4g
•
N
TMSPh
N
NPMBO
 
1-(3-(2-(4-methoxybenzyloxy)phenyl)-1-(trimethylsilyl)-3-phenylpropa-1,2-dienyl)-1H-
benzo[d][1,2,3]triazole (1.5.4g) was purified by flash chromatography (Hexane-EtOAc, v/v 
20/1) as yellow liquid. Isolated yield 90%; Rf (hexanes/ethyl acetate, V/V, 6/1) = 0.58; UV 
absorption: 231(0.186), 263(0.145), 299(0.128); IR (neat), 2976, 1583, 1493, 1450, 1286, 1240, 
1063, 938, 831, 757, 692; 1H-NMR (600 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 1H), 7.98 (d, J = 
8.4 Hz, 1H), 7.42-7.31 (m, 7H), 7.24 (t, J = 8.4 Hz, 1H), 7.07-7.03 (m, 2H), 6.85 (d, J = 8.4 Hz, 
2H), 6.81 (s, 1H), 6.69 (d, J = 8.4 Hz, 2H), 4.93 (q, J = 11.4 Hz, 2H), 3.78 (s, 3H), 0.5(s, 9H); 
13C-NMR (150 MHz, CDCl3) δ 200.0 (C), 159.0 (C), 156.1 (C), 145.9 (C), 136.4 (C), 132.4 (C), 
130.8 (C), 129.5 (C), 128.6 (CH), 128.5 (CH), 128.4 (CH), 127.5 (CH), 127.4 (CH), 127.0 (CH), 
125.0 (CH), 124.1 (CH), 121.0 (CH), 119.4 (CH), 113.5 (CH), 112.8 (CH), 112.3 (CH), 111.8 
(C), 108.4 (C), 69.5 (CH2), 55.2 (CH3), -0.4 (CH3); HRMS Calculated for C32H32N3O2Si 
[M+H]+: 517.2179, Found: 517.5180. 
 
1.5.4h
•
N
TMSPh
N
N
OMe
 
1-(3-(2-methoxyphenyl)-1-(trimethylsilyl)-3-phenylpropa-1,2-dienyl)-1H-
benzo[d][1,2,3]triazole (1.5.4h) was purified by flash chromatography (Hexane-EtOAc, v/v 
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20/1) as white solid. Isolated yield 90%; m. p. 131-133 oC; Rf (hexanes/ethyl acetate, V/V, 6/1) = 
0.60; UV absorption: 230(0.200), 264(0.210), 295(0.173); IR (neat), 2957, 1599, 1490, 1453, 
1286, 1245, 1066, 939, 829, 740, 691; 1H-NMR (600 MHz, CDCl3) δ 8.15 (d, J = 7.8 Hz, 1H), 
8.06 (d, J = 7.8 Hz, 1H), 7.42-7.32 (m, 8H), 7.28 (t, J = 7.8 Hz, 1H), 7.03 (t, J = 7.8 Hz, 1H), 
6.98 (d, J = 7.8 Hz, 1H), 3.71 (s, 3H), 0.51(s, 9H); 13C-NMR (150 MHz, CDCl3) δ 200.0 (C), 
157.1 (C), 146.1 (C), 136.0 (C), 132.5 (C), 130.8 (CH), 129.5 (CH), 128.5 (CH), 127.5 (CH), 
127.4 (CH), 127.0 (CH), 124.5 (CH), 124.2 (CH), 120.8 (CH), 119.6 (CH), 112.7 (C), 111.3 (C), 
111.2 (CH), 108.3 (C), 55.1 (CH3), -0.4 (CH3); HRMS Calculated for C25H26N3OSi [M+H]+: 
412.1840, Found: 412.1841. 
 
1.5.4i
•
N
TMSPh
N
N
MeO
 
1-(3-(4-methoxyphenyl)-1-(trimethylsilyl)-3-phenylpropa-1,2-dienyl)-1H-
benzo[d][1,2,3]triazole (1.5.4i) was purified by flash chromatography (Hexane-EtOAc, v/v 
20/1) as yellow liquid. Isolated yield 91%; Rf (hexanes/ethyl acetate, V/V, 6/1) = 0.64; UV 
absorption: 231(0.197), 262(0.184), 296(0.155); IR (neat), 2963, 1603, 1498, 1466, 1270, 1235, 
1055, 930, 821, 747, 695; 1H-NMR (600 MHz, CDCl3) δ 8.08 (d, J = 7.2 Hz, 1H), 7.80 (d, J = 
7.2 Hz, 1H), 7.47 (d, J = 9.0 Hz, 2H), 7.41-7.32 (m, 7H), 6.94 (d, J = 9.0 Hz, 2H), 3.84 (s, 3H), 
0.47 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 200.6 (C), 159.8 (C), 146.4 (C), 136.3 (C), 132.7 
(C), 129.9 (CH), 129.0 (CH), 128.7 (CH), 128.3 (CH), 128.1 (CH), 124.6 (CH), 120.2 (CH), 
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115.3 (C), 114.5 (CH), 112.2 (CH), 108.9 (C), 55.6 (CH3), -0.22 (CH3); HRMS Calculated for 
C25H26N3OSi [M+H]+: 412.1838, Found: 412.1840. 
 
1.5.4j
•
N
TMSPh
N
N
HO
 
4-(3-(1H-benzo[d][1,2,3]triazol-1-yl)-3-(trimethylsilyl)-1-phenylpropa-1,2-dienyl)phenol 
(1.5.4j) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Isolated yield 80%; Rf (hexanes/ethyl acetate, V/V, 4/1) = 0.44; UV absorption: 233(0.217), 
257(0.166), 271(0.187), 300(0.134); IR (neat), 3363, 2988, 1620, 1476, 1433, 1271, 1212, 1055, 
938, 811, 745, 698; 1H-NMR (600 MHz, CDCl3) δ 8.06 (d, J = 7.2 Hz, 1H), 7.80 (d, J = 7.2 Hz, 
1H), 7.45 (d, J = 7.2 Hz, 2H), 7.41-7.37 (m, 4H), 7.36-7.30 (m, 3H), 6.95 (d, J = 7.2 Hz, 2H), 
0.45 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 200.5 (C), 156.4 (C), 145.7 (C), 136.0 (C), 132.5 
(C), 129.8 (CH), 128.7 (CH), 128.5 (CH), 128.0 (CH), 127.3 (CH), 124.7 (CH), 119.6 (CH), 
115.9 (CH), 115.3 (C), 112.2 (CH), 108.6 (C), -0.51 (CH3); HRMS Calculated for C24H24N3OSi 
[M+H]+: 398.1681, Found: 398.1682. 
 
1.5.4k
•
N
t-BuPh
N
N
HO
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4-(3-(1H-benzo[d][1,2,3]triazol-1-yl)-4,4-dimethyl-1-phenylpenta-1,2-dienyl)phenol (1.5.4k) 
was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
83%; Rf (hexanes/ethyl acetate, V/V, 4/1) = 0.43; UV absorption: 231(0.233), 270(0.209), 
298(0.174); IR (neat), 3345, 2995, 1605, 1455, 1445, 1287, 1225, 1043, 936, 814, 748, 695; 1H-
NMR (600 MHz, CDCl3) δ 8.06-8.03 (m, 1H), 7.40-7.35 (m, 5H), 7.33-7.30 (m, 2H), 7.24 (d, J = 
8.4 Hz, 2H), 7.20-7.17 (m, 1H), 6.93 (d, J = 8.4 Hz, 2H), 1.36 (s, 9H); 13C-NMR (150 MHz, 
CDCl3) δ 200.4 (C), 156.5 (C), 144.5 (C), 135.5 (C), 134.4 (C), 132.9 (CH), 130.0 (CH), 128.7 
(CH), 128.6 (CH), 128.3 (CH), 128.2 (CH), 127.7 (CH), 124.1 (CH), 119.4 (CH), 115.7 (CH), 
115.3 (C), 110.8 (C), 37.2 (C), 29.2 (CH3); HRMS Calculated for C25H24N3O [M+H]+: 382.1912, 
Found: 382.1910. 
 
1.5.4l
•
N
TMSPh
N
N
S
 
1-(4,4-dimethyl-1-phenyl-1-(thiophen-2-yl)penta-1,2-dien-3-yl)-1H-benzo[d][1,2,3]triazole 
(1.5.4l) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Isolated yield 95%; Rf (hexanes/ethyl acetate, V/V, 6/1) = 0.46; UV absorption: 236(0.189), 
260(0.237), 289(0.125); IR (neat), 2988, 1621, 1490, 1454, 1268, 1221, 1034, 951, 830, 745, 
688; 1H-NMR (600 MHz, CDCl3) δ 8.09 (d, J = 8.4 Hz, 1H), 7.86 (d, J = 8.4 Hz, 1H), 7.57 (d, J 
= 7.2 Hz, 2H), 7.45-7.36 (m, 5H), 7.34 (dd, J = 5.4 Hz, 1.2 Hz, 1H), 7.12 (dd, J = 3.6 Hz, 1.2 Hz, 
1H), 7.08 (dd, J = 5.4 Hz, 3.6 Hz, 1H), 0.50 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 199.9 (C), 
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146.2 (C), 139.4 (C), 135.5 (C), 132.4 (C), 128.8 (CH), 128.4 (CH), 128.2 (CH), 128.0 (CH), 
127.8 (CH), 127.0 (CH), 126.4 (CH), 124.4 (CH), 120.0 (CH), 111.9 (CH), 110.5 (C), 109.0 (C), 
-0.57 (CH3); HRMS Calculated for C23H22N3S [M+H]+: 372.1528, Found: 372.1527. 
 
N-2-1.5.4m
Ph
•
N
TMSPh
N
N
 
2-(1-(trimethylsilyl)-3,3-diphenylpropa-1,2-dienyl)-4-p-tolyl-2H-1,2,3-triazole (N-2-1.5.4m) 
was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
60%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.62; UV absorption: 237(0.202), 264(0.153), 
299(0.135); IR (neat), 2923, 1633, 1487, 1446, 1281, 1243, 1039, 931, 827, 779, 692; 1H-NMR 
(600 MHz, CDCl3) δ 8.01 (s, 1H), 7.77 (d, J = 7.8 Hz, 2H), 7.45-7.40 (m, 8H), 7.39-7.36 (m, 
2H), 7.24 (d, J = 7.8 Hz, 2H), 2.39 (s, 3H), 0.47 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 201.3 
(C), 147.6 (C), 138.0 (C), 135.2 (C), 129.4 (CH), 128.7 (CH), 128.4 (CH), 128.3 (CH), 127.5 
(C), 125.6 (CH), 117.0 (CH), 116.1 (C), 109.3 (C), 21.2 (CH3), -0.62 (CH3); HRMS Calculated 
for C27H28N3Si [M+H]+: 422.2046, Found: 422.2044. 
 
N-1-1.5.4m
Ph
•
N
TMSPh
N N
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1-(1-(trimethylsilyl)-3,3-diphenylpropa-1,2-dienyl)-4-p-tolyl-1H-1,2,3-triazole (N-1-1.5.4m) 
was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
12%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.29; UV absorption: 236(0.179), 265(0.144), 
297(0.114); IR (neat), 2928, 1635, 1469, 1433, 1287, 1222, 1032, 930, 816, 770, 694; 1H-NMR 
(600 MHz, CDCl3) δ 7.63 (s, 1H), 7.30-7.27 (m, 6H), 7.07 (d, J = 7.8 Hz, 2H), 7.05-7.03 (m, 
4H), 6.73 (d, J = 7.8 Hz, 2H), 2.14 (s, 3H), 0.32 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 203.8 
(C), 138.8 (C), 137.8 (C), 135.0 (C), 133.3 (C), 128.9 (CH), 128.7 (CH), 128.5 (CH), 128.3 
(CH), 127.8 (CH), 124.3 (CH), 114.2 (C), 107.3 (C), 21.2 (CH3), -0.66 (CH3); HRMS Calculated 
for C27H28N3Si [M+H]+: 422.2046, Found: 422.2045. 
 
Ph
N
TMS
NN
Ph
N-2-1.5.4m'  
2-(3-(trimethylsilyl)-1,1-diphenylprop-2-ynyl)-4-p-tolyl-2H-1,2,3-triazole (N-2-1.5.4m') was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
13%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.48; UV absorption: 244(0.408), 255(0.418); IR 
(neat), 3108, 2960, 1490, 1456, 1354, 1296, 1071, 974, 833, 764, 734, 687; 1H-NMR (600 MHz, 
CDCl3) δ 7.91 (s, 1H), 7.68 (d, J = 7.8 Hz, 2H), 7.36-7.33 (m, 6H), 7.32-7.29 (m, 4H), 7.21 (d, J 
= 7.8 Hz, 2H), 2.37 (s, 3H), 0.28 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 148.0 (C), 141.2 (C), 
138.3 (C), 131.2 (CH), 129.4 (CH), 128.3 (CH), 128.2 (CH), 128.1 (CH), 127.5 (C), 126.0 (CH), 
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104.4 (C), 94.2 (C), 73.8 (C), 21.3 (CH3), -0.28 (CH3); HRMS Calculated for C27H28N3Si 
[M+H]+: 422.2046, Found: 422.2047. 
 
Ph
N
TMS
N
N
Ph
N-1-1.5.4m'  
1-(3-(trimethylsilyl)-1,1-diphenylprop-2-ynyl)-4-p-tolyl-2H-1,2,3-triazole (N-1-1.5.4m') was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 5%; 
Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.24; UV absorption: 243(0.314), 253(0.298); IR (neat), 
3083, 2936, 1490, 1456, 1425, 1156, 1073, 976, 833, 751, 730, 686; 1H-NMR (600 MHz, 
CDCl3) δ 7.97 (s, 1H), 7.73 (d, J = 7.8 Hz, 2H), 7.37-7.35 (m, 6H), 7.32-7.29 (m, 4H), 7.22 (d, J 
= 7.8 Hz, 2H), 2.38 (s, 3H), 0.29 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 146.8 (C), 140.6 (C), 
137.9 (C), 129.4 (CH), 128.7 (CH), 128.4 (CH), 128.0 (CH), 127.7 (C), 125.6 (CH), 120.2 (CH), 
104.1 (C), 94.9 (C), 70.0 (C), 21.2 (CH3), -0.37 (CH3); HRMS Calculated for C27H28N3Si 
[M+H]+: 422.2046, Found: 422.2049. 
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N-2-1.5.4n
•
N
TMSPh
N
N OMe
 
4-(4-methoxyphenyl)-2-(1-(trimethylsilyl)-3-phenyl-3-p-tolylpropa-1,2-dienyl)-2H-1,2,3-
triazole (N-2-1.5.4n) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow 
liquid. Rf (hexanes/ethyl acetate, V/V, 6/1) = 0.66; Isolated yield 70%; UV absorption: 
244(0.223), 271(0.189), 298(0.154); IR (neat), 2987, 1621, 1503, 1454, 1268, 1237, 1067, 941, 
832, 754, 687; 1H-NMR (600 MHz, CDCl3) δ 7.92 (s, 1H), 7.77 (d, J = 9.0 Hz, 2H), 7.39 (d, J = 
9.0 Hz, 4H), 7.28 (d, J = 7.8 Hz, 2H), 7.21 (d, J = 7.8 Hz, 2H), 6.94 (d, J = 9.0 Hz, 2H), 3.84 (s, 
3H), 2.39 (s, 3H), 0.42 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 201.3 (C), 159.7 (C), 147.4 (C), 
138.3 (C), 135.4 (C), 132.2 (C), 129.5 (CH), 128.7 (CH), 128.4 (CH), 128.3 (CH), 128.2 (CH), 
127.1 (CH), 123.1 (C), 116.6 (CH), 116.0 (C), 114.2 (CH), 109.2 (C), 55.3 (CH3), 21.2 (CH3), -
0.59 (CH3); HRMS Calculated for C28H30N3OSi [M+H]+: 452.2153, Found: 452.2156. 
 
N-1-1.5.4n
•
N
TMS
N N
OMe
Ph
 
4-(4-methoxyphenyl)-1-(1-(trimethylsilyl)-3-phenyl-3-p-tolylpropa-1,2-dienyl)-1H-1,2,3-
triazole (N-1-1.5.4n) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow 
liquid. Isolated yield 14%; Rf (hexanes/ethyl acetate, V/V, 6/1) = 0.30; UV absorption: 
244(0.165), 273(0.132), 299(0.103); IR (neat), 2960, 1611, 1494, 1469, 1284, 1232, 1049, 938, 
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819, 732, 691; 1H-NMR (600 MHz, CDCl3) δ 7.62 (s, 1H), 7.36-7.33 (m, 2H), 7.20-7.14 (m, 
3H), 7.10 (d, J = 9.0 Hz, 4H), 7.07-7.05 (m, 2H), 6.46 (d, J = 7.8 Hz, 2H), 3.64 (s, 3H), 2.36 (s, 
3H), 0.31 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 204.0 (C), 160.2 (C), 142.9 (C), 137.9 (C), 
135.4 (C), 132.3 (C), 130.5 (CH), 129.3 (CH), 128.8 (CH), 128.5 (CH), 128.3 (CH), 128.2 (CH), 
128.0 (C), 127.9 (CH), 120.0 (C), 113.9 (CH), 107.4 (C), 55.2 (CH3), 21.3 (CH3), -0.45 (CH3); 
HRMS Calculated for C28H30N3OSi [M+H]+: 452.2153, Found: 452.2150. 
 
N
TMS
NN
Ph
OMe
N-2-1.5.4n'  
4-(4-methoxyphenyl)-2-(3-(trimethylsilyl)-1-phenyl-1-p-tolylprop-2-ynyl)-2H-1,2,3-triazole 
(N-2-1.5.4n') was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Isolated yield 10%; Rf (hexanes/ethyl acetate, V/V, 6/1) = 0.51; UV absorption: 256(0.413), 
269(0.424); IR (neat), 3096, 2943, 1482, 1423, 1368, 1299, 1065, 975, 830, 751, 724, 689; 1H-
NMR (600 MHz, CDCl3) δ 7.83 (s, 1H), 7.70 (d, J = 8.4 Hz, 2H), 7.32-7.29 (m, 2H), 7.25-7.23 
(m, 2H), 7.18 (d, J = 8.4 Hz, 2H), 7.12 (t, J = 8.4 Hz, 3H), 6.91 (t, J = 8.4 Hz, 2H), 3.81 (s, 3H), 
2.34 (s, 3H), 0.26 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 159.8 (C), 147.7 (C), 141.5 (C), 138.3 
(C), 137.4 (C), 130.8 (CH), 128.8 (CH), 128.2 (CH), 128.1 (CH), 128.0 (CH), 127.9 (CH), 127.4 
(CH), 123.1 (C), 114.1 (CH), 104.6 (C), 93.9 (C), 73.5 (C), 55.2 (CH3), 21.1 (CH3), -0.26 (CH3); 
HRMS Calculated for C28H30N3OSi [M+H]+: 452.2153, Found: 452.2150. 
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N
TMS
N
N
Ph
OMe
N-1-1.5.4n'  
4-(4-methoxyphenyl)-1-(3-(trimethylsilyl)-1-phenyl-1-p-tolylprop-2-ynyl)-1H-1,2,3-triazole 
(N-1-1.5.4n') was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Isolated yield 4%; Rf (hexanes/ethyl acetate, V/V, 6/1) = 0.33; UV absorption: 256(0.335), 
266(0.356); IR (neat), 3090, 2955, 1498, 1453, 1434, 1149, 1068, 956, 837, 750, 721, 680; 1H-
NMR (600 MHz, CDCl3) δ 7.90 (s, 1H), 7.75 (d, J = 9.0 Hz, 2H), 7.36-7.34 (m, 3H), 7.29-7.25 
(m, 2H), 7.19 (d, J = 8.4 Hz, 2H), 7.15 (d, J = 8.4 Hz, 2H), 6.94 (d, J = 9.0 Hz, 2H), 3.84 (s, 3H), 
2.36 (s, 3H), 0.27 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 159.6 (C), 146.6 (C), 140.8 (C), 138.6 
(C), 137.6 (C), 129.0 (CH), 128.6 (CH), 128.4 (CH), 128.0 (CH), 127.9 (CH), 127.0 (CH), 123.4 
(C), 119.7 (CH), 114.2 (CH), 104.3 (C), 94.6 (C), 69.8 (C), 55.3 (CH3), 21.1 (CH3), -0.35 (CH3); 
HRMS Calculated for C28H30N3OSi [M+H]+: 452.2153, Found: 452.2151. 
 
N-2-1.5.4o
•
N
TMSPh
N
N Cl
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4-(4-chlorophenyl)-2-(1-(trimethylsilyl)-3-phenyl-3-p-tolylpropa-1,2-dienyl)-2H-1,2,3-
triazole (N-2-1.5.4o) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow 
liquid. Isolated yield 57%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.57; UV absorption: 
238(0.329), 269(0.254), 301(0.216); IR (neat), 2937, 1623, 1477, 1450, 1276, 1235, 1063, 932, 
818, 745, 696; 1H-NMR (600 MHz, CDCl3) δ 7.99 (s, 1H), 7.78 (d, J = 8.4 Hz, 2H), 7.40-7.38 
(m, 5H), 7.37-7.35 (m, 2H), 7.28 (d, J = 7.8 Hz, 2H), 7.21 (d, J = 7.8 Hz, 2H), 2.39 (s, 3H), 0.43 
(s, 9H); 13C-NMR (150 MHz, CDCl3) δ 201.3 (C), 146.5 (C), 138.4 (C), 135.3 (C), 134.0 (C), 
132.1 (C), 129.5 (CH), 129.0 (CH), 128.9 (CH), 128.8 (CH), 128.4 (CH), 128.3 (CH), 128.2 (C), 
127.0 (CH), 117.5 (CH), 116.2 (C), 109.2 (C), 21.2 (CH3), -0.62 (CH3); HRMS Calculated for 
C27H27ClN3Si [M+H]+: 456.1655, Found: 456.1652. 
 
N-1-1.5.4o
•
N
TMS
N N
Cl
Ph
 
4-(4-chlorophenyl)-1-(1-(trimethylsilyl)-3-phenyl-3-p-tolylpropa-1,2-dienyl)-1H-1,2,3-
triazole (N-1-1.5.4o) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow 
liquid. Isolated yield 15%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.29; UV absorption: 
242(0.308), 261(0.249), 300(0.233); IR (neat), 2946, 1589, 1480, 1441, 1292, 1231, 1063, 939, 
825, 756, 694; 1H-NMR (600 MHz, CDCl3) δ 7.65 (s, 1H), 7.32-7.28 (m, 3H), 7.11 (d, J = 8.4 
Hz, 2H), 7.07 (d, J = 8.4 Hz, 2H), 7.05-7.02 (m, 2H), 6.92 (d, J = 8.4 Hz, 2H), 6.85 (d, J = 8.4 
Hz, 2H), 2.38 (s, 3H), 0.34 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 204.0 (C), 138.0 (C), 136.6 
(C), 135.0 (C), 134.8 (C), 133.5 (C), 131.6 (C), 129.9 (CH), 129.2 (CH), 128.5 (CH), 128.4 
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(CH), 128.3 (CH), 128.2 (CH), 128.0 (CH), 125.8 (CH), 114.5 (C), 107.2 (C), 21.2 (CH3), -0.67 
(CH3); HRMS Calculated for C27H27ClN3Si [M+H]+: 456.1655, Found: 456.1654. 
 
N
TMS
NN
Ph
Cl
N-2-1.5.4o'  
4-(4-chlorophenyl)-2-(3-(trimethylsilyl)-1-phenyl-1-p-tolylprop-2-ynyl)-2H-1,2,3-triazole 
(N-2-1.5.4o') was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Isolated yield 19%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.47; UV absorption: 250(0.378), 
265(0.345); IR (neat), 3100, 2947, 1498, 1434, 1367, 1292, 1049, 967, 854, 788, 730, 691; 1H-
NMR (600 MHz, CDCl3) δ 7.90 (s, 1H), 7.71 (d, J = 8.4 Hz, 2H), 7.36 (d, J = 8.4 Hz, 2H), 7.35-
7.33 (m, 3H), 7.27-7.24 (m, 2H), 7.18 (d, J = 8.4 Hz, 2H), 7.15 (t, J = 8.4 Hz, 2H), 2.36 (s, 3H), 
0.27 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 146.9 (C), 141.3 (C), 138.3 (C), 138.1 (C), 134.2 
(C), 131.2 (CH), 128.9 (CH), 128.8 (CH), 128.3 (CH), 128.2 (CH), 128.1 (CH), 128.0 (CH), 
127.4 (CH), 104.4 (C), 94.2 (C), 73.8 (C), 21.1 (CH3), -0.28 (CH3); HRMS Calculated for 
C27H27ClN3Si [M+H]+: 456.1655, Found: 456.1654. 
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N
TMS
N
N
Ph
Cl
N-1-1.5.4o'  
4-(4-chlorophenyl)-1-(3-(trimethylsilyl)-1-phenyl-1-p-tolylprop-2-ynyl)-2H-1,2,3-triazole 
(N-1-1.5.4o') was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Isolated yield 5%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.26; UV absorption: 248(0.268), 
263(0.247); IR (neat), 3054, 2921, 1495, 1458, 1421, 1150, 1054, 971, 827, 749, 720, 688; 1H-
NMR (600 MHz, CDCl3) δ 7.95 (s, 1H), 7.75 (d, J = 8.4 Hz, 2H), 7.38-7.33 (m, 5H), 7.28-7.25 
(m, 2H), 7.18 (d, J = 9.0 Hz, 2H), 7.15 (d, J = 9.0 Hz, 2H), 2.35 (s, 3H), 0.27 (s, 9H); 13C-NMR 
(150 MHz, CDCl3) δ 145.9 (C), 140.8 (C), 139.0 (C), 137.7 (C), 134.0 (C), 129.4 (CH), 129.2 
(CH), 128.9 (CH), 128.6 (CH), 128.2 (CH), 128.1 (CH), 127.2 (CH), 120.8 (CH), 104.3 (C), 95.1 
(C), 70.3 (C), 21.3 (CH3), -0.13 (CH3); HRMS Calculated for C27H27ClN3Si [M+H]+: 456.1655, 
Found: 456.1655. 
 
N-2-1.5.4p
•
N
TMSPh
N
N F
 
4-(4-fluorophenyl)-2-(1-(trimethylsilyl)-3-phenyl-3-p-tolylpropa-1,2-dienyl)-2H-1,2,3-
triazole (N-2-1.5.4p) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow 
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liquid. Isolated yield 62%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.55; UV absorption: 
257(0.405), 263(0.353), 311(0.252); IR (neat), 2966, 1586, 1493, 1444, 1282, 1234, 1039, 933, 
854, 756, 682; 1H-NMR (600 MHz, CDCl3) δ 7.97 (s, 1H), 7.84-7.81 (m, 2H), 7.42-7.40 (m, 
4H), 7.38-7.35 (m, 1H), 7.30 (d, J = 7.8 Hz, 2H), 7.22 (d, J = 7.8 Hz, 2H), 7.11 (t, J = 7.8 Hz, 
2H), 2.40 (s, 3H), 0.44 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 201.3 (C), 163.5 (C), 161.9 (C), 
146.6 (C), 138.4 (C), 135.3 (C), 132.1 (C), 129.5 (CH), 128.7 (CH), 128.4 (CH), 128.3 (CH), 
128.2 (CH), 127.5 (CH), 127.4 (CH), 126.7 (C), 126.6 (C), 117.2 (CH), 116.1 (C), 115.8 (CH), 
115.7 (CH), 109.2 (C), 21.2 (CH3), -0.63 (CH3); HRMS Calculated for C27H27FN3Si [M+H]+: 
440.1951, Found: 440.1950. 
 
N-1-1.5.4p
•
N
TMS
N N
F
Ph
 
4-(4-fluorophenyl)-1-(1-(trimethylsilyl)-3-phenyl-3-p-tolylpropa-1,2-dienyl)-1H-1,2,3-
triazole (N-1-1.5.4p) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow 
liquid. Isolated yield 14%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.25; UV absorption: 
253(0.333), 261(0.279), 313(0.223); IR (neat), 2987, 1618, 1464, 1426, 1289, 1235, 1052, 946, 
823, 745, 688; 1H-NMR (600 MHz, CDCl3) δ 7.64 (s, 1H), 7.31-7.28 (m, 3H), 7.14-7.11 (m, 
2H), 7.10 (d, J = 7.8 Hz, 2H), 7.06-7.03 (m, 2H), 6.94 (d, J = 7.8 Hz, 2H), 6.59 (t, J = 7.8 Hz, 
2H), 2.37 (s, 3H), 0.32 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 203.8 (C), 163.7 (C), 163.0 (C), 
162.0 (C), 138.0 (C), 136.8 (C), 134.9 (C), 133.5 (CH), 131.7 (CH), 130.8 (C), 130.7 (C), 129.2 
(CH), 128.4 (CH), 128.4 (CH), 128.3 (CH), 128.0 (CH), 123.3 (CH), 115.4 (CH), 115.3 (CH), 
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114.4 (C), 107.2 (C), 21.2 (CH3), -0.67 (CH3); HRMS Calculated for C27H27FN3Si [M+H]+: 
440.1951, Found: 440.1954. 
 
N
TMS
NN
Ph
F
N-2-1.5.4p'  
4-(4-fluorophenyl)-2-(3-(trimethylsilyl)-1-phenyl-1-p-tolylprop-2-ynyl)-2H-1,2,3-triazole 
(N-2-1.5.4p') was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Isolated yield 15%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.45; UV absorption: 271(0.513), 
285(0.446); IR (neat), 3118, 2937, 1476, 1424, 1375, 1299, 1055, 963, 850, 781, 727, 690; 1H-
NMR (600 MHz, CDCl3) δ 7.87 (s, 1H), 7.77-7.74 (m, 2H), 7.35-7.32 (m, 3H), 7.28-7.24 (m, 
2H), 7.19 (d, J = 8.4 Hz, 2H), 7.15 (d, J = 8.4 Hz, 2H), 7.08 (t, J = 8.4 Hz, 2H), 2.36 (s, 3H), 
0.27 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 163.7 (C), 162.0 (C), 147.0 (C), 141.4 (C), 138.3 
(C), 138.2 (C), 131.0 (CH), 128.9 (CH), 128.3 (CH), 128.2 (CH), 128.1 (CH), 128.0 (CH), 127.9 
(CH), 127.8 (CH), 126.7 (C), 126.6 (C), 115.8 (CH), 115.6 (CH), 104.4 (C), 94.1 (C), 73.7 (C), 
21.1 (CH3), -0.27 (CH3); HRMS Calculated for C27H27FN3Si [M+H]+: 440.1951, Found: 
440.1948. 
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N
TMS
N
N
Ph
F
N-1-1.5.4p'  
4-(4-fluorophenyl)-1-(3-(trimethylsilyl)-1-phenyl-1-p-tolylprop-2-ynyl)-2H-1,2,3-triazole 
(N-1-1.5.4p') was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Isolated yield 4%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.28; UV absorption: 270(0.436), 
283(0.389); IR (neat), 3089, 2931, 1488, 1433, 1363, 1281, 1042, 965, 864, 774, 735, 695; 1H-
NMR (600 MHz, CDCl3) δ 7.94 (s, 1H), 7.81-7.78 (m, 2H), 7.36-7.34 (m, 3H), 7.29-7.27 (m, 
2H), 7.18 (d, J = 8.4 Hz, 2H), 7.16 (d, J = 8.4 Hz, 2H), 7.10 (t, J = 8.4 Hz, 2H), 2.36 (s, 3H), 
0.28 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 163.5 (C), 161.8 (C), 145.9 (C), 140.6 (C), 138.7 
(C), 137.5 (C), 129.1 (CH), 128.7 (CH), 128.4 (CH), 128.0 (CH), 127.9 (CH), 127.5 (CH), 127.4 
(CH), 125.9 (C), 125.8 (C), 120.3 (CH), 115.8 (CH), 115.7 (CH), 104.1 (C), 94.8 (C), 70.0 (C), 
21.0 (CH3), -0.36 (CH3); HRMS Calculated for C27H27FN3Si [M+H]+: 440.1951, Found: 
440.1953. 
 
N-2-1.5.4q
Ph
•
N
t-BuPh
N
N
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2-(4,4-dimethyl-1,1-diphenylpenta-1,2-dien-3-yl)-4-p-tolyl-2H-1,2,3-triazole (N-2-1.5.4q) 
was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
65%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.60; UV absorption: 240(0.214), 258(0.182), 
294(0.195); IR (neat), 2956, 1588, 1497, 1441, 1264, 1245, 1072, 958, 815, 760, 675; 1H-NMR 
(600 MHz, CDCl3) δ 7.77 (s, 1H), 7.74 (d, J = 7.8 Hz, 2H), 7.44-7.39 (m, 8H), 7.38-7.34 (m, 
2H), 7.22 (d, J = 7.8Hz, 2H), 2.37 (s, 3H), 1.39 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 199.4 
(C), 146.8 (C), 138.0 (C), 135.2 (C), 129.4 (CH), 128.7 (CH), 128.5 (CH), 128.4 (CH), 127.6 
(C), 125.6 (CH), 121.0 (C), 120.6 (CH), 117.6 (C), 36.3 (C), 29.1 (CH3), 21.3 (CH3); HRMS 
Calculated for C28H28N3 [M+H]+: 406.2280, Found: 406.2280. 
 
N-1-1.5.4q
Ph
•
N
t-Bu
N N
Ph
 
1-(4,4-dimethyl-1,1-diphenylpenta-1,2-dien-3-yl)-4-p-tolyl-2H-1,2,3-triazole (N-1-1.5.4q) 
was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
11%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.28; UV absorption: 243(0.253), 259(0.298), 
297(0.203); IR (neat), 2934, 1576, 1501, 1433, 1237, 1216, 1066, 939, 811, 773, 683; 1H-NMR 
(600 MHz, CDCl3) δ 7.69 (s, 1H), 7.40-7.33 (m, 10H), 7.02 (d, J = 7.8 Hz, 2H), 6.84 (d, J = 7.8 
Hz, 2H), 2.29 (s, 3H), 1.11 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 202.6 (C), 163.0 (C), 138.9 
(C), 134.7 (C), 132.1 (CH), 129.1 (CH), 128.9 (CH), 128.7 (CH), 128.6 (CH), 128.3 (CH), 124.2 
(C), 119.1 (C), 117.1 (C), 37.1 (C), 29.1 (CH3), 21.3 (CH3); HRMS Calculated for C28H28N3 
[M+H]+: 406.2280, Found: 406.2285. 
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N
t-Bu
NN
Ph
N-2-1.5.4q'  
2-(4,4-dimethyl-1,1-diphenylpent-2-ynyl)-4-p-tolyl-2H-1,2,3-triazole (N-2-1.5.4q') was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
15%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.45; UV absorption: 240(0.267), 253(0.305); IR 
(neat), 3123, 2956, 1500, 1431, 1362, 1280, 1040, 968, 842, 781, 733, 701; 1H-NMR (600 MHz, 
CDCl3) δ 7.88 (s, 1H), 7.67 (d, J = 7.8 Hz, 2H), 7.35-7.31 (m, 6H), 7.30-7.27 (m, 4H), 7.20 (d, J 
= 7.8 Hz, 2H), 2.37 (s, 3H), 1.35 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 147.7 (C), 142.1 (C), 
138.1 (C), 131.0 (CH), 129.4 (CH), 128.1 (CH), 128.1 (CH), 128.0 (CH), 127.7 (C), 126.0 (CH), 
97.7 (C), 79.0 (C), 73.4 (C), 30.6 (CH3), 27.8 (C), 21.3 (CH3); HRMS Calculated for C28H28N3 
[M+H]+: 406.2280, Found: 406.2284. 
 
N
t-Bu
N
N
Ph
N-1-1.5.4q'  
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1-(4,4-dimethyl-1,1-diphenylpent-2-ynyl)-4-p-tolyl-2H-1,2,3-triazole (N-1-1.5.4q') was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 4%; 
Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.25; UV absorption: 242(0.253), 254(0.236); IR (neat), 
3076, 2927, 1463, 1448, 1354, 1290, 1033, 985, 855, 793, 721, 698; 1H-NMR (600 MHz, 
CDCl3) δ 7.96 (s, 1H), 7.71 (d, J = 7.8 Hz, 2H), 7.36-7.33 (m, 6H), 7.31-7.27 (m, 4H), 7.21 (d, J 
= 7.8 Hz, 2H), 2.37 (s, 3H), 1.35 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 163.0 (C), 146.7 (C), 
141.3 (C), 137.9 (C), 129.4 (CH), 128.5 (CH), 128.3 (CH), 128.0 (CH), 125.6 (CH), 120.2 (CH), 
98.3 (C), 78.9 (C), 69.7 (C), 30.6 (CH3), 27.9 (C), 21.3 (CH3); HRMS Calculated for C28H28N3 
[M+H]+: 406.2280, Found: 406.2279. 
 
N-2-1.5.4r
Ph
•
N
Ph
N
N
 
2-(4-methyl-1,1-diphenylpenta-1,2,4-trien-3-yl)-4-p-tolyl-2H-1,2,3-triazole (N-2-1.5.4r) was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
70%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.64; UV absorption: 231(0.405), 263(0.353), 
311(0.252); IR (neat), 3033, 1586, 1495, 1438, 1266, 1153, 1071, 992, 903, 734, 694; 1H-NMR 
(600 MHz, CDCl3) δ 7.86 (s, 1H), 7.74 (d, J = 8.4 Hz, 2H), 7.47-7.45 (m, 4H), 7.43-7.35 (m, 
6H), 7.23 (d, J = 8.4 Hz, 2H), 5.21 (s, 1H), 4.88 (s, 1H), 2.38 (s, 3H), 2.09 (s, 3H); 13C-NMR 
(150 MHz, CDCl3) δ 203.5 (C), 147.3 (C), 138.1 (C), 136.2 (C), 134.6 (C), 129.5 (CH), 128.9 
(CH), 128.7 (CH), 128.7 (CH), 127.5 (C), 125.7 (CH), 120.8 (CH), 119.0 (C), 115.4 (CH2), 
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114.8 (C), 21.3 (CH3), 20.7 (CH3); HRMS Calculated for C27H24N3 [M+H]+: 390.1960, Found: 
390.1962. 
 
N
NN
Ph
N-2-1.5.4r'  
2-(4-methyl-1,1-diphenylpent-4-en-2-ynyl)-4-p-tolyl-2H-1,2,3-triazole (N-2-1.5.4r') was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
10%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.50; UV absorption: 248(0.231), 259(0.210); IR 
(neat), 3110, 2930, 1471, 1423, 1373, 1297, 1053, 960, 838, 779, 718, 679; 1H-NMR (600 MHz, 
CDCl3) δ 7.91 (s, 1H), 7.67 (d, J = 7.8 Hz, 2H), 7.36-7.33 (m, 6H), 7.31-7.28 (m, 4H), 7.20 (d, J 
= 7.8 Hz, 2H), 5.48 (s, 1H), 5.35 (quin, J = 1.8 Hz, 1H), 2.37 (s, 3H), 2.01 (s, 3H); 13C-NMR 
(150 MHz, CDCl3) δ 148.0 (C), 141.5 (C), 138.4 (C), 131.2 (CH), 129.4 (CH), 128.3 (CH), 
128.2 (CH), 128.1 (CH), 127.5 (C), 126.1 (C), 126.0 (CH), 123.1 (CH2), 90.2 (C), 88.0 (C), 73.8 
(C), 23.2 (CH3), 21.3 (CH3); HRMS Calculated for C27H24N3 [M+H]+: 390.1960, Found: 
390.1962. 
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N-1-1.5.4r
Ph
•
N
N N
Ph
N
N
N
Ph
N-1-1.5.4r'
&
 
Mixture of 1-(4-methyl-1,1-diphenylpenta-1,2,4-trien-3-yl)-4-p-tolyl-2H-1,2,3-triazole (N-2-
1.5.4r) and 1-(4-methyl-1,1-diphenylpent-4-en-2-ynyl)-4-p-tolyl-2H-1,2,3-triazole (N-1-
1.5.4r') couldn’t separated by flash chromatography with different developing solvent systems 
which were Hexane-EtOAc (v/v: 20/1) and Hexane-ethylene chloride (v/v: 5/1) as yellow liquid. 
Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.29; Isolated yield 11%; UV absorption: 233(0.333), 
245(0.200), 261(0.257), 313(0.163); IR (neat), 3066, 2935, 1589, 1477, 1448, 1350, 1284, 1165, 
1049, 997, 913, 857 732, 688; 1H-NMR (600 MHz, CDCl3) δ 7.88 (s, 1.00H), 7.57-7.54 (m, 
3.47H), 7.38-7.34 (m, 3.88H), 7.33-7.28 (m, 7.77H), 7.25-7.23 (m, 4.18H), 7.19 (d, J = 7.8 Hz, 
2.20H), 7.01 (d, J = 7.8 Hz, 2.10H), 2.41 (s, 2.62H), 2.34 (s, 3.00H), 2.01 (s, 3.03H); 13C-NMR 
(150 MHz, CDCl3) δ 205.3 (C), 163.0 (C), 143.2 (C), 139.2 (C), 138.8 (C), 137.0 (C), 134.0 (C), 
131.7 (C), 129.4 (CH), 128.9 (CH), 128.6 (CH), 128.5 (CH), 128.5 (CH), 128.3 (CH), 127.9 
(CH), 126.0 (CH), 123.7 (CH2), 118.8 (C), 115.0 (CH2), 113.9 (C), 92.4 (C), 85.8 (C), 74.5 (C), 
32.7 (CH3), 21.3 (CH3), 20.2 (CH3); HRMS Calculated for C27H24N3 [M+H]+: 390.1960, Found: 
390.1962. 
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N-2-1.5.4s
Ph
•
N
Ph
N
N
 
2-(1-cyclopropyl-3,3-diphenylpropa-1,2-dienyl)-4-p-tolyl-2H-1,2,3-triazole (N-2-1.5.4s) was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
87%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.61; UV absorption: 226(0.242), 257(0.166), 
299(0.129); IR (neat), 2962, 1583, 1480, 1423, 1262, 1151, 1067, 956, 862, 742, 690; 1H-NMR 
(600 MHz, CDCl3) δ 7.97 (s, 1H), 7.74 (d, J = 7.8 Hz, 2H), 7.42-7.36 (m, 10H), 7.23 (d, J = 7.8 
Hz, 2H), 2.38 (s, 3H), 2.29-2.24 (m, 1H), 1.11-1.07 (m, 2H), 0.83-0.79 (m, 2H); 13C-NMR (150 
MHz, CDCl3) δ 196.7 (C), 147.8 (C), 138.1 (C), 135.4 (C), 129.5 (CH), 128.7 (CH), 128.6 (CH), 
128.6 (CH), 127.6 (C), 125.7 (CH), 121.2 (C), 117.4 (CH), 116.6 (C), 21.3 (CH3), 10.8 (CH), 7.5 
(CH2); HRMS Calculated for C27H24N3 [M+H]+: 390.1960, Found: 390.1963. 
 
N-1-1.5.4s
Ph
•
N
N N
Ph
 
1-(1-cyclopropyl-3,3-diphenylpropa-1,2-dienyl)-4-p-tolyl-1H-1,2,3-triazole (N-1-1.5.4s) was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 9%; 
Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.30; UV absorption: 229(0.199), 258(0.113), 
298(0.098); IR (neat), 3001, 1597, 1474, 1444, 1273, 1175, 1073, 976, 849, 737, 694; 1H-NMR 
(600 MHz, CDCl3) δ 7.69 (s, 1H), 7.32-7.27 (m, 6H), 7.17-7.13 (m, 6H), 6.88 (d, J = 7.8 Hz, 
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2H), 2.25 (s, 3H), 1.94-1.88 (m, 1H), 0.91-0.86 (m, 2H), 0.69-0.65 (m, 2H); 13C-NMR (150 
MHz, CDCl3) δ 200.6 (C), 138.9 (C), 137.8 (C), 134.8 (C), 132.8 (CH), 129.2 (CH), 128.8 (CH), 
128.4 (CH), 128.3 (CH), 128.2 (CH), 123.9 (C), 119.1 (C), 114.1 (C), 21.3 (CH3), 13.3 (CH), 7.3 
(CH2); HRMS Calculated for C27H24N3 [M+H]+: 390.1960, Found: 390.1959. 
 
1.5.4t
Ph
•
N
TMS
N
N
TMS
 
1-(1,5-bis(trimethylsilyl)-3-phenylpenta-1,2-dien-4-ynyl)-1H-benzo[d][1,2,3]triazole (1.5.4t) 
was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Isolated yield 
76%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.46; UV absorption: 234(0.093), 250(0.077), 
296(0.054); IR (neat), 3057, 2950, 1587, 1476, 1418, 1256, 1160, 1079, 987, 813, 710, 685; 1H-
NMR (600 MHz, CDCl3) δ 8.07 (d, J = 8.4 Hz, 1H), 7.79 (d, J = 8.4 Hz, 1H), 7.64 (d, J = 8.4 
Hz, 2H), 7.44 (t, J = 8.4 Hz, 1H), 7.39 (t, J = 8.4 Hz, 3H), 7.32 (t, J = 8.4 Hz, 1H), 0.48 (s, 9H), 
0.29 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 205.8 (C), 146.0 (C), 132.8 (C), 132.4 (C), 128.8 
(CH), 128.4 (CH), 128.2 (CH), 126.3 (CH), 124.6 (CH), 119.9 (CH), 111.8 (CH), 110.2 (C), 
102.1 (C), 99.1 (C), 96.9 (C), -0.10 (CH3), -0.63 (CH3); HRMS Calculated for C23H28N3Si2 
[M+H]+: 402.1820, Found: 402.1819. 
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1.5.4u
Ph
•
N
TMS
N
N
N
N
N
Ph
 
1-(3-(1-benzyl-1H-1,2,3-triazol-4-yl)-1-(trimethylsilyl)-3-phenylpropa-1,2-dienyl)-1H-
benzo[d][1,2,3]triazole (1.5.4u) was purified by flash chromatography (Hexane-EtOAc, v/v 
20/1) as white solid. Rf (hexanes/ethyl acetate, V/V, 2/1) = 0.45; UV absorption: 233(0.081), 
253(0.06), 295(0.071); IR (neat), 3150, 3030, 2951, 1448, 1286, 1241, 1108, 1048, 938, 835, 
766, 697; Isolated yield 58%; m. p. 155-157 oC; 1H-NMR (600 MHz, CDCl3) δ 8.05 (d, J = 7.2 
Hz, 1H), 7.87 (d, J = 7.2 Hz, 1H), 7.59-7.56 (m, 2H), 7.48 (s, 1H), 7.41-7.29 (m, 10H), 5.57 (s, 
2H), 0.44 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 200.9 (C), 146.1 (C), 143.6 (C), 134.4 (C), 
134.3 (C), 132.6 (C), 129.2 (CH), 128.9 (CH), 128.4 (CH), 128.1 (CH), 128.0 (CH), 127.8 (CH), 
124.4 (CH), 122.4 (CH), 119.9 (CH), 112.1 (CH), 109.4 (C), 106.0 (C), 54.4 (CH2), -0.55 (CH3); 
HRMS Calculated for C27H27N6Si [M+H]+: 463.2056, Found: 46.04059. 
 
1.5.4v
Ph
•
N
TMS
N
N
O2N
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1-(1-(trimethylsilyl)-3-(4-nitrophenyl)-3-phenylpropa-1,2-dienyl)-1H-
benzo[d][1,2,3]triazole (1.5.4v) was purified by flash chromatography (Hexane-EtOAc, v/v 
20/1) as yellow liquid. Isolated yield 71%; Rf (hexanes/ethyl acetate, V/V, 6/1) = 0.48; UV 
absorption: 231(0.078), 256(0.059), 299(0.041); IR (neat), 2967, 1634, 1523, 1438, 1299, 1235, 
1157, 1045, 933, 847, 722; 1H-NMR (600 MHz, CDCl3) δ 8.24 (d, J = 8.4 Hz, 2H), 8.10 (d, J = 
7.2 Hz, 1H), 7.70 (d, J = 7.2 Hz, 1H), 7.61 (d, J = 8.4 Hz, 2H), 7.46-7.38 (m, 7H), 0.48 (s, 9H); 
13C-NMR (150 MHz, CDCl3) δ 200.9 (C), 147.4 (C), 146.3 (C), 143.0 (C), 134.6 (C), 132.4 (C), 
129.2 (CH), 129.0 (CH), 128.7 (CH), 128.3 (CH), 128.2 (CH), 124.6 (CH), 124.1 (CH), 120.3 
(CH), 114.0 (C), 111.4 (CH), 109.7 (C), -0.45 (CH3); HRMS Calculated for C24H23N4O2Si 
[M+H]+: 427.1593, Found: 427.1590. 
 
1.5.4w
Ph
•
N
TMS
N
N
F
 
1-(3-(4-fluorophenyl)-1-(trimethylsilyl)-3-phenylpropa-1,2-dienyl)-1H-
benzo[d][1,2,3]triazole (1.5.4w) was purified by flash chromatography (Hexane-EtOAc, v/v 
20/1) as white solid. Isolated yield 88%; m. p. 114-116 oC; Rf (hexanes/ethyl acetate, V/V, 10/1) 
= 0.46; UV absorption: 234(0.203), 262(0.160), 300(0.141); IR (neat), 2955, 1603, 1504, 1447, 
1285, 1248, 1155, 1066, 936, 833, 744, 692; 1H-NMR (600 MHz, CDCl3) δ 8.08 (d, J = 7.2 Hz, 
1H), 7.77 (d, J = 7.2 Hz, 1H), 7.46-7.34 (m, 9H), 7.12-7.06 (m, 2H), 0.47 (s, 9H); 13C-NMR (150 
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MHz, CDCl3) δ 200.2 (C), 163.4 (C), 161.7 (C), 146.2 (C), 135.7 (C), 132.4 (C), 131.82 (C), 
131.80 (C), 130.1 (CH), 130.0 (CH), 128.8 (CH), 128.3 (CH), 128.2 (CH), 128.0 (CH), 124.4 
(CH), 120.0 (CH), 115.9 (CH), 115.7 (CH), 114.5 (C), 111.8 (C), 109.0 (CH), -0.49 (CH3); 
HRMS Calculated for C24H23FN3Si [M+H]+: 400.1655, Found: 400.1658. 
 
1.5.4x
Ph
•
N
TMS
N
N
Cl
 
1-(3-(4-chlorophenyl)-1-(trimethylsilyl)-3-phenylpropa-1,2-dienyl)-1H-
benzo[d][1,2,3]triazole (1.5.4x) was purified by flash chromatography (Hexane-EtOAc, v/v 
20/1) as white solid. Isolated yield 72%; m. p. 139-141 oC; Rf (hexanes/ethyl acetate, V/V, 10/1) 
= 0.47; UV absorption: 238(0.229), 264(0.167), 299(0.156); IR (neat), 2957, 1485, 1448, 1285, 
1248, 1156, 1069, 937, 876, 831, 743, 692; 1H-NMR (600 MHz, CDCl3) δ 8.09 (d, J = 7.8 Hz, 
1H), 7.76 (d, J = 7.8 Hz, 1H), 7.46-7.35 (m, 11H), 0.49 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 
200.2 (C), 146.2 (C), 135.4 (C), 134.4 (C), 134.0 (C), 132.4 (C), 129.6 (CH), 129.0 (CH), 128.9 
(CH), 128.3 (CH), 128.2 (CH), 128.0 (CH), 124.4 (CH), 120.0 (CH), 114.4 (C), 111.7 (CH), 
109.1 (C), -0.49 (CH3); HRMS Calculated for C24H23ClN3Si [M+H]+: 416.1344, Found: 
416.1346. 
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1.5.4y
•
N
TMS
N
N
F
F
 
1-(3,3-bis(4-fluorophenyl)-1-(trimethylsilyl)propa-1,2-dienyl)-1H-benzo[d][1,2,3]triazole 
(1.5.4y) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as white solid. Isolated 
yield 84%; m. p. 118-120 oC; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.43; UV absorption: 
235(0.175), 261(0.151), 299(0.127); IR (neat), 2964, 1602, 1504, 1450, 1282, 1223, 1157, 1069, 
937, 836, 752; 1H-NMR (600 MHz, CDCl3) δ 8.08 (d, J = 7.8 Hz, 1H), 7.75 (d, J = 7.8 Hz, 1H), 
7.45-7.40 (m, 5H), 7.38 (t, J = 7.8 Hz, 1H), 7.13-7.08 (m, 4H), 0.48 (s, 9H); 13C-NMR (150 
MHz, CDCl3) δ 200.0 (C), 163.4 (C), 161.7 (C), 146.2 (C), 132.4 (C), 131.7 (C), 131.6 (C), 
130.0 (CH), 129.9 (CH), 128.0 (CH), 124.4 (CH), 120.1 (CH), 116.0 (CH), 115.8 (CH), 113.6 
(C), 111.6 (CH), 109.1 (C), -0.53 (CH3); HRMS Calculated for C24H22F2N3Si [M+H]+: 418.1546, 
Found: 418.1550. 
 
N-2-1.5.4z
•
N
TMSPh
N
N
Cl
  
2-(3-(4-chlorophenyl)-1-(trimethylsilyl)-3-phenylpropa-1,2-dienyl)-4-p-tolyl-2H-1,2,3-
triazole (N-2-1.5.4z) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow 
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liquid. Isolated yield 59%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.60; UV absorption: 
243(0.318), 270(0.267), 295(0.116); IR (neat), 2917, 1613, 1457, 1443, 1278, 1233, 1073, 929, 
816, 738, 699; 1H-NMR (600 MHz, CDCl3) δ 7.94 (s, 1H), 7.74 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 
7.8 Hz, 2H), 7.39-7.36 (m, 5H), 7.34 (d, J = 7.8 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 2.16 (s, 3H), 
0.43 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 201.2 (C), 147.7 (C), 138.2 (C), 134.8 (C), 134.3 
(C), 133.8 (C), 129.6 (CH), 129.5 (CH), 129.0 (CH), 128.9 (CH), 128.5 (CH), 128.3 (CH), 127.4 
(CH), 125.7 (CH), 117.0 (C), 115.2 (CH), 109.7 (C), 21.3 (CH3), -0.60 (CH3); HRMS Calculated 
for C27H27ClN3Si [M+H]+: 456.1655, Found: 456.1652. 
 
N-1-1.5.4z
•
N
TMS
N N
Ph
Cl
 
1-(3-(4-chlorophenyl)-1-(trimethylsilyl)-3-phenylpropa-1,2-dienyl)-4-p-tolyl-2H-1,2,3-
triazole (N-1-1.5.4z) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow 
liquid. Isolated yield 15%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.33; UV absorption: 
244(0.295), 264(0.244), 299(0.138); IR (neat), 2936, 1588, 1477, 1422, 1278, 1213, 1034, 932, 
843, 771, 687; 1H-NMR (600 MHz, CDCl3) δ 7.63 (s, 1H), 7.30-7.28 (m, 3H), 7.24 (d, J = 8.4 
Hz, 2H), 7.05 (d, J = 7.8 Hz, 2H), 7.03-7.01 (m, 2H), 6.96 (d, J = 8.4 Hz, 2H), 6.76 (d, J = 7.8 
Hz, 2H), 2.16 (s, 3H), 0.32 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 203.6 (C), 138.9 (C), 137.8 
(C), 134.6 (C), 133.7 (C), 133.6 (C), 133.4 (C), 129.6 (CH), 129.0 (CH), 128.7 (CH), 128.5 
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(CH), 128.4 (CH), 128.3 (CH), 128.0 (CH), 124.3 (C), 113.2 (CH), 107.6 (C), 21.2 (CH3), -0.68 
(CH3); HRMS Calculated for C27H27ClN3Si [M+H]+: 456.1655, Found: 456.1659. 
 
N
TMS
NN
Ph
N-2-1.5.4z'
Cl
 
2-(1-(4-chlorophenyl)-3-(trimethylsilyl)-1-phenylprop-2-ynyl)-4-p-tolyl-2H-1,2,3-triazole 
(N-2-1.5.4z') was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Isolated yield 15%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.49; UV absorption: 256(0.408), 
271(0.393); IR (neat), 3077, 2934, 1483, 1446, 1343, 1297, 1041, 961, 852, 777, 739, 695; 1H-
NMR (600 MHz, CDCl3) δ 7.91 (s, 1H), 7.67 (d, J = 7.8 Hz, 2H), 7.37-7.34 (m, 3H), 7.33-7.31 
(m, 2H), 7.29-7.26 (m, 4H), 7.21 (d, J = 7.8 Hz, 2H), 2.38 (s, 3H), 0.29 (s, 9H); 13C-NMR (150 
MHz, CDCl3) δ 148.1 (C), 140.9 (C), 139.8 (C), 138.5 (C), 134.4 (C), 131.3 (CH), 129.8 (CH), 
129.4 (CH), 128.5 (CH), 128.3 (CH), 128.2 (CH), 127.9 (CH), 127.4 (C), 126.0 (CH), 103.8 (C), 
94.8 (C), 73.2 (C), 21.3 (CH3), -0.32 (CH3); HRMS Calculated for C27H27ClN3Si [M+H]+: 
456.1655, Found: 456.1652. 
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N
TMS
N
N
Ph
N-1-1.5.4z'
Cl
 
1-(1-(4-chlorophenyl)-3-(trimethylsilyl)-1-phenylprop-2-ynyl)-4-p-tolyl-2H-1,2,3-triazole 
(N-1-1.5.4z') was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Isolated yield 4%; Rf (hexanes/ethyl acetate, V/V, 10/1) = 0.30; UV absorption: 255(0.358), 
273(0.367); IR (neat), 3089, 2928, 1487, 1455, 1433, 1148, 1052, 989, 820, 734, 709, 679; 1H-
NMR (600 MHz, CDCl3) δ 8.01 (s, 1H), 7.73 (d, J = 7.8 Hz, 2H), 7.39-7.35 (m, 3H), 7.33 (d, J = 
8.4 Hz, 2H), 7.29-7.27 (m, 2H), 7.25 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 7.8 Hz, 2H), 2.38 (s, 3H), 
0.29 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 147.0 (C), 140.2 (C), 139.1 (C), 138.0 (C), 134.8 
(C), 129.6 (CH), 129.5 (CH), 128.9 (CH), 128.5 (CH), 128.3 (CH), 127.8 (CH), 127.6 (C), 125.6 
(CH), 120.1 (CH), 103.5 (C), 95.6 (C), 69.5 (C), 21.3 (CH3), -0.41 (CH3); HRMS Calculated for 
C27H27ClN3Si [M+H]+: 456.1655, Found: 456.1650. 
 
1.5.7a
•
N
HPh
N
N
OMe
 
1-(3-(2-methoxyphenyl)-3-phenylpropa-1,2-dienyl)-1H-benzo[d][1,2,3]triazole (1.5.7a) was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as white solid. Isolated yield 98%; 
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m. p. 173-175 oC; Rf (hexanes/ethyl acetate, V/V, 6/1) = 0.42; UV absorption: 235(0.327), 
299(0.206); IR (neat), 3056, 1596, 1491, 1443, 1278, 1172, 1061, 741, 694; 1H-NMR (600 MHz, 
CDCl3) δ 8.26 (s, 1H), 8.07 (d, J = 8.4 Hz, 1H), 8.00 (d, J = 8.4 Hz, 1H), 7.44-7.27 (m, 9H), 7.01 
(t, J = 7.8 Hz, 1H), 6.96 (d, J = 8.4 Hz, 1H), 3.68 (s, 3H); 13C-NMR (150 MHz, CDCl3) δ 196.6 
(C), 157.0 (C), 146.6 (C), 135.3 (C), 131.4 (C), 130.9 (CH), 130.0 (CH), 128.5 (CH), 128.4 
(CH), 127.9 (CH), 127.6 (CH), 124.5 (CH), 124.1 (CH), 120.8 (CH), 119.9 (CH), 117.8 (C), 
111.9 (CH), 111.3 (C), 99.4 (CH), 55.3 (CH3); HRMS Calculated for C22H18N3O [M+H]+: 
340.1458, Found: 340.1455. 
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ORTEP Drawing of the Crystal Structure 
 
Figure S1.5-1. Perspective view of the molecular structure of 1.5.4a (C24H23N3Si) with the atom 
labeling scheme. The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 851290. 
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Figure S1.5-2. Perspective view of the molecular structure of 1.5.4g (C25H25N3SiO) with the 
atom labeling scheme. The thermal ellipsoids are scaled to enclose 30% 
probability. CCDC number: 851291. 
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Figure S1.5-3. Perspective view of the molecular structure of 1.5.4u (C27H26N6Si) with the atom 
labeling scheme. The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 851293. 
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Figure S1.5-4. Perspective view of the molecular structure of 1.5.4y (C24H21F2N3Si) with the 
atom labeling scheme. The thermal ellipsoids are scaled to enclose 30% 
probability. CCDC number: 851294. 
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Figure S1.5-5. Perspective view of the molecular structure of 1.5.7a (C22H17N3O) with the atom 
labeling scheme. The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 851292. 
296 
 
1.6 Mitsunobu reaction of 1,2,3-NH-triazoles: regio- and stereo-selective synthesis of 
triazole derivatives 
General Methods and Materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware and standard syringe/septa techniques. 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 
commercial provider and used without further purification. 1H NMR and 13C NMR spectra were 
recorded on Varian 600 MHz spectrometers. Chemical shifts were reported relative to internal 
tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1H and CDCl3 (δ 77.0 ppm) for 13C. 
Flash column chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250µ) and visualized by 
fluorescence and by charring after treatment with potassium permanganate stain. HRMS were 
recorded on LTQ-FTUHRA spectrometer. Optical rotations were measured with a digital 
polarimeter in the solvent specified. Enantiomeric excess was determined by HPLC analysis, 
using chiral column described below in detail. The configuration of products was determined by 
comparison of rotation sign with the literature data or by analogue. 
 
 
 
Substrates 1.6.4g, 1.6.4h, 1.6.4i, 1.6.4m were reported the literature as below: 
Chen, Y.; Liu, Y.; Petersen, J. L.; Shi, X. Chem. Commun. 2008, 3254-3256. 
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General Procedure for Mitsunobu reaction of 1,2,3-NH-triazole with alcohol. 
A 25 mL round-bottomed flask is equipped with a stirring bar, nitrogen inlet, rubber septum. The 
flask is charged with alcohol (3.0 mmol), NH-triazole (3.6 mmol), triphenylphosphine (PPh3) 
(3.6 mmol), and 12 mL of distilled tetrahydrofuran (THF). The flask is immersed in an ice bath, 
and diisopropyl azodicarboxylate (3.6 mmol) is added dropwise at a rate such that the 
temperature of the reaction mixture is maintained below 10 oC. Upon completion of the addition, 
the flask is removed from the ice bath and the solution is allowed to stir at room temperature for 
3 hours, and monitored by TLC. After the reaction is completed, 30 ml of water is added to 
quench the reaction. The mixture is extracted three times with 20 mL portions of ethyl acetate. 
The combined organic layers are washed with 20 ml brine twice and dried over anhydrous 
sodium sulfate (Na2SO4). Excess solvent and other volatile reaction components are completely 
removed under reduced pressure initially on a rotary evaporator. The residue is applied to a flash 
silica gel chromatography column (hexane/ethyl acetate = 10:1) to give the products. 
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Compounds Characterization 
 
N-2-1.6.3a
N
N
N Ph
 
2-benzyl-2H-benzo[d][1,2,3]triazole (N-2-1.6.3a) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.87-7.85 (m, 2H), 
7.42-7.40 (m, 2H), 7.37-7.30 (m, 5H), 5.87 (s, 2H); 13C-NMR (150 MHz, CDCl3) δ 144.9, 134.9, 
129.1, 128.8, 128.6, 126.6, 118.4, 60.6; HRMS Calculated for C13H12N3 [M+H]+: 210.1031, 
Found: 210.1025. 
 
N
N
N
Ph
N-1-1.6.3a  
1-benzyl-1H-benzo[d][1,2,3]triazole (N-1-1.6.3a) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.05-8.03 (m, 1H), 
7.39-7.23 (m, 8H), 5.82 (s, 2H); 13C-NMR (150 MHz, CDCl3) δ 146.6, 135.0, 133.0, 129.2, 
128.7, 127.8, 127.6, 124.1, 120.3, 109.9, 52.4; HRMS Calculated for C13H12N3 [M+H]+: 
210.1031, Found: 210.1036. 
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N-2-1.6.3b
N
N
N
 
2-allyl-2H-benzo[d][1,2,3]triazole (N-2-1.6.3b) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.87-7.84 (m, 2H), 
7.38-7.34 (m, 2H), 6.23-6.15 (m, 1H), 5.38 (d, J = 10.8 Hz, 1H), 7.37-7.35 (m, 1H), 5.32 (d, J = 
6.6 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 144.7, 131.3, 126.6, 120.4, 118.2, 59.1; HRMS 
Calculated for C9H10N3 [M+H]+: 160.0875, Found: 160.0870. 
 
N
N
N
N-1-1.6.3b  
1-allyl-1H-benzo[d][1,2,3]triazole (N-1-1.6.3b) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.03 (d, J = 8.4 Hz, 
1H), 7.50-7.48 (m, 1H), 7.46-7.42 (m, 1H), 7.35-7.32 (m, 1H), 6.07-6.00 (m, 1H), 5.29 (d, J = 
10.2 Hz, 1H), 5.26-5.21 (m, 3H); 13C-NMR (150 MHz, CDCl3) δ 146.4, 133.1, 131.4, 127.5, 
124.1, 120.2, 119.4, 109.9, 51.0; HRMS Calculated for C9H10N3 [M+H]+: 160.0875, Found: 
160.0879. 
 
N-2-1.6.3c
N
N
N
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2-(prop-2-ynyl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.3c) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.89-7.86 (m, 2H), 
7.40-7.37 (m, 2H), 5.52 (d, J = 3.0 Hz, 2H), 2.61 (t, J = 3.0 Hz, 1H); 13C-NMR (150 MHz, 
CDCl3) δ 144.9, 127.0, 118.4, 75.9, 75.4, 46.2; HRMS Calculated for C9H8N3 [M+H]+: 
158.0718, Found: 158.0711. 
 
N
N
N
N-1-1.6.3c  
1-(prop-2-ynyl)-1H-benzo[d][1,2,3]triazole (N-1-1.6.3c) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.03 (d, J = 8.4 Hz, 
1H), 7.68 (d, J = 8.4 Hz, 1H), 7.49 (t, J = 7.8 Hz, 1H), 7.36 (t, J = 7.8 Hz, 1H), 5.42 (d, J = 2.4 
Hz, 2H), 2.48 (t, J = 2.4 Hz, 1H); 13C-NMR (150 MHz, CDCl3) δ 146.5, 132.7, 128.0, 124.4, 
120.3, 110.0, 75.5, 75.3, 38.2; HRMS Calculated for C9H8N3 [M+H]+: 158.0718, Found: 
158.0725. 
 
N-2-1.6.3d
N
N
N Cl
 
2-(2-chloroethyl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.3d) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
301 
 
7.86-7.83 (m, 2H), 7.36-7.33 (m, 2H), 4.99 (t, J = 6.0 Hz, 2H), 4.11 (t, J = 6.0 Hz, 2H); 13C-
NMR (150 MHz, CDCl3) δ 144.3, 126.5, 117.9, 57.3, 41.4; HRMS Calculated for C8H9ClN3 
[M+H]+: 182.0485, Found: 182.0480. 
 
N
N
N
Cl
N-1-1.6.3d  
1-(2-chloroethyl)-1H-benzo[d][1,2,3]triazole (N-1-1.6.3d) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.08 
(d, J = 8.4 Hz, 1H), 7.59 (d, J = 8.4 Hz, 1H), 7.52 (t, J = 7.8 Hz, 1H), 7.39 (t, J = 7.8 Hz, 1H), 
4.96 (t, J = 6.0 Hz, 2H), 4.05 (t, J = 6.0 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 145.8, 133.5, 
127.7, 124.1, 120.1, 109.3, 49.4, 42.2; HRMS Calculated for C8H9ClN3 [M+H]+: 182.0485, 
Found: 182.0492. 
 
N-2-1.6.3e
N
N
N OEt
 
2-(2-ethoxyethyl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.3e) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.85-7.82 (m, 2H), 7.35-7.32 (m, 2H), 4.86 (t, J = 6.0 Hz, 2H), 4.05 (t, J = 6.0 Hz, 2H), 3.46 (q, J 
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= 7.2 Hz, 2H), 1.09 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 144.3, 126.1, 117.9, 68.3, 
66.5, 56.1, 14.8; HRMS Calculated for C10H14N3O [M+H]+: 192.1137, Found: 192.1126. 
 
N
N
N
OEt
N-1-1.6.3e  
1-(2-ethoxyethyl)-1H-benzo[d][1,2,3]triazole (N-1-1.6.3e) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.01 
(d, J = 8.4 Hz, 1H), 7.62 (d, J = 8.4 Hz, 1H), 7.44 (t, J = 7.8 Hz, 1H), 7.32 (t, J = 7.8 Hz, 1H), 
4.78 (t, J = 6.0 Hz, 2H), 3.88 (t, J = 6.0 Hz, 2H), 3.40 (q, J = 7.2 Hz, 2H), 1.06 (t, J = 7.2 Hz, 
3H); 13C-NMR (150 MHz, CDCl3) δ 145.8, 133.5, 127.7, 124.1, 120.1, 109.3, 49.4, 42.2; HRMS 
Calculated for C10H14N3O [M+H]+: 192.1137, Found: 192.1131. 
 
N-2-1.6.3f
N
N
N
 
(E)-2-(pent-2-en-4-ynyl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.3f) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.87-7.83 (m, 2H), 7.40-7.36 (m, 2H), 6.52 (dt, J = 15.6 Hz, 6.0 Hz, 1H), 5.76 (dq, J = 15.6 Hz, 
1.8 Hz, 1H), 5.36 (dd, J = 6.6 Hz, 1.2 Hz, 2H), 2.95 (d, J = 1.2 Hz, 1H); 13C-NMR (150 MHz, 
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CDCl3) δ 144.5, 136.7, 126.5, 118.0, 114.1, 80.4, 79.5, 57.5; HRMS Calculated for C11H10N3 
[M+H]+: 184.0875, Found: 184.0868. 
 
N
N
N
N-1-1.6.3f  
(E)-1-(pent-2-en-4-ynyl)-1H-benzo[d][1,2,3]triazole (N-1-1.6.3f) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.01 
(d, J = 8.4 Hz, 1H), 7.46-7.41 (m, 2H), 7.34-7.31 (m, 1H), 6.35 (dt, J = 15.6 Hz, 6.0 Hz, 1H), 
5.59 (dq, J = 15.6 Hz, 1.8 Hz, 1H), 5.28 (dd, J = 6.6 Hz, 1.2 Hz, 2H), 2.91 (d, J = 1.2 Hz, 1H); 
13C-NMR (150 MHz, CDCl3) δ 145.9, 137.0, 132.6, 127.5, 123.9, 119.9, 113.0, 109.3, 80.1, 
79.5, 49.3; HRMS Calculated for C11H10N3 [M+H]+: 184.0875, Found: 184.0882. 
 
N-2-1.6.3g
N
N
N
OMe
 
(E)-2-(pent-2-en-4-ynyl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.3g) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.89-7.83 (m, 2H), 7.37-7.32 (m, 2H), 7.30 (dt, J = 7.8 Hz, 1.8 Hz, 1H), 7.11 (dd, J = 7.8 Hz, 1.8 
Hz, 1H), 6.90 (t, J = 7.8 Hz, 2H), 5.94 (s, 2H), 3.85 (s, 3H); 13C-NMR (150 MHz, CDCl3) δ 
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157.3, 144.7, 130.1, 129.9, 126.4, 123.4, 121.0, 118.4, 111.0, 55.8, 55.2; HRMS Calculated for 
C14H14N3O [M+H]+: 240.1137, Found: 240.1127. 
 
N
N
N
N-1-1.6.3g
MeO
 
(E)-1-(pent-2-en-4-ynyl)-1H-benzo[d][1,2,3]triazole (N-1-1.6.3g) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.05 
(d, J = 8.4 Hz, 1H), 7.48 (d, J = 8.4 Hz, 1H), 7.41 (t, J = 7.2 Hz, 1H), 7.33 (t, J = 7.2 Hz, 1H), 
7.29 (d, J = 8.4 Hz, 1H), 7.07 (d, J = 7.2 Hz, 1H), 6.91 (d, J = 8.4 Hz, 1H), 6.88 (t, J = 7.2 Hz, 
1H), 5.86 (s,  2H), 3.88 (s, 3H); 13C-NMR (150 MHz, CDCl3) δ 156.9, 146.1, 133.1, 129.8, 
129.4, 127.1, 123.7, 123.2, 120.9, 119.9, 110.6, 110.0, 55.4, 46.8; HRMS Calculated for 
C14H14N3O [M+H]+: 240.1137, Found: 240.1135. 
 
N-2-1.6.3h
N
N
N
Ph
 
2-(1-phenylallyl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.3h) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.88-7.85 (m, 2H), 7.40-7.36 (m, 4H), 7.31-7.27 (m, 2H), 7.25-7.21 (m, 1H), 6.76 (d, J = 15.6 
Hz, 1H), 6.53 (dt, J = 15.6 Hz, 6.6 Hz, 1H), 5.47 (d, J = 6.6 Hz, 2H); 13C-NMR (150 MHz, 
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CDCl3) δ 144.8, 136.0, 135.5, 128.8, 128.5, 127.0, 126.6, 122.2, 118.3, 58.8; HRMS Calculated 
for C15H14N3 [M+H]+: 236.1188, Found: 236.1180. 
 
N
N
N
N-1-1.6.3h
Ph
 
1-(1-phenylallyl)-1H-benzo[d][1,2,3]triazole (N-1-1.6.3h) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.06 
(d, J = 8.4 Hz, 1H), 7.55 (d, J = 8.4 Hz, 1H), 7.44 (t, J = 7.2 Hz, 1H), 7.37-7.32 (m, 3H), 7.31-
7.27 (m, 2H), 7.26-7.22 (m, 1H), 6.66 (d, J = 8.4 Hz, 1H), 6.38 (dt, J = 15.6 Hz, 6.0 Hz, 1H), 
5.42 (dd, J = 15.6 Hz, 6.0 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 146.5, 135.8, 134.7, 133.1, 
128.9, 128.6, 127.6, 126.9, 124.2, 122.4, 120.3, 110.0, 50.8; HRMS Calculated for C15H14N3 
[M+H]+: 236.1188, Found: 236.1178. 
 
N-2-1.6.3i
N
N
N
 
(E)-2-(pent-3-en-2-yl)-2H-benzo[d][1,2,3]triazole (N-2-3i) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.90-7.85 (m, 2H), 7.40-7.35 (m, 2H), 5.90 (qq, J = 7.2 Hz, 1.2 Hz, 1H), 5.80 (dqd, J = 15.6 Hz, 
7.2 Hz, 1.2 Hz, 1H), 5.50 (quin, J = 7.2 Hz, 1H), 1.81 (d, J = 7.2 Hz, 3H), 1.73 (dq, J = 7.2 Hz, 
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1.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 144.3, 130.4, 129.4, 126.3, 118.3, 64.9, 21.3, 17.9; 
HRMS Calculated for C11H14N3 [M+H]+: 188.118, Found: 188.1183. 
 
N
N
N
N-1-1.6.3i  
(E)-1-(pent-3-en-2-yl)-1H-benzo[d][1,2,3]triazole (N-1-1.6.3i) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.03 
(d, J = 8.4 Hz, 1H), 7.52 (d, J = 8.4 Hz, 1H), 7.42 (t, J = 7.2 Hz, 1H), 7.32 (t, J = 7.2 Hz, 1H), 
5.81 (qq, J = 7.2 Hz, 1.2 Hz, 1H), 5.71 (dqd, J = 15.6 Hz, 7.2 Hz, 1.2 Hz, 1H), 5.47 (quin, J = 7.2 
Hz, 1H), 1.81 (d, J = 7.2 Hz, 3H), 1.70 (d, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 
146.6, 132.4, 130.2, 128.8, 127.0, 123.9, 120.2, 110.4, 57.6, 20.3, 17.8; HRMS Calculated for 
C11H14N3 [M+H]+: 188.118, Found: 188.1189. 
 
N-2-1.6.3j
N
N
N
 
2-(2,3-dihydro-1H-inden-2-yl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.3j) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.87-7.83 (m, 2H), 7.37-7.32 (m, 3H), 7.30 (t, J = 7.2 Hz, 1H), 7.21-7.15 (m, 2H), 6.47 (t, J = 7.2 
Hz, 1H), 3.47-3.41 (m, 1H), 3.13-3.07 (m, 1H), 2.90-2.82 (m, 2H); 13C-NMR (150 MHz, CDCl3) 
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δ 144.6, 144.2, 140.7, 129.3, 127.2, 126.4, 125.4, 125.0, 118.4, 71.5, 33.0, 31.2; HRMS 
Calculated for C16H16N3 [M+H]+: 250.1344, Found: 250.1349. 
 
N
N
N
N-1-1.6.3j  
2-(2,3-dihydro-1H-inden-2-yl)-2H-benzo[d][1,2,3]triazole (N-1-1.6.3j) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.04 
(d, J = 7.2 Hz, 1H), 7.40 (d, J = 7.2 Hz, 1H), 7.33 (t, J = 7.2 Hz, 1H), 7.31-7.24 (m, 2H), 7.14 (t, 
J = 7.2 Hz, 1H), 6.98 (d, J = 7.2 Hz, 1H), 6.91 (d, J = 7.2 Hz, 1H), 6.63 (t, J = 7.2 Hz, 1H), 3.31 
(ddd, J = 15.6 Hz, 9.0 Hz, 4.2 Hz, 1H), 3.13 (quin, J = 7.2 Hz, 1H), 2.89-2.82 (m, 1H), 2.56-2.49 
(m, 1H); 13C-NMR (150 MHz, CDCl3) δ 147.0, 143.7, 139.5, 131.9, 129.3, 127.4, 127.2, 125.5, 
125.0, 124.0, 120.4, 110.6, 65.1, 32.8, 31.0; HRMS Calculated for C16H16N3 [M+H]+: 250.1344, 
Found: 250.1343. 
 
N-2-1.6.3k
N
N
N
 
2-(2,3-dihydro-1H-inden-2-yl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.3k) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.89-7.84 (m, 2H), 7.40-7.35 (m, 2H), 7.32-7.29 (m, 2H), 7.27-7.23 (m, 2H), 5.80 (tt, J = 8.4 Hz, 
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6.6 Hz, 1H), 3.84 (d, J = 6.6 Hz, 1H), 3.82 (d, J = 6.6 Hz, 1H), 3.71 (d, J = 8.4 Hz, 1H), 3.68 (d, 
J = 8.4 Hz, 1H); 13C-NMR (150 MHz, CDCl3) δ 144.1, 139.8, 127.2, 126.2, 124.5, 118.0, 66.2, 
39.9; HRMS Calculated for C16H16N3 [M+H]+: 250.1344, Found: 250.1351. 
 
N
N
N
N-1-1.6.3k  
2-(2,3-dihydro-1H-inden-2-yl)-2H-benzo[d][1,2,3]triazole (N-1-1.6.3k) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.07 
(d, J = 8.4 Hz, 1H), 7.42-7.38 (m, 1H), 7.37-7.27 (m, 6H), 5.82 (quin, J = 7.2 Hz, 1H), 3.69 (s, 
2H), 3.67 (s, 2H); 13C-NMR (150 MHz, CDCl3) δ 146.6, 139.9, 132.0, 127.4, 127.1, 124.6, 
123.8, 120.2, 109.9, 59.4, 38.9; HRMS Calculated for C16H16N3 [M+H]+: 250.1344, Found: 
250.1353. 
 
N-2-1.6.3l
N
N
N Ph
 
2-(1-phenylethyl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.3l) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.88-7.82 (m, 2H), 7.40-7.38 (m, 2H), 7.37-7.25 (m, 5H), 6.14 (q, J = 7.2 Hz, 1H), 2.13 (d, J = 
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7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 144.4, 140.4, 129.0, 128.5, 126.8, 126.4, 118.4, 
66.4, 21.6; HRMS Calculated for C14H14N3 [M+H]+: 224.1188, Found: 224.1189. 
 
N
N
N
Ph
N-1-1.6.3l  
1-(1-phenylethyl)-1H-benzo[d][1,2,3]triazole (N-1-1.6.3l) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.03 
(d, J = 7.2 Hz, 1H), 7.33-7.22 (m, 8H), 6.02 (q, J = 7.2 Hz, 1H), 2.16 (d, J = 7.2 Hz, 3H); 13C-
NMR (150 MHz, CDCl3) δ 146.4, 140.1, 132.4, 128.9, 128.2, 127.0, 126.2, 123.8, 119.9, 110.1, 
59.0, 21.1; HRMS Calculated for C14H14N3 [M+H]+: 224.1188, Found: 224.1191. 
 
N-2-1.6.3m
N
N
N Ph
 
2-(2,2-dimethyl-1-phenylpropyl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.3m) was purified by 
flash chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) 
δ 7.91-7.86 (m, 2H), 7.77-7.73 (m, 2H), 7.38-7.28 (m, 5H), 5.82 (s, 1H), 1.11 (s, 9H); 13C-NMR 
(150 MHz, CDCl3) δ 143.7, 135.8, 129.6, 128.0, 127.8, 126.0, 118.2, 80.5, 36.9, 27.1; HRMS 
Calculated for C17H20N3 [M+H]+: 266.1657, Found: 266.1663. 
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N
N
N
Ph
N-1-1.6.3m  
2-(2,2-dimethyl-1-phenylpropyl)-2H-benzo[d][1,2,3]triazole (N-1-1.6.3m) was purified by 
flash chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) 
δ 8.03 (d, J = 8.4 Hz, 1H), 7.64-7.61 (m, 2H), 7.49 (d, J = 8.4 Hz, 1H), 7.41 (t, J = 7.2 Hz, 1H), 
7.32-7.23 (m, 4H), 5.43 (s, 1H), 1.13 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 144.7, 136.4, 
134.3, 129.4, 127.9, 127.0, 123.7, 119.8, 109.4, 72.5, 37.2, 27.6; HRMS Calculated for C17H20N3 
[M+H]+: 266.1657, Found: 266.1648. 
 
N-2-1.6.4a
Ph N
N
N Ph
 
2-benzyl-4-phenyl-2H-1,2,3-triazole (N-2-1.6.4a) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.93 (s, 1H), 7.87-
7.84 (m, 2H), 7.46 (t, J = 8.4 Hz, 2H), 7.43-7.33 (m, 6H), 5.67 (s, 2H); 13C-NMR (150 MHz, 
CDCl3) δ 147.9, 135.2, 131.3, 130.2, 128.7, 128.6, 128.3, 128.1, 127.8, 125.8, 58.5; HRMS 
Calculated for C15H14N3 [M+H]+: 236.1188, Found: 236.1178. 
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Ph N
N
N
Ph
N-1-1.6.4a  
1-benzyl-4-phenyl-1H-1,2,3-triazole (N-1-1.6.4a) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.81-7.79 (m, 2H), 
7.66 (s, 1H), 7.41-7.35 (m, 5H), 7.33-7.29 (m, 3H), 5.57 (s, 2H); 13C-NMR (150 MHz, CDCl3) δ 
148.2, 134.7, 130.5, 129.1, 128.8, 128.1, 128.0, 125.7, 119.4, 54.2; HRMS Calculated for 
C15H14N3 [M+H]+: 236.1188, Found: 236.1178. 
 
N-2-1.6.4b
Ph N
N
N
 
2-allyl-4-phenyl-2H-1,2,3-triazole (N-2-1.6.4b) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.86 (s, 1H), 7.81-
7.78 (m, 2H), 7.40 (t, J = 7.8 Hz, 2H), 7.34-7.30 (m, 1H), 6.15-6.07 (m, 1H), 5.31-5.26 (m, 2H), 
5.05 (dt, J = 6.0 Hz, 1.2 Hz,  2H); 13C-NMR (150 MHz, CDCl3) δ 147.6, 131.5, 130.9, 130.1, 
128.6, 128.1, 125.6, 118.9, 57.1; HRMS Calculated for C11H12N3 [M+H]+: 186.1031, Found: 
186.1032. 
 
312 
 
Ph N
N
N
N-1-1.6.4b  
1-allyl-4-phenyl-1H-1,2,3-triazole (N-1-1.6.4b) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.84-7.82 (m, 2H), 
7.76 (s, 1H), 7.44-7.40 (m, 2H), 7.35-7.31 (m, 1H), 6.10-6.03 (m, 1H), 5.40-5.36 (m, 1H), 5.34-
5.33 (m, 1H), 5.03 (dt, J = 6.0 Hz, 1.2 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 148.0, 131.3, 
130.6, 128.8, 128.1, 125.7, 120.2, 119.4, 93.0, 52.8; HRMS Calculated for C11H12N3 [M+H]+: 
186.1031, Found: 186.1043. 
 
N-2-1.6.4c
Ph N
N
N
 
4-phenyl-2-(prop-2-ynyl)-2H-1,2,3-triazole (N-2-1.6.4c) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.89 (s, 1H), 7.80-
7.78 (m, 2H), 7.44-7.40 (m, 2H), 7.37-7.33 (m, 1H), 5.25 (d, J = 2.4 Hz,  2H), 2.54 (t, J = 2.4 
Hz,  1H); 13C-NMR (150 MHz, CDCl3) δ 148.5, 131.7, 129.9, 128.8, 128.5, 125.9, 75.7, 74.8, 
44.4; HRMS Calculated for C11H10N3 [M+H]+: 184.0875, Found: 184.0879. 
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Ph N
N
N
N-1-1.6.4c  
4-phenyl-1-(prop-2-ynyl)-1H-1,2,3-triazole (N-1-1.6.4c) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.97 (s, 1H), 7.83-
7.81 (m, 2H), 7.42-7.39 (m, 2H), 7.34-7.30 (m, 1H), 5.18 (d, J = 2.4 Hz, 2H), 2.59 (t, J = 2.4 Hz,  
1H); 13C-NMR (150 MHz, CDCl3) δ 148.0, 130.2, 128.7, 128.2, 125.6, 119.3, 75.7, 75.1, 39.7; 
HRMS Calculated for C11H10N3 [M+H]+: 184.0875, Found: 184.0885. 
 
N-2-1.6.4d
Ph N
N
N
Ph
 
4-phenyl-2-(1-phenylethyl)-2H-1,2,3-triazole (N-2-1.6.4d) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.87 
(s, 1H), 7.82-7.80 (m, 2H), 7.44-7.41 (m, 2H), 7.37-7.32 (m, 5H), 7.31-7.27 (m, 1H), 5.89 (q, J = 
7.2 Hz,  1H), 2.04 (d, J = 7.2 Hz,  3H); 13C-NMR (150 MHz, CDCl3) δ 147.4, 140.9, 130.9, 
130.6, 128.8, 128.6, 128.3, 128.0, 126.4, 125.9, 64.5, 21.3; HRMS Calculated for C16H16N3 
[M+H]+: 250.1344, Found: 250.1343. 
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Ph N
N
N
Ph
N-1-1.6.4d  
4-phenyl-1-(1-phenylethyl)-1H-1,2,3-triazole (N-1-1.6.4d) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.82-7.79 (m, 2H), 7.66 (s, 1H), 7.41-7.28 (m, 8H), 5.86 (q, J = 7.2 Hz,  1H), 2.02 (d, J = 7.2 Hz,  
3H); 13C-NMR (150 MHz, CDCl3) δ 147.7, 139.9, 130.6, 129.0, 128.7, 128.5, 128.0, 126.4, 
125.6, 118.3, 60.2, 21.2; HRMS Calculated for C16H16N3 [M+H]+: 250.1344, Found: 250.1352. 
 
N-2-1.6.4e
Ph N
N
N
Ph
 
2-(2,2-dimethyl-1-phenylpropyl)-4-phenyl-2H-1,2,3-triazole (N-2-1.6.4e) was purified by 
flash chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) 
δ 7.85 (s, 1H), 7.84-7.82 (m, 2H), 7.70-7.67 (m, 2H), 7.45-7.41 (m, 2H), 7.36-7.27 (m, 4H), 5.55 
(s,  1H), 1.08 (s,  9H); 13C-NMR (150 MHz, CDCl3) δ 146.9, 136.3, 130.7, 130.1, 129.5, 128.8, 
128.2, 127.7, 125.9, 78.8, 36.8, 27.1; HRMS Calculated for C19H22N3 [M+H]+: 292.1814, Found: 
292.1810. 
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Ph N
N
N
Ph
N-1-1.6.4e  
2-(2,2-dimethyl-1-phenylpropyl)-4-phenyl-2H-1,2,3-triazole (N-1-1.6.4e) was purified by 
flash chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) 
δ 7.85 (s, 1H), 7.84-7.82 (m, 2H), 7.60-7.57 (m, 2H), 7.41 (t, J = 7.8 Hz,  2H), 7.37-7.31 (m,  
4H), 5.30 (s, 1H), 1.11 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 136.3, 130.7, 129.3, 128.8, 128.1, 
128.0, 125.6, 120.6, 75.8, 36.6, 27.5; HRMS Calculated for C19H22N3 [M+H]+: 292.1814, Found: 
292.1810. 
 
N-2-1.6.4f
Ph N
N
N
 
2-(2,3-dihydro-1H-inden-1-yl)-4-phenyl-2H-1,2,3-triazole (N-2-1.6.4f) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.86 
(s, 1H), 7.79 (d, J = 7.8 Hz,  2H), 7.42 (t, J = 7.8 Hz,  2H), 7.35-7.32 (m, 2H), 7.30 (t, J = 7.8 Hz,  
1H), 7.24 (d, J = 7.8 Hz,  1H), 7.20 (t, J = 7.8 Hz,  1H), 6.22 (t, J = 7.8 Hz,  1H), 3.39-3.33 (m, 
1H), 3.08-3.02 (m, 1H), 2.82-2.72 (m, 2H); 13C-NMR (150 MHz, CDCl3) δ 147.5, 143.7, 140.7, 
131.0, 130.5, 128.7, 128.2, 126.8, 125.9, 125.0, 124.7, 69.6, 32.2, 30.7; HRMS Calculated for 
C18H18N3 [M+H]+: 276.1501, Found: 276.1498. 
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Ph N
N
N
N-1-1.6.4f  
1-(2,3-dihydro-1H-inden-1-yl)-4-phenyl-1H-1,2,3-triazole (N-1-1.6.4f) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.80-7.77 (m, 2H), 7.48 (s, 1H), 7.40-7.35 (m, 4H), 7.32-7.28 (m, 2H), 7.28-7.21 (m, 1H), 6.31-
6.28 (m, 1H), 3.25-3.19 (m, 1H), 3.10-3.04 (m, 1H), 2.90-2.83 (m, 1H), 2.45-2.39 (m, 1H); 13C-
NMR (150 MHz, CDCl3) δ 147.9, 143.9, 139.8, 130.7, 129.4, 128.7, 128.1, 127.4, 125.7, 125.3, 
124.9, 117.6, 65.5, 34.2, 30.4; HRMS Calculated for C18H18N3 [M+H]+: 276.1501, Found: 
276.1495. 
 
N-2-1.6.4j
Ph N
N
N Ph
 
2-benzyl-4-cyclohexenyl-5-phenyl-2H-1,2,3-triazole (N-2-1.6.4j) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.71-7.68 (m, 2H), 7.43-7.40 (m, 4H), 7.38-7.35 (m, 3H), 7.34-7.30 (m, 1H), 6.07 (sep, J = 1.8 
Hz, 1H), 5.59 (s, 2H), 7.38-7.34 (m, 2H), 2.18-2.14 (m, 2H), 1.79-1.73 (m, 2H), 1.72-1.67 (m, 
2H); 13C-NMR (150 MHz, CDCl3) δ 146.6, 144.0, 135.4, 131.6, 129.2, 128.6, 128.5, 128.3, 
128.0, 127.9, 127.8, 127.7, 58.3, 27.6, 25.3, 22.6, 21.8,; HRMS Calculated for C21H22N3 
[M+H]+: 316.1814, Found: 316.1821. 
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N-2-1.6.4k
Ph N
N
N
 
2-allyl-4-cyclohexenyl-5-phenyl-2H-1,2,3-triazole (N-2-1.6.4k) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.66-7.64 (m, 2H), 7.38 (t, J = 7.2 Hz, 2H), 7.34-7.30 (m, 1H), 6.16-6.08 (m, 1H), 6.03 (sep, J = 
1.8 Hz, 1H), 5.33-5.28 (m, 2H), 5.01 (d, J = 7.2 Hz, 2H), 2.34-2.30 (m, 2H), 2.15-2.11 (m, 2H), 
1.75-1.70 (m, 2H), 1.68-1.63 (m, 2H); 13C-NMR (150 MHz, CDCl3) δ 146.5, 143.9, 131.7, 
131.6, 129.2, 128.5, 128.3, 127.8, 119.0, 57.1, 27.5, 25.3, 22.5, 21.8; HRMS Calculated for 
C17H20N3 [M+H]+: 266.1657, Found: 266.1650. 
 
N-2-1.6.4l
Ph N
N
N
Ph
 
4-cyclohexenyl-5-phenyl-2-(1-phenylethyl)-2H-1,2,3-triazole (N-2-1.6.4l) was purified by 
flash chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) 
δ 7.78-7.76 (m, 2H), 7.45 (t, J = 7.2 Hz, 4H), 7.40-7.36 (m, 3H), 7.32 (tt, J = 7.2 Hz, 1.2 Hz, 
1H), 6.13 (sep, J = 1.8 Hz,  1H), 5.91 (q, J = 7.2 Hz, 1H), 2.46-2.41 (m, 2H), 2.22-2.18 (m, 2H), 
2.07 (d, J = 7.2 Hz,  3H), 1.83-1.78 (m, 2H), 1.76-1.71 (m, 2H); 13C-NMR (150 MHz, CDCl3) δ 
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145.9, 143.4, 141.0, 131.8, 128.9, 128.7, 128.4, 128.2, 127.8, 127.7, 127.6, 126.3, 64.1, 27.5, 
25.3, 22.5, 21.7, 21.3; HRMS Calculated for C22H24N3 [M+H]+: 330.1970, Found: 330.1965. 
 
N
N
N
N
N
N
1.6.5a  
1,6-di(2H-benzo[d][1,2,3]triazol-2-yl)hexane (1.6.5a) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.86-7.82 (m, 4H), 
7.39-7.35 (m, 4H), 4.71 (t, J = 7.2 Hz, 4H), 2.14-2.09 (m, 4H), 1.43-1.40 (m, 4H); 13C-NMR 
(150 MHz, CDCl3) δ 144.3, 126.2, 117.9, 56.3, 29.8, 26.0; HRMS Calculated for C18H21N6 
[M+H]+: 321.1828, Found: 321.1820. 
 
Ph N
N
N
N
N
N Ph
1.6.5b  
1,6-bis(4-phenyl-2H-1,2,3-triazol-2-yl)hexane (1.6.5b) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.80 (s, 2H), 7.78-
7.76 (m, 4H), 7.42 (t, J = 7.2 Hz, 4H), 7.34 (tt, J = 7.2 Hz, 1.2 Hz, 2H), 7.34 (t, J = 7.2 Hz, 4H), 
2.03-1.98 (m, 4H), 1.42-1.39 (m, 4H); 13C-NMR (150 MHz, CDCl3) δ 147.7, 130.6, 130.5, 
128.8, 128.3, 125.8, 54.8, 29.5, 26.0; HRMS Calculated for C22H25N6 [M+H]+: 373.2141, Found: 
373.2150. 
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N
N
N
N
N
N
1.6.5c  
(Z)-1,4-bis(4-phenyl-2H-1,2,3-triazol-2-yl)but-2-ene (1.6.5c) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.88-7.85 (m, 4H), 7.40-7.36 (m, 4H), 6.27 (t, J = 6.0 Hz, 2H), 5.62 (d, J = 6.0 Hz, 4H); 13C-
NMR (150 MHz, CDCl3) δ 144.6, 127.8, 126.5, 118.0, 52.9; HRMS Calculated for C16H15N6 
[M+H]+: 291.1358, Found: 291.1350. 
 
N
N
N
N
N
N
1.6.5d  
(Z)-1,4-bis(4-p-tolyl-2H-1,2,3-triazol-2-yl)but-2-ene (1.6.5d) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.83 
(s, 2H), 7.68 (d, J = 7.8 Hz, 4H), 7.23 (d, J = 7.8 Hz, 4H), 6.13 (t, J = 4.8 Hz, 2H), 5.29 (d, J = 
4.8 Hz, 4H), 2.39 (s, 6H); 13C-NMR (150 MHz, CDCl3) δ 148.2, 138.3, 131.0, 129.5, 127.6, 
127.4, 125.8, 51.5, 21.2; HRMS Calculated for C22H23N6 [M+H]+: 371.1984, Found: 371.1989. 
 
1.6.5e
N
N N
NN
N
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1,4-bis((2H-benzo[d][1,2,3]triazol-2-yl)methyl)benzene (1.6.5e) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.85-7.82 (m, 4H), 7.41 (s, 4H), 7.37-7.34 (m, 4H), 5.84 (s, 4H); 13C-NMR (150 MHz, CDCl3) δ 
144.6, 135.1, 128.9, 126.4, 118.1, 59.9; HRMS Calculated for C20H17N6 [M+H]+: 341.1515, 
Found: 341.1519. 
 
1.6.5f
N
N N
NN
N
 
1,4-bis((4-p-tolyl-2H-1,2,3-triazol-2-yl)methyl)benzene (1.6.5f) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.79 
(s, 2H), 7.63 (d, J = 7.8 Hz, 4H), 7.31 (s, 4H), 7.20 (d, J = 7.8 Hz, 4H), 5.57 (s, 4H), 2.36 (s, 
6H); 13C-NMR (150 MHz, CDCl3) δ 148.2, 138.3, 135.5, 131.3, 129.5, 128.4, 127.4, 125.8, 58.2, 
21.3; HRMS Calculated for C26H25N6 [M+H]+: 421.2141, Found: 421.2137. 
 
N-2-1.6.6a
N
N
N
 
cis-2-(2-methylcyclohexyl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.6a) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.89-7.85 (m, 2H), 7.37-7.33 (m, 2H), 4.97 (quin, J = 4.8 Hz, 1H), 2.58-2.53 (m, 1H), 2.44-2.36 
(m, 1H), 2.17-2.03 (m, 2H), 1.89-1.83 (m, 1H), 1.76-1.64 (m, 2H), 1.55-1.46 (m, 2H), 0.70 (d, J 
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= 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 143.7, 125.8, 118.0, 67.9, 34.8, 30.8, 26.7, 24.1, 
21.2, 13.5; HRMS Calculated for C13H18N3 [M+H]+: 216.1501, Found: 216.1498. 
 
N
N
N
N-1-1.6.6a  
cis-1-(2-methylcyclohexyl)-1H-benzo[d][1,2,3]triazole (N-1-1.6.6a) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.06 
(d, J = 8.4 Hz, 1H), 7.53 (d, J = 8.4 Hz, 1H), 7.44 (t, J = 8.4 Hz, 1H), 7.34 (t, J = 8.4 Hz, 1H), 
4.82 (quin, J = 4.8 Hz, 1H), 2.55-2.48 (m, 1H), 2.43-2.36 (m, 1H), 2.12-2.04 (m, 2H), 1.92-1.88 
(m, 1H), 1.78-1.69 (m, 2H), 1.59-1.50 (m, 2H), 0.72 (d, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, 
CDCl3) δ 145.7, 133.2, 126.7, 123.6, 120.1, 109.7, 60.8, 34.2, 30.9, 27.0, 24.4, 21.4, 14.0; 
HRMS Calculated for C13H18N3 [M+H]+: 216.1501, Found: 216.1495. 
 
N-2-1.6.6b
N
N
N
Ph
 
cis-2-(2-methylcyclohexyl)-4-phenyl-2H-1,2,3-triazole (N-2-1.6.6b) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.83 
(s, 1H), 7.80 (d, J = 7.2 Hz, 2H), 7.42 (t, J = 7.2 Hz, 2H), 7.33 (tt, J = 7.2 Hz, 1.2 Hz, 1H), 4.71 
322 
 
(quin, J = 4.8 Hz, 1H), 2.46-2.39 (m, 1H), 2.31-2.23 (m, 1H), 2.06-1.99 (m, 2H), 1.86-1.78 (m, 
1H), 1.71-1.62 (m, 2H), 1.52-1.44 (m, 2H), 0.75 (d, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, 
CDCl3) δ 146.7, 130.9, 129.9, 128.7, 128.0, 125.8, 66.1, 34.5, 30.5, 26.8, 23.8, 21.5, 13.9; 
HRMS Calculated for C15H20N3 [M+H]+: 242.1657, Found: 242.1655. 
 
N
N
N
N-1-1.6.6b
Ph
 
cis-1-(2-methylcyclohexyl)-4-phenyl-1H-1,2,3-triazole (N-1-1.6.6b) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.84 
(d, J = 7.2 Hz, 2H), 7.75 (s, 1H), 7.42 (t, J = 7.2 Hz, 2H), 7.32 (tt, J = 7.2 Hz, 1.2 Hz, 1H), 4.82 
(dt, J = 10.8 Hz, 4.8 Hz, 1H), 2.47-2.43 (m, 1H), 2.17-2.09 (m, 1H), 2.04-1.95 (m, 2H), 1.75-
1.69 (m, 2H), 1.68-1.57 (m, 1H), 1.56-1.48 (m, 2H), 0.78 (d, J = 7.2 Hz, 3H); 13C-NMR (150 
MHz, CDCl3) δ 130.9, 128.8, 127.9, 125.6, 118.5, 62.4, 34.2, 30.8, 26.5, 24.6, 20.7, 13.1; HRMS 
Calculated for C15H20N3 [M+H]+: 242.1657, Found: 242.1655. 
 
N-2-1.6.6c
N
N
N
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cis-2-(2-methylcyclopentyl)-2H-benzo[d][1,2,3]triazole (N-2-1.6.6c) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.88-7.84 (m, 2H), 7.34-7.31 (m, 2H), 5.31-5.27 (m, 1H), 2.62-2.55 (m, 1H), 2.48-2.33 (m, 2H), 
2.23-2.16 (m, 1H), 1.93-1.87 (m, 1H), 1.81-1.71 (m, 2H), 0.55 (d, J = 7.2 Hz, 3H); 13C-NMR 
(150 MHz, CDCl3) δ 143.8, 125.8, 117.9, 70.8, 40.5, 32.5, 31.5, 23.6, 13.8; HRMS Calculated 
for C12H16N3 [M+H]+: 202.1344, Found: 202.1340. 
 
N
N
N
N-1-1.6.6c  
cis-1-(2-methylcyclopentyl)-1H-benzo[d][1,2,3]triazole (N-1-1.6.6c) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.06 
(d, J = 7.2 Hz, 1H), 7.53 (d, J = 7.2 Hz, 1H), 7.45 (t, J = 7.2 Hz, 1H), 7.34 (t, J = 7.2 Hz, 1H), 
5.11-5.07 (m, 1H), 2.68-2.63 (m, 1H), 2.51-2.45 (m, 1H), 2.44-2.37 (m, 1H), 2.25-2.19 (m, 1H), 
1.99-1.94 (m, 1H), 1.84-1.73 (m, 2H), 0.53 (d, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 
145.4, 134.0, 126.8, 123.6, 119.9, 109.6, 62.9, 39.8, 32.6, 31.0, 23.3, 14.3; HRMS Calculated for 
C12H16N3 [M+H]+: 202.1344, Found: 202.1337. 
 
N-2-1.6.6d
N
N
N
Ph
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cis-2-(2-methylcyclopentyl)-4-phenyl-2H-1,2,3-triazole (N-2-1.6.6d) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.82 
(s, 1H), 7.81 (d, J = 7.2 Hz, 2H), 7.42 (t, J = 7.2 Hz, 2H), 7.33 (tt, J = 7.2 Hz, 1.2 Hz, 1H), 5.06-
5.02 (m, 1H), 2.49-2.43 (m, 1H), 2.39-2.26 (m, 2H), 2.17-2.11 (m, 1H), 1.92-1.86 (m, 1H), 1.74-
1.67 (m, 2H), 0.65 (d, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 146.8, 130.9, 130.0, 
128.7, 128.1, 125.8, 69.2, 40.3, 32.4, 31.1, 23.5, 14.0; HRMS Calculated for C14H18N3 [M+H]+: 
228.1501, Found: 228.1496. 
 
N
N
N
N-1-1.6.6d
Ph
 
cis-1-(2-methylcyclopentyl)-4-phenyl-1H-1,2,3-triazole (N-1-1.6.6d) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.85 
(d, J = 7.2 Hz, 2H), 7.68 (s, 1H), 7.42 (t, J = 7.2 Hz, 2H), 7.32 (t, J = 7.2 Hz, 1H), 4.98-4.94 (m, 
1H), 2.42-2.33 (m, 2H), 2.32-2.26 (m, 1H), 2.14-2.08 (m, 1H), 2.00-1.93 (m, 1H), 1.84-1.77 (m, 
1H), 1.61-1.54 (m, 1H), 0.70 (d, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 147.1, 130.9, 
128.8, 127.9, 125.6, 119.3, 65.3, 39.4, 32.1, 31.2, 22.9, 14.2; HRMS Calculated for C14H18N3 
[M+H]+: 228.1501, Found: 228.1506. 
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(R)-N-2-1.6.7a
N
N
N
Ph
 
(R)-2-(1-phenylethyl)-2H-benzo[d][1,2,3]triazole ((R)-N-2-1.6.7a) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 
7.91-7.87 (m, 2H), 7.43-7.40 (m, 2H), 7.39-7.32 (m, 4H), 7.29 (tt, J = 7.2 Hz, 1.2 Hz, 1H), 6.16 
(q, J = 7.2 Hz, 1H), 2.16 (d, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 144.1, 140.2, 128.7, 
128.3, 126.5, 126.2, 118.1, 66.1, 21.3; HRMS Calculated for C14H14N3 [M+H]+: 224.1188, 
Found: 224.1179. Enantiomeric excess was determined by HPLC with a Chiralcel OD-H 
column; λ = 254 nm; eluent: Hexane/Isopropanol = 95/5; Flow rate: 1.0 mL/min; tR = 6.8 min, tR 
= 11.4 min; 87% ee. 
 
(R)-N-1-1.6.7a
N
N
N
Ph
 
(R)-1-(1-phenylethyl)-1H-benzo[d][1,2,3]triazole ((R)-N-1-1.6.7a) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.02 
(d, J = 7.2 Hz, 1H), 7.32-7.22 (m, 8H), 6.02 (q, J = 7.2 Hz, 1H), 2.15 (d, J = 7.2 Hz, 3H); 13C-
NMR (150 MHz, CDCl3) δ 146.7, 140.4, 132.7, 129.1, 128.4, 127.2, 126.5, 124.0, 120.1, 110.4, 
59.3, 21.4; HRMS Calculated for C14H14N3 [M+H]+: 224.1188, Found: 224.1190. Enantiomeric 
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excess was determined by HPLC with a Chiralcel OD-H column; λ = 254 nm; eluent: 
Hexane/Isopropanol = 95/5; Flow rate: 1.0 mL/min; tR = 6.8 min, tR = 11.4 min; 87% ee. 
 
N
N
N
O
HH
N
N
N-2-1.6.7b  
(2S,4S,7R)-2-((S)-(2H-benzo[d][1,2,3]triazol-2-yl)(6-methoxyquinolin-4-yl)methyl)-7-
vinylquinuclidine (N-2-1.6.7b) was purified by flash chromatography (Hexane-EtOAc, v/v 
10/1) as white solid. [ ]25D = -243.20 (CH2Cl2, c 1.0); 1H-NMR (600 MHz, CDCl3) δ 8.83 (d, J 
= 4.8 Hz, 1H), 8.01 (d, J = 9.0 Hz, 1H), 7.84 (d, J = 4.2 Hz, 1H), 7.83-7.79 (m, 2H), 7.77 (s, 1H), 
7.36 (dd, J = 9.0 Hz, 3.0 Hz, 1H), 7.31-7.27 (m, 2H), 6.74 (d, J = 11.4 Hz, 1H), 5.99-5.92 (m, 
1H), 5.12-5.10 (m, 1H), 5.08 (s, 1H), 4.45 (q, J = 8.4 Hz, 1H), 4.02 (s, 3H), 3.57-3.51 (m, 1H), 
3.14 (dd, J = 13.8 Hz, 10.2 Hz, 1H), 2.84 (d, J = 14.4 Hz, 1H), 2.79-2.73 (m, 1H), 2.31 (s, 1H), 
1.90 (t, J = 12.0 Hz, 1H), 1.76 (sex, J = 3.0 Hz, 1H), 1.69-1.57 (m, 2H), 0.93 (dd, J = 13.2 Hz, 
7.2 Hz, 1H); 13C-NMR (150 MHz, CDCl3) δ 158.4, 148.1, 147.6, 147.0, 144.9, 144.1, 141.4, 
139.0, 128.3, 126.2, 122.0, 118.3, 118.1, 114.7, 101.1, 58.6, 55.8, 55.7, 41.1, 39.3, 27.8, 27.7, 
26.8; HRMS Calculated for C26H28N5O [M+H]+: 426.2294, Found: 426.2290. 
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N
N
N
O
HH
N
N
N-1-1.6.7b  
(2S,4S,7R)-2-((S)-(1H-benzo[d][1,2,3]triazol-1-yl)(6-methoxyquinolin-4-yl)methyl)-7-
vinylquinuclidine (N-1-1.6.7b) was purified by flash chromatography (Hexane-EtOAc, v/v 
10/1) as white solid. [ ]25D = -96.20 (CH2Cl2, c 1.0); 1H-NMR (600 MHz, CDCl3) δ 8.84 (d, J = 
4.8 Hz, 1H), 7.98 (dd, J = 11.4 Hz, 9.0 Hz, 2H), 7.72 (d, J = 4.2 Hz, 1H), 7.66 (d, J = 2.4 Hz, 
1H), 7.41 (d, J = 8.4 Hz, 1H), 7.33 (dd, J =9.0 Hz, 2.4 Hz, 1H), 7.30 (tt, J = 7.8 Hz, 1.2 Hz, 1H), 
7.23 (tt, J = 7.8 Hz, 1.2 Hz, 1H), 6.70 (d, J = 11.4 Hz, 1H), 5.99-5.93 (m, 1H), 5.10 (tt, J = 9.0 
Hz, 1.2 Hz, 2H), 4.39 (s, 1H), 3.95 (s, 3H), 3.51-3.45 (m, 1H), 3.07 (dd, J = 13.8 Hz, 9.0 Hz, 
1H), 2.73 (d, J = 12.6 Hz, 1H), 2.70-2.65 (m, 1H), 2.31 (s, 1H), 2.07-2.02 (m, 1H), 1.81 (sex, J = 
3.0 Hz, 1H), 1.70-1.64 (m, 1H), 1.61-1.55 (m, 1H), 1.04 (dd, J = 13.2 Hz, 7.2 Hz, 1H); 13C-NMR 
(150 MHz, CDCl3) δ 158.5, 147.1, 146.3, 145.1, 141.5, 138.2, 132.2, 132.0, 128.4, 127.2, 123.6, 
122.2, 120.4, 114.7, 109.7, 101.0, 56.4, 55.9, 55.8, 41.0, 39.2, 27.8, 27.7; HRMS Calculated for 
C26H28N5O [M+H]+: 426.2294, Found: 426.2302. 
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III. ORTEP Drawing of the Crystal Structure  
 
 
 
 
 
 
 
 
 
 
Figure S1.6-1. Perspective view of the molecular structure of 1.6.5a (C18H20N6) with the atom 
labeling scheme.  The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 775283 
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Figure S1.6-2. Perspective view of the molecular structure of N-2-1.6.7b (C26H27N5O) with the 
atom labeling scheme.  The thermal ellipsoids are scaled to enclose 30% 
probability. CCDC number: 775283 
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Chapter Two: 1,2,3-trizazoles applied as ligands in transition metal catalysis 
2.2 Synthesis of [Ir(L^X)(ArTriaz)2] and [Ir(bbpy)(ArTriaz)2]Cl complexes and their 
application in photoredox catalysis 
General Methods and Materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware and standard syringe/septa techniques. 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 
commercial provider and used without further purification. 1H NMR and 13C NMR spectra were 
recorded on Varian 600 MHz spectrometers. Chemical shifts were reported relative to internal 
tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1H and CDCl3 (δ 77.0 ppm) for 13C. 
Melting points were measured on a Mel-Temp 1001D apparatus and uncorrected. Flash column 
chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250µ) and visualized by 
fluorescence and by charring after treatment with potassium permanganate stain. HRMS were 
recorded on LTQ-FTUHRA spectrometer.  
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Procedure for preparation of 2-Phenyl-1,2,3-triazole (2.2.1) 
 
H
O
H
O
+ PhNHNH2 NNPhHN NHPh
CuSO4, H2O N
N
N
2.2.1
60% in 2 steps 	  
 
To a 40% aqueous solution of glyoxal (50 mmol) was added phenylhydrazine (100 mmol) with 
stirring. Immediately a yellow solid was formed. To the reaction solution was added methanol 
(150 mL), and the yellow suspension was stirred for 0.5 h at room temperature and filtered to 
yield the resulting products Glyoxalbis(N-phenyl)osazone which was pure enough for running 
the next step.  
A mixture of glyoxal phenylosazone from previous step and Cu(OTf)2 (0.2 equiv.) was 
heated in water to reflux at 100 oC for 2 hours. The reaction mixture then purified by vacuum 
distillation to give the mixture products 2-phenyl-1,2,3-triazole and aniline at 120°C. For the 
isolation of the target product, 100 ml of ether have been added in the distillate. The solution 
then was treated in succession with 1 N HCl (3×10 ml) until PH = 6. The extract was dried with 
potassium carbonate, followed by the removal of ether to give the final products 2.2.1 as yellow 
liquid (60% yield in two steps). 
332 
 
General procedure for preparation of N-2-aryl-1,2,3-triazole-Ir(III) complex 
	  
N
2-EtOEtOH, H2O
IrCl3
LX, Na2CO3
Ir
L
X
=
N
OO
Ir
N
ON
H
Ir
N
NR
Cl
Cl
N
N
N
N
N N
R
R
Ir
N
N
N
N
NN
R
R
Ir
1.2.5c, R = Ph
2.2.1, R = H
2.2.2
L
X
N
N
N
N
N N
R
R
Ir
[Ir(L^X)(ArTriaz)2] 2.2.3
>91% yield in 2 steps
a b
or
N
N
	  
	  
[(ArTriaz)2Ir(µ-Cl)]2: IrCl3‧H2O (1 mmol) and N-2-aryl-1,2,3-triazole (4 mmol) were dissolved 
in 40 mL mixed solution of 2-EtOEtOH and H2O (V/V: 3/1), and refluxed at 140 oC for 24 hours. 
After cooling, yellow precipitate was filtered and washed with 40 mL water. The washed product 
was dried in air to give yellow-green solids. 
[Ir(L^X)(ArTriaz)2]: [(ArTriaz)2Ir(µ-Cl)]2 complex (1 mmol), sodium corbonate (10 mmol) and 
ancilaary ligand (2.5 mmol) were dissolved in 80 mL of 2-EtOEtOH under the nitrogen 
environment. The reaction mixture was heated up to 140 oC and stirred for 12 hours. Then cooled 
reaction mixture was poured to ethyl acetate (200 mL) and washed with water to remove 2-
EtOEtOH. Silica column purification with dichloromethane gave the pure products. 
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General procedure for 1,2,3,4-tetrahydroisoquinoline substrates 
 
NH
+ ArI N
Ar
CuI, K3PO4
ethylene glycol
2-propanol
2.2.5 	  
 
Copper(I) iodide (0.1 mmol) and potassium phosphate (2.0 mmol) were put into a 100 mL 
round-bottom flask. The flask was evacuated and refilled with nitrogen. 2-Propanol (10 mL), 
ethylene glycol (2.0 mmol), 1,2,3,4-tetrahydro-isoquinoline (1.0 mmol) and iodobenzene (1.2 
mmol) were added successively using a syringe at room temperature. The reaction mixture 
was heated at 90 °C and kept for 24 h and then allowed to cool down to room temperature. 
Diethyl ether (20 mL) and water (20 mL) were then added to the reaction mixture. The 
organic layer was extracted by diethyl ether (2 × 20 mL). The combined organic phases were 
washed with brine and dried over magnesium sulfate. The solvent was removed by rotary 
evaporation and purified by column chromatography on silica gel (hexane/ethyl acetate=20:1) 
to give the desired product 2.2.5. 
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General procedure for reaction of photoredox catalysis 
 
N
Ar
Ir(III) complex
light source, rt
N
Ar
NO2
 MeNO2 +
2.2.62.2.5  
 
To a 20 mL white cap vial equipped with a magnetic stir bar were added 
[Ir(bbpy)(ArTriaz)2]Cl (0.005 mmol), a 1,2,3,4- tetrahydroisoquinoline derivative (0.5 mmol), 
and nitromethane (2.0 mL). The reaction stirred open to air at room temperature at a distance of 
~10 cm from a blue LED light. After the reaction completed (monitored by TLC analysis), the 
solvent was removed in vacuo. The residue was purified by column chromatography on silica 
gel (hexane/ethyl acetate=10:1) to yield pure 2-aryl-1-(nitromethyl)-1,2,3,4-
tetrahydroisoquinoline 2.2.6. 
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Compounds Characterization 
 
N
N
N
2.2.1  
2-Phenyl-1,2,3-triazole (2.2.1) was purified by flash chromatography as yellow liquid. Isolated 
yield 60%; 1H NMR (CDCl3, 600 MHz) δ 8.12-8.08 (m, 2H), 7.79 (s, 2H), 7.48-7.44 (m, 2H), 
7.35-7.31 (m, 1H); 13C-NMR (150 MHz, CDCl3) δ 139.8, 135.4, 129.2, 127.4, 118.8. 
 
N
Ph
2.2.5a  
1,2,3,4-Tetrahydro-2-phenylisoquinoline (2.2.5a) was purified by flash chromatography as 
brown solid. 1H NMR (CDCl3, 600 MHz) δ 7.36-7.33 (m, 2H), 7.25-7.19 (m, 4H), 7.04(d, J = 
7.8 Hz, 2H), 6.89 (dd, J = 7.2, 7.2 Hz, 1H), 4.46 (s, 2H), 3.61 (dd, J = 6.0, 6.0 Hz, 2H), 3.04 
(dd, J = 6.0, 6.0 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 150.5, 134.8, 134.4, 129.1, 128.5, 
1 2 6 . 5 ,  126.3, 126.0, 118.6, 115.1, 50.7, 46.5, 29.1. 
 
N
2.2.5b
O
 
336 
 
1,2,3,4-Tetrahydro-2-(4-methoxyphenyl)isoquinoline (2.2.5b) was purified by flash 
chromatography as brown solid. 1H NMR (CDCl3, 600 MHz) δ 7.19-7.12 (m, 4H), 6.99 (d, J = 
9.0 Hz, 2H), 6.88 (d, J = 9.0 Hz, 2H), 4.31 (s, 2H), 3.79 (s, 3H), 3.46 (dd, J = 6.0, 6.0 Hz, 2H), 
3.00 (dd, J = 6.0, 6.0 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 153.5, 145.4, 134.6, 134.5, 128.7, 
126.5, 126.2, 125.9, 118.0, 114.6, 55.6, 52.7, 48.4, 29.1. 
 
N
2.2.5c
F
 
1,2,3,4-Tetrahydro-2-(4-fluorophenyl)isoquinoline (2.2.5c) was purified by flash 
chromatography as brown solid. 1H NMR (CDCl3, 600 MHz) δ 7.21-7.14 (m, 4H), 7.02-6.98 (m, 
2H), 6.98-6.94 (m, 2H), 4.35 (s, 2H), 3.79 (s, 3H), 3.50 (dd, J = 6.0, 6.0 Hz, 2H), 3.00 (dd, J = 
6.0, 6.0 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 157.5, 155.9, 147.3, 134.5, 134.2, 128.6, 126.5, 
126.4, 126.0, 117.2, 117.1, 115.6, 115.5, 51.9, 47.8, 29.0. 
 
N
Ph
NO2
2.2.6a  
1-(Nitromethyl)-2-phenyl-1,2,3,4-tetrahydroisoquinoline (2.2.6a)  purified by flash 
chromatography as yellow liquid. Reaction time about 12 h; Isolated yield 75%; 1H NMR 
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(CDCl3, 600 MHz) δ 7.28-7.22 (m, 3H), 7.21-7.17 (m, 2 H), 7.12 (d, J = 7.8 Hz, 1 H), 6.97 
(d, J = 8.4 Hz, 2 H), 6.84 (t, J = 7.2 Hz, 1 H), 5.54 (d, J = 7.2 Hz, 1 H), 4.86 (dd, J = 12.6, 7.8 
Hz, 1 H), 4.41 (dd, J = 12.0, 6.6 Hz, 1 H), 3.68-3.58 (m, 2 H), 3.08 (ddd, J = 16.0, 8.4, 6.0 
Hz, 1 H), 2.78 (dt, J = 16.8, 5.1, 4.8 Hz, 1 H); 13C-NMR (150 MHz, CDCl3) δ 148.4, 135.3, 
133.0, 129.5, 129.2, 128.1, 127.0, 126.7, 119.5, 115.1, 78.8, 58.2, 42.1, 26.5. 
 
N
O
N
N
N
N
N N
Ir
2.2.3e
O
	  
[Ir(Flrpic)(PhTriaz)2] (2.2.3e) was purified by flash chromatography as yellow solid. 1H NMR 
(CDCl3, 600 MHz) δ 8.22 (d, J = 7.2 Hz, 1 H), 7.92 (d, J = 4.8 Hz, 2 H), 7.85 (t, J = 7.8 Hz, 1 
H), 7.82 (d, J = 4.8 Hz, 1 H), 7.79 (s, 1H), 7.64 (d, J = 7.8 Hz, 1 H), 7.54 (d, J = 7.8 Hz, 1 H), 
7.27 (d, J = 6.0 Hz, 1 H), 6.97 (t, J = 7.2 Hz, 2 H), 6.87 (t, J = 7.2 Hz, 1 H), 6.80 (t, J = 7.2 
Hz, 1 H), 6.73 (t, J = 7.2 Hz, 1 H), 6.28 (d, J = 7.8 Hz, 1 H), 6.15 (d, J = 7.8 Hz, 1 H); 13C-
NMR (150 MHz, CDCl3) δ 172.9, 151.7, 148.8, 141.6, 141.5, 138.5, 135.1, 135.0, 133.0, 132.9, 
132.6, 131.9, 127.94, 127.92, 127.87, 127.49, 127.33, 125.1, 122.9, 114.2, 113.9. 
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N
N
H
N
N
N
N
N N
Ir
2.2.3f
O
	  
[Ir(Flrpca)(PhTriaz)2] (2.2.3f) was purified by flash chromatography as yellow solid. 1H NMR 
(CDCl3, 600 MHz) δ 8.24 (d, J = 7.2 Hz, 1 H), 7.92 (d, J = 16.8 Hz, 2 H), 7.89 (d, J = 6.0 Hz, 
2 H), 7.87 (t, J = 6.0 Hz, 1 H), 7.71 (d, J = 7.8 Hz, 1 H), 7.66 (d, J = 7.8 Hz, 1 H), 7.25 (t, J = 
6.6 Hz, 2 H), 7.04 (t, J = 7.2 Hz, 1 H), 6.99 (s,  1H),  6.97 (t, J = 7.2 Hz, 1 H), 6.80 (t, J = 
7.2 Hz, 1 H), 6.44 (t, J = 7.2 Hz, 1 H), 6.21 (d, J = 7.8 Hz, 1 H), 5.89 (br, 1 H); 13C-NMR (150 
MHz, CDCl3) δ 173.8, 156.3, 149.7, 142.1, 141.2, 138.1, 135.18, 135.09, 135.00, 133.3, 133.2, 
132.7, 131.7, 128.3, 128.1, 127.6, 126.9, 126.4, 122.8, 122.5, 114.3, 114.1. 
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ORTEP Drawing of the Crystal Structure	  	  
	  
	  
 
Figure S2.2-1. Perspective view of the molecular structure of 2.2.3b (C34H25IrN8O) with the 
atom labeling scheme. The thermal ellipsoids are scaled to enclose 30% 
probability. 
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Figure S2.2-2. Perspective view of the molecular structure of 2.2.3c (C34H22F2IrN7O2) with the 
atom labeling scheme. The thermal ellipsoids are scaled to enclose 30% 
probability. 
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Figure S2.2-3. Perspective view of the molecular structure of 2.2.3d (C34H23F2IrN8O) with the 
atom labeling scheme. The thermal ellipsoids are scaled to enclose 30% 
probability. 
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2.3 1,2,3-Triazole as Unique Ligand in Promoting Iron Catalyzed Propargyl Alcohol 
Dehydration for the Synthesis of Conjugated Enynes 
General Methods and Materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware and standard syringe/septa techniques. 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 
commercial provider and used without further purification. 1H NMR and 13C NMR spectra were 
recorded on Varian 600 MHz spectrometers. Chemical shifts were reported relative to internal 
tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1H and CDCl3 (δ 77.0 ppm) for 13C. 
Melting points were measured on a Mel-Temp 1001D apparatus and uncorrected. Flash column 
chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250µ) and visualized by 
fluorescence and by charring after treatment with potassium permanganate stain. HRMS were 
recorded on LTQ-FTUHRA spectrometer.  
 
 
 
 
 
 
 
 
 
 
 
Propargylic alcohols 2.3.1 were synthesized according to the literatures as below: 
Yan, W.; Wang, Q.; Chen, Y.; Petersen, J.; Shi, X. Org. Lett. 2010, 12, 3308-3311. 
Representative procedure for propargyl alcohol dehydration reaction 
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R3
R2
HO 10% FeCl3, 20% L10 R3
R2
2.3.1 2.3.2
MeCN, 60 oC,12 hR1
R1
L10
N
N
N
OH
 
 
A 20 mL screw-cap vial was charged with the catalyst FeCl3 (16.2 mg, 0.1 mmol) and the ligand 
2-(1H-benzo[d][1,2,3]triazol-1-yl)ethanol L10 (32.4 mg, 0.2 mmol) in 5 mL MeCN. The vial 
was placed in a preheated metal block at 60 oC for 15 mins, and then propargyl alcohol (1 mmol) 
was added. The reaction mixture was stirred at 60 oC and monitored by TLC. After the reaction 
was completed (about 2-7 h), the solvent was removed under reduced pressure and the residue 
was purified by flash chromatograpgy on silica gel (ethyl acetate/hexane = 1:40, V/V) to give 
desired enyne product as yellow oil. 
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General procedure for NBS promoted enyne activation reaction. 
 
2.3.2s
DABCO ( 0.2 eq), 
NBS (1.2 eq)
CHCl3, rt
O
O
Ph-p-F
Ph
Br
2.3.3e
80%
2.3.2t or 2.3.2u
DABCO ( 0.2 eq), 
NBS (1.2 eq)
CHCl3, rt
•
Br
R
O
O
Ph-p-F
syn
2.3.3f, R = TMS, 95% yield
   syn:anti > 20:1
2.3.3g, R = n-Bu, 78% yield
    syn:anti > 20:1
d.r. > 20:1
 
 
The enynyl acid (1 mmol), NBS (230 mg, 1.2 mmol), DABCO (2 mg, 0.02 mmol) and 5 mL 
chloroform CHCl3 were combined in a 20 mL vial. The reaction mixture was stirred ar rt until all 
the enynyl acid consumed as indicated by TLC. The reaction mixture was concentrated under 
reduced pressure and directly purified by flash chromatography on silica gel (ethyl 
acetate/hexane = 1:20, V/V) to give product as yellow oil. 
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Optimization of solventsa 
Bu
Ph
HO 10 mol% FeCl3, solvent Bu
Ph
2.3.1a 2.3.2a
7 h
 
 catalyst loading (%) solv. temp (oC) time (h) conv. (%)b yield (%)c 
18 FeCl3 10 MeCN 60 7 95 29 
19 FeCl3 10 Acetone 60 7 66 13 
20 FeCl3 10 THF 60 7 73 20 
21 FeCl3 10 Toluene 60 7 35 <5 
22 FeCl3 10 MeOH 60 7 65 <5 
23 FeCl3 10 MeNO2 60 7 70 18 
24 FeCl3 10 DMSO 60 7 <5 <5 
25 FeCl3 10 DMF 60 7 <5 <5 
26 FeCl3 10 CHCl3 60 7 80 17 
27 FeCl3 10 EtOAc 60 7 78 15 
28 FeCl3 10 DCE 60 7 81 24 
a General reaction conditions: 1a (0.25 mmol, 1.0 equiv.) and FeCl3 (10 mol%) in solvent (5 
mL); b Conversions were determined based on the consumption of propargyl alcohol; c NMR 
yields of 2a with 1,3,5-trimethoxybenzene as internal standard. 
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Compounds Characterization 
 
n-Bu
Ph
2.3.2a  
Oct-1-en-3-yn-2-ylbenzene (2.3.2a) was purified by flash chromatography (Hexane-EtOAc, v/v 
40/1) as yellow liquid. Reaction time about 10 h; Isolated yield 91%; 1H-NMR (600 MHz, 
CDCl3) δ 7.67-7.64 (m, 2H), 7.37-7.33 (m, 2H), 7.31-7.28 (m, 1H), 5.84 (s, 1H), 5.58 (s, 1H), 
2.42 (t, J = 7.2 Hz, 2H), 1.61 (quin, J = 7.2 Hz, 2H), 1.49 (sex, J = 7.2 Hz, 2H), 0.96 (t, J = 7.2 
Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 137.8, 131.0, 128.2, 128.0, 126.0, 119.3, 92.0, 79.7, 
30.8, 22.0, 19.0, 13.6; HRMS Calculated for C14H17 [M+H]+: 185.1330, Found: 185.1333. 
 
n-Bu
Ph
Et
2.3.2b  
(Z)-dec-3-en-5-yn-4-ylbenzene (2.3.2b) was purified by flash chromatography (Hexane-EtOAc, 
v/v 40/1) as yellow liquid. Reaction time about 2 h; Isolated yield 95%; 1H-NMR (600 MHz, 
CDCl3) δ 7.61-7.59 (m, 2H), 7.34-7.31 (m, 2H), 7.26-7.23 (m, 1H), 6.33 (t, J = 7.2 Hz, 1H), 2.49 
(quin, J = 7.2 Hz, 2H), 2.47 (t, J = 7.2 Hz, 2H), 1.62 (quin, J = 7.2 Hz, 2H), 1.51 (sex, J = 7.2 
Hz, 2H), 1.11 (t, J = 7.2 Hz, 3H), 0.97 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 138.9, 
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138.7, 128.2, 127.1, 125.9, 123.2, 96.2, 77.6, 31.0, 24.5, 22.0, 19.3, 13.6, 13.5; HRMS 
Calculated for C16H21 [M+H]+: 213.1643, Found: 213.1640. 
 
TMS
Ph
2.3.2c  
Trimethyl(3-phenylbut-3-en-1-ynyl)silane (2.3.2c) was purified by flash chromatography 
(Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 10 h; Isolated yield 81%; 1H-
NMR (600 MHz, CDCl3) δ 7.67-7.64 (m, 2H), 7.38-7.35 (m, 2H), 7.33-7.30 (m, 1H), 5.94 (s, 
1H), 5.72 (s, 1H), 0.27 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 136.9, 130.6, 128.3, 128.2, 126.0, 
121.4, 104.1, 95.9, -0.1; HRMS Calculated for C13H17Si [M+H]+: 201.1100, Found: 201.1093. 
 
Ph
2.3.2d  
(5-methylhexa-1,5-dien-3-yn-2-yl)benzene (2.3.2d) was purified by flash chromatography 
(Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 10 h; Isolated yield 90%; 1H-
NMR (600 MHz, CDCl3) δ 7.67-7.64 (m, 2H), 7.38-7.34 (m, 2H), 7.33-7.29 (m, 1H), 5.92 (s, 
1H), 5.66 (s, 1H), 5.40 (q, J = 1.2 Hz, 1H), 5.31 (quin, J = 1.2 Hz, 1H), 1.99 (t, J = 1.2 Hz, 3H); 
13C-NMR (150 MHz, CDCl3) δ 137.3, 130.6, 128.3, 128.2, 126.7, 126.0, 122.2, 120.5, 92.0, 
87.5, 23.4; HRMS Calculated for C13H13 [M+H]+: 169.1017, Found: 169.1006. 
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Ph
Ph
2.3.2e  
But-3-en-1-yne-1,3-diyldibenzene (2.3.2e) was purified by flash chromatography (Hexane-
EtOAc, v/v 40/1) as yellow liquid. Reaction time about 10 h; Isolated yield 88%; 1H-NMR (600 
MHz, CDCl3) δ 7.74-7.72 (m, 2H), 7.55-7.53 (m, 2H), 7.41-7.36 (m, 2H), 7.35-7.33 (m, 4H), 
5.98 (s, 1H), 5.76 (s, 1H); 13C-NMR (150 MHz, CDCl3) δ 137.3, 131.7, 130.6, 128.4, 128.3, 
126.1, 123.1, 120.7, 90.7, 88.5; HRMS Calculated for C16H13 [M+H]+: 205.1017, Found: 
205.1013. 
 
Ph
2.3.2f  
(4-cyclohexylbut-1-en-3-yn-2-yl)benzene (2.3.2f) was purified by flash chromatography 
(Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 10 h; Isolated yield 85%; 1H-
NMR (600 MHz, CDCl3) δ 7.68-7.66 (m, 2H), 7.37-7.33 (m, 2H), 7.31-7.28 (m, 1H), 5.84 (s, 
1H), 5.59 (s, 1H), 2.64-2.59 (m, 1H), 1.91-1.88 (m, 2H), 1.79-1.74 (m, 2H), 1.56-1.54 (m, 2H), 
1.40-1.34 (m, 4H); 13C-NMR (150 MHz, CDCl3) δ 137.8, 130.9, 128.2, 128.0, 126.0, 119.1, 
96.0, 79.0, 32.7, 29.7, 25.9, 24.9; HRMS Calculated for C16H19 [M+H]+: 211.1487, Found: 
211.1480. 
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Ph
2.3.2g  
(4-cyclopropylbut-1-en-3-yn-2-yl)benzene (2.3.2g) was purified by flash chromatography 
(Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 10 h; Isolated yield 85%; 1H-
NMR (600 MHz, CDCl3) δ 7.63-7.61 (m, 2H), 7.36-7.32 (m, 2H), 7.31-7.27 (m, 1H), 5.82 (s, 
1H), 5.56 (s, 1H), 1.48-1.43 (m, 1H), 0.89-0.85 (m, 2H), 0.82-0.79 (m, 2H); 13C-NMR (150 
MHz, CDCl3) δ ,137.8, 130.8, 128.2, 128.1, 126.0, 119.4, 95.0, 75.0, 8.6, 0.2; HRMS Calculated 
for C13H13 [M+H]+: 169.1017, Found: 169.1000. 
 
TMS
Ph
2.3.2h  
(Z)-trimethyl(3-phenylpent-3-en-1-ynyl)silane (2.3.2h) was purified by flash chromatography 
(Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 2 h; Isolated yield 70%; 1H-
NMR (600 MHz, CDCl3) δ 7.60-7.58 (m, 2H), 7.36-7.32 (m, 2H), 7.28-7.25 (m, 1H), 6.52 (q, J = 
7.2 Hz, 1H), 2.10 (d, J = 7.2 Hz, 3H), 0.29 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 138.0, 134.2, 
128.3, 127.3, 125.8, 124.6, 102.2, 100.7, 17.0, 0.12; HRMS Calculated for C14H19Si [M+H]+: 
215.1256, Found: 215.1250. 
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TMS
2.3.2i  
(Cyclohexenylethynyl)trimethylsilane (2.3.2i) was purified by flash chromatography (Hexane-
EtOAc, v/v 40/1) as yellow liquid. Reaction time about 10 h; Isolated yield 46% (conv. 50%); 
1H-NMR (600 MHz, CDCl3) δ 6.19-6.17 (m, 1H), 2.15-2.11 (m, 2H), 2.10-2.06 (m, 2H), 1.64-
1.60 (m, 2H), 1.58-1.54 (m, 2H), 0.18 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 136.2, 120.8, 
107.3, 90.8, 29.0, 25.6, 22.2, 21.4, 0.14; HRMS Calculated for C11H19Si [M+H]+: 179.1256, 
Found: 179.1262. 
 
2.3.2j
O
 
1-(4-cyclohexylbut-1-en-3-yn-2-yl)-4-methoxybenzene (2.3.2j) was purified by flash 
chromatography (Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 10 h; Isolated 
yield 81%; 1H-NMR (600 MHz, CDCl3) δ 7.60 (d, J = 9.0 Hz, 2H), 6.87 (d, J = 9.0 Hz, 2H), 
5.73 (s, 1H), 5.48 (s, 1H), 2.63-2.59 (m, 1H), 1.91-1.88 (m, 2H), 1.79-1.73 (m, 2H), 1.59-1.53 
(m, 2H), 1.40-1.32 (m, 4H); 13C-NMR (150 MHz, CDCl3) δ 159.8, 130.7, 130.4, 127.5, 117.5, 
113.7, 96.0, 80.0, 55.5, 32.9, 29.9, 26.1, 25.1; HRMS Calculated for C17H21O [M+H]+: 241.1592, 
Found: 241.1590. 
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Ph
2.3.2k
O
 
1-methoxy-4-(4-phenylbut-1-en-3-yn-2-yl)benzene (2.3.2k) was purified by flash 
chromatography (Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 10 h; Isolated 
yield 75%; 1H-NMR (600 MHz, CDCl3) δ 7.67 (d, J = 9.0 Hz, 2H), 7.55-7.52 (m, 2H), 7.38-7.33 
(m,3H), 6.91 (d, J = 9.0 Hz, 2H), 5.88 (s, 1H), 5.66 (s, 1H), 3.84 (s, 3H); 13C-NMR (150 MHz, 
CDCl3) δ 159.8, 131.6, 129.9, 128.3, 127.3, 123.2, 118.7, 113.7, 102.8, 90.5, 88.8, 55.3; HRMS 
Calculated for C17H15O [M+H]+: 235.1123, Found: 235.1122. 
 
TMS
2.3.2l  
((1H-inden-3-yl)ethynyl)trimethylsilanetriazole (2.3.2l) was purified by flash chromatography 
(Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 2 h; Isolated yield 80%; 1H-
NMR (600 MHz, CDCl3) δ 7.53 (d, J = 7.8 Hz, 1H), 7.44 (d, J = 7.8 Hz, 1H), 7.35 (t, J = 7.2 Hz, 
1H), 7.24 (t, J = 7.2 Hz, 1H), 6.79 (t, J = 2.4 Hz, 1H), 3.46 (d, J = 2.4 Hz, 2H), 0.29 (s, 9H); 13C-
NMR (150 MHz, CDCl3) δ 145.9, 137.0, 132.6, 127.5, 123.9, 119.9, 113.0, 109.3, 80.1, 79.5, 
49.3; HRMS Calculated for C14H17Si [M+H]+: 213.1100, Found: 213.1113. 
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2.3.2m
TMS
O
n-Pr
 
(Z)-(3-(2-methoxyphenyl)hept-3-en-1-ynyl)trimethylsilane (2.3.2m) was purified by flash 
chromatography (Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 2 h; Isolated 
yield 85%; 1H-NMR (600 MHz, CDCl3) δ 7.39 (dd, J = 7.2 Hz, 1.8 Hz, 1H), 7.23 (dt, J = 7.2 Hz, 
1.8 Hz, 1H ), 6.94 (dt, J = 7.2 Hz, 1.2 Hz, 1H), 6.90 (dd, J = 7.2 Hz, 1.2 Hz, 1H), 6.39 (t, J = 7.8 
Hz, 1H), 3.84 (s, 3H), 2.47 (q, J = 7.8 Hz, 2H), 1.54 (sex, J = 7.8 Hz, 2H), 0.99 (t, J = 7.8 Hz, 
3H), 0.22 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 156.8, 144.2, 130.1, 128.4, 128.3, 120.6, 
120.5, 111.6, 103.4, 98.1, 55.6, 33.3, 22.2, 13.9, 0.1, 55.2; HRMS Calculated for C17H25OSi 
[M+H]+: 273.1675, Found: 273.1671. 
 
Ph
2.3.2n
Ph
CO2H
 
(Z)-5,7-diphenylhept-4-en-6-ynoic acid (2.3.2n) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as white solid. Reaction time about 0.5 h; Isolated yield 91%; 1H-
NMR (600 MHz, CDCl3) δ 7.68-7.65 (m, 2H), 7.56-7.53 (m, 2H), 7.39-7.34 (m, 5H), 7.32-7.29 
(m, 1H), 6.48 (t, J = 7.2 Hz, 1H), 2.91 (q, J = 7.2 Hz, 2H), 2.64 (t, J = 7.2 Hz, 2H); 13C-NMR 
(150 MHz, CDCl3) δ 179.0, 137.6, 135.2, 131.6, 128.40, 128.38, 128.35, 127.8, 126.1, 125.1, 
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123.2, 96.1, 86.1, 33.3, 26.3; HRMS Calculated for C19H17O2 [M+H]+: 277.1229, Found: 
277.1230. 
 
2.3.2o
n-Bu
Ph
CO2H
 
(Z)-5-phenylundec-4-en-6-ynoic acid (2.3.2o) was purified by flash chromatography (Hexane-
EtOAc, v/v 10/1) as yellow liquid. Reaction time about 0.5 h; Isolated yield 89%; 1H-NMR (600 
MHz, CDCl3) δ 7.60-7.57 (m, 2H), 7.34-7.30 (m, 2H), 7.27-7.24 (m, 1H), 6.34 (t, J = 7.2 Hz, 
1H), 2.79 (q, J = 7.2 Hz, 2H), 2.57 (t, J = 7.2 Hz, 2H), 2.47 (t, J = 7.2 Hz, 2H), 1.62 (quin, J = 
7.2 Hz, 2H), 1.50 (sex, J = 7.2 Hz, 2H), 0.95 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 
178.9, 138.4, 133.6, 128.2, 127.5, 126.0, 125.5, 97.4, 33.3, 30.9, 26.0, 22.0, 19.3, 13.6; HRMS 
Calculated for C17H21O2 [M+H]+: 257.1542, Found: 257.1536. 
 
Ph
2.3.2p
Ph
CO2H
 
(Z)-6,8-diphenyloct-5-en-7-ynoic acid (2.3.2p) was purified by flash chromatography (Hexane-
EtOAc, v/v 10/1) as yellow liquid. Reaction time about 0.5 h; Isolated yield 92%; 1H-NMR (600 
MHz, CDCl3) δ 7.67-7.64 (m, 2H), 7.54-7.51 (m, 2H), 7.38-7.32 (m, 5H), 7.31-7.27 (m, 1H), 
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6.43 (t, J = 7.2 Hz, 1H), 2.65 (q, J = 7.2 Hz, 2H), 2.47 (t, J = 7.2 Hz, 2H), 1.91 (quin, J = 7.2 Hz, 
2H); 13C-NMR (150 MHz, CDCl3) δ 179.0, 137.9, 136.7, 131.5, 128.4, 128.3, 128.2, 127.7, 
126.0, 124.8, 123.3, 95.5, 86.5, 33.2, 30.5, 24.0; HRMS Calculated for C15H14N3 [M+H]+: 
236.1188, Found: 236.1178. 
 
2.3.2q
n-Bu
Ph
CO2H
 
(Z)-6-phenyldodec-5-en-7-ynoic acid (2.3.2q) was purified by flash chromatography (Hexane-
EtOAc, v/v 10/1) as yellow liquid. Reaction time about 0.5 h; Isolated yield 88%; 1H-NMR (600 
MHz, CDCl3) δ 7.60-7.57 (m, 2H), 7.34-7.30 (m, 2H), 7.27-7.23 (m, 1H), 6.29 (t, J = 7.2 Hz, 
1H), 2.54 (q, J = 7.2 Hz, 2H), 2.46 (t, J = 7.2 Hz, 2H), 2.44 (t, J = 7.2 Hz, 2H), 1.86 (quin, J = 
7.2 Hz, 2H), 1.61 (quin, J = 7.2 Hz, 2H), 1.49 (sex, J = 7.2 Hz, 2H), 0.96 (t, J = 7.2 Hz, 3H); 13C-
NMR (150 MHz, CDCl3) δ 179.8, 138.6, 135.1, 128.2, 127.4, 125.9, 125.1, 96.7, 77.5, 33.4, 
30.9, 30.3, 24.0, 22.0, 19.2, 13.6; HRMS Calculated for C18H23O2 [M+H]+: 271.1698, Found: 
271.1704. 
 
H
2.3.2r
Ph
CO2H
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(E)-5-phenylhept-4-en-6-ynoic acid (2.3.2r) was purified by flash chromatography (Hexane-
EtOAc, v/v 10/1) as yellow liquid. Reaction time about 0.5 h; Isolated yield 85%; 1H-NMR (600 
MHz, CDCl3) δ 7.60-7.58 (m, 2H), 7.36-7.32 (m, 2H), 7.29-7.27 (m, 1H), 7.32-7.29 (m, 1H), 
6.50 (t, J = 7.2 Hz, 1H), 3.38 (s, 1H), 2.83 (q, J = 7.2 Hz, 2H), 2.59 (t, J = 7.2 Hz, 2H); 13C-NMR 
(150 MHz, CDCl3) δ 178.5, 137.2, 136.8, 128.4, 127.9, 125.9, 124.2, 83.9, 80.3, 33.0, 26.1; 
HRMS Calculated for C13H13O2 [M+H]+: 201.0916, Found: 201.0912. 
 
Ph
2.3.2s
CO2H
F
 
(E)-5-(4-fluorophenyl)hept-4-en-6-ynoic acid (2.3.2s) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. Reaction time about 0.5 h; Isolated yield 92%; 1H-
NMR (600 MHz, CDCl3) δ 7.63-7.60 (m, 2H), 7.54-7.51 (m, 2H), 7.37-7.34 (m, 3H), 7.06-7.03 
(m, 2H), 6.40 (t, J = 7.2 Hz, 1H), 2.88 (q, J = 7.2 Hz, 2H), 2.63 (t, J = 7.2 Hz, 2H); 13C-NMR 
(150 MHz, CDCl3) δ 178.4, 163.3, 161.7, 134.9, 133.9, 133.8, 131.6, 128.5, 128.4, 127.7, 127.6, 
124.1, 123.0, 115.3, 115.2, 96.3, 85.8, 33.2, 26.3; HRMS Calculated for C13H12FO2 [M+H]+: 
219.0821, Found: 219.0815. 
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TMS
2.3.2t
CO2H
F
 
(Z)-5-(4-fluorophenyl)-7-(trimethylsilyl)hept-4-en-6-ynoic acidtriazole (2.3.2t) was purified 
by flash chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. Reaction time about 0.5 h; 
Isolated yield 88%; 1H-NMR (600 MHz, CDCl3) δ 7.55-7.52 (m, 2H), 7.03-7.00 (m, 2H), 6.38 (t, 
J = 7.2 Hz, 1H), 2.80 (q, J = 7.2 Hz, 2H), 2.59 (t, J = 7.2 Hz, 2H), 0.26 (s, 9H); 13C-NMR (150 
MHz, CDCl3) δ 178.9, 163.3, 161.7, 135.9, 133.5, 133.4, 127.6, 127.5, 124.2, 115.2, 115.1, 
101.9, 101.3, 33.0, 26.2, -0.05; HRMS Calculated for C16H20FO2Si [M+H]+: 291.1217, Found: 
291.1200. 
 
n-Bu
2.3.2u
CO2H
F
 
(Z)-5-(4-fluorophenyl)undec-4-en-6-ynoic acid (2.3.2u) was purified by flash chromatography 
(Hexane-EtOAc, v/v 10/1) as yellow liquid. Reaction time about 0.5 h; Isolated yield 83%; 1H-
NMR (600 MHz, CDCl3) δ 7.56-7.53 (m, 2H), 7.02-6.99 (m, 2H), 6.26 (t, J = 7.2 Hz, 1H), 2.77 
(q, J = 7.2 Hz, 2H), 2.57 (t, J = 7.2 Hz, 2H), 2.46 (t, J = 7.2 Hz, 2H), 1.61 (quin, J = 7.2 Hz, 2H), 
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1.48 (sex, J = 7.2 Hz, 2H), 0.95 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 178.9, 163.2, 
161.6, 134.5, 134.4, 133.3, 127.6, 127.5, 124.5, 115.1, 115.0, 97.7, 33.2, 30.9, 26.0, 22.0, 19.2, 
13.6; HRMS Calculated for C17H20FO2 [M+H]+: 275.1447, Found: 275.1441. 
 
PhPh
2.3.2v  
(3-(propan-2-ylidene)penta-1,4-diyne-1,5-diyl)dibenzene (2.3.2v) was purified by flash 
chromatography (Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 7 h; Isolated 
yield 87%; 1H-NMR (600 MHz, CDCl3) δ 7.53-7.50 (m, 4H), 7.36-7.31 (m, 6H), 2.18 (s, 6H); 
13C-NMR (150 MHz, CDCl3) δ 154.2, 131.4, 128.2, 128.0, 123.4, 101.3, 91.1, 86.4, 22.8; HRMS 
Calculated for C20H17 [M+H]+: 257.1330, Found: 257.1333. 
 
TMSPh
2.3.2w  
Trimethyl(4-methyl-3-(phenylethynyl)pent-3-en-1-ynyl)silane (2.3.2w) was purified by flash 
chromatography (Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 7 h; Isolated 
yield 90%; 1H-NMR (600 MHz, CDCl3) δ 7.48-7.45 (m, 2H), 7.33-7.28 (m, 3H), 2.09 (s, 3H), 
2.08 (s, 3H), 0.23 (s, 9H); 13C-NMR (150 MHz, CDCl3) δ 155.6, 131.4, 128.2, 128.0, 123.4, 
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101.6, 101.5, 96.1, 91.3, 86.1, 22.8, 22.7, -0.03; HRMS Calculated for C17H21Si [M+H]+: 
253.1413, Found: 253.1420.  
 
n-BuPh
2.3.2x  
(3-(propan-2-ylidene)nona-1,4-diynyl)benzene (2.3.2x) was purified by flash chromatography 
(Hexane-EtOAc, v/v 40/1) as yellow liquid. Reaction time about 7 h; Isolated yield 79%; 1H-
NMR (600 MHz, CDCl3) δ 7.47-7.45 (m, 2H), 7.32-7.27 (m, 3H), 2.39 (t, J = 7.2 Hz, 2H), 2.07 
(s, 3H), 2.05 (s, 3H), 1.57 (quin, J = 7.2 Hz, 2H), 1.47 (sex, J = 7.2 Hz, 2H), 0.94 (t, J = 7.2 Hz, 
3H); 13C-NMR (150 MHz, CDCl3) δ 152.4, 131.4, 128.1, 127.9, 123.6, 101.4, 92.3, 90.5, 87.1, 
77.4, 30.9, 22.6, 22.5, 22.0, 19.2, 13.6; HRMS Calculated for C18H21 [M+H]+: 237.1643, Found: 
237.1635.  
 
PhPh
2.3.2y
CO2Me
 
Methyl 7-phenyl-5-(phenylethynyl)hept-4-en-6-ynoate (2.3.2y) was purified by flash 
chromatography (Hexane-EtOAc, v/v 30/1) as yellow liquid. Reaction time about 0.5 h; Isolated 
yield 93%; 1H-NMR (600 MHz, CDCl3) δ 7.53-7.51 (m, 2H), 7.50-7.48 (m, 2H), 7.35-7.33 (m, 
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3H), 7.33-7.31 (m, 3H), 6.46 (t, J = 7.2 Hz, 1H), 3.71 (s, 3H), 2.81 (q, J = 7.2 Hz, 2H), 2.53 (t, J 
= 7.2 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 172.9, 164.2, 131.7, 131.6, 128.6, 128.4, 128.3, 
128.2, 122.8, 122.7, 107.1, 93.6, 87.2, 87.0, 84.3, 51.7, 32.8, 26.2; HRMS Calculated for 
C22H19O2 [M+H]+: 315.1385, Found: 315.1392. 
 
n-Bun-Bu
2.3.2z
CO2Me
 
Methyl 5-(hex-1-ynyl)undec-4-en-6-ynoate (2.3.2z) was purified by flash chromatography 
(Hexane-EtOAc, v/v 30/1) as yellow liquid. Reaction time about 0.5 h; Isolated yield 90%; 1H-
NMR (600 MHz, CDCl3) δ 6.11 (t, J = 7.2 Hz, 1H), 3.67 (s, 3H), 2.60 (q, J = 7.2 Hz, 2H), 2.40 
(t, J = 7.2 Hz, 2H), 2.35 (t, J = 7.2 Hz, 2H), 2.28 (t, J = 7.2 Hz, 2H), 1.53 (quin, J = 7.2 Hz, 2H), 
1.50 (quin, J = 7.2 Hz, 2H), 1.42 (sex, J = 7.2 Hz, 2H), 1.39 (sex, J = 7.2 Hz, 2H), 0.91 (t, J = 7.2 
Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 173.1, 143.4, 107.3, 94.5, 87.6, 
78.8, 76.2, 51.6, 32.9, 30.6, 25.7, 22.0, 21.9, 19.1, 18.9, 13.6, 13.5; HRMS Calculated for 
C18H27O2 [M+H]+: 275.2011, Found: 275.2023. 
 
O
Br
Ph
F
2.3.3e  
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Syn-1-(2-bromo-1-(hex-1-ynyl)cyclohexyl)-4-fluorobenzene (2.3.3e) was purified by flash 
chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Check 1H, 13C-NMR data in section 
(Full NMR characterizations of 3e, 3f, 3g); HRMS Calculated for C18H23BrF [M+H]+: 
337.0967, Found: 337.0960. 
 
•
Br
TMS
F
O
O
2.3.3f  
Syn-5-(3-bromo-1-(4-fluorophenyl)-3-(trimethylsilyl)propa-1,2-dienyl)dihydrofuran-2(3H)-
one (2.3.3f) was purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. 
Check 1H, 13C-NMR data in section (Full NMR characterizations of 3e, 3f, 3g); HRMS 
Calculated for C16H19BrFO2Si [M+H]+: 369.0322, Found: 369.0315. 
 
•
Br
n-Bu
F
O
O
2.3.3g  
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Syn-5-(3-bromo-1-(4-fluorophenyl)hepta-1,2-dienyl)dihydrofuran-2(3H)-one (2.3.3g) was 
purified by flash chromatography (Hexane-EtOAc, v/v 20/1) as yellow liquid. Check 1H, 13C-
NMR data in section (Full NMR characterizations of 3e, 3f, 3g); HRMS Calculated for 
C17H19BrFO2 [M+H]+: 353.0552, Found: 353.0556. 
 
n-Bu
Ph
2.3.5a
Cl
 
(Z)-(1-chlorodec-3-en-5-yn-4-yl)benzene (2.3.5a) was purified by flash chromatography 
(Hexane-EtOAc, v/v 40/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 7.62-7.59 (m, 2H), 
7.35-7.32 (m, 2H), 7.29-7.25 (m, 1H), 6.36 (t, J = 7.2 Hz, 1H), 3.66 (t, J = 7.2 Hz, 2H), 2.94 (q, J 
= 7.2 Hz, 2H), 2.47 (t, J = 7.2 Hz, 2H), 1.62 (quin, J = 7.2 Hz, 2H), 1.50 (sex, J = 7.2 Hz, 2H), 
0.97 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 138.2, 131.3, 128.3, 127.8, 126.6, 126.0, 
97.5, 77.3, 43.6, 34.2, 30.9, 22.0, 19.3, 13.6; HRMS Calculated for C16H20Cl [M+H]+: 247.1254, 
Found: 247.1250. 
 
n-Bu
Ph
2.3.5b
N
N
N
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(Z)-1-(4-phenyldec-3-en-5-ynyl)-1H-benzo[d][1,2,3]triazole (2.3.5b) was purified by flash 
chromatography (Hexane-EtOAc, v/v 10/1) as yellow liquid. 1H-NMR (600 MHz, CDCl3) δ 8.07 
(d, J = 8.4 Hz, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.50-7.48 (m, 2H), 7.46 (t, J = 7.8 Hz, 1H), 7.36 (t, 
J = 7.8 Hz, 1H), 7.32-7.28 (m, 2H), 7.27-7.23 (m, 1H), 6.26 (t, J = 7.2 Hz, 1H), 4.81 (t, J = 7.2 
Hz, 2H), 3.15 (q, J = 7.2 Hz, 2H), 2.41 (t, J = 7.2 Hz, 2H), 1.57 (quin, J = 7.2 Hz, 2H), 1.45 (sex, 
J = 7.2 Hz, 2H), 0.94 (t, J = 7.2 Hz, 3H); 13C-NMR (150 MHz, CDCl3) δ 146.0, 138.0, 133.0, 
130.0, 128.3, 127.8, 127.4, 127.1, 126.0, 123.7, 120.0, 109.4, 97.8, 76.8, 47.3, 31.4, 30.8, 22.1, 
19.2, 13.6; HRMS Calculated for C22H24N3 [M+H]+: 330.1970, Found: 330.1977. 
 
TMS
Ph
2.3.5c
N
N
N
 
(Z)-1-(4-phenyl-6-(trimethylsilyl)hex-3-en-5-ynyl)-1H-benzo[d][1,2,3]triazole (2.3.5c) was 
purified by flash chromatography (Hexane-EtOAc, v/v 10/1) as white solid. Isolated yield 75%; 
1H-NMR (600 MHz, CDCl3) δ 8.07 (d, J = 8.4 Hz, 1H), 7.58 (d, J = 8.4 Hz, 1H), 7.51-7.48 (m, 
2H), 7.47 (t, J = 7.8 Hz, 1H), 7.37 (t, J = 7.8 Hz, 1H), 7.33-7.29 (m, 2H), 7.28-7.25 (m, 1H), 6.38 
(t, J = 7.2 Hz, 1H), 4.82 (t, J = 7.2 Hz, 2H), 3.18 (q, J = 7.2 Hz, 2H), 0.26 (s, 9H); 13C-NMR 
(150 MHz, CDCl3) δ 146.0, 137.0, 133.0, 132.4, 128.3, 128.0, 127.1, 127.0, 126.0, 123.8, 120.0, 
109.3, 102.0, 101.2, 47.1, 31.6, -0.06; HRMS Calculated for C21H24N3Si [M+H]+: 346.1739, 
Found: 346.1745. 
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ORTEP Drawing of the Crystal Structure 
 
 
Figure S2.3-1. Perspective view of the molecular structure of 2.3.2n (C19H16O2) with the atom 
labeling scheme. The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 861258. 
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Figure S2.3-2. Perspective view of the molecular structure of 2.3.5b (C21H23N3Si) with the atom 
labeling scheme.  The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 861257. 
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Full NMR characterizations of 2.3.3e, 2.3.3f, 2.3.3g	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Chapter Three: N-2-aryl-1,2,3-triazoles: a new class of UV-Blue emitting 
fluorophores through Planar-Intramolecular-Charge-
Transfer (PICT) 
General Methods and Materials 
 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware and standard syringe/septa techniques. 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 
commercial provider and used without further purification. 1H NMR and 13C NMR spectra were 
recorded on Varian 600 MHz spectrometers. Chemical shifts were reported relative to internal 
tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1H and CDCl3 (δ 77.0 ppm) for 13C. 
Flash column chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250µ) and visualized by 
fluorescence and by charring after treatment with potassium permanganate stain. HRMS were 
recorded on LTQ-FTUHRA spectrometer. UV-visible spectra were obtained on a Shimadzu UV-
2500. Fluorescence spectra for emission and excitation were obtained on a Hitachi 7000. 
 
 
 
All N-H triazoles were synthesized according to the literatures as below: 
1. Quiclet-Sire, B.; Zard, S. Z.; Synthesis 2005, 19, 3319. 
2. Sengupta, S.; Duan, H.; Lu, W.; Petersen, J. L.; Shi, X. Org. Lett. 2008, 10, 1493. 
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General Procedure for preparation of N-2-aryl-1,2,3-triazoles. 
 
N
NH
NR2
R1
+ X Ar
proline 20%, CuCl 10%
K2CO3, DMSO, 85 oC N
N
NR2
R1
Ar
65-90%
1
2
3
4
5
 
 
 To a 25 mL round-bottom bottle was successively added N-H triazole (1 mmol), potassium 
carbonate (345 mg, 2.5 mmol), L-proline (23 mg, 0.2 mmol), copper (I) chloride (10 mg, 0.1 
mmol) and iodo-substituted benzene (1.2 mmol) in 10 mL DMSO under N2 protection. The 
reaction mixture was stirred and heated up to 85 oC for 4 hours, and monitored by TLC. After the 
reaction was completed, water (20 mL) was added. The mixture was extracted with ethyl acetate 
(3 x 30 mL). The combined organic phases were washed with brine and dried with anhydrous 
Na2SO4. The solvent was removed under reduced pressure to get a residue, the residue was 
purified by flash silica gel chromatography (hexane/ethyl acetate = 20:1) to give the product. All 
yields were about 60% - 75% (N-2 isomer). 
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Procedure for the synthesis of Nα-(1,1-dimethylethoxycarbonyl)-L-lysine-methyl ester(3.5) 
 
The Nα-tBoc-Nε-(carbobenzyloxy)-L-lysine 3.4 (1.14 g, 3 mmol), 4-dimethyl-aminopyridine 
(DMAP, 225 mg, 1.83 mmol), and 1- ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC, 1.15 
g, 6 mmol) were added in dry CH2Cl2 (4 ml), and then dry MeOH (2 ml, 33 mmol) was injected 
by syringe under N2 protection. After the reaction mixture was stirred at room temperature for 20 
h, 20 ml CH2Cl2 was added. The mixture was washed with water and brine, dried with anhydrous 
Na2SO4 and concentrated under reduced pressure to give a yellow residue. The crude residue was 
purified by flash silica gel chromatography to produce the Nα-tBoc-Nε-(carbobenzyloxy)-L-
lysine-methyl ester as yellow oil.  
 
The Nα-tBoc-Nε-(carbobenzyloxy)-L-lysine-methyl ester from last step was dissolved in 10 ml of 
MeOH–CH2Cl2 (1:1) with the addition of palladium-activated carbon (0.157 g, 1.5 mmol).The 
mixture was stirred under high pressure hydrogen gas for 30 min, and filtered by vacuum 
filtration to remove the palladium-activated carbon catalyst. The solvent was removed under 
reduced pressure to get a residue, the residue was purified by flash silica gel chromatography to 
afford product 3.5 (0.663 g, 85%). 
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Procedure for the synthesis of methyl 2-(tert-butoxycarbonylamino)-6-(2-(4-
iodophenyl)acetamido)hexanoate(3.7) 
 
To a solution of 2-(4-iodophenyl)acetic acid 3.6 (1.44, 5.5 mmol)  and N -(1,1-
dimethylethoxycarbonyl)-L-lysine-methyl ester 3.5 (1.3, 5 mmol) were dissolved in 20 mL 
CH2Cl2 was added 4-dimethyl-aminopyridine (DMAP, 62 mg, 0.5 mmol), and 1- ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC, 1.15 g, 6 mmol). The reaction mixture was stirred 
under N2 protection for 12 h at room temperature, washed with water and brine, dried with 
anhydrous Na2SO4 and concentrated under reduced pressure to give the residue. , the residue was 
purified by flash silica gel chromatography to give product 3.7 (2.02 g, 80%).  
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UV absorption spectra: 
 
Absorption spectra were recorded on a Shimadzu UV-2500 spectrophotometer in 1 cm-length 
quartz cell with a resolution of 0.2 nm. All samples were measured from the 10-5 M solution of 
N-2-aryl-1,2,3-triazole in MeOH with the wavelength range between 200 nm and 800 nm. 
 
Fluorescence excitation and emission spectra: 
 
Fluorescence excitation and emission spectra were measured on a Hitachi 7000 fluorophotometer 
with a slit width of 2.5 nm. The photomultiplier voltage was 400 V and the scanning speed was 
240 nm/min.  The emission spectra were obtained from the 10-5 M solution of N-2-aryl-1,2,3-
triazole in MeOH with an excitation wavelength at 254 nm or 310 nm and the excitation spectra 
were recorded with the emission wavelength λmax which depended on different triazoles. 
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Quantum yield: 
  
Quantum yields were determined by using an integrated emission area and comparing that value 
to the area measured for the standard quinine sulfate dihydrate when excited at 365 nm (Φreference 
= 0.564) in water. Quantum yields were calculated by using the following equation, where Φ is 
the quantum yield, Int is the area of emission peak, A represents absorbance at the excitation 
wavelength and n is reflective index of the solvent. The subscript reference is the respective 
values of the standard quinine sulfate dihydrate. 
 
= !reference x
Int
Intreference
Areferencex x n2
x A x nreference2
!
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Compounds Characterization 
 
N
N
N
3.1e  
2,4-diphenyl-2H-1,2,3-triazole (3.1e) was purified by flash chromatography (Hexane- EtOAc, 
v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.15 (d, J = 7.8 Hz, 2H), 8.06 (m, 1H), 
7.91 (d, J = 6.6 Hz, 2H), 7.52-7.46 (m, 4H), 7.42-7.35 (m, 2H); 13C-NMR (150 MHz, CDCl3) δ 
148.9, 139.9, 132.5, 130.1, 129.3, 128.9, 128.8, 127.4, 126.1, 118.8; HRMS Calculated for 
C14H11N3 [M+H]+: 222.1032, Found:222.1025. 
 
 
N
N
N
3.2a
CN
 
4-(4-phenyl-2H-1,2,3-triazol-2-yl)benzonitrile (3.2a) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.28 (d, J = 9.0 Hz, 
2H), 8.12 (s, 1H), 7.90 (d, J = 7.2 Hz, 2H), 7.80 (d, J = 9.0 Hz, 2H), 7.50-7.48 (m, 2H), 7.45-
7.42 (m, 1H); 13C-NMR (150 MHz, CDCl3) δ 150.1, 142.4, 133.9, 133.5, 129.4, 129.3, 129.1, 
126.3, 119.0, 118.3, 110.7; HRMS Calculated for C15H10N4 [M+H]+: 247.0984, Found: 
247.0978. 
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N
N
N
3.2b
F
 
2-(4-fluorophenyl)-4-phenyl-2H-1,2,3-triazole (3.2b) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.13-8.11 (m, 2H), 
8.04 (s, 1H), 7.89 (d, J = 7.2 Hz, 2H), 7.48 (t, J = 7.8 Hz, 2H), 7.40 (t, J = 7.2 Hz, 1H), 7.19 (t, J 
= 8.4 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 162.6, 161.0, 149.0, 136.2, 132.6, 130.0, 129.0, 
128.9, 126.1, 120.6, 120.5, 116.2, 116.0; HRMS Calculated for C14H10FN3 [M+H]+: 240.0938, 
Found: 240.0931. 
 
N
N
N
3.2c
Cl
 
2-(4-chlorophenyl)-4-phenyl-2H-1,2,3-triazole (3.2c) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.09 (d, J = 9.0 Hz, 
2H), 8.05 (s, 1H), 7.89 (d, J = 7.8 Hz, 2H), 7.48 (t, J = 8.4 Hz, 4H), 7.41 (t, J = 7.2 Hz, 1H); 13C-
NMR (150 MHz, CDCl3) δ 149.2, 138.4, 133.0, 132.8, 129.8, 129.4, 129.0, 126.2, 120.0; HRMS 
Calculated for C14H10ClN3 [M+H]+: 256.0642, Found: 256.0636. 
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N
N
N
3.2d
OMe
 
2-(4-methoxyphenyl)-4-phenyl-2H-1,2,3-triazole (3.2d) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.05 (d, J = 9.0 Hz, 
2H), 8.02 (s, 1H), 7.89 (d, J = 6.6 Hz, 2H), 7.47 (t, J = 7.8 Hz, 2H), 7.40-7.37 (m, 1H), 7.01 (t, J 
= 9.0 Hz, 1H); 13C-NMR (150 MHz, CDCl3) δ 159.2, 148.7, 134.0, 132.3, 130.4, 129.1, 128.9, 
126.3, 120.5, 114.6, 55.8; HRMS Calculated for C15H13N3O [M+H]+: 252.1138, Found: 
252.1170. 
 
N
N
N
3.2e
NO2
 
2-(4-nitrophenyl)-4-phenyl-2H-1,2,3-triazole (3.2e) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as yellow solid. 1H-NMR (600 MHz, CDCl3) δ 8.38 (d, J = 9.0 Hz, 
2H), 8.32 (d, J = 9.0 Hz, 2H), 8.15 (s, 1H), 7.92-7.88 (m, 2H), 7.52-7.48 (m, 2H), 7.46-7.43 (m, 
1H); 13C-NMR (150 MHz, CDCl3) δ 150.4, 146.3, 143.7, 134.3, 129.5, 129.2, 129.1, 126.3, 
125.2, 118.8; HRMS Calculated for C14H11N4O2 [M+H]+: 267.0804, Found: 267.0836. 
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N
N
N
3.2f
Ph
O
 
phenyl(4-(4-phenyl-2H-1,2,3-triazol-2-yl)phenyl)methanone (3.2f) was purified by flash 
chromatography (Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.27 
(d, J = 9.0 Hz, 2H), 8.12 (s, 1H), 7.97 (d, J = 9.0 Hz, 2H), 7.93-7.91 (m, 2H), 7.84-7.82 (m, 2H), 
7.64-7.60 (m, 1H), 7.53-7.47 (m, 4H),  7.44-7.40 (m, 1H); 13C-NMR (150 MHz, CDCl3) δ 195.5, 
149.7, 142.4, 137.5, 136.1, 133.5, 132.5, 131.5, 129.9, 129.6, 129.1, 129.0, 128.4, 126.2, 118.3; 
HRMS Calculated for C21H16N3O [M+H]+: 326.1215, Found: 326.1220. 
 
N
N
N
N
3.2g  
4-(4-phenyl-2H-1,2,3-triazol-2-yl)pyridine (3.2g) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.72 (d, J = 6.0 Hz, 
2H), 8.13 (s, 1H), 8.05 (d, J = 6.0 Hz, 2H), 7.89 (d, J = 7.2 Hz, 2H), 7.49 (t, J = 7.8 Hz, 2H), 
7.43 (t, J = 7.8 Hz, 1H); 13C-NMR (150 MHz, CDCl3) δ 151.0, 150.2, 145.7, 134.2, 129.5, 129.2, 
129.1, 126.3, 112.6; HRMS Calculated for C13H11N4 [M+H]+: 223.0905, Found: 223.0930. 
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N
N
N
N
3.2h  
2-(4-phenyl-2H-1,2,3-triazol-2-yl)pyridine (3.2h) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.81 (s, 1H), 8.52 (d, J 
= 4.2 Hz, 1H), 8.25 (d, J = 8.4 Hz, 1H), 7.96-7.91 (m, 3H), 7.47 (t, J = 7.2 Hz, 2H), 7.39-7.34 
(m, 2H); 13C-NMR (150 MHz, CDCl3) δ 149.2, 148.5, 148.0, 139.1, 130.2, 128.9, 128.4, 125.9, 
123.5, 116.8, 113.8; HRMS Calculated for C13H11N4 [M+H]+: 223.0905, Found: 223.0930. 
 
N
N
N
3.2i  
2-(naphthalen-1-yl)-4-phenyl-2H-1,2,3-triazole (3.2i) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.29-8.26 (m, 1H), 
8.21 (s, 1H), 7.99-7.93 (m, 4H), 7.87 (d, J = 7.2 Hz, 1H), 7.61-7.56 (m, 3H), 7.49 (t, J = 7.2 Hz, 
2H), 7.41 (t, J = 7.2 Hz, 1H); 13C-NMR (150 MHz, CDCl3) δ 148.9, 136.9, 134.4, 132.5, 130.1, 
129.6, 129.0, 128.8, 128.2, 127.6, 127.4, 126.6, 126.2, 125.0, 123.6, 122.8; HRMS Calculated 
for C18H14N3 [M+H]+: 272.1109, Found: 272.1125. 
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N
N
N
3.3a
F
 
4-(4-fluorophenyl)-2-phenyl-2H-1,2,3-triazole (3.3a) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.13 (d, J = 7.8 Hz, 
2H), 8.01 (s, 1H), 7.88 (dd, J = 8.4 Hz, 5.4 Hz, 2H), 7.50 (t, J = 7.8 Hz, 2H), 7.37 (t, J = 7.2 Hz, 
1H), 7.16 (t, J = 9.0 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 164.1, 162.5, 148.2, 140.0, 132.5, 
129.5, 128.2, 128.1, 127.7, 126.5, 119.0, 116.3, 116.1; HRMS Calculated for C14H10FN3 
[M+H]+: 240.0938, Found: 240.0931. 
 
N
N
N
3.3b
F
CN
 
4-(4-(4-fluorophenyl)-2H-1,2,3-triazol-2-yl)benzonitrile (3.3b) was purified by flash 
chromatography (Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.26 
(d, J = 8.4 Hz, 2H), 8.07 (s, 1H), 7.88-7.86 (m, 2H), 7.79 (d, J = 8.4 Hz, 2H), 7.17 (t, J = 9.0 Hz, 
2H); 13C-NMR (150 MHz, CDCl3) δ 149.2, 142.4, 133.7, 133.5, 128.2, 128.1, 125.5, 119.0, 
118.3, 116.3, 116.1, 110.8, 29.7; HRMS Calculated for C15H9FN4 [M+H]+: 265.0890, Found: 
265.0884. 
 
410 
 
N
N
N
3.3c
F
F
 
2,4-bis(4-fluorophenyl)-2H-1,2,3-triazole (3.3c) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.10 (q, J = 4.8 Hz, 
2H), 7.99 (s, 1H), 7.86 (dd, J = 8.4 Hz, 5.4 Hz, 2H), 7.20-7.15 (m, 4H); 13C-NMR (150 MHz, 
CDCl3) δ 164.0, 162.7, 162.3, 161.0, 148.1, 136.2, 132.3, 128.0, 127.9, 126.2, 120.6, 120.5, 
116.2, 116.1, 116.0, 115.9; HRMS Calculated for C14H9F2N3 [M+H]+: 258.0843, Found: 
258.0837. 
 
N
N
N
3.3d
F
Cl
 
2-(4-chlorophenyl)-4-(4-fluorophenyl)-2H-1,2,3-triazole (3.3d) was purified by flash 
chromatography (Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.07 
(d, J = 8.4 Hz, 2H), 8.00 (s, 1H), 7.86 (dd, J = 5.4 Hz, 8.4 Hz, 2H), 7.47 (d, J = 9.0 Hz, 2H), 7.16 
(t, J = 8.4 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 164.0, 162.4, 148.3, 138.3, 133.1, 132.6, 
129.4, 128.0, 127.9, 126.0, 120.0, 116.1, 116.0; HRMS Calculated for C14H9ClFN3 [M+H]+: 
274.0548, Found: 274.0541. 
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N
N
N
3.3e
F
OMe
 
4-(4-fluorophenyl)-2-(4-methoxyphenyl)-2H-1,2,3-triazole (3.3e) was purified by flash 
chromatography (Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.03 
(d, J = 9.0 Hz, 2H), 7.96 (s, 1H), 7.86 (dd, J = 8.4 Hz, 5.4 Hz, 2H), 7.15 (t, J = 8.4 Hz, 2H), 7.10 
(d, J = 9.0 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 163.8, 162.2, 159.0, 147.6, 133.7, 131.8, 
127.9, 127.8, 126.4, 120.3, 116.0, 115.9, 114.4, 55.6; HRMS Calculated for C15H12FN3O 
[M+H]+: 270.1043, Found: 270.1037. 
 
N
N
N
3.3f
MeO
 
4-(4-methoxyphenyl)-2-phenyl-2H-1,2,3-triazole (3.3f) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.13 (d, J = 7.2 Hz, 
2H), 7.99 (s, 1H), 7.83 (d, J = 8.4 Hz, 2H), 7.50 (t, J = 7.8 Hz, 2H), 7.35 (t, J = 7.2 Hz, 1H), 6.50 
(d, J = 7.8 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 160.2, 148.7, 139.9, 132.1, 129.2, 127.5, 
127.2, 122.7, 118.7, 114.4, 55.4; HRMS Calculated for C15H13N3O [M+H]+: 252.1138, Found: 
252.1131. 
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N
N
N
3.3g
MeO
CN
 
4-(4-(4-methoxyphenyl)-2H-1,2,3-triazol-2-yl)benzonitrile (3.3g) was purified by flash 
chromatography (Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.24 
(d, J = 8.4 Hz, 2H), 8.04 (s, 1H), 7.82 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 9.0 Hz, 2H), 6.51 (d, J = 
9.0 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 160.6, 149.9, 142.4, 133.5, 133.4, 127.6, 121.9, 
118.9, 118.4, 114.5, 110.4, 55.4; HRMS Calculated for C16H12N4O [M+H]+: 277.1090, Found: 
277.1083. 
 
N
N
N
3.3h
MeO
F
 
2-(4-fluorophenyl)-4-(4-methoxyphenyl)-2H-1,2,3-triazole (3.3h) was purified by flash 
chromatography (Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.08 
(q, J = 4.8 Hz, 2H), 7.95 (s, 1H), 7.80 (d, J = 8.4 Hz, 2H), 7.16 (t, J = 8.4 Hz, 2H), 6.98 (d, J = 
8.4 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 136.3, 132.1, 127.4, 122.5, 120.4, 120.3, 116.1, 
116.0, 114.4, 55.3; HRMS Calculated for C15H12FN3O [M+H]+: 270.1043, Found: 270.1037. 
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N
N
N
3.3i
MeO
Cl
 
2-(4-chlorophenyl)-4-(4-methoxyphenyl)-2H-1,2,3-triazole (3.3i) was purified by flash 
chromatography (Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.07 
(d, J = 9.0 Hz, 2H), 7.97 (s, 1H), 7.81 (d, J = 8.4 Hz, 2H), 7.45 (d, J = 8.4 Hz, 2H), 6.99 (d, J = 
8.4 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 160.3, 149.0, 138.4, 132.8, 132.4, 129.3, 127.5, 
122.4, 119.8, 114.4, 55.3; HRMS Calculated for C15H13ClN3O [M+H]+: 286.0748, Found: 
286.0776. 
 
N
N
N
3.3j
MeO
OMe
 
2,4-bis(4-methoxyphenyl)-2H-1,2,3-triazole (3.3j) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.03 (d, J = 9.0 Hz, 
2H), 7.94 (s, 1H), 7.81 (d, J = 9.0 Hz, 2H), 7.00 (dd, J = 7.8 Hz, 1.8 Hz, 4H), 3.86 (d, J = 1.8 Hz, 
6H); 13C-NMR (150 MHz, CDCl3) δ 160.0, 158.8, 148.3, 133.8, 131.5, 127.4, 122.9, 120.2, 
114.3, 55.6, 55.3; HRMS Calculated for C16H15N3O2 [M+H]+: 282.1243, Found: 282.1237. 
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N
N
N
3.3k
Cl
 
4-(4-chlorophenyl)-2-phenyl-2H-1,2,3-triazole (3.3k) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.13 (d, J = 7.8 Hz, 
2H), 8.02 (s, 1H), 7.83 (d, J = 8.4 Hz, 2H), 7.50 (t, J = 7.8 Hz, 2H), 7.44 (d, J = 8.4 Hz, 2H), 
7.34 (t, J = 7.8 Hz, 1H); 13C-NMR (150 MHz, CDCl3) δ 148.0, 140.0, 134.9, 132.7, 129.5, 129.4, 
128.8, 127.8, 127.6, 119.0; HRMS Calculated for C14H10ClN3 [M+H]+: 256.0642, Found: 
256.0636. 
 
N
N
N
3.3l
Cl
CN
 
4-(4-(4-chlorophenyl)-2H-1,2,3-triazol-2-yl)benzonitrile (3.3l) was purified by flash 
chromatography (Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.27 
(d, J = 9.0 Hz, 2H), 8.10 (s, 1H), 7.84 (d, J = 8.4 Hz, 2H), 7.81 (d, J = 8.4 Hz, 2H), 7.47 (d, J = 
8.4 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 149.0, 142.3, 135.4, 133.8, 133.5, 129.3, 127.8, 
127.5, 119.1, 118.3, 111.0; HRMS Calculated for C15H9ClN4 [M+H]+: 281.0595, Found: 
281.0588. 
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N
N
N
3.3m
Cl
F
 
4-(4-chlorophenyl)-2-(4-fluorophenyl)-2H-1,2,3-triazole (3.3m) was purified by flash 
chromatography (Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.10 
(q, J = 4.8 Hz, 2H), 8.01 (s, 1H), 7.81 (d, J = 8.4 Hz, 2H), 7.44 (d, J = 8.0 Hz, 2H), 7.19 (t, J = 
8.4 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 162.7, 161.0, 147.9, 136.1, 134.7, 132.5, 129.2, 
128.4, 127.3, 120.6, 120.5, 116.2, 116.1; HRMS Calculated for C14H9ClFN3 [M+H]+: 274.0548, 
Found: 274.0541. 
 
N
N
N
3.3n
Cl
Cl
 
2,4-bis(4-chlorophenyl)-2H-1,2,3-triazole (3.3n) was purified by flash chromatography 
(Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.07 (d, J = 8.4 Hz, 
2H), 8.02 (s, 1H), 7.82 (d, J = 8.4 Hz, 2H), 7.45 (dd, J = 14.4 Hz, 9.0 Hz, 4H); 13C-NMR (150 
MHz, CDCl3) δ 148.1, 138.3, 134.9, 133.2, 132.7, 129.4, 129.2, 128.3, 127.4, 120.0; HRMS 
Calculated for C14H9Cl2N3 [M+H]+: 290.0252, Found: 290.0246. 
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N
N
N
3.3o
Cl
OMe
 
4-(4-chlorophenyl)-2-(4-methoxyphenyl)-2H-1,2,3-triazole (3.3o) was purified by flash 
chromatography (Hexane- EtOAc, v/v 10/1) as white solid. 1H-NMR (600 MHz, CDCl3) δ 8.03 
(d, J = 9.0 Hz, 2H), 7.99 (s, 1H), 7.82 (d, J = 7.8 Hz, 2H), 7.43 (d, J = 7.8 Hz, 2H), 7.01 (d, J = 
8.4 Hz, 2H); 13C-NMR (150 MHz, CDCl3) δ 159.1, 147.4, 134.5, 133.6, 132.0, 129.1, 128.7, 
127.3, 120.3, 114.4, 55.6; HRMS Calculated for C15H12ClN3O [M+H]+: 286.0748, Found: 
286.0741. 
 
NH
NH2
O
O
O
O
3.5  
Nα-(1,1-dimethylethoxycarbonyl)-L-lysine-methyl ester (3.5). 1H NMR (600 MHz, CDCl3): δ  
5.18 (br, 1H), 4.23 (br, 1H), 3.68 (s, 3H), 1.81-1.70 (m, 1H), 1.62-1.56 (m, 1H), 1.49-1.40 (m, 
1H), 1.38 (s, 9H), 1.37–1.30 (m, 3H). 13C NMR (150 MHz, CDCl3): δ 173.5, 155.6, 79.9, 53.5, 
52.4, 41.7, 32.6, 28.5, 22.8. HRMS Calculated for C12H25N2O4 [M+H]+: 261.1736, Found: 
261.1773. 
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O
O
O
N
H
INH
O
O
3.7  
Methyl 2-(tert-butoxycarbonylamino)-6-(2-(4-iodophenyl)acetamido)hexanoate (3.7). 1H 
NMR (600 MHz, CDCl3): δ  7.58 (d, J = 8.4 Hz, 2H), 6.95 (d, J = 8.4 Hz, 2H), 5.98 (s, 1H), 5.16 
(br, 1H), 4.18 (br, 1H), 3.66 (s, 3H), 3.39 (s, 2H), 3.15-3.10 (m, 2H), 1.72-1.69 (m, 1H), 1.59-
1.54 (m, 1H), 1.43-1.40 (m, 2H), 1.38 (s, 9H), 1.30–1.23 (m, 2H). 13C NMR (150 MHz, CDCl3): 
δ 173.0, 170.2, 155.4, 137.6, 134.7, 131.1, 92.4, 79.7, 53.0, 52.1, 42.8, 39.1, 32.0, 28.7, 28.2, 
22.4. HRMS Calculated for C20H30IN2O5 [M+H]+: 505.1121, Found: 505.1153. 
 
 
 
O O
O
NH
N
N NH
NO
O
3.4b  
Methyl 2-(tert-butoxycarbonylamino)-6-(2-(4-(4-phenyl-2H-1,2,3-triazol-2-
yl)phenyl)acetamido)hexanoate (3.4b) was prepared from 4-phenyl-2H-1,2,3-triazole and iodo-
substituted benzene by using the previously reported procedure of arylation. 1H NMR (600 MHz, 
418 
 
CDCl3): δ  8.13 (d, J = 8.4 Hz, 2H), 8.05 (s, 1H), 7.90 (d, J = 8.4 Hz, 2H), 7.49-7.45 (m, 2H), 
7.41-7.38 (m, 3H),  5.55 (br, 1H), 5.06 (br, 1H), 4.26 (br, 1H), 3.72 (s, 3H), 3.62 (s, 2H), 3.25-
3.20 (m, 2H), 1.84-1.72 (m, 2H), 1.65-1.58 (m, 1H), 1.51-1.45 (m, 2H), 1.43 (s, 9H), 1.36–1.28 
(m, 3H). 13C NMR (150 MHz, CDCl3): δ 187.1, 173.1, 170.5, 149.0, 139.1, 134.2, 132.7, 130.3, 
129.9, 129.0, 128.9, 126.1, 119.3, 79.9, 53.1, 52.3, 43.3, 39.3, 32.4, 28.9, 28.3, 22.5. HRMS 
Calculated for C28H36N5O5 [M+H]+: 522.2638, Found: 522.2680. 
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ORTEP Drawing of the Crystal Structure 
 
 
Figure S3-1. Perspective view of the molecular structure of 3.2h (C13H10N4) with the atom 
labeling scheme. The thermal ellipsoids are scaled to enclose 30% probability. 
CCDC number: 775283. 
 
Reported crystal structures 
 
Compound # CCDC 
3.1b 702800 
3.1c 702801 
3.2g 702802 
3.4a 702803 
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The Data of Fluorophores with Emission Spectra 
 
Sample preparation: To a 20 ml white cap vial was added the N-2-aryl-1,2,3-triazoles (0.01 
mmol) in 10 ml MeOH.  The solution was shook several times. After triazoles was absolutely 
dissolved, the 100 µl triazole solution has been transferred to another new 20 ml white cap vial 
by using Socorex wheaton single-channel pipetter (50-200 µl), and was then diluted with 
additional 9.9 ml MeOH. 
 
Integrated emission area: All the areas were integrated from the original spectra by FL 
Solution 2.0 software at the wavelength range which was 260 nm to 500 nm with an excitation 
wavelength at 254 nm or 320 nm to 500 nm with an excitation wavelength at 310 nm. 
 
Quantum yield determination: All the quantum yields of samples were determined based on 
1.0 x 10-5 mol/L Quinine sulfate dihydrate in H2O (Φ = 0.564). 
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Figure S3-2. Photoemission of N-2-aryl-1,2,3-triazole: sample preparation: 1.0 x 10-5 mol/L in 
MeOH, excitation at 254 nm with 5 nm slit, quantum yield of 3.1a Φ = 0.154,  
quantum yield of 3.1a' Φ = 0.009. 
 
 
 
	  	   Absorption(nm)	   Excitation (λmax)	  
Emission 
(λmax)	  
Stoke 
Shift(nm)	   Φ  
Fluorescence 
Intensity	  
3.1a	   222 (0.127), 305 (0.222) 305	   362	   57	   0.15	   19576.0	  
3.1a'	   222(0.108), 292(0.116) n.d.	   343	   n.d.	   0.01	   1444.8	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Figure S3-3. Photoemission of N-2-aryl-1,2,3-triazole: sample information: 1.0 x 10-5 mol/L in 
MeOH, excitation at 310 nm with 2.5 nm slit. 
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   Absorption(nm)	   Excitation (λmax)	  
Emission 
(λmax)	  
Stoke 
Shift(nm)	   Φ  
Fluorescence 
Intensity	  
3.1a	   222 (0.127), 305 (0.222) 305	   362 57	   0.15  19576.0	  
3.1b	   206 (0.128), 263 (0.250) n.d.	   316 n.d.	   0.02  4662.9	  
3.1c	   227 (0.257), 292 (0.268) n.d.	   380, 400 n.d.	   0.06  10822.5	  
3.1d	   220 (0.146), 296 (0.276) n.d.	   348 n.d.	   0.09  23036.8	  
3.1e	   220 (0.118), 294 (0.263) 298	   347 49	   0.35  48541.7	  
3.1f	   220 (0.111), 290 (0.253) 284	   342 58	   0.45  56612.5	  
3.1g	   221 (0.128), 285 (0.265) 285	   342 57	   0.30  52417.0	  
STD-
1*	  
207 (0.452), 234 (0.228), 
349 (0.710) 
361	   402, 422 41, 61	   0.23  63090.6	  
STD-
2	   234 (0.423), 334 (0.068) 
n.d.	   365 n.d.	   0.56  42012.4	  
 
* STD-1 = Disodium 4,4'-bis(2-sulfostyryl)biphenyl (DSBP). STD-2 = Quinine sulfate 
dihydrate. 
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Figure S3-4. Photoemission of N-2-aryl-1,2,3-triazole: sample information: 1.0 x 10-5 mol/L in 
MeOH, excitation at 310 nm with 2.5 nm slit. 
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425 
 
 
	  	   Absorption(nm)	   Excitation (λmax)	  
Emission 
(λmax)	  
Stoke 
Shift(nm)	   Φ  
Fluorescence 
Intensity	  
3.1e	   220(0.118), 294(0.263) 298 347 49 0.35 46309.1  
3.2a	   224 (0.154), 309 (0.397) 312 350 38 0.31 137679.5  
3.2b	   240 (0.056), 294 (0.212) 298 343 45 0.34 34963.0  
3.2c	   298 (0.274) 292 344 52 0.35 72108.9  
3.2d	   245 (0.041), 298 (0.226) 304 374 70 0.31 61629.7  
3.2e	   225 (0.181), 336 (0.205) n.d. 342 n.d. 0.003 443.5  
3.2f	   228 (0.135), 250 (0.14), 
317 (0.365) 
n.d. 343 n.d. 0.001 269.2  
3.2g	   220.5 (0.133), 300 (0.242) 302 341 39 0.28 52195.1  
3.2h	   238 (0.156), 276 (0.093) 301 341 40 0.15 1684.2  
3.2i	   222 (0.482), 260 (0.115),  
296 (0.127) 
289 375 86 0.27 29619.9  
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Figure S3-5-1. Photoemission of N-2-aryl-1,2,3-triazole: sample information: 1.0 x 10-5 mol/L 
in MeOH, excitation at 310 nm with 2.5 nm slit. 
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   Absorption(nm)	   Excitation (λmax)	  
Emission 
(λmax)	  
Stoke 
Shift(nm)	   Φ  
Fluorescence 
Intensity	  
3.1e	   220(0.118), 294(0.263) 298 347 49 0.344 46309.1	  
3.2a	   224 (0.154), 309 (0.397) 312 350 38 0.311 137679.5 
3.2b	   240 (0.056), 294 (0.212) 298 343 45 0.335 34963.0 
3.2c	   298 (0.274) 292 344 52 0.346 72108.9	  
3.2d	   245 (0.041), 298 (0.226) 304 374 70 0.311 61629.7 
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Figure S3-5-2. Photoemission of N-2-aryl-1,2,3-triazole: sample information: 1.0 x 10-5 mol/L 
in MeOH, excitation at 310 nm with 2.5 nm slit. 
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3.3e: R1 = F, R2 = OMe  
 
 
 
 
 
 
 
	   Absorption(nm)	   Excitation (λmax)	  
Emission 
(λmax)	  
Stoke 
Shift(nm)	   Φ  
Fluorescence 
Intensity	  
3.3a	   279 (0.147), 295 (0.152) 278 343 65 0.393 35187.2 
3.3b	   310 (0.173) 305 351 46 0.511 99110.2 
3.3c	   279 (0.203), 295 (0.202) 277 343 66 0.398 45465.3 
3.3d	   281 (0.328), 299 (0.399) 279 343 64 0.254 79606.4 
3.3e	   300 (0.319) 280 373 93 0.325 96251.2 
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Figure S3-5-3. Photoemission of N-2-aryl-1,2,3-triazole: sample information: 1.0 x 10-5 mol/L 
in MeOH, excitation at 310 nm with 2.5 nm slit. 
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3.3i: R1 = OMe, R2 = Cl
3.3j: R1 = OMe, R2 = OMe  
 
 
 
 
 
 
 
	   Absorption(nm)	  
Excitation 
(λmax)	  
Emission 
(λmax)	  
Stoke 
Shift(nm)	  
Φ  Fluorescence 
Intensity	  
3.3f	   245 (0.067), 287 (0.213), 
305 (0.198) 
284 360 76 0.388 82234.7 
3.3g	   250 (0.162), 322 (0.388) 318 401 83 0.317 111193.8 
3.3h	   245 (0.086), 287 (0.241), 
305 (0.221) 
283 360 77 0.337 78555.8 
3.3i	   245 (0.096), 289 (0.208), 
309 (0.236) 
287 364 77 0.341 89760.8 
3.3j	   255 (0.105), 289 (0.292), 
308 (0.299) 
284 369 85 0.344 114055.5 
 
429 
 
Figure S3-5-4. Photoemission of N-2-aryl-1,2,3-triazole: sample information: 1.0 x 10-5 mol/L 
in MeOH, excitation at 310 nm with 2.5 nm slit. 
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3.3o: R1 = Cl, R2 = OMe  
 
 
 
 
 
 
	   Absorption(nm)	   Excitation (λmax)	  
Emission 
(λmax)	  
Stoke 
Shift(nm)	   Φ  
Fluorescence 
Intensity	  
3.3k	   284 (0.539), 298 (0.532) 280 341 61 0.345 133654.1 
3.3l	   211 (0.086), 245 (0.075), 
311 (0.350) 
306 352 46 0.446 173975.0 
3.3m	   283 (0.275) 281 343 62 0.406 77275.4 
3.3n	   245 (0.059), 301 (0.298) 283 345 62 0.361 99041.4 
3.3o	   303 (0.281) 285 376 91 0.349 100999.4 
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Figure S3-6. Comparison of photoluminescent spectra of 3.1e and 3.4b  
 
Sample preparation: 1.0 x 10-5 mol/L in MeOH, excitation at 310 nm, quantum yields of 1e Φ 
= 0.344, and 4b Φ = 0.346. 
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Solvent Screening Data 
 
N
N
N R
 
 
R Solvent Excitation (λmax) 
Emission 
(λmax) 
Stoke 
Shift Α310 
Fluorescence 
Intensity n 
Φ  
CN MeOH 312 350 38 0.395 137679.5 1.3314  0.311  
H MeOH 298 347 49 0.12 46309.1 1.3314  0.344  
F MeOH 298 343 45 0.093 34963.0 1.3314  0.335  
OMe MeOH 304 374 70 0.177 61629.7 1.3314  0.311  
CN DCM 313 351 38 0.276 101203.8 1.4242  0.374  
H DCM 298 345 47 0.118 41036.9 1.4242  0.355  
F DCM 298 345 47 0.089 29776.1 1.4242  0.342  
OMe DCM 305 367 62 0.182 53109.8 1.4242  0.298  
CN MeCN 311 350 39 0.281 103597.2 1.3460  0.336  
H MeCN 297 346 49 0.112 40844.0 1.3460  0.333  
F MeCN 296 346 50 0.076 28906.5 1.3460  0.347  
OMe MeCN 304 369 65 0.158 51515.4 1.3460  0.297  
CN DCE 314 352 38 0.363 96899.2 1.4448  0.281  
H DCE 298 346 48 0.157 38441.3 1.4448  0.257  
F DCE 299 346 47 0.124 27725.3 1.4448  0.235  
OMe DCE 308 368 60 0.211 51679.6 1.4448  0.257  
CN EtOAc 312 348 36 0.306 118760.7 1.3720  0.368  
H EtOAc 297 344 47 0.097 43464.0 1.3720  0.425  
F EtOAc 297 343 46 0.081 39862.7 1.3720  0.466  
OMe EtOAc 305 365 60 0.214 66321.1 1.3720  0.294  
CN THF 313 349 36 0.27 93017.5 1.4070  0.343  
H THF 300 344 44 0.134 51646.0 1.4070  0.384  
F THF 302 343 41 0.154 54748.2 1.4070  0.354  
OMe THF 306 364 58 0.219 69518.7 1.4070  0.316  
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Figure S3-7-1. Photoluminescent spectra of 2a in different solvents 
 
Figure S3-7-2. Photoluminescent spectra of 1e in different solvents 
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Figure S3-7-3. Photoluminescent spectra of 2b in different solvents 
 
Figure S3-7-4. Photoluminescent spectra of 2d in different solvents 
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Calculated HUMO-LUMO energy gaps 
 
Figure S3-8. HOMO and LUMO orbitals of compounds 3.2d, 3.3g and N-1-3.1e’ 
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Calculated HOMO and LUMO energy gaps of 3.1e to 3.3o 
  excitation (λmax) 
emission 
(λmax) 
Φ  Fluorescence Intensity (x 103) 
Stoke shift 
(nm) Eg (eV) 
LUMO-
HOMO (eV) 
3.1e 298 347 0.34 46.3 49 4.16 3.95 
3.2a 312 350 0.31 138 38 3.97 3.6 
3.2b 298 343 0.34 35 45 4.16 4.06 
3.2c 292 344 0.35 72.1 52 4.25 4.06 
3.2d 304 374 0.31 61.6 70 4.08 3.94 
3.3a 278 343 0.39 35.2 65 4.46 4.29 
3.3b 305 351 0.51 99.1 46 4.07 3.94 
3.3c 277 343 0.4 45.5 66 4.48 4.78 
3.3d 279 343 0.25 79.6 64 4.44 4.77 
3.3e 280 373 0.33 96.3 93 4.43 4.21 
3.3f 284 360 0.39 82.2 76 4.37 4.34 
3.3g 318 401 0.32 111 83 3.9 3.73 
3.3h 283 360 0.34 78.6 77 4.38 4.51 
3.3i 287 364 0.34 89.8 77 4.32 4.51 
3.3j 284 369 0.34 114 85 4.37 3.72 
3.3k 280 341 0.35 134 61 4.43 4.27 
3.3l 306 352 0.45 174 46 4.05 3.9 
3.3m 281 343 0.41 77.3 62 4.41 4.04 
3.3n 283 345 0.36 99 62 4.38 4.03 
3.3o 285 376 0.35 101 91 4.35 4.16 
	   	   	   	   	   	   	   	  
	  
1.2. NMR Spectra Data 
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